annotator	var_ann	blacklist_comparison	PoN_comparison	PoN_comparison	bulk_comparison	bulk_comparison	Original Input	Original Input	Original Input	Original Input	Tapestri_result	Variant Annotation	Variant Annotation	Variant Annotation	Variant Annotation	Variant Annotation	Variant Annotation	Variant Annotation	Variant Annotation	Variant Annotation	1000 Genomes	1000 Genomes	1000 Genomes	1000 Genomes	1000 Genomes	1000 Genomes	CHASMplus	CHASMplus PAAD	CIViC	CIViC	CIViC	CIViC	COSMIC	COSMIC	COSMIC	COSMIC	COSMIC	COSMIC	ClinVar	ClinVar	ClinVar	ClinVar	ClinVar	ClinVar	Gene Ontology	Gene Ontology	Gene Ontology	Gene Ontology	Gene Ontology	Gene Ontology	NDEx NCI Cancer Pathways	NDEx NCI Cancer Pathways	NDEx NCI Cancer Pathways	dbSNP	dbSNP Common	gnomAD3	gnomAD3	gnomAD3	gnomAD3	gnomAD3	gnomAD3	gnomAD3	gnomAD3	gnomAD3
info	Gene_HGVSp	blacklist-base_qual-sc_prev	PoN-superset-normals-occurence	PoN-superset-normals-median_sc_prev	bulk-broad_wes_pon-AF	bulk-matched_bulk_normal-AF	Chrom	Pos	Reference allele	Alternate allele	sc_mut_prev	Variant Note	Coding	Gene	Transcript	Sequence Ontology	Exon Number	cDNA change	Protein Change	End Position	AF	AFR AF	AMR AF	EAS AF	EUR AF	SAS AF	P-value	P-value	Diseases	ID	Variant Evidence Score	Description	ID	Variant Count (Tissue)	Variant Count	Transcript	Protein Change	Match	Clinical Significance	Disease Ref Nums	Disease Names	Review Status	ClinVar ID	Significance Detail	Biological Process	Biological Process GO ID	Cellular Component	Cellular Component GO ID	Molecular Function	Molecular Function GO ID	Number of Networks	Network ID	Network Name	rsID	rsID	Global AF	African AF	Ashkenazi Jewish AF	East Asian AF	Finnish AF	Latino AF	Non-Fin Eur AF	Other AF	South Asian AF
condensed_format																																																																
chr15:89858602:T/C	FANCI p.Gly1302=		5.0	0.8696571569483613	True		chr15	89858602	T	C	329		Yes	FANCI	ENST00000310775.11	synonymous_variant	37.0	c.3906T>C	p.Gly1302=	89315371	0.4123402555910543	0.4667170953101361	0.393371757925072	0.4255952380952381	0.3996023856858847	0.3517382413087934							COSV51519356	"[[""soft tissue"", 14], [""large intestine"", 1], [""breast"", 1]]"	16.0	ENST00000300027.12	G1302%3D	Exact Match	Benign/Likely benign	MONDO:MONDO:0012186,MedGen:C1836861,OMIM:609053,Orphanet:84|MedGen:C4763519|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0019391,MeSH:D005199,MedGen:C0015625,OMIM:PS227650,Orphanet:84	Fanconi anemia complementation group I|POLG-Related Spectrum Disorders|not specified|not provided|Fanconi anemia	criteria provided, multiple submitters, no conflicts	257489.0		positive regulation of protein ubiquitination;interstrand cross-link repair	GO:0031398;GO:0036297	chromatin;nucleoplasm;cytoplasm;cytosol;membrane;DNA repair complex	GO:0000785;GO:0005654;GO:0005737;GO:0005829;GO:0016020;GO:1990391	DNA binding;protein binding;DNA polymerase binding	GO:0003677;GO:0005515;GO:0070182	1.0	c45e106a-5521-11e7-8f50-0ac135e8bacf	Fanconi anemia pathway	rs1138465	rs1138465	0.418091	0.44394	0.377188	0.442197	0.510015	0.3721	0.398881	0.40381	0.399867
chr1:16474839:AC/A	EPHA2 intron_variant		6.0	0.7566137566137566			chr1	16474839	AC	A	328			EPHA2	ENST00000358432.8	intron_variant		c.823+33del		16148345	0.347444089456869	0.4674735249621785	0.4510086455331412	0.0714285714285714	0.4025844930417495	0.3394683026584867													Benign	MedGen:C3661900	not provided	criteria provided, single submitter	1177896.0		skeletal system development;vasculogenesis;osteoblast differentiation;blood vessel endothelial cell proliferation involved in sprouting angiogenesis;inflammatory response;cell adhesion;cell surface receptor protein tyrosine kinase signaling pathway;multicellular organism development;intrinsic apoptotic signaling pathway in response to DNA damage;regulation of lamellipodium assembly;notochord formation;cell migration;negative regulation of angiogenesis;neural tube development;neuron differentiation;keratinocyte differentiation;osteoclast differentiation;positive regulation of cell migration;negative regulation of chemokine production;mammary gland epithelial cell proliferation;regulation of cell adhesion mediated by integrin;positive regulation of kinase activity;post-anal tail morphogenesis;regulation of blood vessel endothelial cell migration;regulation of angiogenesis;cAMP metabolic process;symbiont entry into host cell;bone remodeling;ephrin receptor signaling pathway;axial mesoderm formation;cell motility;defense response to Gram-positive bacterium;notochord cell development;cell chemotaxis;branching involved in mammary gland duct morphogenesis;lens fiber cell morphogenesis;regulation of ERK1 and ERK2 cascade;response to growth factor;protein localization to plasma membrane;activation of GTPase activity;negative regulation of lymphangiogenesis;positive regulation of protein localization to plasma membrane;positive regulation of bicellular tight junction assembly;pericyte cell differentiation	GO:0001501;GO:0001570;GO:0001649;GO:0002043;GO:0006954;GO:0007155;GO:0007169;GO:0007275;GO:0008630;GO:0010591;GO:0014028;GO:0016477;GO:0016525;GO:0021915;GO:0030182;GO:0030216;GO:0030316;GO:0030335;GO:0032682;GO:0033598;GO:0033628;GO:0033674;GO:0036342;GO:0043535;GO:0045765;GO:0046058;GO:0046718;GO:0046849;GO:0048013;GO:0048320;GO:0048870;GO:0050830;GO:0060035;GO:0060326;GO:0060444;GO:0070309;GO:0070372;GO:0070848;GO:0072659;GO:0090630;GO:1901491;GO:1903078;GO:1903348;GO:1904238	plasma membrane;focal adhesion;cell surface;lamellipodium;leading edge membrane;lamellipodium membrane;ruffle membrane;receptor complex;tight junction	GO:0005886;GO:0005925;GO:0009986;GO:0030027;GO:0031256;GO:0031258;GO:0032587;GO:0043235;GO:0070160	virus receptor activity;transmembrane receptor protein tyrosine kinase activity;ephrin receptor activity;protein binding;ATP binding;growth factor binding;cadherin binding;molecular function activator activity	GO:0001618;GO:0004714;GO:0005003;GO:0005515;GO:0005524;GO:0019838;GO:0045296;GO:0140677	5.0	49ac7526-5521-11e7-8f50-0ac135e8bacf,d0573ffe-5521-11e7-8f50-0ac135e8bacf,d269a540-5521-11e7-8f50-0ac135e8bacf,dce0a1a4-5521-11e7-8f50-0ac135e8bacf,fb75759a-5521-11e7-8f50-0ac135e8bacf	Stabilization and expansion of the E-cadherin adherens junction,EPHA2 forward signaling,EPHA forward signaling,Direct p53 effectors,Arf6 signaling events	rs35127370	rs35127370	0.408188	0.490836	0.486755	0.0685458	0.305412	0.409911	0.385486	0.39851	0.378449
chr17:44144993:C/G	KANSL1 p.Pro525Arg		8.0	0.9370400654129192	True		chr17	44144993	C	G	327		Yes	KANSL1	ENST00000262419.10	missense_variant	5.0	c.1574C>G	p.Pro525Arg	46067627							0.0433	0.46											Benign/Likely benign	MedGen:CN169374|MONDO:MONDO:0012496,MedGen:C1864871,OMIM:610443,Orphanet:96169	not specified|Koolen-de Vries syndrome	criteria provided, multiple submitters, no conflicts	377991.0		chromatin organization;positive regulation of DNA-templated transcription;regulation of mitochondrial transcription	GO:0006325;GO:0045893;GO:1903108	histone acetyltransferase complex;kinetochore;nucleus;nucleoplasm;mitochondrion;NSL complex;MLL1 complex	GO:0000123;GO:0000776;GO:0005634;GO:0005654;GO:0005739;GO:0044545;GO:0071339	protein binding;histone acetyltransferase binding	GO:0005515;GO:0035035				rs144838667		0.00105444	0.00328478	0.0	0.0	0.0	0.00073346	1.54875e-05	0.000929368	0.0
chr7:2962753:G/A	CARD11 intron_variant		8.0	0.8912510220768601	True		chr7	2962753	G	A	327			CARD11	ENST00000396946.8	intron_variant		c.2142+13C>T		2923119	0.5053913738019169	0.3048411497730711	0.5994236311239193	0.3849206349206349	0.7733598409542743	0.558282208588957							COSV62755629	"[[""haematopoietic and lymphoid tissue"", 1], [""lung"", 1]]"	2.0	ENST00000396946.8	?	Exact Match	Benign	MONDO:MONDO:0014645,MedGen:C4551967,OMIM:616452,Orphanet:464336|MONDO:MONDO:0014081,MedGen:C3554686,OMIM:615206,Orphanet:357237|MedGen:C3661900|MONDO:MONDO:0054697,MedGen:C4539957,OMIM:617638|MedGen:CN169374	BENTA disease|Severe combined immunodeficiency due to CARD11 deficiency|not provided|Immunodeficiency 11b with atopic dermatitis|not specified	criteria provided, multiple submitters, no conflicts	402479.0		canonical NF-kappaB signal transduction;B cell differentiation;positive regulation of B cell proliferation;T cell costimulation;positive regulation of interleukin-2 production;CD4-positive, alpha-beta T cell proliferation;TORC1 signaling;B cell proliferation;regulation of apoptotic process;positive regulation of canonical NF-kappaB signal transduction;thymic T cell selection;regulation of B cell differentiation;regulation of T cell differentiation;GMP metabolic process;GDP metabolic process;homeostasis of number of cells;positive regulation of T cell receptor signaling pathway;positive regulation of NF-kappaB transcription factor activity;protein homooligomerization;positive regulation of CD4-positive, alpha-beta T cell proliferation	GO:0007249;GO:0030183;GO:0030890;GO:0031295;GO:0032743;GO:0035739;GO:0038202;GO:0042100;GO:0042981;GO:0043123;GO:0045061;GO:0045577;GO:0045580;GO:0046037;GO:0046710;GO:0048872;GO:0050862;GO:0051092;GO:0051260;GO:2000563	immunological synapse;cytoplasm;cytosol;plasma membrane;CBM complex;membrane raft;extracellular exosome	GO:0001772;GO:0005737;GO:0005829;GO:0005886;GO:0032449;GO:0045121;GO:0070062	guanylate kinase activity;protein binding;CARD domain binding	GO:0004385;GO:0005515;GO:0050700	3.0	412efed6-5521-11e7-8f50-0ac135e8bacf,4362cec8-5521-11e7-8f50-0ac135e8bacf,f47e9f46-5521-11e7-8f50-0ac135e8bacf	TCR signaling in naive CD8 T cells,TCR signaling in naive CD4 T cells,BCR signaling pathway	rs2527509	rs2527509	0.627865	0.359411	0.725331	0.371557	0.819893	0.659947	0.771104	0.614312	0.604071
chr6:80751780:G/A	TTK intron_variant		8.0	0.7907074973600845			chr6	80751780	G	A	326			TTK	ENST00000369798.7	intron_variant		c.2491-56G>A		80042063	0.5159744408945687	0.3502269288956127	0.6815561959654178	0.626984126984127	0.5069582504970179	0.5173824130879345							COSV57885789	"[[""haematopoietic and lymphoid tissue"", 1], [""lung"", 1]]"	2.0	ENST00000509894.5	?	Exact Match							spindle organization;mitotic spindle organization;chromosome segregation;mitotic spindle assembly checkpoint signaling;positive regulation of cell population proliferation;female meiosis chromosome segregation;peptidyl-serine phosphorylation;meiotic spindle assembly checkpoint signaling;protein localization to kinetochore;protein localization to meiotic spindle midzone	GO:0007051;GO:0007052;GO:0007059;GO:0007094;GO:0008284;GO:0016321;GO:0018105;GO:0033316;GO:0034501;GO:1903096	kinetochore;nucleus;cytoplasm;spindle;membrane	GO:0000776;GO:0005634;GO:0005737;GO:0005819;GO:0016020	protein serine/threonine kinase activity;protein serine/threonine/tyrosine kinase activity;protein tyrosine kinase activity;protein binding;ATP binding;identical protein binding;kinetochore binding;protein serine kinase activity	GO:0004674;GO:0004712;GO:0004713;GO:0005515;GO:0005524;GO:0042802;GO:0043515;GO:0106310				rs652752	rs652752	0.480817	0.365954	0.610006	0.637444	0.452589	0.635103	0.510267	0.53125	0.512812
chr4:96035796:G/GAC	BMPR1B intron_variant		8.0	0.5744520030234316			chr4	96035796	G	GAC	326			BMPR1B	ENST00000515059.6	intron_variant		c.144-52_144-51dup		95114647																			Benign	MedGen:C3661900	not provided	criteria provided, single submitter	1290691.0		cartilage condensation;ovarian cumulus expansion;osteoblast differentiation;eye development;chondrocyte development;protein phosphorylation;inflammatory response;dorsal/ventral pattern formation;positive regulation of gene expression;central nervous system neuron differentiation;proteoglycan biosynthetic process;positive regulation of bone mineralization;BMP signaling pathway;retinal ganglion cell axon guidance;positive regulation of chondrocyte differentiation;ovulation cycle;positive regulation of osteoblast differentiation;positive regulation of transcription by RNA polymerase II;retina development in camera-type eye;endochondral bone morphogenesis;positive regulation of cartilage development;cellular response to growth factor stimulus;cellular response to BMP stimulus;positive regulation of extrinsic apoptotic signaling pathway via death domain receptors;negative regulation of chondrocyte proliferation	GO:0001502;GO:0001550;GO:0001649;GO:0001654;GO:0002063;GO:0006468;GO:0006954;GO:0009953;GO:0010628;GO:0021953;GO:0030166;GO:0030501;GO:0030509;GO:0031290;GO:0032332;GO:0042698;GO:0045669;GO:0045944;GO:0060041;GO:0060350;GO:0061036;GO:0071363;GO:0071773;GO:1902043;GO:1902731	plasma membrane;dendrite;neuronal cell body;receptor complex;HFE-transferrin receptor complex	GO:0005886;GO:0030425;GO:0043025;GO:0043235;GO:1990712	protein serine/threonine kinase activity;transmembrane receptor protein serine/threonine kinase activity;transmembrane signaling receptor activity;transforming growth factor beta receptor activity, type I;protein binding;ATP binding;BMP binding;SMAD binding;metal ion binding;BMP receptor activity	GO:0004674;GO:0004675;GO:0004888;GO:0005025;GO:0005515;GO:0005524;GO:0036122;GO:0046332;GO:0046872;GO:0098821	1.0	f1ae1a1c-5521-11e7-8f50-0ac135e8bacf	BMP receptor signaling			0.477196	0.31081	0.650182	0.445525	0.570324	0.595921	0.538806	0.491897	0.455442
chr12:25368462:C/T	KRAS p.Arg161=		8.0	0.9492051182628926	True		chr12	25368462	C	T	326		Yes	KRAS	ENST00000256078.9	synonymous_variant	5.0	c.483G>A	p.Arg161=	25215528	0.9976038338658147	0.9924357034795764	0.9971181556195964	1.0	1.0	1.0																			MAPK cascade;positive regulation of protein phosphorylation;Ras protein signal transduction;visual learning;gene expression;positive regulation of gene expression;glial cell proliferation;Rac protein signal transduction;forebrain astrocyte development;actin cytoskeleton organization;negative regulation of epithelial cell differentiation;regulation of synaptic transmission, GABAergic;positive regulation of Rac protein signal transduction;skeletal muscle cell differentiation;negative regulation of neuron apoptotic process;regulation of long-term neuronal synaptic plasticity;homeostasis of number of cells within a tissue;striated muscle cell differentiation;neuron apoptotic process;positive regulation of glial cell proliferation;epithelial tube branching involved in lung morphogenesis;type I pneumocyte differentiation	GO:0000165;GO:0001934;GO:0007265;GO:0008542;GO:0010467;GO:0010628;GO:0014009;GO:0016601;GO:0021897;GO:0030036;GO:0030857;GO:0032228;GO:0035022;GO:0035914;GO:0043524;GO:0048169;GO:0048873;GO:0051146;GO:0051402;GO:0060252;GO:0060441;GO:0060509	Golgi membrane;cytoplasm;mitochondrial outer membrane;endoplasmic reticulum membrane;cytosol;plasma membrane;focal adhesion;cytoplasmic side of plasma membrane;membrane	GO:0000139;GO:0005737;GO:0005741;GO:0005789;GO:0005829;GO:0005886;GO:0005925;GO:0009898;GO:0016020	GTPase activity;G protein activity;protein binding;GTP binding;GDP binding;protein-membrane adaptor activity;protein-containing complex binding	GO:0003924;GO:0003925;GO:0005515;GO:0005525;GO:0019003;GO:0043495;GO:0044877	21.0	3be95afa-5521-11e7-8f50-0ac135e8bacf,3c88330c-5521-11e7-8f50-0ac135e8bacf,412efed6-5521-11e7-8f50-0ac135e8bacf,4362cec8-5521-11e7-8f50-0ac135e8bacf,576974d6-5521-11e7-8f50-0ac135e8bacf,65205a00-5521-11e7-8f50-0ac135e8bacf,720b3c92-5521-11e7-8f50-0ac135e8bacf,78974324-5521-11e7-8f50-0ac135e8bacf,7ac7dec6-5521-11e7-8f50-0ac135e8bacf,898a6694-5521-11e7-8f50-0ac135e8bacf,8f640d10-5521-11e7-8f50-0ac135e8bacf,95fd0bec-5521-11e7-8f50-0ac135e8bacf,a59cd558-5521-11e7-8f50-0ac135e8bacf,b7824902-5521-11e7-8f50-0ac135e8bacf,c70366de-5521-11e7-8f50-0ac135e8bacf,c92b28e0-5521-11e7-8f50-0ac135e8bacf,ce49e3cc-5521-11e7-8f50-0ac135e8bacf,da3d4700-5521-11e7-8f50-0ac135e8bacf,e1b66caa-5521-11e7-8f50-0ac135e8bacf,e4e93610-5521-11e7-8f50-0ac135e8bacf,ef96f9ea-5521-11e7-8f50-0ac135e8bacf	Trk receptor signaling mediated by the MAPK pathway,Trk receptor signaling mediated by PI3K and PLC-gamma,TCR signaling in naive CD8 T cells,TCR signaling in naive CD4 T cells,SHP2 signaling,Regulation of Ras family activation,Ras signaling in the CD4 TCR pathway,Plasma membrane estrogen receptor signaling,PDGFR-beta signaling pathway,Neurotrophic factor-mediated Trk receptor signaling,mTOR signaling pathway,Internalization of ErbB1,IL2-mediated signaling events,GMCSF-mediated signaling events,ErbB2ErbB3 signaling events,ErbB1 downstream signaling,EPHB forward signaling,Downstream signaling in naive CD8 T cells,CXCR3-mediated signaling events,Class I PI3K signaling events,C-MYB transcription factor network											
chr1:158612236:A/G	SPTA1 p.Cys1568Arg		7.0	0.8872910733466148	True		chr1	158612236	A	G	326		Yes	SPTA1	ENST00000643759.2	missense_variant	33.0	c.4702T>C	p.Cys1568Arg	158642446	0.5940495207667732	0.6853252647503782	0.5605187319884726	0.6359126984126984	0.5864811133200796	0.4591002044989775	0.528	0.575					COSV63754161	"[[""soft tissue"", 8], [""small intestine"", 2], [""pancreas"", 1], [""large intestine"", 1]]"	12.0	ENST00000643759.1	C1568R	Exact Match	Benign	MedGen:CN169374|MONDO:MONDO:0010053,MedGen:C2678338,OMIM:270970,Orphanet:822|MONDO:MONDO:0007533,MedGen:C1851741,OMIM:130600,Orphanet:288|MedGen:C3661900|Human Phenotype Ontology:HP:0004805,Human Phenotype Ontology:HP:0004839,MONDO:MONDO:0009948,MedGen:C0520739,OMIM:266140,Orphanet:98867	not specified|Hereditary spherocytosis type 3|Elliptocytosis 2|not provided|Pyropoikilocytosis, hereditary	criteria provided, multiple submitters, no conflicts	258942.0		lymphocyte homeostasis;porphyrin-containing compound biosynthetic process;plasma membrane organization;actin filament organization;regulation of cell shape;actin cytoskeleton organization;hemopoiesis;positive regulation of T cell proliferation;actin filament capping	GO:0002260;GO:0006779;GO:0007009;GO:0007015;GO:0008360;GO:0030036;GO:0030097;GO:0042102;GO:0051693	cytosol;plasma membrane;spectrin;cytoplasmic side of plasma membrane;spectrin-associated cytoskeleton;actin cytoskeleton;cell junction;axon;cortical actin cytoskeleton;cuticular plate;cell projection	GO:0005829;GO:0005886;GO:0008091;GO:0009898;GO:0014731;GO:0015629;GO:0030054;GO:0030424;GO:0030864;GO:0032437;GO:0042995	structural constituent of cytoskeleton;calcium ion binding;protein binding;actin filament binding	GO:0005200;GO:0005509;GO:0005515;GO:0051015				rs863931	rs863931	0.604968	0.664392	0.631848	0.629094	0.64716	0.582539	0.568388	0.607707	0.476583
chr10:88679191:C/T	BMPR1A p.Cys377=		8.0	0.9654689687354177			chr10	88679191	C	T	326		Yes	BMPR1A	ENST00000372037.7	synonymous_variant	10.0	c.1131C>T	p.Cys377=	86919434																			Likely benign	MONDO:MONDO:0017380,MedGen:C0345893,OMIM:174900,Orphanet:2929	Juvenile polyposis syndrome	criteria provided, single submitter	2918155.0		angiogenesis;osteoblast differentiation;in utero embryonic development;mesoderm formation;somitogenesis;Mullerian duct regression;positive regulation of mesenchymal cell proliferation;chondrocyte differentiation;outflow tract septum morphogenesis;outflow tract morphogenesis;cardiac conduction system development;atrioventricular valve development;mitral valve morphogenesis;tricuspid valve morphogenesis;endocardial cushion morphogenesis;cardiac right ventricle morphogenesis;ventricular trabecula myocardium morphogenesis;ventricular compact myocardium morphogenesis;endocardial cushion formation;protein phosphorylation;immune response;transforming growth factor beta receptor signaling pathway;ectoderm development;dorsal/ventral axis specification;dorsal/ventral pattern formation;positive regulation of gene expression;negative regulation of gene expression;regulation of cardiac muscle cell apoptotic process;neural crest cell development;negative regulation of smooth muscle cell migration;central nervous system neuron differentiation;pituitary gland development;neural plate mediolateral regionalization;lung development;positive regulation of bone mineralization;BMP signaling pathway;positive regulation of transforming growth factor beta2 production;somatic stem cell population maintenance;hindlimb morphogenesis;dorsal aorta morphogenesis;odontogenesis of dentin-containing tooth;embryonic digit morphogenesis;positive regulation of osteoblast differentiation;positive regulation of transcription by RNA polymerase II;paraxial mesoderm structural organization;lateral mesoderm development;regulation of lateral mesodermal cell fate specification;mesendoderm development;embryonic organ development;developmental growth;epithelial cell proliferation;positive regulation of epithelial cell proliferation;negative regulation of neurogenesis;negative regulation of muscle cell differentiation;roof of mouth development;regulation of cardiac muscle cell proliferation;positive regulation of cardiac muscle cell proliferation;positive regulation of SMAD protein signal transduction;ventricular septum morphogenesis;heart formation;atrioventricular node cell development;pharyngeal arch artery morphogenesis;cellular response to growth factor stimulus;cellular response to BMP stimulus;positive regulation of miRNA transcription;positive regulation of cardiac ventricle development;positive regulation of vascular associated smooth muscle cell proliferation;fibrous ring of heart morphogenesis;regulation of neural crest cell differentiation;regulation of cellular senescence	GO:0001525;GO:0001649;GO:0001701;GO:0001707;GO:0001756;GO:0001880;GO:0002053;GO:0002062;GO:0003148;GO:0003151;GO:0003161;GO:0003171;GO:0003183;GO:0003186;GO:0003203;GO:0003215;GO:0003222;GO:0003223;GO:0003272;GO:0006468;GO:0006955;GO:0007179;GO:0007398;GO:0009950;GO:0009953;GO:0010628;GO:0010629;GO:0010665;GO:0014032;GO:0014912;GO:0021953;GO:0021983;GO:0021998;GO:0030324;GO:0030501;GO:0030509;GO:0032915;GO:0035019;GO:0035137;GO:0035912;GO:0042475;GO:0042733;GO:0045669;GO:0045944;GO:0048352;GO:0048368;GO:0048378;GO:0048382;GO:0048568;GO:0048589;GO:0050673;GO:0050679;GO:0050768;GO:0051148;GO:0060021;GO:0060043;GO:0060045;GO:0060391;GO:0060412;GO:0060914;GO:0060928;GO:0061626;GO:0071363;GO:0071773;GO:1902895;GO:1904414;GO:1904707;GO:1905285;GO:1905292;GO:2000772	plasma membrane;caveola;external side of plasma membrane;membrane;dendrite;neuronal cell body;receptor complex;HFE-transferrin receptor complex	GO:0005886;GO:0005901;GO:0009897;GO:0016020;GO:0030425;GO:0043025;GO:0043235;GO:1990712	protein serine/threonine kinase activity;transmembrane receptor protein serine/threonine kinase activity;transforming growth factor beta receptor activity, type I;protein binding;ATP binding;BMP binding;protein homodimerization activity;SMAD binding;metal ion binding;BMP receptor activity	GO:0004674;GO:0004675;GO:0005025;GO:0005515;GO:0005524;GO:0036122;GO:0042803;GO:0046332;GO:0046872;GO:0098821	1.0	f1ae1a1c-5521-11e7-8f50-0ac135e8bacf	BMP receptor signaling											
chr13:28883061:G/A	FLT1 p.Tyr1213=		7.0	0.8892418784979649	True		chr13	28883061	G	A	325		Yes	FLT1	ENST00000282397.9	synonymous_variant	28.0	c.3639C>T	p.Tyr1213=	28308924	0.7308306709265175	0.2768532526475037	0.8285302593659942	1.0	0.7952286282306164	0.9314928425357872							COSV56717614	"[[""lung"", 1], [""bone"", 1]]"	2.0	ENST00000282397.8	Y1213%3D	Exact Match							angiogenesis;monocyte chemotaxis;cell surface receptor protein tyrosine kinase signaling pathway;multicellular organism development;positive regulation of cell population proliferation;positive regulation of phospholipase C activity;cell migration;peptidyl-tyrosine phosphorylation;cell differentiation;positive regulation of cell migration;positive regulation of kinase activity;cellular response to vascular endothelial growth factor stimulus;vascular endothelial growth factor receptor-1 signaling pathway;vascular endothelial growth factor signaling pathway;positive regulation of MAP kinase activity;positive regulation of MAPK cascade;positive regulation of angiogenesis;protein autophosphorylation;vascular endothelial growth factor receptor signaling pathway;blood vessel morphogenesis;embryonic morphogenesis;positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction;negative regulation of vascular endothelial cell proliferation;hyaloid vascular plexus regression	GO:0001525;GO:0002548;GO:0007169;GO:0007275;GO:0008284;GO:0010863;GO:0016477;GO:0018108;GO:0030154;GO:0030335;GO:0033674;GO:0035924;GO:0036323;GO:0038084;GO:0043406;GO:0043410;GO:0045766;GO:0046777;GO:0048010;GO:0048514;GO:0048598;GO:0051897;GO:1905563;GO:1990384	extracellular space;endosome;plasma membrane;focal adhesion;actin cytoskeleton;receptor complex	GO:0005615;GO:0005768;GO:0005886;GO:0005925;GO:0015629;GO:0043235	transmembrane receptor protein tyrosine kinase activity;vascular endothelial growth factor receptor activity;protein binding;ATP binding;growth factor binding;placental growth factor receptor activity	GO:0004714;GO:0005021;GO:0005515;GO:0005524;GO:0019838;GO:0036332	6.0	32ff1916-5521-11e7-8f50-0ac135e8bacf,33840088-5521-11e7-8f50-0ac135e8bacf,4c90f780-5521-11e7-8f50-0ac135e8bacf,5aadca6c-5521-11e7-8f50-0ac135e8bacf,b2bcaa9c-5521-11e7-8f50-0ac135e8bacf,ba907368-5521-11e7-8f50-0ac135e8bacf	VEGFR1 specific signals,VEGF and VEGFR signaling network,Signaling events mediated by VEGFR1 and VEGFR2,S1P3 pathway,HIF-2-alpha transcription factor network,Glypican 1 network	rs7993418	rs7993418	0.674373	0.359618	0.854305	0.998083	0.793203	0.819161	0.791907	0.712488	0.887393
chr13:25052261:C/T	PARP4 p.Ser534=		4.0	0.7731678945327647	True		chr13	25052261	C	T	325		Yes	PARP4	ENST00000381989.4	synonymous_variant	13.0	c.1602G>A	p.Ser534=	24478123	0.5445287539936102	0.4288956127080182	0.5677233429394812	0.5992063492063492	0.5	0.6738241308793456							COSV67960450	"[[""large intestine"", 3], [""lung"", 2]]"	5.0	ENST00000381989.3	S534%3D	Exact Match							DNA repair;inflammatory response;DNA damage response;response to xenobiotic stimulus;protein modification process;regulation of telomerase activity	GO:0006281;GO:0006954;GO:0006974;GO:0009410;GO:0036211;GO:0051972	nucleus;nucleoplasm;cytoplasm;cytosol;spindle microtubule;membrane;extracellular exosome;ribonucleoprotein complex	GO:0005634;GO:0005654;GO:0005737;GO:0005829;GO:0005876;GO:0016020;GO:0070062;GO:1990904	DNA binding;NAD+ ADP-ribosyltransferase activity;protein binding;nucleotidyltransferase activity;enzyme binding;NAD+-protein ADP-ribosyltransferase activity	GO:0003677;GO:0003950;GO:0005515;GO:0016779;GO:0019899;GO:1990404				rs4770696	rs4770696	0.505827	0.430304	0.511733	0.606526	0.508652	0.52737	0.535918	0.515349	0.643894
chr13:25052420:T/A	PARP4 intron_variant		1.0	0.8828150572831424	True		chr13	25052420	T	A	325			PARP4	ENST00000381989.4	intron_variant		c.1449-6A>T		24478282	0.3023162939297125	0.1301059001512859	0.4106628242074928	0.2698412698412698	0.3180914512922465	0.4754601226993865							COSV67960383	"[[""haematopoietic and lymphoid tissue"", 2], [""lung"", 1], [""bone"", 1]]"	4.0	ENST00000381989.3	?	Exact Match							DNA repair;inflammatory response;DNA damage response;response to xenobiotic stimulus;protein modification process;regulation of telomerase activity	GO:0006281;GO:0006954;GO:0006974;GO:0009410;GO:0036211;GO:0051972	nucleus;nucleoplasm;cytoplasm;cytosol;spindle microtubule;membrane;extracellular exosome;ribonucleoprotein complex	GO:0005634;GO:0005654;GO:0005737;GO:0005829;GO:0005876;GO:0016020;GO:0070062;GO:1990904	DNA binding;NAD+ ADP-ribosyltransferase activity;protein binding;nucleotidyltransferase activity;enzyme binding;NAD+-protein ADP-ribosyltransferase activity	GO:0003677;GO:0003950;GO:0005515;GO:0016779;GO:0019899;GO:1990404				rs17080653	rs17080653	0.288846	0.150301	0.36183	0.312901	0.316007	0.368757	0.342558	0.301491	0.453228
chr11:65481166:T/C	KAT5 intron_variant		8.0	0.983646770237122	True		chr11	65481166	T	C	325			KAT5	ENST00000341318.9	intron_variant		c.615+28T>C		65713695	0.8049121405750799	0.7291981845688351	0.8890489913544669	0.9017857142857144	0.9145129224652088	0.6349693251533742																			negative regulation of transcription by RNA polymerase II;establishment of mitotic spindle orientation;double-strand break repair via homologous recombination;nucleotide-excision repair;double-strand break repair;regulation of transcription by RNA polymerase II;apoptotic process;DNA damage response;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;spermatid development;response to ionizing radiation;positive regulation of autophagy;positive regulation of triglyceride biosynthetic process;peptidyl-lysine acetylation;neural tube development;neurogenesis;negative regulation of interleukin-2 production;sperm DNA condensation;cellular response to glucose starvation;positive regulation of circadian rhythm;regulation of apoptotic process;proteasome-mediated ubiquitin-dependent protein catabolic process;innate immune response;positive regulation of regulatory T cell differentiation;positive regulation of myoblast differentiation;negative regulation of DNA-templated transcription;positive regulation of DNA-templated transcription;positive regulation of transcription by RNA polymerase II;regulation of cell cycle;positive regulation of mitotic sister chromatid segregation;cellular response to glucose stimulus;cellular response to estradiol stimulus;cellular senescence;DNA repair-dependent chromatin remodeling;positive regulation of protein acetylation;regulation of hematopoietic stem cell differentiation;positive regulation of attachment of mitotic spindle microtubules to kinetochore;positive regulation of double-strand break repair via homologous recombination;positive regulation of aggrephagy;lipid droplet disassembly;negative regulation of double-strand break repair via homologous recombination;regulation of double-strand break repair	GO:0000122;GO:0000132;GO:0000724;GO:0006289;GO:0006302;GO:0006357;GO:0006915;GO:0006974;GO:0006978;GO:0007286;GO:0010212;GO:0010508;GO:0010867;GO:0018394;GO:0021915;GO:0022008;GO:0032703;GO:0035092;GO:0042149;GO:0042753;GO:0042981;GO:0043161;GO:0045087;GO:0045591;GO:0045663;GO:0045892;GO:0045893;GO:0045944;GO:0051726;GO:0062033;GO:0071333;GO:0071392;GO:0090398;GO:0140861;GO:1901985;GO:1902036;GO:1902425;GO:1905168;GO:1905337;GO:1905691;GO:2000042;GO:2000779	kinetochore;chromatin;nucleosome;Swr1 complex;nucleus;nucleoplasm;transcription regulator complex;nucleolus;cytoplasm;cytosol;piccolo histone acetyltransferase complex;NuA4 histone acetyltransferase complex;site of double-strand break;intracellular membrane-bounded organelle;perinuclear region of cytoplasm;mitotic spindle pole	GO:0000776;GO:0000785;GO:0000786;GO:0000812;GO:0005634;GO:0005654;GO:0005667;GO:0005730;GO:0005737;GO:0005829;GO:0032777;GO:0035267;GO:0035861;GO:0043231;GO:0048471;GO:0097431	chromatin binding;transcription coregulator activity;transcription coactivator activity;histone acetyltransferase activity;protein binding;histone H4 acetyltransferase activity;acetyltransferase activity;histone H2A acetyltransferase activity;histone H2AK5 acetyltransferase activity;metal ion binding;histone H4K16 acetyltransferase activity;peptide-lysine-N-acetyltransferase activity;peptide 2-hydroxyisobutyryltransferase activity;peptide crotonyltransferase activity;peptide butyryltransferase activity;DNA-binding transcription factor binding	GO:0003682;GO:0003712;GO:0003713;GO:0004402;GO:0005515;GO:0010485;GO:0016407;GO:0043998;GO:0043999;GO:0046872;GO:0046972;GO:0061733;GO:0106226;GO:0140064;GO:0140065;GO:0140297	7.0	3814fa62-5521-11e7-8f50-0ac135e8bacf,6f7a316e-5521-11e7-8f50-0ac135e8bacf,812903c2-5521-11e7-8f50-0ac135e8bacf,81be3ee4-5521-11e7-8f50-0ac135e8bacf,eef8e528-5521-11e7-8f50-0ac135e8bacf,f9c7eca4-5521-11e7-8f50-0ac135e8bacf,fa553886-5521-11e7-8f50-0ac135e8bacf	Validated targets of C-MYC transcriptional activation,Regulation of Androgen receptor activity,p73 transcription factor network,p53 pathway,C-MYC pathway,ATM pathway,ATF-2 transcription factor network	rs1151500	rs1151500	0.862867	0.773879	0.896209	0.892903	0.901318	0.871301	0.916109	0.862326	0.729126
chr17:73627565:A/G	RECQL5 p.Tyr471=		8.0	0.8599018003273322	True		chr17	73627565	A	G	324		Yes	RECQL5	ENST00000317905.10	synonymous_variant	9.0	c.1413T>C	p.Tyr471=	75631485	0.9886182108626198	0.959909228441755	0.9942363112391932	1.0	1.0	1.0							COSV58644108	"[[""thyroid"", 1]]"	1.0	ENST00000423245.6	Y471%3D	Exact Match							mitotic cell cycle;double-strand break repair via homologous recombination;DNA metabolic process;DNA replication;DNA unwinding involved in DNA replication;DNA repair;negative regulation of transcription elongation by RNA polymerase II;cell division;chromosome separation;cellular response to xenobiotic stimulus;cellular response to camptothecin;replication-born double-strand break repair via sister chromatid exchange;mitotic DNA-templated DNA replication;negative regulation of double-strand break repair via homologous recombination	GO:0000278;GO:0000724;GO:0006259;GO:0006260;GO:0006268;GO:0006281;GO:0034244;GO:0051301;GO:0051304;GO:0071466;GO:0072757;GO:1990414;GO:1990506;GO:2000042	nucleus;nucleoplasm;replication fork;chromosome;cytoplasm;cytosol;transcription preinitiation complex	GO:0005634;GO:0005654;GO:0005657;GO:0005694;GO:0005737;GO:0005829;GO:0097550	RNA polymerase II complex binding;DNA binding;DNA helicase activity;helicase activity;ATP binding;four-way junction helicase activity;isomerase activity;ATP hydrolysis activity;3'-5' DNA helicase activity;metal ion binding	GO:0000993;GO:0003677;GO:0003678;GO:0004386;GO:0005524;GO:0009378;GO:0016853;GO:0016887;GO:0043138;GO:0046872				rs820197		0.98872	0.963262	1.0	1.0	1.0	0.996708	0.999861	0.991643	1.0
chr5:38953665:G/GA	RICTOR intron_variant		8.0	0.7833197056418643			chr5	38953665	G	GA	320			RICTOR	ENST00000357387.8	intron_variant		c.2698-11dup		38953564	0.9341054313099042	0.8691376701966718	0.9668587896253602	0.988095238095238	0.9691848906560636	0.9069529652351738																			positive regulation of endothelial cell proliferation;cytoskeleton organization;embryo development ending in birth or egg hatching;regulation of gene expression;peptidyl-serine phosphorylation;actin cytoskeleton organization;positive regulation of cell growth;positive regulation of actin filament polymerization;cellular response to nutrient levels;positive regulation of TOR signaling;regulation of actin cytoskeleton organization;regulation of peptidyl-serine phosphorylation;TORC2 signaling;negative regulation of apoptotic process;regulation of inflammatory response;positive regulation of peptidyl-tyrosine phosphorylation;regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction;positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction;regulation of establishment of cell polarity	GO:0001938;GO:0007010;GO:0009792;GO:0010468;GO:0018105;GO:0030036;GO:0030307;GO:0030838;GO:0031669;GO:0032008;GO:0032956;GO:0033135;GO:0038203;GO:0043066;GO:0050727;GO:0050731;GO:0051896;GO:0051897;GO:2000114	Golgi apparatus;cytosol;TORC2 complex	GO:0005794;GO:0005829;GO:0031932	protein binding;protein kinase binding;ribosome binding;protein serine/threonine kinase activator activity;molecular adaptor activity	GO:0005515;GO:0019901;GO:0043022;GO:0043539;GO:0060090	6.0	8f640d10-5521-11e7-8f50-0ac135e8bacf,98ad85f0-5521-11e7-8f50-0ac135e8bacf,c92b28e0-5521-11e7-8f50-0ac135e8bacf,df93b3b8-5521-11e7-8f50-0ac135e8bacf,e1b66caa-5521-11e7-8f50-0ac135e8bacf,e6f69242-5521-11e7-8f50-0ac135e8bacf	mTOR signaling pathway,Integrin-linked kinase signaling,ErbB1 downstream signaling,CXCR4-mediated signaling events,CXCR3-mediated signaling events,Class I PI3K signaling events mediated by Akt	rs33912683	rs33912683	0.935666	0.883882	0.976709	0.993594	0.960349	0.955095	0.956653	0.947393	0.912316
chr11:107879887:G/C	CUL5 5_prime_UTR_variant		8.0	0.9920671955202988			chr11	107879887	G	C	319			CUL5	ENST00000393094.7	5_prime_UTR_variant	1.0	c.-188G>C		108009161	1.0	1.0	1.0	1.0	1.0	1.0																			G1/S transition of mitotic cell cycle;protein ubiquitination;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;ERBB2 signaling pathway;calcium ion transmembrane transport;intrinsic apoptotic signaling pathway	GO:0000082;GO:0016567;GO:0031146;GO:0038128;GO:0070588;GO:0097193	nucleus;cytosol;SCF ubiquitin ligase complex;Cul5-RING ubiquitin ligase complex;site of DNA damage	GO:0005634;GO:0005829;GO:0019005;GO:0031466;GO:0090734	ubiquitin-protein transferase activity;calcium channel activity;protein binding;protein-macromolecule adaptor activity;ubiquitin protein ligase binding;signaling receptor activity	GO:0004842;GO:0005262;GO:0005515;GO:0030674;GO:0031625;GO:0038023				rs10736442		0.999826	0.999477	1.0	0.999681	1.0	0.999927	1.0	0.999534	1.0
chr1:91859795:T/C	HFM1 p.Ile117Val		8.0	0.8460102659822678	True		chr1	91859795	T	C	316		Yes	HFM1	ENST00000370425.8	missense_variant	4.0	c.349A>G	p.Ile117Val	91394238	0.9992012779552716	0.9969742813918304	1.0	1.0	1.0	1.0	0.769	0.788					COSV107319106	"[[""soft tissue"", 8]]"	8.0	ENST00000370425.7	I117V	Exact Match							resolution of meiotic recombination intermediates;DNA duplex unwinding	GO:0000712;GO:0032508	nucleus	GO:0005634	nucleic acid binding;DNA helicase activity;ATP binding;ATP hydrolysis activity	GO:0003676;GO:0003678;GO:0005524;GO:0016887				rs282009		0.998743	0.995857	1.0	1.0	1.0	0.999707	1.0	0.999067	1.0
chr11:65631167:C/T	MUS81 p.Ala312=		6.0	0.5557122708039492	True		chr11	65631167	C	T	312		Yes	MUS81	ENST00000308110.9	synonymous_variant	9.0	c.936C>T	p.Ala312=	65863696	0.4281150159744409	0.2012102874432677	0.4063400576368876	0.3323412698412698	0.6679920477137177	0.6022494887525562							COSV57259240	"[[""lung"", 4], [""large intestine"", 3], [""prostate"", 1]]"	8.0	ENST00000533035.5	A312%3D	Exact Match							resolution of meiotic recombination intermediates;double-strand break repair via break-induced replication;DNA repair;double-strand break repair;DNA catabolic process;replication fork processing;mitotic intra-S DNA damage checkpoint signaling;osteoblast proliferation;response to intra-S DNA damage checkpoint signaling	GO:0000712;GO:0000727;GO:0006281;GO:0006302;GO:0006308;GO:0031297;GO:0031573;GO:0033687;GO:0072429	nucleus;nucleoplasm;replication fork;nucleolus;nuclear replication fork;Holliday junction resolvase complex;endodeoxyribonuclease complex	GO:0005634;GO:0005654;GO:0005657;GO:0005730;GO:0043596;GO:0048476;GO:1905347	DNA binding;endonuclease activity;protein binding;crossover junction DNA endonuclease activity;metal ion binding;3'-flap endonuclease activity	GO:0003677;GO:0004519;GO:0005515;GO:0008821;GO:0046872;GO:0048257				rs648732	rs648732	0.523623	0.265078	0.640493	0.315217	0.704973	0.472923	0.67142	0.522388	0.625
chr17:41245471:C/T	BRCA1 p.Asp693Asn		1.0	0.9523070957735555	True	0.6111111111111112	chr17	41245471	C	T	310		Yes	BRCA1	ENST00000357654.9	missense_variant	10.0	c.2077G>A	p.Asp693Asn	43093454	0.0335463258785942	0.0113464447806354	0.0576368876080691	0.0	0.0834990059642147	0.0296523517382413	0.00128	0.0705					COSV58789708	"[[""prostate"", 55], [""soft tissue"", 7], [""meninges"", 4], [""haematopoietic and lymphoid tissue"", 1], [""salivary gland"", 1]]"	68.0	ENST00000591849.5	D693N	Exact Match	Benign	MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	Familial cancer of breast|Fanconi anemia, complementation group S|Breast-ovarian cancer, familial, susceptibility to, 1|Pancreatic cancer, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not specified|not provided|Hereditary breast ovarian cancer syndrome	reviewed by expert panel	41808.0		double-strand break repair via homologous recombination;DNA repair;regulation of DNA repair;postreplication repair;double-strand break repair;regulation of transcription by RNA polymerase II;fatty acid biosynthetic process;DNA damage response;chromosome segregation;mitotic G2 DNA damage checkpoint signaling;centrosome cycle;sex-chromosome dosage compensation;intrinsic apoptotic signaling pathway in response to DNA damage;response to ionizing radiation;positive regulation of vascular endothelial growth factor production;positive regulation of gene expression;protein ubiquitination;negative regulation of cell growth;negative regulation of intracellular estrogen receptor signaling pathway;homologous recombination;chordate embryonic development;negative regulation of gene expression via chromosomal CpG island methylation;mitotic G2/M transition checkpoint;negative regulation of fatty acid biosynthetic process;positive regulation of DNA repair;positive regulation of angiogenesis;negative regulation of cell cycle;negative regulation of DNA-templated transcription;positive regulation of DNA-templated transcription;positive regulation of transcription by RNA polymerase II;negative regulation of centriole replication;regulation of cell cycle;protein autoubiquitination;random inactivation of X chromosome;cellular response to tumor necrosis factor;cellular response to ionizing radiation;cellular response to indole-3-methanol;protein K6-linked ubiquitination;DNA strand resection involved in replication fork processing;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors;regulation of DNA damage checkpoint;negative regulation of reactive oxygen species metabolic process	GO:0000724;GO:0006281;GO:0006282;GO:0006301;GO:0006302;GO:0006357;GO:0006633;GO:0006974;GO:0007059;GO:0007095;GO:0007098;GO:0007549;GO:0008630;GO:0010212;GO:0010575;GO:0010628;GO:0016567;GO:0030308;GO:0033147;GO:0035825;GO:0043009;GO:0044027;GO:0044818;GO:0045717;GO:0045739;GO:0045766;GO:0045786;GO:0045892;GO:0045893;GO:0045944;GO:0046600;GO:0051726;GO:0051865;GO:0060816;GO:0071356;GO:0071479;GO:0071681;GO:0085020;GO:0110025;GO:1902042;GO:2000001;GO:2000378	ubiquitin ligase complex;nuclear ubiquitin ligase complex;lateral element;gamma-tubulin ring complex;male germ cell nucleus;XY body;nucleus;nucleoplasm;chromosome;cytoplasm;plasma membrane;nuclear body;BRCA1-BARD1 complex;protein-containing complex;intracellular non-membrane-bounded organelle;BRCA1-A complex;BRCA1-B complex;BRCA1-C complex;DNA repair complex;ribonucleoprotein complex	GO:0000151;GO:0000152;GO:0000800;GO:0000931;GO:0001673;GO:0001741;GO:0005634;GO:0005654;GO:0005694;GO:0005737;GO:0005886;GO:0016604;GO:0031436;GO:0032991;GO:0043232;GO:0070531;GO:0070532;GO:0070533;GO:1990391;GO:1990904	transcription cis-regulatory region binding;DNA-binding transcription activator activity;p53 binding;DNA binding;damaged DNA binding;transcription coactivator activity;RNA binding;ubiquitin-protein transferase activity;protein binding;zinc ion binding;tubulin binding;enzyme binding;ubiquitin protein ligase binding;identical protein binding;RNA polymerase binding	GO:0000976;GO:0001216;GO:0002039;GO:0003677;GO:0003684;GO:0003713;GO:0003723;GO:0004842;GO:0005515;GO:0008270;GO:0015631;GO:0019899;GO:0031625;GO:0042802;GO:0070063	10.0	35f28f90-5521-11e7-8f50-0ac135e8bacf,3ab9dba6-5521-11e7-8f50-0ac135e8bacf,bf04bd82-5521-11e7-8f50-0ac135e8bacf,c45e106a-5521-11e7-8f50-0ac135e8bacf,d6e9881a-5521-11e7-8f50-0ac135e8bacf,e3c4b33c-5521-11e7-8f50-0ac135e8bacf,f6898a78-5521-11e7-8f50-0ac135e8bacf,f823645e-5521-11e7-8f50-0ac135e8bacf,f9c7eca4-5521-11e7-8f50-0ac135e8bacf,fa553886-5521-11e7-8f50-0ac135e8bacf	Validated targets of C-MYC transcriptional repression,Validated nuclear estrogen receptor alpha network,FOXA1 transcription factor network,Fanconi anemia pathway,E2F transcription factor network,Coregulation of Androgen receptor activity,BARD1 signaling events,Aurora A signaling,ATM pathway,ATF-2 transcription factor network	rs4986850	rs4986850	0.0571955	0.0238027	0.0860927	0.000319081	0.0959441	0.0539115	0.0760247	0.0590698	0.0285433
chr17:41245466:G/A	BRCA1 p.Ser694=		6.0	0.9926328034121752	True	0.5945945945945946	chr17	41245466	G	A	310		Yes	BRCA1	ENST00000357654.9	synonymous_variant	10.0	c.2082C>T	p.Ser694=	43093449	0.336461661341853	0.2102874432677761	0.3530259365994236	0.3710317460317461	0.3001988071570576	0.4969325153374234							COSV58784419	"[[""soft tissue"", 13], [""prostate"", 10], [""meninges"", 9], [""haematopoietic and lymphoid tissue"", 3], [""lung"", 3], [""large intestine"", 2], [""stomach"", 1], [""breast"", 1]]"	42.0	ENST00000591849.5	DS693%3D	Exact Match	Benign	MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333|MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	not specified|not provided|Hereditary breast ovarian cancer syndrome|Familial cancer of breast|Pancreatic cancer, susceptibility to, 4|Fanconi anemia, complementation group S|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	reviewed by expert panel	125536.0		double-strand break repair via homologous recombination;DNA repair;regulation of DNA repair;postreplication repair;double-strand break repair;regulation of transcription by RNA polymerase II;fatty acid biosynthetic process;DNA damage response;chromosome segregation;mitotic G2 DNA damage checkpoint signaling;centrosome cycle;sex-chromosome dosage compensation;intrinsic apoptotic signaling pathway in response to DNA damage;response to ionizing radiation;positive regulation of vascular endothelial growth factor production;positive regulation of gene expression;protein ubiquitination;negative regulation of cell growth;negative regulation of intracellular estrogen receptor signaling pathway;homologous recombination;chordate embryonic development;negative regulation of gene expression via chromosomal CpG island methylation;mitotic G2/M transition checkpoint;negative regulation of fatty acid biosynthetic process;positive regulation of DNA repair;positive regulation of angiogenesis;negative regulation of cell cycle;negative regulation of DNA-templated transcription;positive regulation of DNA-templated transcription;positive regulation of transcription by RNA polymerase II;negative regulation of centriole replication;regulation of cell cycle;protein autoubiquitination;random inactivation of X chromosome;cellular response to tumor necrosis factor;cellular response to ionizing radiation;cellular response to indole-3-methanol;protein K6-linked ubiquitination;DNA strand resection involved in replication fork processing;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors;regulation of DNA damage checkpoint;negative regulation of reactive oxygen species metabolic process	GO:0000724;GO:0006281;GO:0006282;GO:0006301;GO:0006302;GO:0006357;GO:0006633;GO:0006974;GO:0007059;GO:0007095;GO:0007098;GO:0007549;GO:0008630;GO:0010212;GO:0010575;GO:0010628;GO:0016567;GO:0030308;GO:0033147;GO:0035825;GO:0043009;GO:0044027;GO:0044818;GO:0045717;GO:0045739;GO:0045766;GO:0045786;GO:0045892;GO:0045893;GO:0045944;GO:0046600;GO:0051726;GO:0051865;GO:0060816;GO:0071356;GO:0071479;GO:0071681;GO:0085020;GO:0110025;GO:1902042;GO:2000001;GO:2000378	ubiquitin ligase complex;nuclear ubiquitin ligase complex;lateral element;gamma-tubulin ring complex;male germ cell nucleus;XY body;nucleus;nucleoplasm;chromosome;cytoplasm;plasma membrane;nuclear body;BRCA1-BARD1 complex;protein-containing complex;intracellular non-membrane-bounded organelle;BRCA1-A complex;BRCA1-B complex;BRCA1-C complex;DNA repair complex;ribonucleoprotein complex	GO:0000151;GO:0000152;GO:0000800;GO:0000931;GO:0001673;GO:0001741;GO:0005634;GO:0005654;GO:0005694;GO:0005737;GO:0005886;GO:0016604;GO:0031436;GO:0032991;GO:0043232;GO:0070531;GO:0070532;GO:0070533;GO:1990391;GO:1990904	transcription cis-regulatory region binding;DNA-binding transcription activator activity;p53 binding;DNA binding;damaged DNA binding;transcription coactivator activity;RNA binding;ubiquitin-protein transferase activity;protein binding;zinc ion binding;tubulin binding;enzyme binding;ubiquitin protein ligase binding;identical protein binding;RNA polymerase binding	GO:0000976;GO:0001216;GO:0002039;GO:0003677;GO:0003684;GO:0003713;GO:0003723;GO:0004842;GO:0005515;GO:0008270;GO:0015631;GO:0019899;GO:0031625;GO:0042802;GO:0070063	10.0	35f28f90-5521-11e7-8f50-0ac135e8bacf,3ab9dba6-5521-11e7-8f50-0ac135e8bacf,bf04bd82-5521-11e7-8f50-0ac135e8bacf,c45e106a-5521-11e7-8f50-0ac135e8bacf,d6e9881a-5521-11e7-8f50-0ac135e8bacf,e3c4b33c-5521-11e7-8f50-0ac135e8bacf,f6898a78-5521-11e7-8f50-0ac135e8bacf,f823645e-5521-11e7-8f50-0ac135e8bacf,f9c7eca4-5521-11e7-8f50-0ac135e8bacf,fa553886-5521-11e7-8f50-0ac135e8bacf	Validated targets of C-MYC transcriptional repression,Validated nuclear estrogen receptor alpha network,FOXA1 transcription factor network,Fanconi anemia pathway,E2F transcription factor network,Coregulation of Androgen receptor activity,BARD1 signaling events,Aurora A signaling,ATM pathway,ATF-2 transcription factor network	rs1799949	rs1799949	0.312058	0.23496	0.361011	0.37364	0.404075	0.327366	0.330006	0.320167	0.494408
chr1:120458924:G/A	NOTCH2 p.Leu2141=				True	0.6774193548387096	chr1	120458924	G	A	300		Yes	NOTCH2	ENST00000256646.7	synonymous_variant	34.0	c.6421C>T	p.Leu2141=	119916301	0.0483226837060702	0.010590015128593	0.0605187319884726	0.0625	0.0198807157057654	0.1053169734151329							COSV56686234	"[[""prostate"", 9], [""meninges"", 9], [""soft tissue"", 3], [""haematopoietic and lymphoid tissue"", 1]]"	22.0	ENST00000256646.6	L2141%3D	Exact Match	Benign	MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0007057,MedGen:C0917715,OMIM:102500,Orphanet:955	not specified|not provided|Hajdu-Cheney syndrome	criteria provided, multiple submitters, no conflicts	261704.0		negative regulation of transcription by RNA polymerase II;in utero embryonic development;cell fate determination;heart looping;morphogenesis of an epithelial sheet;marginal zone B cell differentiation;inflammatory response to antigenic stimulus;atrioventricular node development;pulmonary valve morphogenesis;apoptotic process;humoral immune response;Notch signaling pathway;nervous system development;axon guidance;animal organ morphogenesis;negative regulation of gene expression;positive regulation of keratinocyte proliferation;hemopoiesis;embryonic limb morphogenesis;BMP signaling pathway;positive regulation of BMP signaling pathway;multicellular organism growth;intracellular signal transduction;intrahepatic bile duct development;wound healing;defense response to bacterium;myeloid dendritic cell differentiation;positive regulation of apoptotic process;negative regulation of apoptotic process;positive regulation of osteoclast differentiation;positive regulation of transcription by RNA polymerase II;positive regulation of Ras protein signal transduction;bone remodeling;positive regulation of smooth muscle cell differentiation;atrial septum morphogenesis;placenta blood vessel development;ciliary body morphogenesis;positive regulation of ERK1 and ERK2 cascade;left/right axis specification;cellular response to tumor cell;proximal tubule development;podocyte development;glomerular capillary formation;hepatocyte proliferation;positive regulation of miRNA transcription;cholangiocyte proliferation;regulation of osteoclast development	GO:0000122;GO:0001701;GO:0001709;GO:0001947;GO:0002011;GO:0002315;GO:0002437;GO:0003162;GO:0003184;GO:0006915;GO:0006959;GO:0007219;GO:0007399;GO:0007411;GO:0009887;GO:0010629;GO:0010838;GO:0030097;GO:0030326;GO:0030509;GO:0030513;GO:0035264;GO:0035556;GO:0035622;GO:0042060;GO:0042742;GO:0043011;GO:0043065;GO:0043066;GO:0045672;GO:0045944;GO:0046579;GO:0046849;GO:0051152;GO:0060413;GO:0060674;GO:0061073;GO:0070374;GO:0070986;GO:0071228;GO:0072014;GO:0072015;GO:0072104;GO:0072574;GO:1902895;GO:1990705;GO:2001204	Golgi membrane;extracellular region;nucleus;nucleoplasm;endoplasmic reticulum membrane;plasma membrane;cilium;cell surface;membrane;receptor complex	GO:0000139;GO:0005576;GO:0005634;GO:0005654;GO:0005789;GO:0005886;GO:0005929;GO:0009986;GO:0016020;GO:0043235	cis-regulatory region sequence-specific DNA binding;DNA-binding transcription activator activity, RNA polymerase II-specific;calcium ion binding;protein binding;enzyme binding;signaling receptor activity;NF-kappaB binding	GO:0000987;GO:0001228;GO:0005509;GO:0005515;GO:0019899;GO:0038023;GO:0051059	1.0	84be116e-5521-11e7-8f50-0ac135e8bacf	Notch signaling pathway	rs3795666	rs3795666	0.0231865	0.0140567	0.0219615	0.0756222	0.0307076	0.0399473	0.0183086	0.0208914	0.107026
chr1:11288758:G/A	MTOR p.Asn999=		8.0	0.9590804597701148	True	0.5135135135135135	chr1	11288758	G	A	294		Yes	MTOR	ENST00000361445.9	synonymous_variant	19.0	c.2997C>T	p.Asn999=	11228701	0.700479233226837	0.3350983358547655	0.8141210374639769	0.9186507936507936	0.7236580516898609	0.8650306748466258							COSV63873449	"[[""thyroid"", 1], [""breast"", 1]]"	2.0	ENST00000361445.8	N999%3D	Exact Match	Benign	MONDO:MONDO:0014716,MedGen:C4225259,OMIM:616638,Orphanet:457485|MedGen:CN169374|MedGen:C3661900	Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome|not specified|not provided	criteria provided, multiple submitters, no conflicts	1170840.0		regulation of cell growth;T-helper 1 cell lineage commitment;heart morphogenesis;heart valve morphogenesis;energy reserve metabolic process;'de novo' pyrimidine nucleobase biosynthetic process;protein phosphorylation;inflammatory response;DNA damage response;cytoskeleton organization;lysosome organization;germ cell development;response to nutrient;regulation of cell size;cellular response to starvation;response to heat;post-embryonic development;negative regulation of autophagy;positive regulation of lamellipodium assembly;positive regulation of gene expression;positive regulation of epithelial to mesenchymal transition;positive regulation of myotube differentiation;macroautophagy;regulation of macroautophagy;negative regulation of macroautophagy;phosphorylation;peptidyl-serine phosphorylation;neuronal action potential;protein catabolic process;positive regulation of cell growth;positive regulation of actin filament polymerization;T cell costimulation;ruffle organization;regulation of myelination;protein destabilization;response to nutrient levels;cellular response to nutrient levels;cellular response to nutrient;TOR signaling;positive regulation of phosphoprotein phosphatase activity;cellular response to insulin stimulus;regulation of actin cytoskeleton organization;calcineurin-NFAT signaling cascade;cellular response to amino acid starvation;multicellular organism growth;TORC1 signaling;regulation of circadian rhythm;negative regulation of apoptotic process;response to amino acid;anoikis;regulation of osteoclast differentiation;positive regulation of translation;negative regulation of cell size;positive regulation of glycolytic process;positive regulation of transcription by RNA polymerase III;positive regulation of translational initiation;protein autophosphorylation;positive regulation of lipid biosynthetic process;behavioral response to pain;rhythmic process;oligodendrocyte differentiation;positive regulation of oligodendrocyte differentiation;positive regulation of peptidyl-tyrosine phosphorylation;voluntary musculoskeletal movement;positive regulation of stress fiber assembly;positive regulation of keratinocyte migration;nucleus localization;positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction;cardiac muscle cell development;cardiac muscle contraction;cellular response to methionine;negative regulation of calcineurin-NFAT signaling cascade;cellular response to amino acid stimulus;cellular response to L-leucine;cellular response to hypoxia;cellular response to osmotic stress;regulation of membrane permeability;regulation of cellular response to heat;negative regulation of protein localization to nucleus;regulation of signal transduction by p53 class mediator;positive regulation of transcription of nucleolar large rRNA by RNA polymerase I;positive regulation of wound healing, spreading of epidermal cells;regulation of locomotor rhythm;positive regulation of cytoplasmic translational initiation;negative regulation of lysosome organization;positive regulation of pentose-phosphate shunt;cellular response to leucine starvation;regulation of autophagosome assembly	GO:0001558;GO:0002296;GO:0003007;GO:0003179;GO:0006112;GO:0006207;GO:0006468;GO:0006954;GO:0006974;GO:0007010;GO:0007040;GO:0007281;GO:0007584;GO:0008361;GO:0009267;GO:0009408;GO:0009791;GO:0010507;GO:0010592;GO:0010628;GO:0010718;GO:0010831;GO:0016236;GO:0016241;GO:0016242;GO:0016310;GO:0018105;GO:0019228;GO:0030163;GO:0030307;GO:0030838;GO:0031295;GO:0031529;GO:0031641;GO:0031648;GO:0031667;GO:0031669;GO:0031670;GO:0031929;GO:0032516;GO:0032869;GO:0032956;GO:0033173;GO:0034198;GO:0035264;GO:0038202;GO:0042752;GO:0043066;GO:0043200;GO:0043276;GO:0045670;GO:0045727;GO:0045792;GO:0045821;GO:0045945;GO:0045948;GO:0046777;GO:0046889;GO:0048266;GO:0048511;GO:0048709;GO:0048714;GO:0050731;GO:0050882;GO:0051496;GO:0051549;GO:0051647;GO:0051897;GO:0055013;GO:0060048;GO:0061431;GO:0070885;GO:0071230;GO:0071233;GO:0071456;GO:0071470;GO:0090559;GO:1900034;GO:1900181;GO:1901796;GO:1901838;GO:1903691;GO:1904059;GO:1904690;GO:1905672;GO:1905857;GO:1990253;GO:2000785	Golgi membrane;nucleus;nuclear envelope;nucleoplasm;cytoplasm;mitochondrial outer membrane;lysosome;lysosomal membrane;endoplasmic reticulum membrane;cytosol;endomembrane system;membrane;PML body;dendrite;TORC1 complex;TORC2 complex;phagocytic vesicle	GO:0000139;GO:0005634;GO:0005635;GO:0005654;GO:0005737;GO:0005741;GO:0005764;GO:0005765;GO:0005789;GO:0005829;GO:0012505;GO:0016020;GO:0016605;GO:0030425;GO:0031931;GO:0031932;GO:0045335	RNA polymerase III type 1 promoter sequence-specific DNA binding;RNA polymerase III type 2 promoter sequence-specific DNA binding;RNA polymerase III type 3 promoter sequence-specific DNA binding;TFIIIC-class transcription factor complex binding;protein kinase activity;protein serine/threonine kinase activity;protein binding;ATP binding;kinase activity;identical protein binding;ribosome binding;phosphoprotein binding;protein serine kinase activity	GO:0001002;GO:0001003;GO:0001006;GO:0001156;GO:0004672;GO:0004674;GO:0005515;GO:0005524;GO:0016301;GO:0042802;GO:0043022;GO:0051219;GO:0106310	15.0	5189b3dc-5521-11e7-8f50-0ac135e8bacf,603902ca-5521-11e7-8f50-0ac135e8bacf,8f640d10-5521-11e7-8f50-0ac135e8bacf,945aa686-5521-11e7-8f50-0ac135e8bacf,a04a1220-5521-11e7-8f50-0ac135e8bacf,a8411a5c-5521-11e7-8f50-0ac135e8bacf,aa5b6ede-5521-11e7-8f50-0ac135e8bacf,afa50a56-5521-11e7-8f50-0ac135e8bacf,c70366de-5521-11e7-8f50-0ac135e8bacf,c92b28e0-5521-11e7-8f50-0ac135e8bacf,d5aa2a46-5521-11e7-8f50-0ac135e8bacf,df93b3b8-5521-11e7-8f50-0ac135e8bacf,e1b66caa-5521-11e7-8f50-0ac135e8bacf,e6f69242-5521-11e7-8f50-0ac135e8bacf,e92d968a-5521-11e7-8f50-0ac135e8bacf	Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met),Regulation of Telomerase,mTOR signaling pathway,LKB1 signaling events,IL4-mediated signaling events,IL2 signaling events mediated by PI3K,IL12-mediated signaling events,IFN-gamma pathway,ErbB2ErbB3 signaling events,ErbB1 downstream signaling,EGFR-dependent Endothelin signaling events,CXCR4-mediated signaling events,CXCR3-mediated signaling events,Class I PI3K signaling events mediated by Akt,CDC42 signaling events	rs1064261	rs1064261	0.639095	0.388457	0.65512	0.916133	0.744722	0.780906	0.728017	0.693669	0.832896
chr20:46279836:ACAG/A	NCOA3 p.Gln1276del		5.0	0.7571882168736117			chr20	46279836	ACAG	A	294		Yes	NCOA3	ENST00000371998.8	inframe_deletion	20.0	c.3789_3791del	p.Gln1276del	47651095													COSV100507777	"[[""stomach"", 1]]"	1.0	ENST00000372004.7	Q1276del	Protein Change							chromatin remodeling;cellular response to hormone stimulus;receptor transactivation;cell dedifferentiation;positive regulation of keratinocyte differentiation;positive regulation of transcription by RNA polymerase II;cellular response to estradiol stimulus;positive regulation of stem cell population maintenance;regulation of stem cell division	GO:0006338;GO:0032870;GO:0035624;GO:0043697;GO:0045618;GO:0045944;GO:0071392;GO:1902459;GO:2000035	chromatin;nucleus;nucleoplasm;cytoplasm;cytosol;protein-containing complex;extracellular exosome	GO:0000785;GO:0005634;GO:0005654;GO:0005737;GO:0005829;GO:0032991;GO:0070062	RNA polymerase II complex binding;transcription coactivator activity;histone acetyltransferase activity;protein binding;nuclear receptor binding;nuclear receptor coactivator activity;nuclear thyroid hormone receptor binding;protein dimerization activity;disordered domain specific binding	GO:0000993;GO:0003713;GO:0004402;GO:0005515;GO:0016922;GO:0030374;GO:0046966;GO:0046983;GO:0097718	5.0	29ff5368-5521-11e7-8f50-0ac135e8bacf,3a1b0394-5521-11e7-8f50-0ac135e8bacf,3ab9dba6-5521-11e7-8f50-0ac135e8bacf,5fa96cf8-5521-11e7-8f50-0ac135e8bacf,bf04bd82-5521-11e7-8f50-0ac135e8bacf	EGF receptor (ErbB1) signaling pathway,Validated nuclear estrogen receptor beta network,Validated nuclear estrogen receptor alpha network,Retinoic acid receptors-mediated signaling,FOXA1 transcription factor network			0.306982	0.184267	0.485104	0.251703	0.298216	0.291888	0.389384	0.329353	0.226918
chr17:8051922:C/T	PER1 intron_variant				True	0.6521739130434783	chr17	8051922	C	T	293			PER1	ENST00000317276.9	intron_variant		c.1048+40G>A		8148604	0.007388178913738	0.0015128593040847	0.0172910662824207	0.0	0.0198807157057654	0.0030674846625766							COSV57919935	"[[""large intestine"", 1]]"	1.0	ENST00000581082.5	?	Exact Match							negative regulation of transcription by RNA polymerase II;regulation of sodium ion transport;chromatin remodeling;circadian rhythm;entrainment of circadian clock;post-transcriptional regulation of gene expression;circadian regulation of gene expression;regulation of hair cycle;regulation of circadian rhythm;negative regulation of canonical NF-kappaB signal transduction;entrainment of circadian clock by photoperiod;negative regulation of DNA-templated transcription;positive regulation of transcription by RNA polymerase II;negative regulation of JNK cascade;response to cAMP;circadian regulation of translation;regulation of cytokine production involved in inflammatory response;regulation of p38MAPK cascade;negative regulation of glucocorticoid receptor signaling pathway	GO:0000122;GO:0002028;GO:0006338;GO:0007623;GO:0009649;GO:0010608;GO:0032922;GO:0042634;GO:0042752;GO:0043124;GO:0043153;GO:0045892;GO:0045944;GO:0046329;GO:0051591;GO:0097167;GO:1900015;GO:1900744;GO:2000323	nucleus;nucleoplasm;cytoplasm;cytosol	GO:0005634;GO:0005654;GO:0005737;GO:0005829	transcription cis-regulatory region binding;RNA polymerase II cis-regulatory region sequence-specific DNA binding;transcription corepressor binding;protein binding;kinase binding;chromatin DNA binding;ubiquitin protein ligase binding;E-box binding;DNA-binding transcription factor binding	GO:0000976;GO:0000978;GO:0001222;GO:0005515;GO:0019900;GO:0031490;GO:0031625;GO:0070888;GO:0140297	1.0	e7781e54-5521-11e7-8f50-0ac135e8bacf	Circadian rhythm pathway	rs55720390	rs55720390	0.0136485	0.00359079	0.0222623	0.000638978	0.0315186	0.0131772	0.0182736	0.0125348	0.00393701
chr20:62303794:G/A	RTEL1 intron_variant		7.0	0.6960393904774165		0.4615384615384615	chr20	62303794	G	A	293			RTEL1	ENST00000360203.10	intron_variant		c.700-115G>A		63672441	0.3356629392971246	0.3721633888048411	0.4221902017291066	0.115079365079365	0.5129224652087475	0.2699386503067484							COSV58895362	"[[""lung"", 1]]"	1.0	ENST00000360203.10	?	Exact Match	Benign	MedGen:C3661900|MONDO:MONDO:0014076,MedGen:C3554656,OMIM:615190|MONDO:MONDO:0014613,MedGen:C4225346,OMIM:616373,Orphanet:2032	not provided|Dyskeratosis congenita, autosomal recessive 5|Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3	criteria provided, multiple submitters, no conflicts	1181603.0		telomere maintenance;DNA strand displacement;DNA repair;regulation of double-strand break repair via homologous recombination;replication fork processing;positive regulation of telomere maintenance;DNA duplex unwinding;telomere maintenance in response to DNA damage;negative regulation of DNA recombination;telomeric loop disassembly;mitotic telomere maintenance via semi-conservative replication;positive regulation of telomere capping;positive regulation of telomere maintenance via telomere lengthening;negative regulation of t-circle formation;negative regulation of telomere maintenance in response to DNA damage;positive regulation of telomeric loop disassembly	GO:0000723;GO:0000732;GO:0006281;GO:0010569;GO:0031297;GO:0032206;GO:0032508;GO:0043247;GO:0045910;GO:0090657;GO:1902990;GO:1904355;GO:1904358;GO:1904430;GO:1904506;GO:1904535	chromosome, telomeric region;nucleus;nucleoplasm;nuclear speck;nuclear membrane	GO:0000781;GO:0005634;GO:0005654;GO:0016607;GO:0031965	DNA binding;DNA helicase activity;protein binding;ATP binding;ATP hydrolysis activity;metal ion binding;4 iron, 4 sulfur cluster binding;DNA polymerase binding	GO:0003677;GO:0003678;GO:0005515;GO:0005524;GO:0016887;GO:0046872;GO:0051539;GO:0070182				rs6062300	rs6062300	0.446933	0.377754	0.490361	0.139795	0.605697	0.42765	0.488788	0.431628	0.31332
chr2:203384776:C/CT	BMPR2 intron_variant		8.0	0.6132461161079313			chr2	203384776	C	CT	291			BMPR2	ENST00000374580.10	intron_variant		c.853-22dup		202520054																			Benign	MedGen:C3661900	not provided	criteria provided, single submitter	1290664.0		blood vessel development;osteoblast differentiation;mesoderm formation;maternal placenta development;endothelial cell proliferation;lymphangiogenesis;blood vessel remodeling;chondrocyte development;negative regulation of systemic arterial blood pressure;outflow tract septum morphogenesis;outflow tract morphogenesis;aortic valve development;pulmonary valve development;atrioventricular valve morphogenesis;mitral valve morphogenesis;tricuspid valve morphogenesis;endocardial cushion development;negative regulation of cell proliferation involved in heart valve morphogenesis;protein phosphorylation;cell surface receptor protein serine/threonine kinase signaling pathway;cellular response to starvation;anterior/posterior pattern specification;positive regulation of gene expression;positive regulation of epithelial cell migration;regulation of lung blood pressure;proteoglycan biosynthetic process;negative regulation of cell growth;positive regulation of bone mineralization;BMP signaling pathway;activin receptor signaling pathway;regulation of cell population proliferation;positive regulation of osteoblast differentiation;positive regulation of ossification;negative regulation of vasoconstriction;positive regulation of transcription by RNA polymerase II;lung alveolus development;negative regulation of smooth muscle cell proliferation;cardiac muscle tissue development;positive regulation of axon extension involved in axon guidance;negative regulation of muscle cell differentiation;limb development;endochondral bone morphogenesis;positive regulation of SMAD protein signal transduction;ventricular septum morphogenesis;atrial septum morphogenesis;lung vasculature development;lymphatic endothelial cell differentiation;artery development;venous blood vessel development;positive regulation of cartilage development;retina vasculature development in camera-type eye;pharyngeal arch artery morphogenesis;cellular response to growth factor stimulus;cellular response to BMP stimulus;endothelial cell apoptotic process;negative regulation of chondrocyte proliferation;semi-lunar valve development	GO:0001568;GO:0001649;GO:0001707;GO:0001893;GO:0001935;GO:0001946;GO:0001974;GO:0002063;GO:0003085;GO:0003148;GO:0003151;GO:0003176;GO:0003177;GO:0003181;GO:0003183;GO:0003186;GO:0003197;GO:0003252;GO:0006468;GO:0007178;GO:0009267;GO:0009952;GO:0010628;GO:0010634;GO:0014916;GO:0030166;GO:0030308;GO:0030501;GO:0030509;GO:0032924;GO:0042127;GO:0045669;GO:0045778;GO:0045906;GO:0045944;GO:0048286;GO:0048662;GO:0048738;GO:0048842;GO:0051148;GO:0060173;GO:0060350;GO:0060391;GO:0060412;GO:0060413;GO:0060426;GO:0060836;GO:0060840;GO:0060841;GO:0061036;GO:0061298;GO:0061626;GO:0071363;GO:0071773;GO:0072577;GO:1902731;GO:1905314	extracellular space;nucleoplasm;plasma membrane;caveola;clathrin-coated pit;adherens junction;basal plasma membrane;cell surface;postsynaptic density;apical plasma membrane;axon;dendrite;neuronal cell body;receptor complex	GO:0005615;GO:0005654;GO:0005886;GO:0005901;GO:0005905;GO:0005912;GO:0009925;GO:0009986;GO:0014069;GO:0016324;GO:0030424;GO:0030425;GO:0043025;GO:0043235	transforming growth factor beta receptor activity;protein binding;ATP binding;activin receptor activity, type II;growth factor binding;BMP binding;cadherin binding;metal ion binding;BMP receptor activity;protein tyrosine kinase binding	GO:0005024;GO:0005515;GO:0005524;GO:0016362;GO:0019838;GO:0036122;GO:0045296;GO:0046872;GO:0098821;GO:1990782	3.0	049349a0-5522-11e7-8f50-0ac135e8bacf,05263ad2-5522-11e7-8f50-0ac135e8bacf,f1ae1a1c-5521-11e7-8f50-0ac135e8bacf	ALK2 signaling events,ALK1 signaling events,BMP receptor signaling			0.559982	0.598818	0.529736	0.721279	0.498284	0.541169	0.541205	0.591887	0.532056
chr3:52637486:C/G	PBRM1 intron_variant		5.0	0.879074587317122	True	0.5227272727272727	chr3	52637486	C	G	288			PBRM1	ENST00000296302.11	intron_variant		c.2779+51G>C		52603470	0.5706869009584664	0.8055975794251135	0.6469740634005764	0.4543650793650793	0.5705765407554672	0.3190184049079754							COSV56271593	"[[""haematopoietic and lymphoid tissue"", 1]]"	1.0	ENST00000409057.5	?	Exact Match	Benign	MedGen:C3661900	not provided	criteria provided, single submitter	1237624.0		mitotic cell cycle;chromatin remodeling;regulation of transcription by RNA polymerase II;transcription elongation by RNA polymerase II;negative regulation of cell population proliferation;regulation of mitotic metaphase/anaphase transition;positive regulation of T cell differentiation;positive regulation of cell differentiation;positive regulation of myoblast differentiation;regulation of G0 to G1 transition;regulation of G1/S transition of mitotic cell cycle;positive regulation of double-strand break repair;regulation of nucleotide-excision repair	GO:0000278;GO:0006338;GO:0006357;GO:0006368;GO:0008285;GO:0030071;GO:0045582;GO:0045597;GO:0045663;GO:0070316;GO:2000045;GO:2000781;GO:2000819	nuclear chromosome;kinetochore;chromatin;nucleus;nucleoplasm;nuclear matrix;SWI/SNF complex;RSC-type complex	GO:0000228;GO:0000776;GO:0000785;GO:0005634;GO:0005654;GO:0016363;GO:0016514;GO:0016586	DNA binding;chromatin binding;protein binding	GO:0003677;GO:0003682;GO:0005515				rs2276824	rs2276824	0.611958	0.748274	0.569536	0.432268	0.512092	0.646093	0.55703	0.616636	0.30198
chr22:29130347:G/GT	CHEK2 intron_variant		2.0	0.7270049099836334		0.3793103448275862	chr22	29130347	G	GT	288			CHEK2	ENST00000404276.6	intron_variant		c.319+43dup		28734360	0.2304313099041533	0.0771558245083207	0.3069164265129683	0.4067460317460317	0.162027833001988	0.2719836400817996													Benign	MedGen:C3661900|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	not provided|Familial cancer of breast|Hereditary breast ovarian cancer syndrome	criteria provided, multiple submitters, no conflicts	1167620.0		DNA damage checkpoint signaling;G2/M transition of mitotic cell cycle;double-strand break repair;regulation of DNA-templated transcription;protein phosphorylation;DNA damage response;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;intrinsic apoptotic signaling pathway in response to DNA damage;protein catabolic process;mitotic intra-S DNA damage checkpoint signaling;regulation of protein catabolic process;signal transduction in response to DNA damage;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;mitotic DNA damage checkpoint signaling;positive regulation of DNA-templated transcription;protein autophosphorylation;protein stabilization;cell division;thymocyte apoptotic process;cellular response to gamma radiation;mitotic spindle assembly;replicative senescence;regulation of signal transduction by p53 class mediator;regulation of autophagosome assembly	GO:0000077;GO:0000086;GO:0006302;GO:0006355;GO:0006468;GO:0006974;GO:0006977;GO:0006978;GO:0008630;GO:0030163;GO:0031573;GO:0042176;GO:0042770;GO:0042771;GO:0044773;GO:0045893;GO:0046777;GO:0050821;GO:0051301;GO:0070242;GO:0071480;GO:0090307;GO:0090399;GO:1901796;GO:2000785	chromosome, telomeric region;nucleus;nucleoplasm;cytoplasm;Golgi apparatus;PML body	GO:0000781;GO:0005634;GO:0005654;GO:0005737;GO:0005794;GO:0016605	protein serine/threonine kinase activity;protein binding;ATP binding;protein kinase binding;ubiquitin protein ligase binding;identical protein binding;protein homodimerization activity;metal ion binding;protein serine kinase activity	GO:0004674;GO:0005515;GO:0005524;GO:0019901;GO:0031625;GO:0042802;GO:0042803;GO:0046872;GO:0106310	4.0	76f15b4e-5521-11e7-8f50-0ac135e8bacf,81be3ee4-5521-11e7-8f50-0ac135e8bacf,bddf504e-5521-11e7-8f50-0ac135e8bacf,f9c7eca4-5521-11e7-8f50-0ac135e8bacf	PLK3 signaling events,p53 pathway,FOXM1 transcription factor network,ATM pathway	rs3841692	rs3841692	0.165602	0.101525	0.324503	0.406709	0.165421	0.269067	0.158745	0.198509	0.278144
chr2:148657117:G/A	ACVR2A p.Pro118=		5.0	0.8385955720791554	True	0.6585365853658537	chr2	148657117	G	A	279		Yes	ACVR2A	ENST00000241416.12	synonymous_variant	3.0	c.354G>A	p.Pro118=	147899548	0.3526357827476038	0.2851739788199697	0.4610951008645533	0.4672619047619048	0.3270377733598409	0.2750511247443762							COSV54020221	"[[""large intestine"", 2], [""biliary tract"", 1], [""kidney"", 1], [""urinary tract"", 1], [""haematopoietic and lymphoid tissue"", 1], [""breast"", 1]]"	7.0	ENST00000535787.5	P118%3D	Exact Match							gastrulation with mouth forming second;positive regulation of protein phosphorylation;protein phosphorylation;cell surface receptor protein serine/threonine kinase signaling pathway;spermatogenesis;determination of left/right symmetry;mesoderm development;anterior/posterior pattern specification;positive regulation of bone mineralization;BMP signaling pathway;activin receptor signaling pathway;positive regulation of activin receptor signaling pathway;odontogenesis of dentin-containing tooth;sperm ejaculation;penile erection;regulation of nitric oxide biosynthetic process;positive regulation of erythrocyte differentiation;positive regulation of osteoblast differentiation;positive regulation of transcription by RNA polymerase II;embryonic skeletal system development;Sertoli cell proliferation;positive regulation of SMAD protein signal transduction;cellular response to growth factor stimulus;cellular response to BMP stimulus	GO:0001702;GO:0001934;GO:0006468;GO:0007178;GO:0007283;GO:0007368;GO:0007498;GO:0009952;GO:0030501;GO:0030509;GO:0032924;GO:0032927;GO:0042475;GO:0042713;GO:0043084;GO:0045428;GO:0045648;GO:0045669;GO:0045944;GO:0048706;GO:0060011;GO:0060391;GO:0071363;GO:0071773	cytoplasm;plasma membrane;cell surface;inhibin-betaglycan-ActRII complex;receptor complex;activin receptor complex	GO:0005737;GO:0005886;GO:0009986;GO:0034673;GO:0043235;GO:0048179	protein serine/threonine kinase activity;transmembrane receptor protein serine/threonine kinase activity;protein binding;ATP binding;coreceptor activity;activin receptor activity;growth factor binding;PDZ domain binding;inhibin binding;metal ion binding;activin binding;BMP receptor activity	GO:0004674;GO:0004675;GO:0005515;GO:0005524;GO:0015026;GO:0017002;GO:0019838;GO:0030165;GO:0034711;GO:0046872;GO:0048185;GO:0098821	1.0	05263ad2-5522-11e7-8f50-0ac135e8bacf	ALK1 signaling events	rs1128919	rs1128919	0.322912	0.298964	0.328012	0.534251	0.335938	0.379282	0.313869	0.356542	0.316776
chr20:46279896:G/A	NCOA3 p.Gln1274=		8.0	0.8576557550158395			chr20	46279896	G	A	279		Yes	NCOA3	ENST00000371998.8	synonymous_variant	20.0	c.3822G>A	p.Gln1274=	47651152													COSV59069073	"[[""liver"", 2]]"	2.0	ENST00000372004.7	Q1274%3D	Exact Match							chromatin remodeling;cellular response to hormone stimulus;receptor transactivation;cell dedifferentiation;positive regulation of keratinocyte differentiation;positive regulation of transcription by RNA polymerase II;cellular response to estradiol stimulus;positive regulation of stem cell population maintenance;regulation of stem cell division	GO:0006338;GO:0032870;GO:0035624;GO:0043697;GO:0045618;GO:0045944;GO:0071392;GO:1902459;GO:2000035	chromatin;nucleus;nucleoplasm;cytoplasm;cytosol;protein-containing complex;extracellular exosome	GO:0000785;GO:0005634;GO:0005654;GO:0005737;GO:0005829;GO:0032991;GO:0070062	RNA polymerase II complex binding;transcription coactivator activity;histone acetyltransferase activity;protein binding;nuclear receptor binding;nuclear receptor coactivator activity;nuclear thyroid hormone receptor binding;protein dimerization activity;disordered domain specific binding	GO:0000993;GO:0003713;GO:0004402;GO:0005515;GO:0016922;GO:0030374;GO:0046966;GO:0046983;GO:0097718	5.0	29ff5368-5521-11e7-8f50-0ac135e8bacf,3a1b0394-5521-11e7-8f50-0ac135e8bacf,3ab9dba6-5521-11e7-8f50-0ac135e8bacf,5fa96cf8-5521-11e7-8f50-0ac135e8bacf,bf04bd82-5521-11e7-8f50-0ac135e8bacf	EGF receptor (ErbB1) signaling pathway,Validated nuclear estrogen receptor beta network,Validated nuclear estrogen receptor alpha network,Retinoic acid receptors-mediated signaling,FOXA1 transcription factor network	rs770187692										
chr19:1220321:T/C	STK11 intron_variant	1.0	5.0	0.2165021005441678			chr19	1220321	T	C	277			STK11	ENST00000326873.12	intron_variant		c.465-51T>C		1220322	0.3596246006389776	0.4402420574886536	0.2723342939481268	0.5416666666666666	0.2157057654075546	0.2730061349693251							COSV58829253	"[[""liver"", 1], [""soft tissue"", 1]]"	2.0	ENST00000586243.5	?	Exact Match	Benign	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|Human Phenotype Ontology:HP:0030359,MONDO:MONDO:0005097,MedGen:C0149782	Hereditary cancer-predisposing syndrome|not provided|Squamous cell lung carcinoma	criteria provided, multiple submitters, no conflicts	873158.0		regulation of cell growth;tissue homeostasis;vasculature development;protein phosphorylation;protein dephosphorylation;autophagy;DNA damage response;signal transduction;spermatogenesis;axonogenesis;negative regulation of cell population proliferation;response to ionizing radiation;positive regulation of autophagy;response to activity;peptidyl-threonine phosphorylation;establishment of cell polarity;regulation of Wnt signaling pathway;negative regulation of cell growth;positive regulation of transforming growth factor beta receptor signaling pathway;activation of protein kinase activity;response to glucagon;response to lipid;protein localization to nucleus;glucose homeostasis;anoikis;positive thymic T cell selection;positive regulation of gluconeogenesis;protein autophosphorylation;regulation of dendrite morphogenesis;positive regulation of axonogenesis;T cell receptor signaling pathway;Golgi localization;regulation of cell cycle;regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction;epithelial cell proliferation involved in prostate gland development;negative regulation of epithelial cell proliferation involved in prostate gland development;G1 to G0 transition;cellular response to UV-B;intrinsic apoptotic signaling pathway by p53 class mediator;negative regulation of canonical Wnt signaling pathway;response to thyroid hormone;dendrite extension;negative regulation of cold-induced thermogenesis;positive regulation of protein localization to nucleus;positive regulation of vesicle transport along microtubule;regulation of signal transduction by p53 class mediator;negative regulation of TORC1 signaling	GO:0001558;GO:0001894;GO:0001944;GO:0006468;GO:0006470;GO:0006914;GO:0006974;GO:0007165;GO:0007283;GO:0007409;GO:0008285;GO:0010212;GO:0010508;GO:0014823;GO:0018107;GO:0030010;GO:0030111;GO:0030308;GO:0030511;GO:0032147;GO:0033762;GO:0033993;GO:0034504;GO:0042593;GO:0043276;GO:0045059;GO:0045722;GO:0046777;GO:0048814;GO:0050772;GO:0050852;GO:0051645;GO:0051726;GO:0051896;GO:0060767;GO:0060770;GO:0070314;GO:0071493;GO:0072332;GO:0090090;GO:0097066;GO:0097484;GO:0120163;GO:1900182;GO:1901610;GO:1901796;GO:1904262	nucleus;nucleoplasm;cytoplasm;mitochondrion;cytosol;membrane;Z disc;extracellular exosome;intracellular protein-containing complex;serine/threonine protein kinase complex	GO:0005634;GO:0005654;GO:0005737;GO:0005739;GO:0005829;GO:0016020;GO:0030018;GO:0070062;GO:0140535;GO:1902554	magnesium ion binding;p53 binding;protein serine/threonine kinase activity;protein binding;ATP binding;LRR domain binding;protein kinase activator activity;protein-containing complex binding;protein serine kinase activity	GO:0000287;GO:0002039;GO:0004674;GO:0005515;GO:0005524;GO:0030275;GO:0030295;GO:0044877;GO:0106310	1.0	945aa686-5521-11e7-8f50-0ac135e8bacf	LKB1 signaling events	rs2075606	rs2075606	0.299175	0.421311	0.232831	0.516677	0.249617	0.28039	0.22609	0.306407	0.291118
chr10:88683209:T/G	BMPR1A p.Val473=					0.5833333333333334	chr10	88683209	T	G	277		Yes	BMPR1A	ENST00000372037.7	synonymous_variant	12.0	c.1419T>G	p.Val473=	86923452	0.0001996805111821	0.0	0.0	0.0	0.0009940357852882	0.0													Conflicting classifications of pathogenicity	MONDO:MONDO:0017380,MedGen:C0345893,OMIM:174900,Orphanet:2929|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0008276,MedGen:C1868081,Orphanet:329971	Juvenile polyposis syndrome|Hereditary cancer-predisposing syndrome|not specified|not provided|Generalized juvenile polyposis/juvenile polyposis coli	criteria provided, conflicting classifications	136526.0	Uncertain significance(1)|Benign(7)|Likely benign(5)	angiogenesis;osteoblast differentiation;in utero embryonic development;mesoderm formation;somitogenesis;Mullerian duct regression;positive regulation of mesenchymal cell proliferation;chondrocyte differentiation;outflow tract septum morphogenesis;outflow tract morphogenesis;cardiac conduction system development;atrioventricular valve development;mitral valve morphogenesis;tricuspid valve morphogenesis;endocardial cushion morphogenesis;cardiac right ventricle morphogenesis;ventricular trabecula myocardium morphogenesis;ventricular compact myocardium morphogenesis;endocardial cushion formation;protein phosphorylation;immune response;transforming growth factor beta receptor signaling pathway;ectoderm development;dorsal/ventral axis specification;dorsal/ventral pattern formation;positive regulation of gene expression;negative regulation of gene expression;regulation of cardiac muscle cell apoptotic process;neural crest cell development;negative regulation of smooth muscle cell migration;central nervous system neuron differentiation;pituitary gland development;neural plate mediolateral regionalization;lung development;positive regulation of bone mineralization;BMP signaling pathway;positive regulation of transforming growth factor beta2 production;somatic stem cell population maintenance;hindlimb morphogenesis;dorsal aorta morphogenesis;odontogenesis of dentin-containing tooth;embryonic digit morphogenesis;positive regulation of osteoblast differentiation;positive regulation of transcription by RNA polymerase II;paraxial mesoderm structural organization;lateral mesoderm development;regulation of lateral mesodermal cell fate specification;mesendoderm development;embryonic organ development;developmental growth;epithelial cell proliferation;positive regulation of epithelial cell proliferation;negative regulation of neurogenesis;negative regulation of muscle cell differentiation;roof of mouth development;regulation of cardiac muscle cell proliferation;positive regulation of cardiac muscle cell proliferation;positive regulation of SMAD protein signal transduction;ventricular septum morphogenesis;heart formation;atrioventricular node cell development;pharyngeal arch artery morphogenesis;cellular response to growth factor stimulus;cellular response to BMP stimulus;positive regulation of miRNA transcription;positive regulation of cardiac ventricle development;positive regulation of vascular associated smooth muscle cell proliferation;fibrous ring of heart morphogenesis;regulation of neural crest cell differentiation;regulation of cellular senescence	GO:0001525;GO:0001649;GO:0001701;GO:0001707;GO:0001756;GO:0001880;GO:0002053;GO:0002062;GO:0003148;GO:0003151;GO:0003161;GO:0003171;GO:0003183;GO:0003186;GO:0003203;GO:0003215;GO:0003222;GO:0003223;GO:0003272;GO:0006468;GO:0006955;GO:0007179;GO:0007398;GO:0009950;GO:0009953;GO:0010628;GO:0010629;GO:0010665;GO:0014032;GO:0014912;GO:0021953;GO:0021983;GO:0021998;GO:0030324;GO:0030501;GO:0030509;GO:0032915;GO:0035019;GO:0035137;GO:0035912;GO:0042475;GO:0042733;GO:0045669;GO:0045944;GO:0048352;GO:0048368;GO:0048378;GO:0048382;GO:0048568;GO:0048589;GO:0050673;GO:0050679;GO:0050768;GO:0051148;GO:0060021;GO:0060043;GO:0060045;GO:0060391;GO:0060412;GO:0060914;GO:0060928;GO:0061626;GO:0071363;GO:0071773;GO:1902895;GO:1904414;GO:1904707;GO:1905285;GO:1905292;GO:2000772	plasma membrane;caveola;external side of plasma membrane;membrane;dendrite;neuronal cell body;receptor complex;HFE-transferrin receptor complex	GO:0005886;GO:0005901;GO:0009897;GO:0016020;GO:0030425;GO:0043025;GO:0043235;GO:1990712	protein serine/threonine kinase activity;transmembrane receptor protein serine/threonine kinase activity;transforming growth factor beta receptor activity, type I;protein binding;ATP binding;BMP binding;protein homodimerization activity;SMAD binding;metal ion binding;BMP receptor activity	GO:0004674;GO:0004675;GO:0005025;GO:0005515;GO:0005524;GO:0036122;GO:0042803;GO:0046332;GO:0046872;GO:0098821	1.0	f1ae1a1c-5521-11e7-8f50-0ac135e8bacf	BMP receptor signaling	rs145756629		0.000579229	4.75783e-05	0.0156438	0.0	0.0	0.000586166	0.000294245	0.0	0.000656599
chr4:2210065:C/A	POLN p.Gln121His		3.0	0.3376016541425974	True	0.3783783783783784	chr4	2210065	C	A	276		Yes	POLN	ENST00000511885.6	missense_variant	5.0	c.363G>T	p.Gln121His	2208338	0.0439297124600639	0.0068078668683812	0.0677233429394812	0.0029761904761904	0.1262425447316103	0.0347648261758691	0.721	0.629					COSV67027662	"[[""soft tissue"", 2], [""urinary tract"", 1]]"	3.0	ENST00000511885.6	Q121H	Exact Match							double-strand break repair via homologous recombination;DNA-templated DNA replication;double-strand break repair;translesion synthesis;interstrand cross-link repair	GO:0000724;GO:0006261;GO:0006302;GO:0019985;GO:0036297	nucleus;nucleoplasm;nucleolus	GO:0005634;GO:0005654;GO:0005730	DNA binding;DNA-directed DNA polymerase activity;protein binding;cyclin binding	GO:0003677;GO:0003887;GO:0005515;GO:0030332				rs2353552	rs2353552	0.0835219	0.0219419	0.120555	0.000319489	0.124497	0.066471	0.122108	0.0860465	0.0459016
chr1:91859801:A/G	HFM1 p.Ser115Pro		5.0	0.2756460001871883	True	0.5	chr1	91859801	A	G	274		Yes	HFM1	ENST00000370425.8	missense_variant	4.0	c.343T>C	p.Ser115Pro	91394244	0.1367811501597444	0.1649016641452345	0.1585014409221902	0.0049603174603174	0.2355864811133201	0.1175869120654396	0.881	0.916					COSV54023753	"[[""soft tissue"", 3], [""pancreas"", 1], [""central nervous system"", 1], [""liver"", 1]]"	6.0	ENST00000370425.7	S115P	Exact Match	Benign	MedGen:C3661900	not provided	criteria provided, single submitter	1277748.0		resolution of meiotic recombination intermediates;DNA duplex unwinding	GO:0000712;GO:0032508	nucleus	GO:0005634	nucleic acid binding;DNA helicase activity;ATP binding;ATP hydrolysis activity	GO:0003676;GO:0003678;GO:0005524;GO:0016887				rs11165778	rs11165778	0.213836	0.176187	0.15431	0.00255428	0.197103	0.180121	0.265107	0.216946	0.125904
chr1:226578099:T/C	PARP1 intron_variant		8.0	0.9411283728536386	True	0.4642857142857143	chr1	226578099	T	C	273			PARP1	ENST00000366794.10	intron_variant		c.617+12A>G		226390398	0.8576277955271565	0.9712556732223904	0.8126801152737753	0.9315476190476192	0.7733598409542743	0.7464212678936605																			negative regulation of transcription by RNA polymerase II;telomere maintenance;DNA repair;double-strand break repair;transcription by RNA polymerase II;apoptotic process;DNA damage response;mitochondrion organization;transforming growth factor beta receptor signaling pathway;response to gamma radiation;positive regulation of cardiac muscle hypertrophy;carbohydrate biosynthetic process;protein autoprocessing;signal transduction involved in regulation of gene expression;macrophage differentiation;DNA ADP-ribosylation;mitochondrial DNA metabolic process;positive regulation of DNA-templated transcription, elongation;cellular response to insulin stimulus;regulation of protein localization;positive regulation of intracellular estrogen receptor signaling pathway;negative regulation of transcription elongation by RNA polymerase II;cellular response to oxidative stress;cellular response to UV;protein modification process;positive regulation of canonical NF-kappaB signal transduction;mitochondrial DNA repair;innate immune response;regulation of circadian sleep/wake cycle, non-REM sleep;negative regulation of innate immune response;negative regulation of DNA-templated transcription;positive regulation of transcription by RNA polymerase II;decidualization;regulation of catalytic activity;positive regulation of mitochondrial depolarization;positive regulation of SMAD protein signal transduction;positive regulation of necroptotic process;protein poly-ADP-ribosylation;protein auto-ADP-ribosylation;protein localization to chromatin;cellular response to zinc ion;replication fork reversal;negative regulation of cGAS/STING signaling pathway;positive regulation of protein localization to nucleus;regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway;positive regulation of single strand break repair;response to aldosterone;negative regulation of adipose tissue development;negative regulation of telomere maintenance via telomere lengthening;cellular response to amyloid-beta;positive regulation of myofibroblast differentiation;regulation of base-excision repair;positive regulation of double-strand break repair via homologous recombination;cellular response to nerve growth factor stimulus;ATP generation from poly-ADP-D-ribose;negative regulation of ATP biosynthetic process	GO:0000122;GO:0000723;GO:0006281;GO:0006302;GO:0006366;GO:0006915;GO:0006974;GO:0007005;GO:0007179;GO:0010332;GO:0010613;GO:0016051;GO:0016540;GO:0023019;GO:0030225;GO:0030592;GO:0032042;GO:0032786;GO:0032869;GO:0032880;GO:0033148;GO:0034244;GO:0034599;GO:0034644;GO:0036211;GO:0043123;GO:0043504;GO:0045087;GO:0045188;GO:0045824;GO:0045892;GO:0045944;GO:0046697;GO:0050790;GO:0051901;GO:0060391;GO:0060545;GO:0070212;GO:0070213;GO:0071168;GO:0071294;GO:0071932;GO:0160049;GO:1900182;GO:1903376;GO:1903518;GO:1904044;GO:1904178;GO:1904357;GO:1904646;GO:1904762;GO:1905051;GO:1905168;GO:1990090;GO:1990966;GO:2001170	chromosome, telomeric region;chromatin;nucleus;nuclear envelope;nucleoplasm;transcription regulator complex;nucleolus;mitochondrion;cytosol;membrane;nuclear body;protein-containing complex;protein-DNA complex;site of double-strand break;nuclear replication fork;site of DNA damage	GO:0000781;GO:0000785;GO:0005634;GO:0005635;GO:0005654;GO:0005667;GO:0005730;GO:0005739;GO:0005829;GO:0016020;GO:0016604;GO:0032991;GO:0032993;GO:0035861;GO:0043596;GO:0090734	DNA binding;chromatin binding;damaged DNA binding;RNA binding;NAD+ ADP-ribosyltransferase activity;protein binding;zinc ion binding;nucleotidyltransferase activity;enzyme binding;protein kinase binding;nuclear estrogen receptor binding;nucleosome binding;ubiquitin protein ligase binding;identical protein binding;protein homodimerization activity;histone deacetylase binding;NAD binding;RNA polymerase II-specific DNA-binding transcription factor binding;R-SMAD binding;NAD DNA ADP-ribosyltransferase activity;transcription regulator activator activity;NAD+-protein-serine ADP-ribosyltransferase activity;NAD+- protein-aspartate ADP-ribosyltransferase activity;NAD+-protein-glutamate ADP-ribosyltransferase activity;NAD+-protein-tyrosine ADP-ribosyltransferase activity;NAD+-protein-histidine ADP-ribosyltransferase activity;NAD+-histone H2BS6 serine ADP-ribosyltransferase activity;NAD+-histone H3S10 serine ADP-ribosyltransferase activity;NAD+-histone H2BE35 glutamate ADP-ribosyltransferase activity;NAD+-protein ADP-ribosyltransferase activity	GO:0003677;GO:0003682;GO:0003684;GO:0003723;GO:0003950;GO:0005515;GO:0008270;GO:0016779;GO:0019899;GO:0019901;GO:0030331;GO:0031491;GO:0031625;GO:0042802;GO:0042803;GO:0042826;GO:0051287;GO:0061629;GO:0070412;GO:0140294;GO:0140537;GO:0140805;GO:0140806;GO:0140807;GO:0140808;GO:0140815;GO:0140816;GO:0140817;GO:0140822;GO:1990404	3.0	841dd9cc-5521-11e7-8f50-0ac135e8bacf,98ad85f0-5521-11e7-8f50-0ac135e8bacf,ebd732be-5521-11e7-8f50-0ac135e8bacf	Notch-mediated HESHEY network,Integrin-linked kinase signaling,Caspase Cascade in Apoptosis	rs1805403	rs1805403	0.836286	0.936961	0.705776	0.945048	0.878182	0.820558	0.773497	0.823256	0.756074
chrX:53565685:A/T	HUWE1 intron_variant		8.0	0.6530564629024732			chrX	53565685	A	T	269			HUWE1	ENST00000262854.11	intron_variant		c.11878+111T>A		53538724													COSV53337240	"[[""lung"", 1], [""liver"", 1]]"	2.0	ENST00000262854.10	?	Exact Match	Benign	MedGen:C3661900	not provided	criteria provided, single submitter	1255095.0		protein polyubiquitination;base-excision repair;chromatin remodeling;ubiquitin-dependent protein catabolic process;protein monoubiquitination;Golgi organization;negative regulation of mitochondrial fusion;cell differentiation;positive regulation of protein ubiquitination;circadian regulation of gene expression;membrane fusion;positive regulation of mitophagy in response to mitochondrial depolarization;positive regulation of protein targeting to mitochondrion	GO:0000209;GO:0006284;GO:0006338;GO:0006511;GO:0006513;GO:0007030;GO:0010637;GO:0030154;GO:0031398;GO:0032922;GO:0061025;GO:0098779;GO:1903955	Golgi membrane;extracellular region;nucleus;nucleoplasm;cytoplasm;mitochondrion;cytosol;membrane;secretory granule lumen;extracellular exosome;ficolin-1-rich granule lumen	GO:0000139;GO:0005576;GO:0005634;GO:0005654;GO:0005737;GO:0005739;GO:0005829;GO:0016020;GO:0034774;GO:0070062;GO:1904813	DNA binding;RNA binding;ubiquitin-protein transferase activity;protein binding;ubiquitin protein ligase activity;histone ubiquitin ligase activity	GO:0003677;GO:0003723;GO:0004842;GO:0005515;GO:0061630;GO:0140852	2.0	3814fa62-5521-11e7-8f50-0ac135e8bacf,81be3ee4-5521-11e7-8f50-0ac135e8bacf	Validated targets of C-MYC transcriptional activation,p53 pathway	rs3008197	rs3008197	0.750883	0.6453	0.829391	0.913863	0.717882	0.84175	0.788816	0.744275	0.783394
chr19:5219829:T/G	PTPRS intron_variant		4.0	0.5444287729196051		0.375	chr19	5219829	T	G	267			PTPRS	ENST00000587303.5	intron_variant		c.3765+121A>C		5219818	0.3961661341853035	0.2473524962178517	0.3198847262247838	0.5972222222222222	0.4145129224652088	0.4253578732106339							COSV53614673	"[[""haematopoietic and lymphoid tissue"", 1]]"	1.0	ENST00000588012.5	?	Exact Match							protein dephosphorylation;negative regulation of neuron projection development;spinal cord development;cerebellum development;hippocampus development;cerebral cortex development;corpus callosum development;negative regulation of axon extension;negative regulation of interferon-alpha production;negative regulation of interferon-beta production;negative regulation of toll-like receptor 9 signaling pathway;peptidyl-tyrosine dephosphorylation;negative regulation of collateral sprouting;negative regulation of axon regeneration;modulation of chemical synaptic transmission;negative regulation of dendritic spine development;establishment of endothelial intestinal barrier;regulation of postsynaptic density assembly;trans-synaptic signaling;synaptic membrane adhesion	GO:0006470;GO:0010977;GO:0021510;GO:0021549;GO:0021766;GO:0021987;GO:0022038;GO:0030517;GO:0032687;GO:0032688;GO:0034164;GO:0035335;GO:0048671;GO:0048681;GO:0050804;GO:0061000;GO:0090557;GO:0099151;GO:0099537;GO:0099560	cytosol;plasma membrane;axon;growth cone;synaptic vesicle membrane;presynaptic membrane;perikaryon;extracellular exosome;Schaffer collateral - CA1 synapse;postsynaptic density membrane;glutamatergic synapse	GO:0005829;GO:0005886;GO:0030424;GO:0030426;GO:0030672;GO:0042734;GO:0043204;GO:0070062;GO:0098685;GO:0098839;GO:0098978	phosphoprotein phosphatase activity;protein tyrosine phosphatase activity;protein binding;heparin binding;chondroitin sulfate binding;heparan sulfate proteoglycan binding	GO:0004721;GO:0004725;GO:0005515;GO:0008201;GO:0035374;GO:0043395				rs34082224	rs34082224	0.375428	0.278657	0.35443	0.60263	0.378498	0.334972	0.430832	0.373141	0.457839
chr3:30686414:A/G	TGFBR2 intron_variant	1.0	5.0	0.7101877605368354	True	0.5882352941176471	chr3	30686414	A	G	267			TGFBR2	ENST00000295754.10	intron_variant		c.263+7A>G		30644922	0.4129392971246006	0.3419062027231467	0.2968299711815562	0.7053571428571429	0.3349900596421471	0.3701431492842536							COSV55442809	"[[""large intestine"", 22], [""soft tissue"", 11], [""lung"", 2], [""haematopoietic and lymphoid tissue"", 1], [""small intestine"", 1]]"	37.0	ENST00000295754.9	?	Exact Match	Benign	Human Phenotype Ontology:HP:0012727,MONDO:MONDO:0005396,MedGen:C0162872|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0007947,MedGen:C0024796,OMIM:154700,Orphanet:284963,Orphanet:558|MONDO:MONDO:0018954,MedGen:C2697932,OMIM:PS609192,Orphanet:60030|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|MONDO:MONDO:0012427,MedGen:C2674574,OMIM:610168,Orphanet:558	Thoracic aortic aneurysm|not specified|not provided|Marfan syndrome|Loeys-Dietz syndrome|Familial thoracic aortic aneurysm and aortic dissection|Loeys-Dietz syndrome 2	criteria provided, multiple submitters, no conflicts	36867.0		blood vessel development;branching involved in blood vessel morphogenesis;vasculogenesis;in utero embryonic development;epithelial to mesenchymal transition;heart looping;positive regulation of mesenchymal cell proliferation;lens development in camera-type eye;positive regulation of tolerance induction to self antigen;positive regulation of B cell tolerance induction;positive regulation of T cell tolerance induction;outflow tract septum morphogenesis;membranous septum morphogenesis;outflow tract morphogenesis;aortic valve morphogenesis;atrioventricular valve morphogenesis;tricuspid valve morphogenesis;cardiac left ventricle morphogenesis;endocardial cushion fusion;growth plate cartilage chondrocyte growth;protein phosphorylation;apoptotic process;transforming growth factor beta receptor signaling pathway;Notch signaling pathway;smoothened signaling pathway;gastrulation;brain development;heart development;positive regulation of cell population proliferation;response to xenobiotic stimulus;regulation of gene expression;positive regulation of epithelial cell migration;positive regulation of epithelial to mesenchymal transition;activation of protein kinase activity;activin receptor signaling pathway;embryonic hemopoiesis;aorta morphogenesis;regulation of cell population proliferation;myeloid dendritic cell differentiation;positive regulation of angiogenesis;embryonic cranial skeleton morphogenesis;artery morphogenesis;positive regulation of NK T cell differentiation;roof of mouth development;positive regulation of SMAD protein signal transduction;SMAD protein signal transduction;ventricular septum morphogenesis;bronchus morphogenesis;trachea formation;mammary gland morphogenesis;lung lobe morphogenesis;Langerhans cell differentiation;secondary palate development;response to cholesterol;cellular response to growth factor stimulus;regulation of stem cell proliferation;positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation;cell proliferation involved in endocardial cushion morphogenesis;superior endocardial cushion morphogenesis;inferior endocardial cushion morphogenesis;lens fiber cell apoptotic process;miRNA transport;positive regulation of reactive oxygen species metabolic process;positive regulation of CD4-positive, alpha-beta T cell proliferation;regulation of stem cell differentiation	GO:0001568;GO:0001569;GO:0001570;GO:0001701;GO:0001837;GO:0001947;GO:0002053;GO:0002088;GO:0002651;GO:0002663;GO:0002666;GO:0003148;GO:0003149;GO:0003151;GO:0003180;GO:0003181;GO:0003186;GO:0003214;GO:0003274;GO:0003430;GO:0006468;GO:0006915;GO:0007179;GO:0007219;GO:0007224;GO:0007369;GO:0007420;GO:0007507;GO:0008284;GO:0009410;GO:0010468;GO:0010634;GO:0010718;GO:0032147;GO:0032924;GO:0035162;GO:0035909;GO:0042127;GO:0043011;GO:0045766;GO:0048701;GO:0048844;GO:0051138;GO:0060021;GO:0060391;GO:0060395;GO:0060412;GO:0060434;GO:0060440;GO:0060443;GO:0060463;GO:0061520;GO:0062009;GO:0070723;GO:0071363;GO:0072091;GO:1905007;GO:1905315;GO:1905316;GO:1905317;GO:1990086;GO:1990428;GO:2000379;GO:2000563;GO:2000736	extracellular region;cytosol;plasma membrane;caveola;external side of plasma membrane;membrane;receptor complex;membrane raft;transforming growth factor beta ligand-receptor complex	GO:0005576;GO:0005829;GO:0005886;GO:0005901;GO:0009897;GO:0016020;GO:0043235;GO:0045121;GO:0070021	transmembrane receptor protein serine/threonine kinase activity;transforming growth factor beta receptor activity;transforming growth factor beta receptor activity, type II;protein binding;ATP binding;glycosaminoglycan binding;activin receptor activity;kinase activator activity;type I transforming growth factor beta receptor binding;SMAD binding;metal ion binding;activin binding;transforming growth factor beta binding;molecular adaptor activity	GO:0004675;GO:0005024;GO:0005026;GO:0005515;GO:0005524;GO:0005539;GO:0017002;GO:0019209;GO:0034713;GO:0046332;GO:0046872;GO:0048185;GO:0050431;GO:0060090	5.0	05263ad2-5522-11e7-8f50-0ac135e8bacf,408a0c44-5521-11e7-8f50-0ac135e8bacf,9697501e-5521-11e7-8f50-0ac135e8bacf,ba907368-5521-11e7-8f50-0ac135e8bacf,f2ca3880-5521-11e7-8f50-0ac135e8bacf	ALK1 signaling events,TGF-beta receptor signaling,Integrins in angiogenesis,Glypican 1 network,Beta3 integrin cell surface interactions	rs1155705	rs1155705	0.343625	0.336265	0.260686	0.689942	0.383093	0.302525	0.337824	0.356145	0.368836
chr19:5219803:T/C	PTPRS intron_variant		7.0	0.4284024428352364		0.4333333333333333	chr19	5219803	T	C	265			PTPRS	ENST00000587303.5	intron_variant		c.3765+147A>G		5219792	0.3761980830670926	0.1762481089258699	0.3126801152737752	0.5982142857142857	0.4105367793240557	0.4274028629856851																			protein dephosphorylation;negative regulation of neuron projection development;spinal cord development;cerebellum development;hippocampus development;cerebral cortex development;corpus callosum development;negative regulation of axon extension;negative regulation of interferon-alpha production;negative regulation of interferon-beta production;negative regulation of toll-like receptor 9 signaling pathway;peptidyl-tyrosine dephosphorylation;negative regulation of collateral sprouting;negative regulation of axon regeneration;modulation of chemical synaptic transmission;negative regulation of dendritic spine development;establishment of endothelial intestinal barrier;regulation of postsynaptic density assembly;trans-synaptic signaling;synaptic membrane adhesion	GO:0006470;GO:0010977;GO:0021510;GO:0021549;GO:0021766;GO:0021987;GO:0022038;GO:0030517;GO:0032687;GO:0032688;GO:0034164;GO:0035335;GO:0048671;GO:0048681;GO:0050804;GO:0061000;GO:0090557;GO:0099151;GO:0099537;GO:0099560	cytosol;plasma membrane;axon;growth cone;synaptic vesicle membrane;presynaptic membrane;perikaryon;extracellular exosome;Schaffer collateral - CA1 synapse;postsynaptic density membrane;glutamatergic synapse	GO:0005829;GO:0005886;GO:0030424;GO:0030426;GO:0030672;GO:0042734;GO:0043204;GO:0070062;GO:0098685;GO:0098839;GO:0098978	phosphoprotein phosphatase activity;protein tyrosine phosphatase activity;protein binding;heparin binding;chondroitin sulfate binding;heparan sulfate proteoglycan binding	GO:0004721;GO:0004725;GO:0005515;GO:0008201;GO:0035374;GO:0043395				rs12975955	rs12975955	0.355406	0.223074	0.351506	0.603804	0.37814	0.327434	0.42604	0.349767	0.460066
chr13:32913055:A/G	BRCA2 p.Leu1521=	1.0	8.0	0.4536824877250409	True		chr13	32913055	A	G	263		Yes	BRCA2	ENST00000380152.7	synonymous_variant	11.0	c.4563A>G	p.Leu1521=	32338918	0.9740415335463258	0.9039334341906202	0.9971181556195964	1.0	0.9990059642147118	1.0							COSV101203861	"[[""meninges"", 18]]"	18.0	ENST00000544455.5	L1521%3D	Exact Match	Benign	.|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,Orphanet:319462|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555,Orphanet:145|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0007254,MedGen:C0006142	BRCA2-related condition|Hereditary cancer-predisposing syndrome|not specified|not provided|Hereditary breast ovarian cancer syndrome|Fanconi anemia complementation group D1|Breast-ovarian cancer, familial, susceptibility to, 2|Familial cancer of breast|Malignant tumor of breast	reviewed by expert panel	132779.0		telomere maintenance via recombination;double-strand break repair via homologous recombination;oocyte maturation;inner cell mass cell proliferation;nucleotide-excision repair;double-strand break repair;chromatin remodeling;regulation of DNA-templated transcription;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;male meiosis I;spermatogenesis;brain development;female gonad development;response to X-ray;response to UV-C;response to gamma radiation;regulation of cytokinesis;negative regulation of mammary gland epithelial cell proliferation;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;positive regulation of DNA-templated transcription;positive regulation of mitotic cell cycle;centrosome duplication;establishment of protein localization to telomere;hematopoietic stem cell proliferation;cellular response to ionizing radiation;cellular senescence;mitotic recombination-dependent replication fork processing;regulation of DNA damage checkpoint	GO:0000722;GO:0000724;GO:0001556;GO:0001833;GO:0006289;GO:0006302;GO:0006338;GO:0006355;GO:0006978;GO:0007141;GO:0007283;GO:0007420;GO:0008585;GO:0010165;GO:0010225;GO:0010332;GO:0032465;GO:0033600;GO:0042771;GO:0045893;GO:0045931;GO:0051298;GO:0070200;GO:0071425;GO:0071479;GO:0090398;GO:1990426;GO:2000001	nuclear ubiquitin ligase complex;chromosome, telomeric region;lateral element;nucleus;nucleoplasm;centrosome;cytosol;secretory granule;protein-containing complex;BRCA2-MAGE-D1 complex;DNA repair complex	GO:0000152;GO:0000781;GO:0000800;GO:0005634;GO:0005654;GO:0005813;GO:0005829;GO:0030141;GO:0032991;GO:0033593;GO:1990391	protease binding;single-stranded DNA binding;histone acetyltransferase activity;protein binding;histone H3 acetyltransferase activity;histone H4 acetyltransferase activity;identical protein binding;gamma-tubulin binding	GO:0002020;GO:0003697;GO:0004402;GO:0005515;GO:0010484;GO:0010485;GO:0042802;GO:0043015	5.0	34a994cc-5521-11e7-8f50-0ac135e8bacf,812903c2-5521-11e7-8f50-0ac135e8bacf,bddf504e-5521-11e7-8f50-0ac135e8bacf,c45e106a-5521-11e7-8f50-0ac135e8bacf,f93a0482-5521-11e7-8f50-0ac135e8bacf	Validated transcriptional targets of deltaNp63 isoforms,p73 transcription factor network,FOXM1 transcription factor network,Fanconi anemia pathway,ATR signaling pathway	rs206075	rs206075	0.977421	0.926797	1.0	0.999681	1.0	0.992675	0.999613	0.985102	0.999672
chr17:56436109:C/T	RNF43 p.Arg343His		4.0	0.765867418899859	True	0.53125	chr17	56436109	C	T	263		Yes	RNF43	ENST00000407977.6	missense_variant	9.0	c.1028G>A	p.Arg343His	58358748	0.0652955271565495	0.0090771558245083	0.11671469740634	0.0009920634920634	0.1630218687872763	0.0705521472392638	0.0219	0.0106					COSV107515311	"[[""lung"", 1], [""soft tissue"", 1]]"	2.0	ENST00000584437.5	R343H	Exact Match	Benign	MedGen:CN169374|MedGen:C3661900	not specified|not provided	criteria provided, multiple submitters, no conflicts	1165097.0		ubiquitin-dependent protein catabolic process;Wnt signaling pathway;protein ubiquitination;negative regulation of Wnt signaling pathway;Wnt receptor catabolic process;stem cell proliferation	GO:0006511;GO:0016055;GO:0016567;GO:0030178;GO:0038018;GO:0072089	nuclear envelope;endoplasmic reticulum membrane;plasma membrane	GO:0005635;GO:0005789;GO:0005886	ubiquitin-protein transferase activity;frizzled binding;protein binding;metal ion binding;ubiquitin protein ligase activity	GO:0004842;GO:0005109;GO:0005515;GO:0046872;GO:0061630	1.0	812903c2-5521-11e7-8f50-0ac135e8bacf	p73 transcription factor network	rs34523089	rs34523089	0.113096	0.0342365	0.162455	0.000319285	0.167722	0.116185	0.159331	0.135601	0.0636483
chr3:189604149:T/G	TP63 intron_variant		6.0	0.9324137931034484	True	0.3636363636363636	chr3	189604149	T	G	259			TP63	ENST00000264731.8	intron_variant		c.1350-34T>G		189886360	0.6988817891373802	0.7413010590015129	0.5936599423631124	0.6071428571428571	0.7852882703777336	0.721881390593047													Benign	MedGen:CN169374	not specified	criteria provided, single submitter	259128.0		negative regulation of transcription by RNA polymerase II;skeletal system development;establishment of planar polarity;epithelial cell development;chromatin remodeling;regulation of transcription by RNA polymerase II;transcription by RNA polymerase II;apoptotic process;Notch signaling pathway;spermatogenesis;ectoderm and mesoderm interaction;determination of adult lifespan;proximal/distal pattern formation;epidermal cell division;regulation of epidermal cell division;positive regulation of keratinocyte proliferation;keratinocyte differentiation;polarized epithelial cell differentiation;hair follicle morphogenesis;negative regulation of intracellular estrogen receptor signaling pathway;embryonic forelimb morphogenesis;embryonic hindlimb morphogenesis;post-anal tail morphogenesis;odontogenesis of dentin-containing tooth;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;skin morphogenesis;keratinocyte proliferation;negative regulation of keratinocyte differentiation;positive regulation of osteoblast differentiation;positive regulation of Notch signaling pathway;negative regulation of DNA-templated transcription;positive regulation of DNA-templated transcription;positive regulation of transcription by RNA polymerase II;sympathetic nervous system development;female genitalia morphogenesis;protein tetramerization;neuron apoptotic process;cloacal septation;prostatic bud formation;squamous basal epithelial stem cell differentiation involved in prostate gland acinus development;establishment of skin barrier;stem cell proliferation;cellular senescence;positive regulation of somatic stem cell population maintenance;cranial skeletal system development;positive regulation of fibroblast apoptotic process;negative regulation of mesoderm development;positive regulation of stem cell proliferation;positive regulation of apoptotic signaling pathway	GO:0000122;GO:0001501;GO:0001736;GO:0002064;GO:0006338;GO:0006357;GO:0006366;GO:0006915;GO:0007219;GO:0007283;GO:0007499;GO:0008340;GO:0009954;GO:0010481;GO:0010482;GO:0010838;GO:0030216;GO:0030859;GO:0031069;GO:0033147;GO:0035115;GO:0035116;GO:0036342;GO:0042475;GO:0042771;GO:0043589;GO:0043616;GO:0045617;GO:0045669;GO:0045747;GO:0045892;GO:0045893;GO:0045944;GO:0048485;GO:0048807;GO:0051262;GO:0051402;GO:0060197;GO:0060513;GO:0060529;GO:0061436;GO:0072089;GO:0090398;GO:1904674;GO:1904888;GO:2000271;GO:2000381;GO:2000648;GO:2001235	chromatin;nucleus;nucleoplasm;cytoplasm;dendrite	GO:0000785;GO:0005634;GO:0005654;GO:0005737;GO:0030425	RNA polymerase II cis-regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;p53 binding;DNA binding;damaged DNA binding;DNA-binding transcription factor activity;protein binding;identical protein binding;metal ion binding;WW domain binding;MDM2/MDM4 family protein binding;promoter-specific chromatin binding	GO:0000978;GO:0000981;GO:0001228;GO:0002039;GO:0003677;GO:0003684;GO:0003700;GO:0005515;GO:0042802;GO:0046872;GO:0050699;GO:0097371;GO:1990841	4.0	3416f1ba-5521-11e7-8f50-0ac135e8bacf,34a994cc-5521-11e7-8f50-0ac135e8bacf,812903c2-5521-11e7-8f50-0ac135e8bacf,dce0a1a4-5521-11e7-8f50-0ac135e8bacf	Validated transcriptional targets of TAp63 isoforms,Validated transcriptional targets of deltaNp63 isoforms,p73 transcription factor network,Direct p53 effectors	rs1554131	rs1554131	0.745257	0.747246	0.692053	0.587124	0.7032	0.623039	0.788398	0.744641	0.712171
chr10:88683122:T/C	BMPR1A intron_variant		5.0	0.9246184214592836	True	0.4523809523809524	chr10	88683122	T	C	257			BMPR1A	ENST00000372037.7	intron_variant		c.1343-11T>C		86923365	0.4966054313099041	0.726928895612708	0.3429394812680115	0.7003968253968254	0.2733598409542743	0.3139059304703476													Benign	MONDO:MONDO:0017380,MedGen:C0345893,OMIM:174900,Orphanet:2929|MONDO:MONDO:0008276,MedGen:C1868081,Orphanet:329971|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MedGen:C3661900	Juvenile polyposis syndrome|Generalized juvenile polyposis/juvenile polyposis coli|Hereditary cancer-predisposing syndrome|not specified|not provided	criteria provided, multiple submitters, no conflicts	259286.0		angiogenesis;osteoblast differentiation;in utero embryonic development;mesoderm formation;somitogenesis;Mullerian duct regression;positive regulation of mesenchymal cell proliferation;chondrocyte differentiation;outflow tract septum morphogenesis;outflow tract morphogenesis;cardiac conduction system development;atrioventricular valve development;mitral valve morphogenesis;tricuspid valve morphogenesis;endocardial cushion morphogenesis;cardiac right ventricle morphogenesis;ventricular trabecula myocardium morphogenesis;ventricular compact myocardium morphogenesis;endocardial cushion formation;protein phosphorylation;immune response;transforming growth factor beta receptor signaling pathway;ectoderm development;dorsal/ventral axis specification;dorsal/ventral pattern formation;positive regulation of gene expression;negative regulation of gene expression;regulation of cardiac muscle cell apoptotic process;neural crest cell development;negative regulation of smooth muscle cell migration;central nervous system neuron differentiation;pituitary gland development;neural plate mediolateral regionalization;lung development;positive regulation of bone mineralization;BMP signaling pathway;positive regulation of transforming growth factor beta2 production;somatic stem cell population maintenance;hindlimb morphogenesis;dorsal aorta morphogenesis;odontogenesis of dentin-containing tooth;embryonic digit morphogenesis;positive regulation of osteoblast differentiation;positive regulation of transcription by RNA polymerase II;paraxial mesoderm structural organization;lateral mesoderm development;regulation of lateral mesodermal cell fate specification;mesendoderm development;embryonic organ development;developmental growth;epithelial cell proliferation;positive regulation of epithelial cell proliferation;negative regulation of neurogenesis;negative regulation of muscle cell differentiation;roof of mouth development;regulation of cardiac muscle cell proliferation;positive regulation of cardiac muscle cell proliferation;positive regulation of SMAD protein signal transduction;ventricular septum morphogenesis;heart formation;atrioventricular node cell development;pharyngeal arch artery morphogenesis;cellular response to growth factor stimulus;cellular response to BMP stimulus;positive regulation of miRNA transcription;positive regulation of cardiac ventricle development;positive regulation of vascular associated smooth muscle cell proliferation;fibrous ring of heart morphogenesis;regulation of neural crest cell differentiation;regulation of cellular senescence	GO:0001525;GO:0001649;GO:0001701;GO:0001707;GO:0001756;GO:0001880;GO:0002053;GO:0002062;GO:0003148;GO:0003151;GO:0003161;GO:0003171;GO:0003183;GO:0003186;GO:0003203;GO:0003215;GO:0003222;GO:0003223;GO:0003272;GO:0006468;GO:0006955;GO:0007179;GO:0007398;GO:0009950;GO:0009953;GO:0010628;GO:0010629;GO:0010665;GO:0014032;GO:0014912;GO:0021953;GO:0021983;GO:0021998;GO:0030324;GO:0030501;GO:0030509;GO:0032915;GO:0035019;GO:0035137;GO:0035912;GO:0042475;GO:0042733;GO:0045669;GO:0045944;GO:0048352;GO:0048368;GO:0048378;GO:0048382;GO:0048568;GO:0048589;GO:0050673;GO:0050679;GO:0050768;GO:0051148;GO:0060021;GO:0060043;GO:0060045;GO:0060391;GO:0060412;GO:0060914;GO:0060928;GO:0061626;GO:0071363;GO:0071773;GO:1902895;GO:1904414;GO:1904707;GO:1905285;GO:1905292;GO:2000772	plasma membrane;caveola;external side of plasma membrane;membrane;dendrite;neuronal cell body;receptor complex;HFE-transferrin receptor complex	GO:0005886;GO:0005901;GO:0009897;GO:0016020;GO:0030425;GO:0043025;GO:0043235;GO:1990712	protein serine/threonine kinase activity;transmembrane receptor protein serine/threonine kinase activity;transforming growth factor beta receptor activity, type I;protein binding;ATP binding;BMP binding;protein homodimerization activity;SMAD binding;metal ion binding;BMP receptor activity	GO:0004674;GO:0004675;GO:0005025;GO:0005515;GO:0005524;GO:0036122;GO:0042803;GO:0046332;GO:0046872;GO:0098821	1.0	f1ae1a1c-5521-11e7-8f50-0ac135e8bacf	BMP receptor signaling	rs7074064	rs7074064	0.403393	0.658005	0.38842	0.709295	0.374712	0.328301	0.251271	0.40065	0.313285
chr16:68857289:T/C	CDH1 intron_variant		2.0	0.8306112925804946	True	0.5666666666666667	chr16	68857289	T	C	245			CDH1	ENST00000261769.10	intron_variant		c.1937-13T>C		68823386	0.0579073482428115	0.0083207261724659	0.0561959654178674	0.0684523809523809	0.1202783300198807	0.0511247443762781							COSV55727021	"[[""soft tissue"", 6], [""meninges"", 2], [""lung"", 1]]"	9.0	ENST00000422392.6	?	Exact Match	Benign	MONDO:MONDO:0100488,MedGen:CN311521|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0007648,MedGen:C1708349,OMIM:137215,Orphanet:26106|Human Phenotype Ontology:HP:0012125,MONDO:MONDO:0008315,MedGen:C0376358,OMIM:176807,Orphanet:1331	CDH1-related diffuse gastric and lobular breast cancer syndrome|Hereditary cancer-predisposing syndrome|not specified|not provided|Hereditary diffuse gastric adenocarcinoma|Malignant tumor of prostate	reviewed by expert panel	140806.0		cell morphogenesis;cell-cell junction assembly;homophilic cell adhesion via plasma membrane adhesion molecules;multicellular organism development;synapse assembly;response to xenobiotic stimulus;response to toxic substance;regulation of gene expression;calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules;cell migration;pituitary gland development;negative regulation of cell-cell adhesion;negative regulation of cell migration;negative regulation of axon extension;neuron projection development;adherens junction organization;positive regulation of protein import into nucleus;cell-cell adhesion mediated by cadherin;positive regulation of DNA-templated transcription;cellular response to lithium ion;cellular response to indole-3-methanol;protein localization to plasma membrane;cell-cell adhesion;regulation of protein catabolic process at postsynapse, modulating synaptic transmission;response to Gram-positive bacterium	GO:0000902;GO:0007043;GO:0007156;GO:0007275;GO:0007416;GO:0009410;GO:0009636;GO:0010468;GO:0016339;GO:0016477;GO:0021983;GO:0022408;GO:0030336;GO:0030517;GO:0031175;GO:0034332;GO:0042307;GO:0044331;GO:0045893;GO:0071285;GO:0071681;GO:0072659;GO:0098609;GO:0099576;GO:0140459	extracellular region;endosome;trans-Golgi network;plasma membrane;adherens junction;cytoplasmic side of plasma membrane;actin cytoskeleton;membrane;lateral plasma membrane;catenin complex;flotillin complex;lamellipodium;cell junction;cortical actin cytoskeleton;apical junction complex;perinuclear region of cytoplasm;extracellular exosome;postsynapse;glutamatergic synapse	GO:0005576;GO:0005768;GO:0005802;GO:0005886;GO:0005912;GO:0009898;GO:0015629;GO:0016020;GO:0016328;GO:0016342;GO:0016600;GO:0030027;GO:0030054;GO:0030864;GO:0043296;GO:0048471;GO:0070062;GO:0098794;GO:0098978	calcium ion binding;protein binding;beta-catenin binding;ankyrin binding;GTPase activating protein binding;identical protein binding;gamma-catenin binding;cadherin binding;cell adhesion molecule binding;protein tyrosine kinase binding	GO:0005509;GO:0005515;GO:0008013;GO:0030506;GO:0032794;GO:0042802;GO:0045295;GO:0045296;GO:0050839;GO:1990782	12.0	05bf4684-5522-11e7-8f50-0ac135e8bacf,49ac7526-5521-11e7-8f50-0ac135e8bacf,5189b3dc-5521-11e7-8f50-0ac135e8bacf,6aae5178-5521-11e7-8f50-0ac135e8bacf,73325776-5521-11e7-8f50-0ac135e8bacf,74f0d05c-5521-11e7-8f50-0ac135e8bacf,8e3d8e6c-5521-11e7-8f50-0ac135e8bacf,bf958bd4-5521-11e7-8f50-0ac135e8bacf,d8fe5e5c-5521-11e7-8f50-0ac135e8bacf,d992af1e-5521-11e7-8f50-0ac135e8bacf,e92d968a-5521-11e7-8f50-0ac135e8bacf,fae73f58-5521-11e7-8f50-0ac135e8bacf	a6b1 and a6b4 Integrin signaling,Stabilization and expansion of the E-cadherin adherens junction,Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met),Regulation of nuclear beta catenin signaling and target gene transcription,RAC1 signaling pathway,Posttranslational regulation of adherens junction stability and dissassembly,Nectin adhesion pathway,FGF signaling pathway,E-cadherin signaling in the nascent adherens junction,E-cadherin signaling in keratinocytes,CDC42 signaling events,Arf6 trafficking events	rs2276330	rs2276330	0.0953425	0.0251367	0.129061	0.077046	0.160509	0.0667301	0.137982	0.0967442	0.0492126
chr4:187538942:T/G	FAT1 p.Gln2933Pro		8.0	0.8772967265047519	True	0.4857142857142857	chr4	187538942	T	G	242		Yes	FAT1	ENST00000441802.7	missense_variant	10.0	c.8798A>C	p.Gln2933Pro	186617788	0.5920527156549521	0.7655068078668684	0.6037463976945245	0.6309523809523809	0.5467196819085487	0.3558282208588957	0.0597	0.315					COSV71672137	"[[""soft tissue"", 6], [""haematopoietic and lymphoid tissue"", 1], [""urinary tract"", 1]]"	8.0	ENST00000614102.4	Q2933P	Exact Match	Benign	MedGen:C3661900	not provided	criteria provided, multiple submitters, no conflicts	1230564.0		lens development in camera-type eye;epithelial cell morphogenesis;establishment of epithelial cell apical/basal polarity involved in camera-type eye morphogenesis;actin filament organization;cell adhesion;homophilic cell adhesion via plasma membrane adhesion molecules;establishment or maintenance of cell polarity;cell-cell signaling;anatomical structure morphogenesis;cell migration;cell-cell adhesion;cellular response to angiotensin;positive regulation of vascular associated smooth muscle cell migration	GO:0002088;GO:0003382;GO:0003412;GO:0007015;GO:0007155;GO:0007156;GO:0007163;GO:0007267;GO:0009653;GO:0016477;GO:0098609;GO:1904385;GO:1904754	nucleus;cytosol;plasma membrane;cell-cell junction;focal adhesion;apical plasma membrane;lamellipodium;filopodium;perinuclear region of cytoplasm;extracellular exosome	GO:0005634;GO:0005829;GO:0005886;GO:0005911;GO:0005925;GO:0016324;GO:0030027;GO:0030175;GO:0048471;GO:0070062	calcium ion binding;protein binding	GO:0005509;GO:0005515				rs1280098	rs1280098	0.594	0.697335	0.574308	0.632438	0.528769	0.610078	0.541407	0.582326	0.432762
chr7:151945071:G/GT	KMT2C p.Tyr816Ter		8.0	0.865139116202946			chr7	151945071	G	GT	238		Yes	KMT2C	ENST00000262189.11	frameshift_elongation	14.0	c.2447dup	p.Tyr816Ter	152247987													COSV51275813	"[[""haematopoietic and lymphoid tissue"", 15], [""large intestine"", 12], [""central nervous system"", 8], [""soft tissue"", 8], [""skin"", 3], [""thyroid"", 2], [""oesophagus"", 1], [""endometrium"", 1], [""breast"", 1]]"	51.0	ENST00000355193.6	Y816*	Protein Change	Benign	Human Phenotype Ontology:HP:0000730,Human Phenotype Ontology:HP:0001249,Human Phenotype Ontology:HP:0001267,Human Phenotype Ontology:HP:0001286,Human Phenotype Ontology:HP:0002122,Human Phenotype Ontology:HP:0002192,Human Phenotype Ontology:HP:0002316,Human Phenotype Ontology:HP:0002382,Human Phenotype Ontology:HP:0002386,Human Phenotype Ontology:HP:0002402,Human Phenotype Ontology:HP:0002458,Human Phenotype Ontology:HP:0002482,Human Phenotype Ontology:HP:0002499,Human Phenotype Ontology:HP:0002543,Human Phenotype Ontology:HP:0003767,Human Phenotype Ontology:HP:0006833,Human Phenotype Ontology:HP:0007154,Human Phenotype Ontology:HP:0007176,Human Phenotype Ontology:HP:0007180,MONDO:MONDO:0001071,MeSH:D008607,MedGen:C3714756|MedGen:CN169374	Intellectual disability|not specified	criteria provided, single submitter	403020.0		chromatin remodeling;methylation;positive regulation of transcription by RNA polymerase II;response to electrical stimulus	GO:0006338;GO:0032259;GO:0045944;GO:0051602	nucleus;nucleoplasm;cytosol;histone methyltransferase complex;MLL3/4 complex	GO:0005634;GO:0005654;GO:0005829;GO:0035097;GO:0044666	DNA binding;transcription coactivator activity;RNA binding;protein binding;acyltransferase activity;histone methyltransferase activity;histone H3K4 methyltransferase activity;metal ion binding;histone H3K4 monomethyltransferase activity;histone H3K4 trimethyltransferase activity	GO:0003677;GO:0003713;GO:0003723;GO:0005515;GO:0016746;GO:0042054;GO:0042800;GO:0046872;GO:0140945;GO:0140999				rs150073007	rs150073007	0.494615	0.496522	0.494014	0.5	0.493691	0.494983	0.493048	0.492118	0.497987
chr17:56492800:T/C	RNF43 p.Ile47Val		7.0	0.796165531942362	True	0.4666666666666667	chr17	56492800	T	C	234		Yes	RNF43	ENST00000407977.6	missense_variant	2.0	c.139A>G	p.Ile47Val	58415439	0.3738019169329074	0.1694402420574886	0.531700288184438	0.5257936507936508	0.3717693836978131	0.3834355828220859	0.0403	0.0339					COSV60415571	"[[""soft tissue"", 7], [""breast"", 3], [""lung"", 2], [""large intestine"", 1]]"	13.0	ENST00000584437.5	I47V	Exact Match	Benign	MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374	not provided|Hereditary cancer-predisposing syndrome|not specified	criteria provided, multiple submitters, no conflicts	403385.0		ubiquitin-dependent protein catabolic process;Wnt signaling pathway;protein ubiquitination;negative regulation of Wnt signaling pathway;Wnt receptor catabolic process;stem cell proliferation	GO:0006511;GO:0016055;GO:0016567;GO:0030178;GO:0038018;GO:0072089	nuclear envelope;endoplasmic reticulum membrane;plasma membrane	GO:0005635;GO:0005789;GO:0005886	ubiquitin-protein transferase activity;frizzled binding;protein binding;metal ion binding;ubiquitin protein ligase activity	GO:0004842;GO:0005109;GO:0005515;GO:0046872;GO:0061630	1.0	812903c2-5521-11e7-8f50-0ac135e8bacf	p73 transcription factor network	rs3744093	rs3744093	0.342059	0.220839	0.383574	0.508969	0.359958	0.443458	0.380245	0.383721	0.413531
chr8:30933859:C/T	WRN intron_variant		8.0	0.8265162200282088		0.7027027027027027	chr8	30933859	C	T	228			WRN	ENST00000298139.7	intron_variant		c.839+56C>T		31076343	0.4836261980830671	0.2518910741301059	0.6138328530259366	0.5714285714285714	0.6252485089463221	0.4683026584867075							COSV53304984	"[[""small intestine"", 2], [""haematopoietic and lymphoid tissue"", 1], [""lung"", 1]]"	4.0	ENST00000298139.5	?	Exact Match	Benign	MedGen:C3661900	not provided	criteria provided, single submitter	1259276.0		telomere maintenance;double-strand break repair via homologous recombination;DNA synthesis involved in DNA repair;DNA metabolic process;DNA replication;DNA unwinding involved in DNA replication;base-excision repair;double-strand break repair;DNA damage response;response to oxidative stress;determination of adult lifespan;cellular response to starvation;response to UV-C;replication fork processing;telomere maintenance via semi-conservative replication;DNA duplex unwinding;regulation of growth rate;G-quadruplex DNA unwinding;positive regulation of hydrolase activity;telomeric D-loop disassembly;cellular response to gamma radiation;cellular senescence;replicative senescence;t-circle formation;positive regulation of strand invasion;protein localization to nucleolus	GO:0000723;GO:0000724;GO:0000731;GO:0006259;GO:0006260;GO:0006268;GO:0006284;GO:0006302;GO:0006974;GO:0006979;GO:0008340;GO:0009267;GO:0010225;GO:0031297;GO:0032201;GO:0032508;GO:0040009;GO:0044806;GO:0051345;GO:0061820;GO:0071480;GO:0090398;GO:0090399;GO:0090656;GO:0098530;GO:1902570	chromosome, telomeric region;nucleus;nucleoplasm;replication fork;chromosome;nucleolus;cytoplasm;centrosome;nuclear speck	GO:0000781;GO:0005634;GO:0005654;GO:0005657;GO:0005694;GO:0005730;GO:0005737;GO:0005813;GO:0016607	magnesium ion binding;four-way junction DNA binding;Y-form DNA binding;bubble DNA binding;DNA binding;DNA helicase activity;chromatin binding;exonuclease activity;protein binding;ATP binding;3'-5' exonuclease activity;four-way junction helicase activity;isomerase activity;ATP hydrolysis activity;manganese ion binding;MutLalpha complex binding;protein homodimerization activity;3'-5' DNA helicase activity;protein-containing complex binding;G-quadruplex DNA binding;forked DNA-dependent helicase activity;telomeric D-loop binding;telomeric G-quadruplex DNA binding;3'-flap-structured DNA binding;8-hydroxy-2'-deoxyguanosine DNA binding	GO:0000287;GO:0000400;GO:0000403;GO:0000405;GO:0003677;GO:0003678;GO:0003682;GO:0004527;GO:0005515;GO:0005524;GO:0008408;GO:0009378;GO:0016853;GO:0016887;GO:0030145;GO:0032405;GO:0042803;GO:0043138;GO:0044877;GO:0051880;GO:0061749;GO:0061821;GO:0061849;GO:0070337;GO:1905773	1.0	603902ca-5521-11e7-8f50-0ac135e8bacf	Regulation of Telomerase	rs4733221	rs4733221	0.522435	0.300526	0.649366	0.565722	0.667711	0.581773	0.620894	0.543233	0.476744
chr15:67462956:T/C	SMAD3 intron_variant		8.0	0.5576451349141456			chr15	67462956	T	C	225			SMAD3	ENST00000327367.9	intron_variant		c.658+14T>C		67170618																									negative regulation of transcription by RNA polymerase II;ureteric bud development;response to hypoxia;in utero embryonic development;mesoderm formation;somitogenesis;liver development;heart looping;osteoblast development;immune system development;regulation of DNA-templated transcription;regulation of transcription by RNA polymerase II;activation of cysteine-type endopeptidase activity involved in apoptotic process;immune response;transforming growth factor beta receptor signaling pathway;JNK cascade;endoderm development;cell population proliferation;negative regulation of cell population proliferation;anatomical structure morphogenesis;embryonic pattern specification;positive regulation of gene expression;negative regulation of gene expression;positive regulation of epithelial to mesenchymal transition;regulation of striated muscle tissue development;regulation of transforming growth factor beta receptor signaling pathway;signal transduction involved in regulation of gene expression;cell differentiation;negative regulation of cell growth;adrenal gland development;positive regulation of cell migration;positive regulation of bone mineralization;thyroid gland development;primary miRNA processing;positive regulation of chondrocyte differentiation;positive regulation of interleukin-1 beta production;regulation of transforming growth factor beta2 production;positive regulation of transforming growth factor beta3 production;activin receptor signaling pathway;negative regulation of osteoblast proliferation;nodal signaling pathway;wound healing;T cell activation;negative regulation of protein catabolic process;positive regulation of protein import into nucleus;negative regulation of apoptotic process;cell-cell junction organization;positive regulation of nitric oxide biosynthetic process;negative regulation of fat cell differentiation;negative regulation of osteoblast differentiation;positive regulation of DNA-templated transcription;positive regulation of transcription by RNA polymerase II;paraxial mesoderm morphogenesis;developmental growth;embryonic foregut morphogenesis;embryonic cranial skeleton morphogenesis;regulation of epithelial cell proliferation;negative regulation of inflammatory response;regulation of immune response;protein stabilization;positive regulation of positive chemotaxis;positive regulation of DNA-binding transcription factor activity;negative regulation of cytosolic calcium ion concentration;positive regulation of stress fiber assembly;positive regulation of focal adhesion assembly;pericardium development;transdifferentiation;SMAD protein signal transduction;negative regulation of wound healing;negative regulation of lung blood pressure;lens fiber cell differentiation;cellular response to glucose stimulus;cellular response to transforming growth factor beta stimulus;positive regulation of canonical Wnt signaling pathway;extrinsic apoptotic signaling pathway;cellular response to virus;positive regulation of extracellular matrix assembly;regulation of miRNA transcription;negative regulation of miRNA transcription;positive regulation of miRNA transcription;negative regulation of cardiac muscle hypertrophy in response to stress;response to angiotensin	GO:0000122;GO:0001657;GO:0001666;GO:0001701;GO:0001707;GO:0001756;GO:0001889;GO:0001947;GO:0002076;GO:0002520;GO:0006355;GO:0006357;GO:0006919;GO:0006955;GO:0007179;GO:0007254;GO:0007492;GO:0008283;GO:0008285;GO:0009653;GO:0009880;GO:0010628;GO:0010629;GO:0010718;GO:0016202;GO:0017015;GO:0023019;GO:0030154;GO:0030308;GO:0030325;GO:0030335;GO:0030501;GO:0030878;GO:0031053;GO:0032332;GO:0032731;GO:0032909;GO:0032916;GO:0032924;GO:0033689;GO:0038092;GO:0042060;GO:0042110;GO:0042177;GO:0042307;GO:0043066;GO:0045216;GO:0045429;GO:0045599;GO:0045668;GO:0045893;GO:0045944;GO:0048340;GO:0048589;GO:0048617;GO:0048701;GO:0050678;GO:0050728;GO:0050776;GO:0050821;GO:0050927;GO:0051091;GO:0051481;GO:0051496;GO:0051894;GO:0060039;GO:0060290;GO:0060395;GO:0061045;GO:0061767;GO:0070306;GO:0071333;GO:0071560;GO:0090263;GO:0097191;GO:0098586;GO:1901203;GO:1902893;GO:1902894;GO:1902895;GO:1903243;GO:1990776	chromatin;nucleus;nuclear inner membrane;nucleoplasm;transcription regulator complex;cytoplasm;cytosol;plasma membrane;receptor complex;SMAD protein complex;heteromeric SMAD protein complex	GO:0000785;GO:0005634;GO:0005637;GO:0005654;GO:0005667;GO:0005737;GO:0005829;GO:0005886;GO:0043235;GO:0071141;GO:0071144	transcription cis-regulatory region binding;RNA polymerase II cis-regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;cis-regulatory region sequence-specific DNA binding;DNA-binding transcription repressor activity;transcription corepressor binding;transcription coactivator binding;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA binding;DNA-binding transcription factor activity;transforming growth factor beta receptor binding;protein binding;collagen binding;beta-catenin binding;zinc ion binding;nuclear receptor binding;DEAD/H-box RNA helicase binding;protein kinase binding;phosphatase binding;chromatin DNA binding;ubiquitin protein ligase binding;nuclear mineralocorticoid receptor binding;sterol response element binding;nuclear glucocorticoid receptor binding;identical protein binding;protein homodimerization activity;ubiquitin binding;bHLH transcription factor binding;sequence-specific DNA binding;RNA polymerase II-specific DNA-binding transcription factor binding;co-SMAD binding;I-SMAD binding;R-SMAD binding;DNA-binding transcription factor binding;promoter-specific chromatin binding	GO:0000976;GO:0000978;GO:0000981;GO:0000987;GO:0001217;GO:0001222;GO:0001223;GO:0001228;GO:0003677;GO:0003700;GO:0005160;GO:0005515;GO:0005518;GO:0008013;GO:0008270;GO:0016922;GO:0017151;GO:0019901;GO:0019902;GO:0031490;GO:0031625;GO:0031962;GO:0032810;GO:0035259;GO:0042802;GO:0042803;GO:0043130;GO:0043425;GO:0043565;GO:0061629;GO:0070410;GO:0070411;GO:0070412;GO:0140297;GO:1990841	7.0	35f28f90-5521-11e7-8f50-0ac135e8bacf,3814fa62-5521-11e7-8f50-0ac135e8bacf,408a0c44-5521-11e7-8f50-0ac135e8bacf,603902ca-5521-11e7-8f50-0ac135e8bacf,68975856-5521-11e7-8f50-0ac135e8bacf,6cb6085a-5521-11e7-8f50-0ac135e8bacf,b354a4de-5521-11e7-8f50-0ac135e8bacf	Validated targets of C-MYC transcriptional repression,Validated targets of C-MYC transcriptional activation,TGF-beta receptor signaling,Regulation of Telomerase,Regulation of nuclear SMAD23 signaling,Regulation of cytoplasmic and nuclear SMAD23 signaling,HIF-1-alpha transcription factor network											
chr11:64572557:A/G	MEN1 p.His433=		8.0	0.635480464625132	True		chr11	64572557	A	G	220		Yes	MEN1	ENST00000450708.6	synonymous_variant	9.0	c.1299T>C	p.His433=	64805085	0.9760383386581468	0.911497730711044	0.9956772334293948	1.0	1.0	1.0													Benign	MedGen:CN169374|MONDO:MONDO:0007540,MeSH:D018761,MedGen:C0025267,OMIM:131100,Orphanet:652	not specified|Multiple endocrine neoplasia, type 1	criteria provided, multiple submitters, no conflicts	167288.0		negative regulation of transcription by RNA polymerase II;MAPK cascade;negative regulation of protein phosphorylation;osteoblast development;DNA repair;regulation of transcription by RNA polymerase II;DNA damage response;negative regulation of cell population proliferation;response to UV;response to gamma radiation;positive regulation of transforming growth factor beta receptor signaling pathway;negative regulation of DNA-binding transcription factor activity;T-helper 2 cell differentiation;negative regulation of osteoblast differentiation;negative regulation of cyclin-dependent protein serine/threonine kinase activity;negative regulation of cell cycle;transcription initiation-coupled chromatin remodeling;negative regulation of DNA-templated transcription;positive regulation of transcription by RNA polymerase II;negative regulation of JNK cascade;negative regulation of telomerase activity	GO:0000122;GO:0000165;GO:0001933;GO:0002076;GO:0006281;GO:0006357;GO:0006974;GO:0008285;GO:0009411;GO:0010332;GO:0030511;GO:0043433;GO:0045064;GO:0045668;GO:0045736;GO:0045786;GO:0045815;GO:0045892;GO:0045944;GO:0046329;GO:0051974	chromosome, telomeric region;chromatin;nucleus;nucleoplasm;cytoplasm;endoplasmic reticulum lumen;cytosol;nuclear matrix;transcription repressor complex;cleavage furrow;protein-containing complex;histone methyltransferase complex;MLL1/2 complex;MLL1 complex	GO:0000781;GO:0000785;GO:0005634;GO:0005654;GO:0005737;GO:0005788;GO:0005829;GO:0016363;GO:0017053;GO:0032154;GO:0032991;GO:0035097;GO:0044665;GO:0071339	four-way junction DNA binding;Y-form DNA binding;transcription cis-regulatory region binding;chromatin binding;double-stranded DNA binding;protein binding;protein-macromolecule adaptor activity;phosphoprotein binding;R-SMAD binding	GO:0000400;GO:0000403;GO:0000976;GO:0003682;GO:0003690;GO:0005515;GO:0030674;GO:0051219;GO:0070412				rs540012	rs540012	0.976457	0.923293	1.0	1.0	1.0	0.992902	0.999799	0.98143	1.0
chr4:55980456:C/T	KDR intron_variant		4.0	0.6618796198521647	True	0.4545454545454545	chr4	55980456	C	T	218			KDR	ENST00000263923.5	intron_variant		c.659-24G>A		55114289	0.1461661341853035	0.0431164901664145	0.1440922190201729	0.2003968253968254	0.1928429423459244	0.1830265848670756							COSV55758738	"[[""soft tissue"", 7], [""small intestine"", 2], [""haematopoietic and lymphoid tissue"", 1], [""meninges"", 1]]"	11.0	ENST00000645273.1	?	Exact Match							angiogenesis;ovarian follicle development;branching involved in blood vessel morphogenesis;vasculogenesis;positive regulation of protein phosphorylation;positive regulation of endothelial cell proliferation;lymph vessel development;cell migration involved in sprouting angiogenesis;positive regulation of mesenchymal cell proliferation;epithelial cell maturation;endocardium development;endothelium development;cell surface receptor protein tyrosine kinase signaling pathway;multicellular organism development;positive regulation of cell population proliferation;regulation of cell shape;mesenchymal cell proliferation;positive regulation of endothelial cell migration;negative regulation of gene expression;positive regulation of macroautophagy;cell migration;peptidyl-tyrosine phosphorylation;positive regulation of cell migration;positive regulation of BMP signaling pathway;positive regulation of kinase activity;embryonic hemopoiesis;cellular response to vascular endothelial growth factor stimulus;vascular endothelial growth factor receptor-2 signaling pathway;peptidyl-tyrosine autophosphorylation;vascular endothelial growth factor signaling pathway;surfactant homeostasis;regulation of MAPK cascade;positive regulation of MAPK cascade;negative regulation of neuron apoptotic process;positive regulation of blood vessel endothelial cell migration;cell fate commitment;endothelial cell differentiation;positive regulation of angiogenesis;protein autophosphorylation;vascular endothelial growth factor receptor signaling pathway;lung alveolus development;post-embryonic camera-type eye morphogenesis;epithelial cell proliferation;positive regulation of positive chemotaxis;positive regulation of nitric-oxide synthase biosynthetic process;positive regulation of focal adhesion assembly;positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction;positive regulation of mitochondrial depolarization;calcium ion homeostasis;blood vessel endothelial cell differentiation;vascular wound healing;positive regulation of ERK1 and ERK2 cascade;semaphorin-plexin signaling pathway;stem cell proliferation;positive regulation of cell migration involved in sprouting angiogenesis;positive regulation of mitochondrial fission;regulation of hematopoietic progenitor cell differentiation;regulation of bone development;cellular response to hydrogen sulfide;negative regulation of endothelial cell apoptotic process;positive regulation of stem cell proliferation;positive regulation of endothelial cell chemotaxis;positive regulation of vasculogenesis	GO:0001525;GO:0001541;GO:0001569;GO:0001570;GO:0001934;GO:0001938;GO:0001945;GO:0002042;GO:0002053;GO:0002070;GO:0003157;GO:0003158;GO:0007169;GO:0007275;GO:0008284;GO:0008360;GO:0010463;GO:0010595;GO:0010629;GO:0016239;GO:0016477;GO:0018108;GO:0030335;GO:0030513;GO:0033674;GO:0035162;GO:0035924;GO:0036324;GO:0038083;GO:0038084;GO:0043129;GO:0043408;GO:0043410;GO:0043524;GO:0043536;GO:0045165;GO:0045446;GO:0045766;GO:0046777;GO:0048010;GO:0048286;GO:0048597;GO:0050673;GO:0050927;GO:0051770;GO:0051894;GO:0051897;GO:0051901;GO:0055074;GO:0060837;GO:0061042;GO:0070374;GO:0071526;GO:0072089;GO:0090050;GO:0090141;GO:1901532;GO:1903010;GO:1904881;GO:2000352;GO:2000648;GO:2001028;GO:2001214	extracellular region;nucleus;endosome;early endosome;endoplasmic reticulum;Golgi apparatus;plasma membrane;external side of plasma membrane;cell junction;receptor complex;membrane raft;anchoring junction;sorting endosome	GO:0005576;GO:0005634;GO:0005768;GO:0005769;GO:0005783;GO:0005794;GO:0005886;GO:0009897;GO:0030054;GO:0043235;GO:0045121;GO:0070161;GO:0097443	protein tyrosine kinase activity;transmembrane receptor protein tyrosine kinase activity;vascular endothelial growth factor receptor activity;integrin binding;protein binding;ATP binding;coreceptor activity;growth factor binding;vascular endothelial growth factor binding;identical protein binding;cadherin binding;Hsp90 protein binding	GO:0004713;GO:0004714;GO:0005021;GO:0005178;GO:0005515;GO:0005524;GO:0015026;GO:0019838;GO:0038085;GO:0042802;GO:0045296;GO:0051879	9.0	33840088-5521-11e7-8f50-0ac135e8bacf,4c90f780-5521-11e7-8f50-0ac135e8bacf,4f25fa44-5521-11e7-8f50-0ac135e8bacf,576974d6-5521-11e7-8f50-0ac135e8bacf,5be67180-5521-11e7-8f50-0ac135e8bacf,841dd9cc-5521-11e7-8f50-0ac135e8bacf,9697501e-5521-11e7-8f50-0ac135e8bacf,b2bcaa9c-5521-11e7-8f50-0ac135e8bacf,f2ca3880-5521-11e7-8f50-0ac135e8bacf	VEGF and VEGFR signaling network,Signaling events mediated by VEGFR1 and VEGFR2,Signaling events mediated by TCPTP,SHP2 signaling,S1P1 pathway,Notch-mediated HESHEY network,Integrins in angiogenesis,HIF-2-alpha transcription factor network,Beta3 integrin cell surface interactions	rs2305949	rs2305949	0.159611	0.0758059	0.303249	0.174024	0.16437	0.141706	0.205896	0.171773	0.171269
chr6:101099555:A/C	ASCC3 intron_variant				True	0.6222222222222222	chr6	101099555	A	C	214			ASCC3	ENST00000369162.7	intron_variant		c.2989-33T>G		100651679	0.0343450479233226	0.0726172465960665	0.0100864553314121	0.0436507936507936	0.0159045725646123	0.00920245398773																			DNA alkylation repair;cell population proliferation;DNA duplex unwinding;ribosome disassembly;rescue of stalled ribosome;ribosome-associated ubiquitin-dependent protein catabolic process	GO:0006307;GO:0008283;GO:0032508;GO:0032790;GO:0072344;GO:1990116	nucleus;nucleoplasm;cytosol;membrane;nuclear speck;cytosolic ribosome;activating signal cointegrator 1 complex;DNA repair complex	GO:0005634;GO:0005654;GO:0005829;GO:0016020;GO:0016607;GO:0022626;GO:0099053;GO:1990391	RNA binding;protein binding;ATP binding;ATP hydrolysis activity;3'-5' DNA helicase activity	GO:0003723;GO:0005515;GO:0005524;GO:0016887;GO:0043138				rs41288407	rs41288407	0.0306144	0.0537041	0.0153522	0.0543131	0.0164645	0.0156595	0.0220826	0.0251631	0.0125082
chr18:19762992:T/G	GATA6 p.Pro536=		8.0	0.4500818330605565			chr18	19762992	T	G	213		Yes	GATA6	ENST00000269216.9	synonymous_variant	6.0	c.1608T>G	p.Pro536=	22183031																									negative regulation of transcription by RNA polymerase II;in utero embryonic development;liver development;sebaceous gland cell differentiation;regulation of antimicrobial humoral response;outflow tract septum morphogenesis;atrioventricular node development;sinoatrial node development;type B pancreatic cell differentiation;pancreatic A cell differentiation;phospholipid metabolic process;endodermal cell fate determination;male gonad development;response to xenobiotic stimulus;response to toxic substance;gene expression;positive regulation of cardiac muscle cell apoptotic process;cardiac muscle hypertrophy in response to stress;positive regulation of BMP signaling pathway;epithelial cell differentiation;response to retinoic acid;negative regulation of transforming growth factor beta1 production;negative regulation of transforming growth factor beta2 production;tube morphogenesis;atrioventricular canal development;odontogenesis of dentin-containing tooth;negative regulation of apoptotic process;response to estrogen;cell fate commitment;positive regulation of angiogenesis;negative regulation of DNA-templated transcription;positive regulation of DNA-templated transcription;positive regulation of transcription by RNA polymerase II;animal organ formation;stem cell differentiation;smooth muscle cell differentiation;response to cAMP;cardiac muscle cell differentiation;cardiac muscle cell proliferation;positive regulation of cardiac muscle cell proliferation;heart contraction;lung saccule development;club cell differentiation;type II pneumocyte differentiation;intestinal epithelial cell differentiation;cardiac vascular smooth muscle cell differentiation;G1 to G0 transition involved in cell differentiation;response to growth factor;cellular response to gonadotropin stimulus;cellular response to hypoxia;cellular response to BMP stimulus;skin epidermis development;positive regulation of cardiac muscle myoblast proliferation;negative regulation of miRNA transcription;negative regulation of sebum secreting cell proliferation	GO:0000122;GO:0001701;GO:0001889;GO:0001949;GO:0002759;GO:0003148;GO:0003162;GO:0003163;GO:0003309;GO:0003310;GO:0006644;GO:0007493;GO:0008584;GO:0009410;GO:0009636;GO:0010467;GO:0010666;GO:0014898;GO:0030513;GO:0030855;GO:0032526;GO:0032911;GO:0032912;GO:0035239;GO:0036302;GO:0042475;GO:0043066;GO:0043627;GO:0045165;GO:0045766;GO:0045892;GO:0045893;GO:0045944;GO:0048645;GO:0048863;GO:0051145;GO:0051591;GO:0055007;GO:0060038;GO:0060045;GO:0060047;GO:0060430;GO:0060486;GO:0060510;GO:0060575;GO:0060947;GO:0070315;GO:0070848;GO:0071371;GO:0071456;GO:0071773;GO:0098773;GO:0110024;GO:1902894;GO:1904003	chromatin;nucleus;nucleoplasm;transcription regulator complex;nuclear membrane	GO:0000785;GO:0005634;GO:0005654;GO:0005667;GO:0031965	transcription cis-regulatory region binding;RNA polymerase II cis-regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;transcription coactivator binding;chromatin binding;DNA-binding transcription factor activity;protein binding;zinc ion binding;protein kinase binding;NFAT protein binding;DNA-binding transcription factor binding;sequence-specific double-stranded DNA binding	GO:0000976;GO:0000978;GO:0000981;GO:0001223;GO:0003682;GO:0003700;GO:0005515;GO:0008270;GO:0019901;GO:0051525;GO:0140297;GO:1990837	1.0	841dd9cc-5521-11e7-8f50-0ac135e8bacf	Notch-mediated HESHEY network											
chr9:21968199:C/G	CDKN2A 3_prime_UTR_variant		8.0	0.9921440261865794	True	0.725	chr9	21968199	C	G	211			CDKN2A	ENST00000498124.1	3_prime_UTR_variant	4.0	c.*193G>C		21968200	0.9021565495207668	0.8358547655068078	0.9221902017291066	0.9811507936507936	0.8518886679920478	0.9478527607361964							COSV58682765	"[[""soft tissue"", 22], [""meninges"", 17], [""skin"", 11], [""oesophagus"", 1], [""liver"", 1]]"	52.0	ENST00000579755.1	?	Exact Match	Benign	MedGen:CN169374|MedGen:C3661900|Human Phenotype Ontology:HP:0030359,MONDO:MONDO:0005097,MedGen:C0149782	not specified|not provided|Squamous cell lung carcinoma	criteria provided, single submitter	873162.0		regulation of cyclin-dependent protein serine/threonine kinase activity;negative regulation of cell-matrix adhesion;Ras protein signal transduction;negative regulation of cell population proliferation;negative regulation of cell growth;negative regulation of NF-kappaB transcription factor activity;positive regulation of smooth muscle cell apoptotic process;negative regulation of phosphorylation;negative regulation of cyclin-dependent protein serine/threonine kinase activity;negative regulation of DNA-templated transcription;regulation of cell cycle;cellular senescence;replicative senescence;regulation of G1/S transition of mitotic cell cycle;positive regulation of macrophage apoptotic process	GO:0000079;GO:0001953;GO:0007265;GO:0008285;GO:0030308;GO:0032088;GO:0034393;GO:0042326;GO:0045736;GO:0045892;GO:0051726;GO:0090398;GO:0090399;GO:2000045;GO:2000111	nucleus;cytoplasm;cytosol;senescence-associated heterochromatin focus	GO:0005634;GO:0005737;GO:0005829;GO:0035985	RNA binding;cyclin-dependent protein serine/threonine kinase inhibitor activity;protein binding;protein kinase binding;NF-kappaB binding	GO:0003723;GO:0004861;GO:0005515;GO:0019901;GO:0051059	14.0	3416f1ba-5521-11e7-8f50-0ac135e8bacf,34a994cc-5521-11e7-8f50-0ac135e8bacf,34a994cc-5521-11e7-8f50-0ac135e8bacf,354c647e-5521-11e7-8f50-0ac135e8bacf,6309aefe-5521-11e7-8f50-0ac135e8bacf,6aae5178-5521-11e7-8f50-0ac135e8bacf,81be3ee4-5521-11e7-8f50-0ac135e8bacf,b1ac7318-5521-11e7-8f50-0ac135e8bacf,bddf504e-5521-11e7-8f50-0ac135e8bacf,d6e9881a-5521-11e7-8f50-0ac135e8bacf,e3c4b33c-5521-11e7-8f50-0ac135e8bacf,eef8e528-5521-11e7-8f50-0ac135e8bacf,ef96f9ea-5521-11e7-8f50-0ac135e8bacf,fd2c9b80-5521-11e7-8f50-0ac135e8bacf	Validated transcriptional targets of TAp63 isoforms,Validated transcriptional targets of deltaNp63 isoforms,Validated transcriptional targets of deltaNp63 isoforms,Validated transcriptional targets of AP1 family members Fra1 and Fra2,Regulation of retinoblastoma protein,Regulation of nuclear beta catenin signaling and target gene transcription,p53 pathway,Hypoxic and oxygen homeostasis regulation of HIF-1-alpha,FOXM1 transcription factor network,E2F transcription factor network,Coregulation of Androgen receptor activity,C-MYC pathway,C-MYB transcription factor network,AP-1 transcription factor network	rs11515	rs11515	0.858874	0.838089	0.820289	0.978233	0.866827	0.8836	0.857938	0.86093	0.941021
chr12:49434074:C/A	KMT2D p.Gly2493=		6.0	0.8385049365303244	True	0.4	chr12	49434074	C	A	206		Yes	KMT2D	ENST00000301067.11	synonymous_variant	31.0	c.7479G>T	p.Gly2493=	49040291	0.4355031948881789	0.4795763993948563	0.3270893371757925	0.4513888888888889	0.3966202783300199	0.476482617586912							COSV56407715	"[[""soft tissue"", 13], [""meninges"", 12], [""haematopoietic and lymphoid tissue"", 3], [""large intestine"", 1], [""upper aerodigestive tract"", 1], [""liver"", 1]]"	31.0	ENST00000301067.11	G2493%3D	Exact Match	Benign	MONDO:MONDO:0016512,MedGen:C0796004,OMIM:PS147920,Orphanet:2322|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0007843,MedGen:CN030661,OMIM:147920,Orphanet:2322	Kabuki syndrome|not specified|not provided|Kabuki syndrome 1	criteria provided, multiple submitters, no conflicts	94248.0		oocyte growth;regulation of DNA-templated transcription;positive regulation of cell population proliferation;heterochromatin formation;methylation;positive regulation of intracellular estrogen receptor signaling pathway;response to estrogen;positive regulation of transcription by RNA polymerase II;oogenesis;beta-catenin-TCF complex assembly	GO:0001555;GO:0006355;GO:0008284;GO:0031507;GO:0032259;GO:0033148;GO:0043627;GO:0045944;GO:0048477;GO:1904837	nucleus;nucleoplasm;MLL3/4 complex	GO:0005634;GO:0005654;GO:0044666	transcription cis-regulatory region binding;DNA binding;transcription coactivator activity;protein binding;histone H3K4 methyltransferase activity;metal ion binding;histone H3K4 monomethyltransferase activity;histone H3K4 trimethyltransferase activity	GO:0000976;GO:0003677;GO:0003713;GO:0005515;GO:0042800;GO:0046872;GO:0140945;GO:0140999				rs10747559	rs10747559	0.430628	0.470015	0.280422	0.447537	0.428325	0.366588	0.424848	0.415814	0.469657
chr17:7578115:T/C	TP53 intron_variant		8.0	0.990834697217676	True	0.4827586206896552	chr17	7578115	T	C	204			TP53	ENST00000269305.8	intron_variant		c.672+62A>G		7674797	0.8336661341853036	0.6845688350983359	0.909221902017291	0.9761904761904762	0.856858846918489	0.810838445807771													Benign	Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374	Li-Fraumeni syndrome 1|not provided|Hereditary cancer-predisposing syndrome|not specified	criteria provided, multiple submitters, no conflicts	256603.0		negative regulation of transcription by RNA polymerase II;mitophagy;in utero embryonic development;somitogenesis;release of cytochrome c from mitochondria;hematopoietic progenitor cell differentiation;T cell proliferation involved in immune response;B cell lineage commitment;T cell lineage commitment;response to ischemia;nucleotide-excision repair;double-strand break repair;regulation of DNA-templated transcription;regulation of transcription by RNA polymerase II;protein import into nucleus;autophagy;DNA damage response;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;ER overload response;transforming growth factor beta receptor signaling pathway;Ras protein signal transduction;gastrulation;neuroblast proliferation;negative regulation of neuroblast proliferation;protein localization;negative regulation of DNA replication;negative regulation of cell population proliferation;determination of adult lifespan;mRNA transcription;rRNA transcription;response to salt stress;response to inorganic substance;response to X-ray;response to gamma radiation;positive regulation of gene expression;cardiac muscle cell apoptotic process;positive regulation of cardiac muscle cell apoptotic process;glial cell proliferation;viral process;glucose catabolic process to lactate via pyruvate;cerebellum development;negative regulation of cell growth;DNA damage response, signal transduction by p53 class mediator;negative regulation of transforming growth factor beta receptor signaling pathway;mitotic G1 DNA damage checkpoint signaling;negative regulation of telomere maintenance via telomerase;T cell differentiation in thymus;tumor necrosis factor-mediated signaling pathway;regulation of tissue remodeling;cellular response to UV;multicellular organism growth;positive regulation of mitochondrial membrane permeability;cellular response to glucose starvation;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;regulation of apoptotic process;positive regulation of apoptotic process;negative regulation of apoptotic process;entrainment of circadian clock by photoperiod;mitochondrial DNA repair;regulation of DNA damage response, signal transduction by p53 class mediator;positive regulation of neuron apoptotic process;transcription initiation-coupled chromatin remodeling;negative regulation of proteolysis;negative regulation of DNA-templated transcription;positive regulation of DNA-templated transcription;positive regulation of RNA polymerase II transcription preinitiation complex assembly;positive regulation of transcription by RNA polymerase II;response to antibiotic;fibroblast proliferation;negative regulation of fibroblast proliferation;circadian behavior;bone marrow development;embryonic organ development;positive regulation of peptidyl-tyrosine phosphorylation;protein stabilization;negative regulation of helicase activity;protein tetramerization;chromosome organization;neuron apoptotic process;regulation of cell cycle;hematopoietic stem cell differentiation;negative regulation of glial cell proliferation;type II interferon-mediated signaling pathway;cardiac septum morphogenesis;positive regulation of programmed necrotic cell death;protein-containing complex assembly;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;thymocyte apoptotic process;positive regulation of thymocyte apoptotic process;necroptotic process;cellular response to hypoxia;cellular response to xenobiotic stimulus;cellular response to ionizing radiation;cellular response to gamma radiation;cellular response to UV-C;stem cell proliferation;signal transduction by p53 class mediator;intrinsic apoptotic signaling pathway by p53 class mediator;reactive oxygen species metabolic process;cellular response to actinomycin D;positive regulation of release of cytochrome c from mitochondria;cellular senescence;replicative senescence;oxidative stress-induced premature senescence;intrinsic apoptotic signaling pathway;oligodendrocyte apoptotic process;positive regulation of execution phase of apoptosis;negative regulation of mitophagy;regulation of mitochondrial membrane permeability involved in apoptotic process;regulation of intrinsic apoptotic signaling pathway by p53 class mediator;regulation of cell cycle G2/M phase transition;positive regulation of miRNA transcription;negative regulation of G1 to G0 transition;negative regulation of miRNA processing;negative regulation of glucose catabolic process to lactate via pyruvate;negative regulation of pentose-phosphate shunt;intrinsic apoptotic signaling pathway in response to hypoxia;regulation of fibroblast apoptotic process;negative regulation of reactive oxygen species metabolic process;positive regulation of reactive oxygen species metabolic process;negative regulation of stem cell proliferation;positive regulation of cellular senescence;positive regulation of intrinsic apoptotic signaling pathway	GO:0000122;GO:0000423;GO:0001701;GO:0001756;GO:0001836;GO:0002244;GO:0002309;GO:0002326;GO:0002360;GO:0002931;GO:0006289;GO:0006302;GO:0006355;GO:0006357;GO:0006606;GO:0006914;GO:0006974;GO:0006977;GO:0006978;GO:0006983;GO:0007179;GO:0007265;GO:0007369;GO:0007405;GO:0007406;GO:0008104;GO:0008156;GO:0008285;GO:0008340;GO:0009299;GO:0009303;GO:0009651;GO:0010035;GO:0010165;GO:0010332;GO:0010628;GO:0010659;GO:0010666;GO:0014009;GO:0016032;GO:0019661;GO:0021549;GO:0030308;GO:0030330;GO:0030512;GO:0031571;GO:0032211;GO:0033077;GO:0033209;GO:0034103;GO:0034644;GO:0035264;GO:0035794;GO:0042149;GO:0042771;GO:0042981;GO:0043065;GO:0043066;GO:0043153;GO:0043504;GO:0043516;GO:0043525;GO:0045815;GO:0045861;GO:0045892;GO:0045893;GO:0045899;GO:0045944;GO:0046677;GO:0048144;GO:0048147;GO:0048512;GO:0048539;GO:0048568;GO:0050731;GO:0050821;GO:0051097;GO:0051262;GO:0051276;GO:0051402;GO:0051726;GO:0060218;GO:0060253;GO:0060333;GO:0060411;GO:0062100;GO:0065003;GO:0070059;GO:0070242;GO:0070245;GO:0070266;GO:0071456;GO:0071466;GO:0071479;GO:0071480;GO:0071494;GO:0072089;GO:0072331;GO:0072332;GO:0072593;GO:0072717;GO:0090200;GO:0090398;GO:0090399;GO:0090403;GO:0097193;GO:0097252;GO:1900119;GO:1901525;GO:1902108;GO:1902253;GO:1902749;GO:1902895;GO:1903451;GO:1903799;GO:1904024;GO:1905856;GO:1990144;GO:2000269;GO:2000378;GO:2000379;GO:2000647;GO:2000774;GO:2001244	chromatin;nucleus;nucleoplasm;replication fork;transcription regulator complex;nucleolus;cytoplasm;mitochondrion;mitochondrial matrix;endoplasmic reticulum;centrosome;cytosol;nuclear matrix;nuclear body;PML body;transcription repressor complex;protein-containing complex;site of double-strand break;germ cell nucleus	GO:0000785;GO:0005634;GO:0005654;GO:0005657;GO:0005667;GO:0005730;GO:0005737;GO:0005739;GO:0005759;GO:0005783;GO:0005813;GO:0005829;GO:0016363;GO:0016604;GO:0016605;GO:0017053;GO:0032991;GO:0035861;GO:0043073	transcription cis-regulatory region binding;RNA polymerase II cis-regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;cis-regulatory region sequence-specific DNA binding;core promoter sequence-specific DNA binding;TFIID-class transcription factor complex binding;DNA-binding transcription repressor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;protease binding;p53 binding;DNA binding;chromatin binding;DNA-binding transcription factor activity;mRNA 3'-UTR binding;copper ion binding;protein binding;zinc ion binding;enzyme binding;receptor tyrosine kinase binding;ubiquitin protein ligase binding;histone deacetylase regulator activity;ATP-dependent DNA/DNA annealing activity;identical protein binding;histone deacetylase binding;protein heterodimerization activity;protein-folding chaperone binding;protein phosphatase 2A binding;RNA polymerase II-specific DNA-binding transcription factor binding;14-3-3 protein binding;MDM2/MDM4 family protein binding;disordered domain specific binding;general transcription initiation factor binding;molecular function activator activity;promoter-specific chromatin binding	GO:0000976;GO:0000978;GO:0000981;GO:0000987;GO:0001046;GO:0001094;GO:0001227;GO:0001228;GO:0002020;GO:0002039;GO:0003677;GO:0003682;GO:0003700;GO:0003730;GO:0005507;GO:0005515;GO:0008270;GO:0019899;GO:0030971;GO:0031625;GO:0035033;GO:0036310;GO:0042802;GO:0042826;GO:0046982;GO:0051087;GO:0051721;GO:0061629;GO:0071889;GO:0097371;GO:0097718;GO:0140296;GO:0140677;GO:1990841	13.0	3814fa62-5521-11e7-8f50-0ac135e8bacf,4b62628c-5521-11e7-8f50-0ac135e8bacf,538cfdee-5521-11e7-8f50-0ac135e8bacf,76f15b4e-5521-11e7-8f50-0ac135e8bacf,7f189a50-5521-11e7-8f50-0ac135e8bacf,81be3ee4-5521-11e7-8f50-0ac135e8bacf,945aa686-5521-11e7-8f50-0ac135e8bacf,b1ac7318-5521-11e7-8f50-0ac135e8bacf,bb3d7c4a-5521-11e7-8f50-0ac135e8bacf,dce0a1a4-5521-11e7-8f50-0ac135e8bacf,f6898a78-5521-11e7-8f50-0ac135e8bacf,f823645e-5521-11e7-8f50-0ac135e8bacf,fd2c9b80-5521-11e7-8f50-0ac135e8bacf	Validated targets of C-MYC transcriptional activation,Signaling mediated by p38-alpha and p38-beta,Signaling events mediated by HDAC Class III,PLK3 signaling events,p75(NTR)-mediated signaling,p53 pathway,LKB1 signaling events,Hypoxic and oxygen homeostasis regulation of HIF-1-alpha,Glucocorticoid receptor regulatory network,Direct p53 effectors,BARD1 signaling events,Aurora A signaling,AP-1 transcription factor network	rs1625895	rs1625895	0.827395	0.713632	0.840157	0.964217	0.890048	0.885343	0.872169	0.836431	0.807819
chr12:49424235:G/A	KMT2D intron_variant						chr12	49424235	G	A	200			KMT2D	ENST00000301067.11	intron_variant		c.13840-13C>T		49030452																			Uncertain significance	MONDO:MONDO:0016512,MedGen:C0796004,OMIM:PS147920,Orphanet:2322	Kabuki syndrome	criteria provided, single submitter	2981604.0		oocyte growth;regulation of DNA-templated transcription;positive regulation of cell population proliferation;heterochromatin formation;methylation;positive regulation of intracellular estrogen receptor signaling pathway;response to estrogen;positive regulation of transcription by RNA polymerase II;oogenesis;beta-catenin-TCF complex assembly	GO:0001555;GO:0006355;GO:0008284;GO:0031507;GO:0032259;GO:0033148;GO:0043627;GO:0045944;GO:0048477;GO:1904837	nucleus;nucleoplasm;MLL3/4 complex	GO:0005634;GO:0005654;GO:0044666	transcription cis-regulatory region binding;DNA binding;transcription coactivator activity;protein binding;histone H3K4 methyltransferase activity;metal ion binding;histone H3K4 monomethyltransferase activity;histone H3K4 trimethyltransferase activity	GO:0000976;GO:0003677;GO:0003713;GO:0005515;GO:0042800;GO:0046872;GO:0140945;GO:0140999				rs1287530860		8.31628e-06	0.0	0.0	0.0	0.0	0.0	1.73871e-05	0.0	0.0
chr1:163298548:T/C	NUF2 intron_variant		3.0	0.7221850352514194		0.5925925925925926	chr1	163298548	T	C	198			NUF2	ENST00000271452.8	intron_variant		c.276-88T>C		163328758	0.1222044728434504	0.1603630862329803	0.1671469740634005	0.0228174603174603	0.1918489065606362	0.0695296523517382																			mitotic spindle organization;chromosome segregation;mitotic spindle assembly checkpoint signaling;attachment of spindle microtubules to kinetochore;meiotic chromosome segregation;cell division;attachment of mitotic spindle microtubules to kinetochore;kinetochore organization	GO:0007052;GO:0007059;GO:0007094;GO:0008608;GO:0045132;GO:0051301;GO:0051315;GO:0051383	kinetochore;nucleoplasm;cytosol;membrane;Ndc80 complex	GO:0000776;GO:0005654;GO:0005829;GO:0016020;GO:0031262	molecular_function;protein binding;microtubule binding;protein-containing complex binding	GO:0003674;GO:0005515;GO:0008017;GO:0044877				rs2271226	rs2271226	0.171812	0.156499	0.172486	0.0280791	0.215203	0.153372	0.189182	0.168063	0.100592
chr13:32929232:A/G	BRCA2 p.Ser2414=		6.0	0.8252045826513912	True	0.5555555555555556	chr13	32929232	A	G	195		Yes	BRCA2	ENST00000380152.7	synonymous_variant	14.0	c.7242A>G	p.Ser2414=	32355095	0.2326277955271565	0.2072617246596066	0.1988472622478386	0.369047619047619	0.2087475149105368	0.1748466257668711							COSV66447569	"[[""soft tissue"", 11], [""meninges"", 6], [""prostate"", 5], [""small intestine"", 2], [""breast"", 1], [""haematopoietic and lymphoid tissue"", 1]]"	26.0	ENST00000544455.5	S2414%3D	Exact Match	Benign	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,Orphanet:319462|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555,Orphanet:145|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535	Hereditary cancer-predisposing syndrome|not specified|not provided|Hereditary breast ovarian cancer syndrome|Fanconi anemia complementation group D1|Breast-ovarian cancer, familial, susceptibility to, 2|Familial cancer of breast	reviewed by expert panel	126133.0		telomere maintenance via recombination;double-strand break repair via homologous recombination;oocyte maturation;inner cell mass cell proliferation;nucleotide-excision repair;double-strand break repair;chromatin remodeling;regulation of DNA-templated transcription;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;male meiosis I;spermatogenesis;brain development;female gonad development;response to X-ray;response to UV-C;response to gamma radiation;regulation of cytokinesis;negative regulation of mammary gland epithelial cell proliferation;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;positive regulation of DNA-templated transcription;positive regulation of mitotic cell cycle;centrosome duplication;establishment of protein localization to telomere;hematopoietic stem cell proliferation;cellular response to ionizing radiation;cellular senescence;mitotic recombination-dependent replication fork processing;regulation of DNA damage checkpoint	GO:0000722;GO:0000724;GO:0001556;GO:0001833;GO:0006289;GO:0006302;GO:0006338;GO:0006355;GO:0006978;GO:0007141;GO:0007283;GO:0007420;GO:0008585;GO:0010165;GO:0010225;GO:0010332;GO:0032465;GO:0033600;GO:0042771;GO:0045893;GO:0045931;GO:0051298;GO:0070200;GO:0071425;GO:0071479;GO:0090398;GO:1990426;GO:2000001	nuclear ubiquitin ligase complex;chromosome, telomeric region;lateral element;nucleus;nucleoplasm;centrosome;cytosol;secretory granule;protein-containing complex;BRCA2-MAGE-D1 complex;DNA repair complex	GO:0000152;GO:0000781;GO:0000800;GO:0005634;GO:0005654;GO:0005813;GO:0005829;GO:0030141;GO:0032991;GO:0033593;GO:1990391	protease binding;single-stranded DNA binding;histone acetyltransferase activity;protein binding;histone H3 acetyltransferase activity;histone H4 acetyltransferase activity;identical protein binding;gamma-tubulin binding	GO:0002020;GO:0003697;GO:0004402;GO:0005515;GO:0010484;GO:0010485;GO:0042802;GO:0043015	5.0	34a994cc-5521-11e7-8f50-0ac135e8bacf,812903c2-5521-11e7-8f50-0ac135e8bacf,bddf504e-5521-11e7-8f50-0ac135e8bacf,c45e106a-5521-11e7-8f50-0ac135e8bacf,f93a0482-5521-11e7-8f50-0ac135e8bacf	Validated transcriptional targets of deltaNp63 isoforms,p73 transcription factor network,FOXM1 transcription factor network,Fanconi anemia pathway,ATR signaling pathway	rs1799955	rs1799955	0.220199	0.216178	0.212996	0.394231	0.236837	0.181058	0.220511	0.232093	0.236047
chr20:31387954:C/G	DNMT3B intron_variant		6.0	0.8931362196409715	True	0.5333333333333333	chr20	31387954	C	G	194			DNMT3B	ENST00000328111.6	intron_variant		c.1760-5C>G		32800148	0.7140575079872205	0.7655068078668684	0.6426512968299711	0.9930555555555556	0.4184890656063618	0.7116564417177914													Benign	MONDO:MONDO:0000133,MedGen:C0398788,OMIM:PS242860,Orphanet:2268|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0009454,MedGen:C4551557,OMIM:242860,Orphanet:2268	Centromeric instability of chromosomes 1,9 and 16 and immunodeficiency|not specified|not provided|Immunodeficiency-centromeric instability-facial anomalies syndrome 1	criteria provided, multiple submitters, no conflicts	338175.0		negative regulation of transcription by RNA polymerase II;positive regulation of gene expression;methylation	GO:0000122;GO:0010628;GO:0032259	nucleus;nucleoplasm;catalytic complex	GO:0005634;GO:0005654;GO:1902494	DNA binding;transcription corepressor activity;DNA (cytosine-5-)-methyltransferase activity;protein binding;DNA-methyltransferase activity;metal ion binding;DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates	GO:0003677;GO:0003714;GO:0003886;GO:0005515;GO:0009008;GO:0046872;GO:0051718				rs1997797	rs1997797	0.558078	0.722172	0.508735	0.994572	0.451037	0.575081	0.439474	0.555452	0.695538
chr3:9793343:T/G	OGG1 intron_variant					0.5128205128205128	chr3	9793343	T	G	187			OGG1	ENST00000302036.11	intron_variant		c.386-111T>G		9751659	0.0031948881789137	0.0	0.0086455331412103	0.0	0.0019880715705765	0.0081799591002045																			base-excision repair;base-excision repair, AP site formation;nucleotide-excision repair;regulation of DNA-templated transcription;DNA damage response;response to oxidative stress;response to radiation;response to xenobiotic stimulus;response to light stimulus;response to estradiol;cellular response to reactive oxygen species;negative regulation of apoptotic process;positive regulation of gene expression via chromosomal CpG island demethylation;depurination;depyrimidination;response to ethanol;positive regulation of transcription by RNA polymerase II;response to folic acid;cellular response to cadmium ion;negative regulation of double-strand break repair via single-strand annealing	GO:0006284;GO:0006285;GO:0006289;GO:0006355;GO:0006974;GO:0006979;GO:0009314;GO:0009410;GO:0009416;GO:0032355;GO:0034614;GO:0043066;GO:0044029;GO:0045007;GO:0045008;GO:0045471;GO:0045944;GO:0051593;GO:0071276;GO:1901291	nucleus;nucleoplasm;mitochondrial matrix;cytosol;nuclear matrix;nuclear speck;protein-containing complex	GO:0005634;GO:0005654;GO:0005759;GO:0005829;GO:0016363;GO:0016607;GO:0032991	RNA polymerase II cis-regulatory region sequence-specific DNA binding;damaged DNA binding;endonuclease activity;protein binding;microtubule binding;oxidized purine nucleobase lesion DNA N-glycosylase activity;enzyme binding;oxidized purine DNA binding;8-oxo-7,8-dihydroguanine DNA N-glycosylase activity;class I DNA-(apurinic or apyrimidinic site) endonuclease activity	GO:0000978;GO:0003684;GO:0004519;GO:0005515;GO:0008017;GO:0008534;GO:0019899;GO:0032357;GO:0034039;GO:0140078	1.0	3416f1ba-5521-11e7-8f50-0ac135e8bacf	Validated transcriptional targets of TAp63 isoforms	rs4986999		0.00242912	0.000475919	0.0177497	0.0	9.54745e-05	0.00666471	0.00219971	0.00232126	0.00984898
chr6:7229346:T/C	RREB1 p.His338=		6.0	0.6777150916784203	True	0.6521739130434783	chr6	7229346	T	C	177		Yes	RREB1	ENST00000379938.7	synonymous_variant	10.0	c.1014T>C	p.His338=	7229113	0.40814696485623	0.791981845688351	0.2146974063400576	0.2718253968253968	0.341948310139165	0.2351738241308793							COSV58562540	"[[""upper aerodigestive tract"", 1]]"	1.0	ENST00000379938.6	H338%3D	Exact Match	Benign		RREB1-related condition	criteria provided, single submitter	3059547.0		negative regulation of transcription by RNA polymerase II;regulation of DNA-templated transcription;regulation of transcription by RNA polymerase II;transcription by RNA polymerase II;positive regulation of epithelial cell migration;positive regulation of mammary gland epithelial cell proliferation;positive regulation of DNA-templated transcription;positive regulation of transcription by RNA polymerase II;positive regulation of brown fat cell differentiation;positive regulation of substrate adhesion-dependent cell spreading;positive regulation of wound healing, spreading of epidermal cells;positive regulation of lamellipodium morphogenesis	GO:0000122;GO:0006355;GO:0006357;GO:0006366;GO:0010634;GO:0033601;GO:0045893;GO:0045944;GO:0090336;GO:1900026;GO:1903691;GO:2000394	fibrillar center;nucleus;cytoplasm;nuclear body;nuclear speck;extracellular exosome	GO:0001650;GO:0005634;GO:0005737;GO:0016604;GO:0016607;GO:0070062	RNA polymerase II transcription regulatory region sequence-specific DNA binding;RNA polymerase II cis-regulatory region sequence-specific DNA binding;DNA-binding transcription activator activity, RNA polymerase II-specific;metal ion binding	GO:0000977;GO:0000978;GO:0001228;GO:0046872				rs2714315	rs2714315	0.425651	0.697511	0.305003	0.255598	0.38841	0.256008	0.317766	0.398234	0.220907
chr10:88635779:C/A	BMPR1A p.Pro2Thr		5.0	0.4109952589448454	True	0.5454545454545454	chr10	88635779	C	A	171		Yes	BMPR1A	ENST00000372037.7	missense_variant	3.0	c.4C>A	p.Pro2Thr	86876022	0.4998003194888178	0.7239031770045385	0.361671469740634	0.7093253968253969	0.2753479125248509	0.3098159509202454	0.0499	0.373					COSV64409048	"[[""large intestine"", 1], [""haematopoietic and lymphoid tissue"", 1], [""soft tissue"", 1]]"	3.0	ENST00000372037.7	P2T	Exact Match	Benign	MONDO:MONDO:0017380,MedGen:C0345893,OMIM:174900,Orphanet:2929|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0008276,MedGen:C1868081,Orphanet:329971	Juvenile polyposis syndrome|Hereditary cancer-predisposing syndrome|not specified|not provided|Generalized juvenile polyposis/juvenile polyposis coli	criteria provided, multiple submitters, no conflicts	41782.0		angiogenesis;osteoblast differentiation;in utero embryonic development;mesoderm formation;somitogenesis;Mullerian duct regression;positive regulation of mesenchymal cell proliferation;chondrocyte differentiation;outflow tract septum morphogenesis;outflow tract morphogenesis;cardiac conduction system development;atrioventricular valve development;mitral valve morphogenesis;tricuspid valve morphogenesis;endocardial cushion morphogenesis;cardiac right ventricle morphogenesis;ventricular trabecula myocardium morphogenesis;ventricular compact myocardium morphogenesis;endocardial cushion formation;protein phosphorylation;immune response;transforming growth factor beta receptor signaling pathway;ectoderm development;dorsal/ventral axis specification;dorsal/ventral pattern formation;positive regulation of gene expression;negative regulation of gene expression;regulation of cardiac muscle cell apoptotic process;neural crest cell development;negative regulation of smooth muscle cell migration;central nervous system neuron differentiation;pituitary gland development;neural plate mediolateral regionalization;lung development;positive regulation of bone mineralization;BMP signaling pathway;positive regulation of transforming growth factor beta2 production;somatic stem cell population maintenance;hindlimb morphogenesis;dorsal aorta morphogenesis;odontogenesis of dentin-containing tooth;embryonic digit morphogenesis;positive regulation of osteoblast differentiation;positive regulation of transcription by RNA polymerase II;paraxial mesoderm structural organization;lateral mesoderm development;regulation of lateral mesodermal cell fate specification;mesendoderm development;embryonic organ development;developmental growth;epithelial cell proliferation;positive regulation of epithelial cell proliferation;negative regulation of neurogenesis;negative regulation of muscle cell differentiation;roof of mouth development;regulation of cardiac muscle cell proliferation;positive regulation of cardiac muscle cell proliferation;positive regulation of SMAD protein signal transduction;ventricular septum morphogenesis;heart formation;atrioventricular node cell development;pharyngeal arch artery morphogenesis;cellular response to growth factor stimulus;cellular response to BMP stimulus;positive regulation of miRNA transcription;positive regulation of cardiac ventricle development;positive regulation of vascular associated smooth muscle cell proliferation;fibrous ring of heart morphogenesis;regulation of neural crest cell differentiation;regulation of cellular senescence	GO:0001525;GO:0001649;GO:0001701;GO:0001707;GO:0001756;GO:0001880;GO:0002053;GO:0002062;GO:0003148;GO:0003151;GO:0003161;GO:0003171;GO:0003183;GO:0003186;GO:0003203;GO:0003215;GO:0003222;GO:0003223;GO:0003272;GO:0006468;GO:0006955;GO:0007179;GO:0007398;GO:0009950;GO:0009953;GO:0010628;GO:0010629;GO:0010665;GO:0014032;GO:0014912;GO:0021953;GO:0021983;GO:0021998;GO:0030324;GO:0030501;GO:0030509;GO:0032915;GO:0035019;GO:0035137;GO:0035912;GO:0042475;GO:0042733;GO:0045669;GO:0045944;GO:0048352;GO:0048368;GO:0048378;GO:0048382;GO:0048568;GO:0048589;GO:0050673;GO:0050679;GO:0050768;GO:0051148;GO:0060021;GO:0060043;GO:0060045;GO:0060391;GO:0060412;GO:0060914;GO:0060928;GO:0061626;GO:0071363;GO:0071773;GO:1902895;GO:1904414;GO:1904707;GO:1905285;GO:1905292;GO:2000772	plasma membrane;caveola;external side of plasma membrane;membrane;dendrite;neuronal cell body;receptor complex;HFE-transferrin receptor complex	GO:0005886;GO:0005901;GO:0009897;GO:0016020;GO:0030425;GO:0043025;GO:0043235;GO:1990712	protein serine/threonine kinase activity;transmembrane receptor protein serine/threonine kinase activity;transforming growth factor beta receptor activity, type I;protein binding;ATP binding;BMP binding;protein homodimerization activity;SMAD binding;metal ion binding;BMP receptor activity	GO:0004674;GO:0004675;GO:0005025;GO:0005515;GO:0005524;GO:0036122;GO:0042803;GO:0046332;GO:0046872;GO:0098821	1.0	f1ae1a1c-5521-11e7-8f50-0ac135e8bacf	BMP receptor signaling	rs11528010	rs11528010	0.405201	0.655944	0.393373	0.712092	0.376346	0.34319	0.252379	0.405292	0.313693
chr20:57415767:G/A	GNAS p.Arg202=		8.0	0.3584288052373158			chr20	57415767	G	A	169		Yes	GNAS	ENST00000313949.11	synonymous_variant	1.0	c.606G>A	p.Arg202=	58840712																									adenylate cyclase-activating G protein-coupled receptor signaling pathway;adenylate cyclase-activating dopamine receptor signaling pathway;sensory perception of chemical stimulus;developmental growth;bone development;platelet aggregation;positive regulation of cold-induced thermogenesis	GO:0007189;GO:0007191;GO:0007606;GO:0048589;GO:0060348;GO:0070527;GO:0120162	cytoplasm;cytosol;heterotrimeric G-protein complex;membrane;apical plasma membrane;extracellular exosome	GO:0005737;GO:0005829;GO:0005834;GO:0016020;GO:0016324;GO:0070062	GTPase activity;insulin-like growth factor receptor binding;protein binding;GTP binding;adenylate cyclase activator activity;G-protein beta/gamma-subunit complex binding;beta-2 adrenergic receptor binding;D1 dopamine receptor binding;mu-type opioid receptor binding;ionotropic glutamate receptor binding;metal ion binding;corticotropin-releasing hormone receptor 1 binding	GO:0003924;GO:0005159;GO:0005515;GO:0005525;GO:0010856;GO:0031683;GO:0031698;GO:0031748;GO:0031852;GO:0035255;GO:0046872;GO:0051430	4.0	72929504-5521-11e7-8f50-0ac135e8bacf,78974324-5521-11e7-8f50-0ac135e8bacf,916de6d2-5521-11e7-8f50-0ac135e8bacf,d306cfa2-5521-11e7-8f50-0ac135e8bacf	Rapid glucocorticoid signaling,Plasma membrane estrogen receptor signaling,LPA4-mediated signaling events,Endothelins	rs1483221839										
chr17:7573996:A/T	TP53 p.Leu344Gln						chr17	7573996	A	T	169		Yes	TP53	ENST00000269305.8	missense_variant	10.0	c.1031T>A	p.Leu344Gln	7670678							6.21e-05	0.0					COSV53045945	"[[""pancreas"", 1], [""haematopoietic and lymphoid tissue"", 1]]"	2.0	ENST00000610623.4	L344Q	Exact Match							negative regulation of transcription by RNA polymerase II;mitophagy;in utero embryonic development;somitogenesis;release of cytochrome c from mitochondria;hematopoietic progenitor cell differentiation;T cell proliferation involved in immune response;B cell lineage commitment;T cell lineage commitment;response to ischemia;nucleotide-excision repair;double-strand break repair;regulation of DNA-templated transcription;regulation of transcription by RNA polymerase II;protein import into nucleus;autophagy;DNA damage response;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;ER overload response;transforming growth factor beta receptor signaling pathway;Ras protein signal transduction;gastrulation;neuroblast proliferation;negative regulation of neuroblast proliferation;protein localization;negative regulation of DNA replication;negative regulation of cell population proliferation;determination of adult lifespan;mRNA transcription;rRNA transcription;response to salt stress;response to inorganic substance;response to X-ray;response to gamma radiation;positive regulation of gene expression;cardiac muscle cell apoptotic process;positive regulation of cardiac muscle cell apoptotic process;glial cell proliferation;viral process;glucose catabolic process to lactate via pyruvate;cerebellum development;negative regulation of cell growth;DNA damage response, signal transduction by p53 class mediator;negative regulation of transforming growth factor beta receptor signaling pathway;mitotic G1 DNA damage checkpoint signaling;negative regulation of telomere maintenance via telomerase;T cell differentiation in thymus;tumor necrosis factor-mediated signaling pathway;regulation of tissue remodeling;cellular response to UV;multicellular organism growth;positive regulation of mitochondrial membrane permeability;cellular response to glucose starvation;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;regulation of apoptotic process;positive regulation of apoptotic process;negative regulation of apoptotic process;entrainment of circadian clock by photoperiod;mitochondrial DNA repair;regulation of DNA damage response, signal transduction by p53 class mediator;positive regulation of neuron apoptotic process;transcription initiation-coupled chromatin remodeling;negative regulation of proteolysis;negative regulation of DNA-templated transcription;positive regulation of DNA-templated transcription;positive regulation of RNA polymerase II transcription preinitiation complex assembly;positive regulation of transcription by RNA polymerase II;response to antibiotic;fibroblast proliferation;negative regulation of fibroblast proliferation;circadian behavior;bone marrow development;embryonic organ development;positive regulation of peptidyl-tyrosine phosphorylation;protein stabilization;negative regulation of helicase activity;protein tetramerization;chromosome organization;neuron apoptotic process;regulation of cell cycle;hematopoietic stem cell differentiation;negative regulation of glial cell proliferation;type II interferon-mediated signaling pathway;cardiac septum morphogenesis;positive regulation of programmed necrotic cell death;protein-containing complex assembly;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;thymocyte apoptotic process;positive regulation of thymocyte apoptotic process;necroptotic process;cellular response to hypoxia;cellular response to xenobiotic stimulus;cellular response to ionizing radiation;cellular response to gamma radiation;cellular response to UV-C;stem cell proliferation;signal transduction by p53 class mediator;intrinsic apoptotic signaling pathway by p53 class mediator;reactive oxygen species metabolic process;cellular response to actinomycin D;positive regulation of release of cytochrome c from mitochondria;cellular senescence;replicative senescence;oxidative stress-induced premature senescence;intrinsic apoptotic signaling pathway;oligodendrocyte apoptotic process;positive regulation of execution phase of apoptosis;negative regulation of mitophagy;regulation of mitochondrial membrane permeability involved in apoptotic process;regulation of intrinsic apoptotic signaling pathway by p53 class mediator;regulation of cell cycle G2/M phase transition;positive regulation of miRNA transcription;negative regulation of G1 to G0 transition;negative regulation of miRNA processing;negative regulation of glucose catabolic process to lactate via pyruvate;negative regulation of pentose-phosphate shunt;intrinsic apoptotic signaling pathway in response to hypoxia;regulation of fibroblast apoptotic process;negative regulation of reactive oxygen species metabolic process;positive regulation of reactive oxygen species metabolic process;negative regulation of stem cell proliferation;positive regulation of cellular senescence;positive regulation of intrinsic apoptotic signaling pathway	GO:0000122;GO:0000423;GO:0001701;GO:0001756;GO:0001836;GO:0002244;GO:0002309;GO:0002326;GO:0002360;GO:0002931;GO:0006289;GO:0006302;GO:0006355;GO:0006357;GO:0006606;GO:0006914;GO:0006974;GO:0006977;GO:0006978;GO:0006983;GO:0007179;GO:0007265;GO:0007369;GO:0007405;GO:0007406;GO:0008104;GO:0008156;GO:0008285;GO:0008340;GO:0009299;GO:0009303;GO:0009651;GO:0010035;GO:0010165;GO:0010332;GO:0010628;GO:0010659;GO:0010666;GO:0014009;GO:0016032;GO:0019661;GO:0021549;GO:0030308;GO:0030330;GO:0030512;GO:0031571;GO:0032211;GO:0033077;GO:0033209;GO:0034103;GO:0034644;GO:0035264;GO:0035794;GO:0042149;GO:0042771;GO:0042981;GO:0043065;GO:0043066;GO:0043153;GO:0043504;GO:0043516;GO:0043525;GO:0045815;GO:0045861;GO:0045892;GO:0045893;GO:0045899;GO:0045944;GO:0046677;GO:0048144;GO:0048147;GO:0048512;GO:0048539;GO:0048568;GO:0050731;GO:0050821;GO:0051097;GO:0051262;GO:0051276;GO:0051402;GO:0051726;GO:0060218;GO:0060253;GO:0060333;GO:0060411;GO:0062100;GO:0065003;GO:0070059;GO:0070242;GO:0070245;GO:0070266;GO:0071456;GO:0071466;GO:0071479;GO:0071480;GO:0071494;GO:0072089;GO:0072331;GO:0072332;GO:0072593;GO:0072717;GO:0090200;GO:0090398;GO:0090399;GO:0090403;GO:0097193;GO:0097252;GO:1900119;GO:1901525;GO:1902108;GO:1902253;GO:1902749;GO:1902895;GO:1903451;GO:1903799;GO:1904024;GO:1905856;GO:1990144;GO:2000269;GO:2000378;GO:2000379;GO:2000647;GO:2000774;GO:2001244	chromatin;nucleus;nucleoplasm;replication fork;transcription regulator complex;nucleolus;cytoplasm;mitochondrion;mitochondrial matrix;endoplasmic reticulum;centrosome;cytosol;nuclear matrix;nuclear body;PML body;transcription repressor complex;protein-containing complex;site of double-strand break;germ cell nucleus	GO:0000785;GO:0005634;GO:0005654;GO:0005657;GO:0005667;GO:0005730;GO:0005737;GO:0005739;GO:0005759;GO:0005783;GO:0005813;GO:0005829;GO:0016363;GO:0016604;GO:0016605;GO:0017053;GO:0032991;GO:0035861;GO:0043073	transcription cis-regulatory region binding;RNA polymerase II cis-regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;cis-regulatory region sequence-specific DNA binding;core promoter sequence-specific DNA binding;TFIID-class transcription factor complex binding;DNA-binding transcription repressor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;protease binding;p53 binding;DNA binding;chromatin binding;DNA-binding transcription factor activity;mRNA 3'-UTR binding;copper ion binding;protein binding;zinc ion binding;enzyme binding;receptor tyrosine kinase binding;ubiquitin protein ligase binding;histone deacetylase regulator activity;ATP-dependent DNA/DNA annealing activity;identical protein binding;histone deacetylase binding;protein heterodimerization activity;protein-folding chaperone binding;protein phosphatase 2A binding;RNA polymerase II-specific DNA-binding transcription factor binding;14-3-3 protein binding;MDM2/MDM4 family protein binding;disordered domain specific binding;general transcription initiation factor binding;molecular function activator activity;promoter-specific chromatin binding	GO:0000976;GO:0000978;GO:0000981;GO:0000987;GO:0001046;GO:0001094;GO:0001227;GO:0001228;GO:0002020;GO:0002039;GO:0003677;GO:0003682;GO:0003700;GO:0003730;GO:0005507;GO:0005515;GO:0008270;GO:0019899;GO:0030971;GO:0031625;GO:0035033;GO:0036310;GO:0042802;GO:0042826;GO:0046982;GO:0051087;GO:0051721;GO:0061629;GO:0071889;GO:0097371;GO:0097718;GO:0140296;GO:0140677;GO:1990841	13.0	3814fa62-5521-11e7-8f50-0ac135e8bacf,4b62628c-5521-11e7-8f50-0ac135e8bacf,538cfdee-5521-11e7-8f50-0ac135e8bacf,76f15b4e-5521-11e7-8f50-0ac135e8bacf,7f189a50-5521-11e7-8f50-0ac135e8bacf,81be3ee4-5521-11e7-8f50-0ac135e8bacf,945aa686-5521-11e7-8f50-0ac135e8bacf,b1ac7318-5521-11e7-8f50-0ac135e8bacf,bb3d7c4a-5521-11e7-8f50-0ac135e8bacf,dce0a1a4-5521-11e7-8f50-0ac135e8bacf,f6898a78-5521-11e7-8f50-0ac135e8bacf,f823645e-5521-11e7-8f50-0ac135e8bacf,fd2c9b80-5521-11e7-8f50-0ac135e8bacf	Validated targets of C-MYC transcriptional activation,Signaling mediated by p38-alpha and p38-beta,Signaling events mediated by HDAC Class III,PLK3 signaling events,p75(NTR)-mediated signaling,p53 pathway,LKB1 signaling events,Hypoxic and oxygen homeostasis regulation of HIF-1-alpha,Glucocorticoid receptor regulatory network,Direct p53 effectors,BARD1 signaling events,Aurora A signaling,AP-1 transcription factor network											
chr13:32914437:GT/G	BRCA2 p.Ser1982ArgfsTer22					0.5531914893617021	chr13	32914437	GT	G	167		Yes	BRCA2	ENST00000380152.7	frameshift_truncation	11.0	c.5946del	p.Ser1982ArgfsTer22	32340301													COSV66447676	"[[""prostate"", 4], [""breast"", 4], [""upper aerodigestive tract"", 1], [""pancreas"", 1], [""NS"", 1], [""lung"", 1]]"	12.0	ENST00000544455.5	S1982Rfs*22	Exact Match	Pathogenic	Human Phenotype Ontology:HP:0010623,Human Phenotype Ontology:HP:0100013,MONDO:MONDO:0021100,MeSH:D001943,MedGen:C1458155|MONDO:MONDO:0011584,MedGen:C1838457,OMIM:605724,Orphanet:319462|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267,OMIM:167000|MONDO:MONDO:0012933,MedGen:C2675520,OMIM:612555,Orphanet:145|MONDO:MONDO:0013235,MedGen:C3150546,OMIM:613347,Orphanet:1333|Human Phenotype Ontology:HP:0012114,MONDO:MONDO:0002447,MedGen:C0476089,OMIM:608089|MedGen:CN239275|MedGen:CN221562|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535	Breast neoplasm|Fanconi anemia complementation group D1|Hereditary breast ovarian cancer syndrome|not provided|Neoplasm of ovary|Breast-ovarian cancer, familial, susceptibility to, 2|Pancreatic cancer, susceptibility to, 2|Endometrial carcinoma|BRCA2-Related Disorders|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|Familial cancer of breast	reviewed by expert panel	9325.0		telomere maintenance via recombination;double-strand break repair via homologous recombination;oocyte maturation;inner cell mass cell proliferation;nucleotide-excision repair;double-strand break repair;chromatin remodeling;regulation of DNA-templated transcription;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;male meiosis I;spermatogenesis;brain development;female gonad development;response to X-ray;response to UV-C;response to gamma radiation;regulation of cytokinesis;negative regulation of mammary gland epithelial cell proliferation;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;positive regulation of DNA-templated transcription;positive regulation of mitotic cell cycle;centrosome duplication;establishment of protein localization to telomere;hematopoietic stem cell proliferation;cellular response to ionizing radiation;cellular senescence;mitotic recombination-dependent replication fork processing;regulation of DNA damage checkpoint	GO:0000722;GO:0000724;GO:0001556;GO:0001833;GO:0006289;GO:0006302;GO:0006338;GO:0006355;GO:0006978;GO:0007141;GO:0007283;GO:0007420;GO:0008585;GO:0010165;GO:0010225;GO:0010332;GO:0032465;GO:0033600;GO:0042771;GO:0045893;GO:0045931;GO:0051298;GO:0070200;GO:0071425;GO:0071479;GO:0090398;GO:1990426;GO:2000001	nuclear ubiquitin ligase complex;chromosome, telomeric region;lateral element;nucleus;nucleoplasm;centrosome;cytosol;secretory granule;protein-containing complex;BRCA2-MAGE-D1 complex;DNA repair complex	GO:0000152;GO:0000781;GO:0000800;GO:0005634;GO:0005654;GO:0005813;GO:0005829;GO:0030141;GO:0032991;GO:0033593;GO:1990391	protease binding;single-stranded DNA binding;histone acetyltransferase activity;protein binding;histone H3 acetyltransferase activity;histone H4 acetyltransferase activity;identical protein binding;gamma-tubulin binding	GO:0002020;GO:0003697;GO:0004402;GO:0005515;GO:0010484;GO:0010485;GO:0042802;GO:0043015	5.0	34a994cc-5521-11e7-8f50-0ac135e8bacf,812903c2-5521-11e7-8f50-0ac135e8bacf,bddf504e-5521-11e7-8f50-0ac135e8bacf,c45e106a-5521-11e7-8f50-0ac135e8bacf,f93a0482-5521-11e7-8f50-0ac135e8bacf	Validated transcriptional targets of deltaNp63 isoforms,p73 transcription factor network,FOXM1 transcription factor network,Fanconi anemia pathway,ATR signaling pathway	rs80359550		0.000181491	0.0	0.00602773	0.0	0.0	0.0	9.29598e-05	0.0	0.0
chr17:7579472:G/C	TP53 p.Pro72Arg		8.0	0.4834697217675941	True	0.5	chr17	7579472	G	C	166		Yes	TP53	ENST00000269305.8	missense_variant	4.0	c.215C>G	p.Pro72Arg	7676154	0.5429313099041534	0.3313161875945537	0.6829971181556196	0.5863095238095238	0.7147117296222664	0.5081799591002045	0.0249	0.0163	Breast Cancer, Cervical Cancer, Lung Carcinoma, Oligodendroglioma	531.0	45.0	This polymorphism is relatively widely studied across cancer types, but meta-analyses in breast, lung and cervical cancer cohorts have so far been inconclusive as to the significance of a patient's genotype at this locus as it relates to cancer susceptibility and prognosis.	COSV52666208	"[[""large intestine"", 38], [""soft tissue"", 30], [""meninges"", 18], [""bone"", 15], [""skin"", 12], [""pancreas"", 11], [""penis"", 9], [""prostate"", 7], [""upper aerodigestive tract"", 5], [""lung"", 5], [""liver"", 4], [""biliary tract"", 3], [""central nervous system"", 3], [""small intestine"", 2], [""thyroid"", 2], [""urinary tract"", 1], [""stomach"", 1], [""pleura"", 1], [""endometrium"", 1]]"	168.0	ENST00000455263.6	P72R	Exact Match	Benign	Human Phenotype Ontology:HP:0200022,MONDO:MONDO:0009837,MedGen:C0205770,OMIM:260500,Orphanet:251899,Orphanet:2807|Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|MONDO:MONDO:0024498,MedGen:C2750850,OMIM:137800|MONDO:MONDO:0002629,MedGen:C0585442,OMIM:259500,Orphanet:668|MONDO:MONDO:0008734,MedGen:C1859972,OMIM:202300,Orphanet:1501|MONDO:MONDO:0005575,MedGen:C0346629,OMIM:114500|MONDO:MONDO:0013876,MedGen:C3553606,OMIM:614740|MONDO:MONDO:0005192,MeSH:C562463,MedGen:C0235974,OMIM:260350,Orphanet:1333,Orphanet:217074|MONDO:MONDO:0015459,MedGen:C2931822,OMIM:607107,Orphanet:150|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0032573,MedGen:C4748488,OMIM:618165|Human Phenotype Ontology:HP:0001402,Human Phenotype Ontology:HP:0002899,Human Phenotype Ontology:HP:0003007,Human Phenotype Ontology:HP:0006750,MONDO:MONDO:0007256,MedGen:C2239176,OMIM:114550,Orphanet:88673|MedGen:C3661900|MONDO:MONDO:0023644,MedGen:C0220641|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|.|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|Human Phenotype Ontology:HP:0001914,Human Phenotype Ontology:HP:0004808,Human Phenotype Ontology:HP:0004843,Human Phenotype Ontology:HP:0005516,Human Phenotype Ontology:HP:0006724,Human Phenotype Ontology:HP:0006728,MONDO:MONDO:0018874,MeSH:D015470,MedGen:C0023467,OMIM:601626,Orphanet:519|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524	Choroid plexus papilloma|Li-Fraumeni syndrome 1|Glioma susceptibility 1|Bone osteosarcoma|Adrenocortical carcinoma, hereditary|Colorectal cancer|Basal cell carcinoma, susceptibility to, 7|Carcinoma of pancreas|Nasopharyngeal carcinoma|Familial cancer of breast|Bone marrow failure syndrome 5|Hepatocellular carcinoma|not provided|Lip and oral cavity carcinoma|Hereditary cancer-predisposing syndrome|not specified|CODON 72 POLYMORPHISM|Hereditary breast ovarian cancer syndrome|Acute myeloid leukemia|Li-Fraumeni syndrome	criteria provided, multiple submitters, no conflicts	12351.0		negative regulation of transcription by RNA polymerase II;mitophagy;in utero embryonic development;somitogenesis;release of cytochrome c from mitochondria;hematopoietic progenitor cell differentiation;T cell proliferation involved in immune response;B cell lineage commitment;T cell lineage commitment;response to ischemia;nucleotide-excision repair;double-strand break repair;regulation of DNA-templated transcription;regulation of transcription by RNA polymerase II;protein import into nucleus;autophagy;DNA damage response;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;ER overload response;transforming growth factor beta receptor signaling pathway;Ras protein signal transduction;gastrulation;neuroblast proliferation;negative regulation of neuroblast proliferation;protein localization;negative regulation of DNA replication;negative regulation of cell population proliferation;determination of adult lifespan;mRNA transcription;rRNA transcription;response to salt stress;response to inorganic substance;response to X-ray;response to gamma radiation;positive regulation of gene expression;cardiac muscle cell apoptotic process;positive regulation of cardiac muscle cell apoptotic process;glial cell proliferation;viral process;glucose catabolic process to lactate via pyruvate;cerebellum development;negative regulation of cell growth;DNA damage response, signal transduction by p53 class mediator;negative regulation of transforming growth factor beta receptor signaling pathway;mitotic G1 DNA damage checkpoint signaling;negative regulation of telomere maintenance via telomerase;T cell differentiation in thymus;tumor necrosis factor-mediated signaling pathway;regulation of tissue remodeling;cellular response to UV;multicellular organism growth;positive regulation of mitochondrial membrane permeability;cellular response to glucose starvation;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;regulation of apoptotic process;positive regulation of apoptotic process;negative regulation of apoptotic process;entrainment of circadian clock by photoperiod;mitochondrial DNA repair;regulation of DNA damage response, signal transduction by p53 class mediator;positive regulation of neuron apoptotic process;transcription initiation-coupled chromatin remodeling;negative regulation of proteolysis;negative regulation of DNA-templated transcription;positive regulation of DNA-templated transcription;positive regulation of RNA polymerase II transcription preinitiation complex assembly;positive regulation of transcription by RNA polymerase II;response to antibiotic;fibroblast proliferation;negative regulation of fibroblast proliferation;circadian behavior;bone marrow development;embryonic organ development;positive regulation of peptidyl-tyrosine phosphorylation;protein stabilization;negative regulation of helicase activity;protein tetramerization;chromosome organization;neuron apoptotic process;regulation of cell cycle;hematopoietic stem cell differentiation;negative regulation of glial cell proliferation;type II interferon-mediated signaling pathway;cardiac septum morphogenesis;positive regulation of programmed necrotic cell death;protein-containing complex assembly;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;thymocyte apoptotic process;positive regulation of thymocyte apoptotic process;necroptotic process;cellular response to hypoxia;cellular response to xenobiotic stimulus;cellular response to ionizing radiation;cellular response to gamma radiation;cellular response to UV-C;stem cell proliferation;signal transduction by p53 class mediator;intrinsic apoptotic signaling pathway by p53 class mediator;reactive oxygen species metabolic process;cellular response to actinomycin D;positive regulation of release of cytochrome c from mitochondria;cellular senescence;replicative senescence;oxidative stress-induced premature senescence;intrinsic apoptotic signaling pathway;oligodendrocyte apoptotic process;positive regulation of execution phase of apoptosis;negative regulation of mitophagy;regulation of mitochondrial membrane permeability involved in apoptotic process;regulation of intrinsic apoptotic signaling pathway by p53 class mediator;regulation of cell cycle G2/M phase transition;positive regulation of miRNA transcription;negative regulation of G1 to G0 transition;negative regulation of miRNA processing;negative regulation of glucose catabolic process to lactate via pyruvate;negative regulation of pentose-phosphate shunt;intrinsic apoptotic signaling pathway in response to hypoxia;regulation of fibroblast apoptotic process;negative regulation of reactive oxygen species metabolic process;positive regulation of reactive oxygen species metabolic process;negative regulation of stem cell proliferation;positive regulation of cellular senescence;positive regulation of intrinsic apoptotic signaling pathway	GO:0000122;GO:0000423;GO:0001701;GO:0001756;GO:0001836;GO:0002244;GO:0002309;GO:0002326;GO:0002360;GO:0002931;GO:0006289;GO:0006302;GO:0006355;GO:0006357;GO:0006606;GO:0006914;GO:0006974;GO:0006977;GO:0006978;GO:0006983;GO:0007179;GO:0007265;GO:0007369;GO:0007405;GO:0007406;GO:0008104;GO:0008156;GO:0008285;GO:0008340;GO:0009299;GO:0009303;GO:0009651;GO:0010035;GO:0010165;GO:0010332;GO:0010628;GO:0010659;GO:0010666;GO:0014009;GO:0016032;GO:0019661;GO:0021549;GO:0030308;GO:0030330;GO:0030512;GO:0031571;GO:0032211;GO:0033077;GO:0033209;GO:0034103;GO:0034644;GO:0035264;GO:0035794;GO:0042149;GO:0042771;GO:0042981;GO:0043065;GO:0043066;GO:0043153;GO:0043504;GO:0043516;GO:0043525;GO:0045815;GO:0045861;GO:0045892;GO:0045893;GO:0045899;GO:0045944;GO:0046677;GO:0048144;GO:0048147;GO:0048512;GO:0048539;GO:0048568;GO:0050731;GO:0050821;GO:0051097;GO:0051262;GO:0051276;GO:0051402;GO:0051726;GO:0060218;GO:0060253;GO:0060333;GO:0060411;GO:0062100;GO:0065003;GO:0070059;GO:0070242;GO:0070245;GO:0070266;GO:0071456;GO:0071466;GO:0071479;GO:0071480;GO:0071494;GO:0072089;GO:0072331;GO:0072332;GO:0072593;GO:0072717;GO:0090200;GO:0090398;GO:0090399;GO:0090403;GO:0097193;GO:0097252;GO:1900119;GO:1901525;GO:1902108;GO:1902253;GO:1902749;GO:1902895;GO:1903451;GO:1903799;GO:1904024;GO:1905856;GO:1990144;GO:2000269;GO:2000378;GO:2000379;GO:2000647;GO:2000774;GO:2001244	chromatin;nucleus;nucleoplasm;replication fork;transcription regulator complex;nucleolus;cytoplasm;mitochondrion;mitochondrial matrix;endoplasmic reticulum;centrosome;cytosol;nuclear matrix;nuclear body;PML body;transcription repressor complex;protein-containing complex;site of double-strand break;germ cell nucleus	GO:0000785;GO:0005634;GO:0005654;GO:0005657;GO:0005667;GO:0005730;GO:0005737;GO:0005739;GO:0005759;GO:0005783;GO:0005813;GO:0005829;GO:0016363;GO:0016604;GO:0016605;GO:0017053;GO:0032991;GO:0035861;GO:0043073	transcription cis-regulatory region binding;RNA polymerase II cis-regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;cis-regulatory region sequence-specific DNA binding;core promoter sequence-specific DNA binding;TFIID-class transcription factor complex binding;DNA-binding transcription repressor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;protease binding;p53 binding;DNA binding;chromatin binding;DNA-binding transcription factor activity;mRNA 3'-UTR binding;copper ion binding;protein binding;zinc ion binding;enzyme binding;receptor tyrosine kinase binding;ubiquitin protein ligase binding;histone deacetylase regulator activity;ATP-dependent DNA/DNA annealing activity;identical protein binding;histone deacetylase binding;protein heterodimerization activity;protein-folding chaperone binding;protein phosphatase 2A binding;RNA polymerase II-specific DNA-binding transcription factor binding;14-3-3 protein binding;MDM2/MDM4 family protein binding;disordered domain specific binding;general transcription initiation factor binding;molecular function activator activity;promoter-specific chromatin binding	GO:0000976;GO:0000978;GO:0000981;GO:0000987;GO:0001046;GO:0001094;GO:0001227;GO:0001228;GO:0002020;GO:0002039;GO:0003677;GO:0003682;GO:0003700;GO:0003730;GO:0005507;GO:0005515;GO:0008270;GO:0019899;GO:0030971;GO:0031625;GO:0035033;GO:0036310;GO:0042802;GO:0042826;GO:0046982;GO:0051087;GO:0051721;GO:0061629;GO:0071889;GO:0097371;GO:0097718;GO:0140296;GO:0140677;GO:1990841	13.0	3814fa62-5521-11e7-8f50-0ac135e8bacf,4b62628c-5521-11e7-8f50-0ac135e8bacf,538cfdee-5521-11e7-8f50-0ac135e8bacf,76f15b4e-5521-11e7-8f50-0ac135e8bacf,7f189a50-5521-11e7-8f50-0ac135e8bacf,81be3ee4-5521-11e7-8f50-0ac135e8bacf,945aa686-5521-11e7-8f50-0ac135e8bacf,b1ac7318-5521-11e7-8f50-0ac135e8bacf,bb3d7c4a-5521-11e7-8f50-0ac135e8bacf,dce0a1a4-5521-11e7-8f50-0ac135e8bacf,f6898a78-5521-11e7-8f50-0ac135e8bacf,f823645e-5521-11e7-8f50-0ac135e8bacf,fd2c9b80-5521-11e7-8f50-0ac135e8bacf	Validated targets of C-MYC transcriptional activation,Signaling mediated by p38-alpha and p38-beta,Signaling events mediated by HDAC Class III,PLK3 signaling events,p75(NTR)-mediated signaling,p53 pathway,LKB1 signaling events,Hypoxic and oxygen homeostasis regulation of HIF-1-alpha,Glucocorticoid receptor regulatory network,Direct p53 effectors,BARD1 signaling events,Aurora A signaling,AP-1 transcription factor network	rs1042522	rs1042522	0.624518	0.389429	0.719578	0.558221	0.736968	0.702572	0.743925	0.647114	0.53125
chr18:48575694:G/A	SMAD4 p.Ala152Thr		8.0	0.4971381847914963			chr18	48575694	G	A	165		Yes	SMAD4	ENST00000342988.8	missense_variant	4.0	c.454G>A	p.Ala152Thr	51049324							0.0199	0.0175											Uncertain significance	MONDO:MONDO:0017380,MedGen:C0345893,OMIM:174900,Orphanet:2929	Juvenile polyposis syndrome	criteria provided, single submitter	2180105.0		negative regulation of transcription by RNA polymerase II;ovarian follicle development;osteoblast differentiation;branching involved in ureteric bud morphogenesis;response to hypoxia;in utero embryonic development;gastrulation with mouth forming second;epithelial to mesenchymal transition;outflow tract septum morphogenesis;cardiac conduction system development;atrioventricular valve formation;epithelial to mesenchymal transition involved in endocardial cushion formation;left ventricular cardiac muscle tissue morphogenesis;positive regulation of cell proliferation involved in heart valve morphogenesis;brainstem development;DNA-templated transcription;regulation of DNA-templated transcription;regulation of transcription by RNA polymerase II;transcription by RNA polymerase II;intracellular iron ion homeostasis;transforming growth factor beta receptor signaling pathway;spermatogenesis;single fertilization;axon guidance;cell population proliferation;negative regulation of cell population proliferation;anatomical structure morphogenesis;negative regulation of cardiac muscle hypertrophy;positive regulation of gene expression;epithelial cell migration;positive regulation of cardiac muscle cell apoptotic process;positive regulation of epithelial to mesenchymal transition;neural crest cell differentiation;cardiac muscle hypertrophy in response to stress;cell differentiation;negative regulation of cell growth;adrenal gland development;BMP signaling pathway;positive regulation of transforming growth factor beta receptor signaling pathway;somite rostral/caudal axis specification;regulation of transforming growth factor beta2 production;activin receptor signaling pathway;positive regulation of luteinizing hormone secretion;intracellular signal transduction;atrioventricular canal development;endothelial cell activation;negative regulation of protein catabolic process;embryonic digit morphogenesis;negative regulation of DNA-templated transcription;positive regulation of DNA-templated transcription;positive regulation of transcription by RNA polymerase II;positive regulation of follicle-stimulating hormone secretion;mesendoderm development;developmental growth;neuron fate specification;sebaceous gland development;formation of anatomical boundary;regulation of hair follicle development;uterus development;positive regulation of SMAD protein signal transduction;SMAD protein signal transduction;ventricular septum morphogenesis;endocardial cell differentiation;female gonad morphogenesis;secondary palate development;interleukin-6-mediated signaling pathway;ERK1 and ERK2 cascade;negative regulation of ERK1 and ERK2 cascade;cellular response to glucose stimulus;response to transforming growth factor beta;cellular response to transforming growth factor beta stimulus;cellular response to BMP stimulus;metanephric mesenchyme morphogenesis;nephrogenic mesenchyme morphogenesis;seminiferous tubule development;negative regulation of canonical Wnt signaling pathway;extrinsic apoptotic signaling pathway;positive regulation of extracellular matrix assembly;positive regulation of miRNA transcription;negative regulation of cardiac myofibril assembly	GO:0000122;GO:0001541;GO:0001649;GO:0001658;GO:0001666;GO:0001701;GO:0001702;GO:0001837;GO:0003148;GO:0003161;GO:0003190;GO:0003198;GO:0003220;GO:0003251;GO:0003360;GO:0006351;GO:0006355;GO:0006357;GO:0006366;GO:0006879;GO:0007179;GO:0007283;GO:0007338;GO:0007411;GO:0008283;GO:0008285;GO:0009653;GO:0010614;GO:0010628;GO:0010631;GO:0010666;GO:0010718;GO:0014033;GO:0014898;GO:0030154;GO:0030308;GO:0030325;GO:0030509;GO:0030511;GO:0032525;GO:0032909;GO:0032924;GO:0033686;GO:0035556;GO:0036302;GO:0042118;GO:0042177;GO:0042733;GO:0045892;GO:0045893;GO:0045944;GO:0046881;GO:0048382;GO:0048589;GO:0048665;GO:0048733;GO:0048859;GO:0051797;GO:0060065;GO:0060391;GO:0060395;GO:0060412;GO:0060956;GO:0061040;GO:0062009;GO:0070102;GO:0070371;GO:0070373;GO:0071333;GO:0071559;GO:0071560;GO:0071773;GO:0072133;GO:0072134;GO:0072520;GO:0090090;GO:0097191;GO:1901203;GO:1902895;GO:1905305	chromatin;nucleus;nucleoplasm;transcription regulator complex;cytoplasm;centrosome;cytosol;activin responsive factor complex;SMAD protein complex;heteromeric SMAD protein complex	GO:0000785;GO:0005634;GO:0005654;GO:0005667;GO:0005737;GO:0005813;GO:0005829;GO:0032444;GO:0071141;GO:0071144	transcription cis-regulatory region binding;RNA polymerase II cis-regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;transcription corepressor binding;transcription coactivator binding;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA binding;chromatin binding;DNA-binding transcription factor activity;protein binding;collagen binding;filamin binding;identical protein binding;protein homodimerization activity;sulfate binding;sequence-specific DNA binding;metal ion binding;RNA polymerase II-specific DNA-binding transcription factor binding;I-SMAD binding;R-SMAD binding	GO:0000976;GO:0000978;GO:0000981;GO:0001222;GO:0001223;GO:0001228;GO:0003677;GO:0003682;GO:0003700;GO:0005515;GO:0005518;GO:0031005;GO:0042802;GO:0042803;GO:0043199;GO:0043565;GO:0046872;GO:0061629;GO:0070411;GO:0070412	11.0	049349a0-5522-11e7-8f50-0ac135e8bacf,05263ad2-5522-11e7-8f50-0ac135e8bacf,35f28f90-5521-11e7-8f50-0ac135e8bacf,3814fa62-5521-11e7-8f50-0ac135e8bacf,3ab9dba6-5521-11e7-8f50-0ac135e8bacf,408a0c44-5521-11e7-8f50-0ac135e8bacf,68975856-5521-11e7-8f50-0ac135e8bacf,6cb6085a-5521-11e7-8f50-0ac135e8bacf,945aa686-5521-11e7-8f50-0ac135e8bacf,b354a4de-5521-11e7-8f50-0ac135e8bacf,f1ae1a1c-5521-11e7-8f50-0ac135e8bacf	ALK2 signaling events,ALK1 signaling events,Validated targets of C-MYC transcriptional repression,Validated targets of C-MYC transcriptional activation,Validated nuclear estrogen receptor alpha network,TGF-beta receptor signaling,Regulation of nuclear SMAD23 signaling,Regulation of cytoplasmic and nuclear SMAD23 signaling,LKB1 signaling events,HIF-1-alpha transcription factor network,BMP receptor signaling											
chr17:7579801:G/C	TP53 intron_variant		5.0	0.1178365972496566	True	0.4	chr17	7579801	G	C	163			TP53	ENST00000269305.8	intron_variant		c.74+38C>G		7676483	0.5848642172523961	0.4924357034795764	0.6930835734870316	0.5823412698412699	0.7117296222664016	0.5051124744376279							COSV52668860	"[[""large intestine"", 29], [""meninges"", 18], [""liver"", 1], [""small intestine"", 1]]"	49.0	ENST00000455263.6	?	Exact Match	Benign	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524	Hereditary cancer-predisposing syndrome|not specified|not provided|Hereditary breast ovarian cancer syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	criteria provided, multiple submitters, no conflicts	137691.0		negative regulation of transcription by RNA polymerase II;mitophagy;in utero embryonic development;somitogenesis;release of cytochrome c from mitochondria;hematopoietic progenitor cell differentiation;T cell proliferation involved in immune response;B cell lineage commitment;T cell lineage commitment;response to ischemia;nucleotide-excision repair;double-strand break repair;regulation of DNA-templated transcription;regulation of transcription by RNA polymerase II;protein import into nucleus;autophagy;DNA damage response;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;ER overload response;transforming growth factor beta receptor signaling pathway;Ras protein signal transduction;gastrulation;neuroblast proliferation;negative regulation of neuroblast proliferation;protein localization;negative regulation of DNA replication;negative regulation of cell population proliferation;determination of adult lifespan;mRNA transcription;rRNA transcription;response to salt stress;response to inorganic substance;response to X-ray;response to gamma radiation;positive regulation of gene expression;cardiac muscle cell apoptotic process;positive regulation of cardiac muscle cell apoptotic process;glial cell proliferation;viral process;glucose catabolic process to lactate via pyruvate;cerebellum development;negative regulation of cell growth;DNA damage response, signal transduction by p53 class mediator;negative regulation of transforming growth factor beta receptor signaling pathway;mitotic G1 DNA damage checkpoint signaling;negative regulation of telomere maintenance via telomerase;T cell differentiation in thymus;tumor necrosis factor-mediated signaling pathway;regulation of tissue remodeling;cellular response to UV;multicellular organism growth;positive regulation of mitochondrial membrane permeability;cellular response to glucose starvation;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;regulation of apoptotic process;positive regulation of apoptotic process;negative regulation of apoptotic process;entrainment of circadian clock by photoperiod;mitochondrial DNA repair;regulation of DNA damage response, signal transduction by p53 class mediator;positive regulation of neuron apoptotic process;transcription initiation-coupled chromatin remodeling;negative regulation of proteolysis;negative regulation of DNA-templated transcription;positive regulation of DNA-templated transcription;positive regulation of RNA polymerase II transcription preinitiation complex assembly;positive regulation of transcription by RNA polymerase II;response to antibiotic;fibroblast proliferation;negative regulation of fibroblast proliferation;circadian behavior;bone marrow development;embryonic organ development;positive regulation of peptidyl-tyrosine phosphorylation;protein stabilization;negative regulation of helicase activity;protein tetramerization;chromosome organization;neuron apoptotic process;regulation of cell cycle;hematopoietic stem cell differentiation;negative regulation of glial cell proliferation;type II interferon-mediated signaling pathway;cardiac septum morphogenesis;positive regulation of programmed necrotic cell death;protein-containing complex assembly;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;thymocyte apoptotic process;positive regulation of thymocyte apoptotic process;necroptotic process;cellular response to hypoxia;cellular response to xenobiotic stimulus;cellular response to ionizing radiation;cellular response to gamma radiation;cellular response to UV-C;stem cell proliferation;signal transduction by p53 class mediator;intrinsic apoptotic signaling pathway by p53 class mediator;reactive oxygen species metabolic process;cellular response to actinomycin D;positive regulation of release of cytochrome c from mitochondria;cellular senescence;replicative senescence;oxidative stress-induced premature senescence;intrinsic apoptotic signaling pathway;oligodendrocyte apoptotic process;positive regulation of execution phase of apoptosis;negative regulation of mitophagy;regulation of mitochondrial membrane permeability involved in apoptotic process;regulation of intrinsic apoptotic signaling pathway by p53 class mediator;regulation of cell cycle G2/M phase transition;positive regulation of miRNA transcription;negative regulation of G1 to G0 transition;negative regulation of miRNA processing;negative regulation of glucose catabolic process to lactate via pyruvate;negative regulation of pentose-phosphate shunt;intrinsic apoptotic signaling pathway in response to hypoxia;regulation of fibroblast apoptotic process;negative regulation of reactive oxygen species metabolic process;positive regulation of reactive oxygen species metabolic process;negative regulation of stem cell proliferation;positive regulation of cellular senescence;positive regulation of intrinsic apoptotic signaling pathway	GO:0000122;GO:0000423;GO:0001701;GO:0001756;GO:0001836;GO:0002244;GO:0002309;GO:0002326;GO:0002360;GO:0002931;GO:0006289;GO:0006302;GO:0006355;GO:0006357;GO:0006606;GO:0006914;GO:0006974;GO:0006977;GO:0006978;GO:0006983;GO:0007179;GO:0007265;GO:0007369;GO:0007405;GO:0007406;GO:0008104;GO:0008156;GO:0008285;GO:0008340;GO:0009299;GO:0009303;GO:0009651;GO:0010035;GO:0010165;GO:0010332;GO:0010628;GO:0010659;GO:0010666;GO:0014009;GO:0016032;GO:0019661;GO:0021549;GO:0030308;GO:0030330;GO:0030512;GO:0031571;GO:0032211;GO:0033077;GO:0033209;GO:0034103;GO:0034644;GO:0035264;GO:0035794;GO:0042149;GO:0042771;GO:0042981;GO:0043065;GO:0043066;GO:0043153;GO:0043504;GO:0043516;GO:0043525;GO:0045815;GO:0045861;GO:0045892;GO:0045893;GO:0045899;GO:0045944;GO:0046677;GO:0048144;GO:0048147;GO:0048512;GO:0048539;GO:0048568;GO:0050731;GO:0050821;GO:0051097;GO:0051262;GO:0051276;GO:0051402;GO:0051726;GO:0060218;GO:0060253;GO:0060333;GO:0060411;GO:0062100;GO:0065003;GO:0070059;GO:0070242;GO:0070245;GO:0070266;GO:0071456;GO:0071466;GO:0071479;GO:0071480;GO:0071494;GO:0072089;GO:0072331;GO:0072332;GO:0072593;GO:0072717;GO:0090200;GO:0090398;GO:0090399;GO:0090403;GO:0097193;GO:0097252;GO:1900119;GO:1901525;GO:1902108;GO:1902253;GO:1902749;GO:1902895;GO:1903451;GO:1903799;GO:1904024;GO:1905856;GO:1990144;GO:2000269;GO:2000378;GO:2000379;GO:2000647;GO:2000774;GO:2001244	chromatin;nucleus;nucleoplasm;replication fork;transcription regulator complex;nucleolus;cytoplasm;mitochondrion;mitochondrial matrix;endoplasmic reticulum;centrosome;cytosol;nuclear matrix;nuclear body;PML body;transcription repressor complex;protein-containing complex;site of double-strand break;germ cell nucleus	GO:0000785;GO:0005634;GO:0005654;GO:0005657;GO:0005667;GO:0005730;GO:0005737;GO:0005739;GO:0005759;GO:0005783;GO:0005813;GO:0005829;GO:0016363;GO:0016604;GO:0016605;GO:0017053;GO:0032991;GO:0035861;GO:0043073	transcription cis-regulatory region binding;RNA polymerase II cis-regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;cis-regulatory region sequence-specific DNA binding;core promoter sequence-specific DNA binding;TFIID-class transcription factor complex binding;DNA-binding transcription repressor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;protease binding;p53 binding;DNA binding;chromatin binding;DNA-binding transcription factor activity;mRNA 3'-UTR binding;copper ion binding;protein binding;zinc ion binding;enzyme binding;receptor tyrosine kinase binding;ubiquitin protein ligase binding;histone deacetylase regulator activity;ATP-dependent DNA/DNA annealing activity;identical protein binding;histone deacetylase binding;protein heterodimerization activity;protein-folding chaperone binding;protein phosphatase 2A binding;RNA polymerase II-specific DNA-binding transcription factor binding;14-3-3 protein binding;MDM2/MDM4 family protein binding;disordered domain specific binding;general transcription initiation factor binding;molecular function activator activity;promoter-specific chromatin binding	GO:0000976;GO:0000978;GO:0000981;GO:0000987;GO:0001046;GO:0001094;GO:0001227;GO:0001228;GO:0002020;GO:0002039;GO:0003677;GO:0003682;GO:0003700;GO:0003730;GO:0005507;GO:0005515;GO:0008270;GO:0019899;GO:0030971;GO:0031625;GO:0035033;GO:0036310;GO:0042802;GO:0042826;GO:0046982;GO:0051087;GO:0051721;GO:0061629;GO:0071889;GO:0097371;GO:0097718;GO:0140296;GO:0140677;GO:1990841	13.0	3814fa62-5521-11e7-8f50-0ac135e8bacf,4b62628c-5521-11e7-8f50-0ac135e8bacf,538cfdee-5521-11e7-8f50-0ac135e8bacf,76f15b4e-5521-11e7-8f50-0ac135e8bacf,7f189a50-5521-11e7-8f50-0ac135e8bacf,81be3ee4-5521-11e7-8f50-0ac135e8bacf,945aa686-5521-11e7-8f50-0ac135e8bacf,b1ac7318-5521-11e7-8f50-0ac135e8bacf,bb3d7c4a-5521-11e7-8f50-0ac135e8bacf,dce0a1a4-5521-11e7-8f50-0ac135e8bacf,f6898a78-5521-11e7-8f50-0ac135e8bacf,f823645e-5521-11e7-8f50-0ac135e8bacf,fd2c9b80-5521-11e7-8f50-0ac135e8bacf	Validated targets of C-MYC transcriptional activation,Signaling mediated by p38-alpha and p38-beta,Signaling events mediated by HDAC Class III,PLK3 signaling events,p75(NTR)-mediated signaling,p53 pathway,LKB1 signaling events,Hypoxic and oxygen homeostasis regulation of HIF-1-alpha,Glucocorticoid receptor regulatory network,Direct p53 effectors,BARD1 signaling events,Aurora A signaling,AP-1 transcription factor network	rs1642785	rs1642785	0.659721	0.515854	0.714028	0.556198	0.727457	0.713791	0.738631	0.668534	0.529703
chr6:52149609:T/G	MCM3 2kb_upstream_variant		8.0	0.3965658217497956			chr6	52149609	T	G	161			MCM3	ENST00000596288.7	2kb_upstream_variant		c.-137A>C		52284811							0.285	0.61																	double-strand break repair via break-induced replication;DNA unwinding involved in DNA replication;DNA replication initiation;DNA strand elongation involved in DNA replication;regulation of DNA-templated DNA replication initiation;mitotic DNA replication initiation	GO:0000727;GO:0006268;GO:0006270;GO:0006271;GO:0030174;GO:1902975	chromosome, telomeric region;nucleus;nucleoplasm;alpha DNA polymerase:primase complex;nucleolus;centrosome;membrane;MCM complex;perinuclear region of cytoplasm;CMG complex	GO:0000781;GO:0005634;GO:0005654;GO:0005658;GO:0005730;GO:0005813;GO:0016020;GO:0042555;GO:0048471;GO:0071162	DNA binding;single-stranded DNA binding;protein binding;ATP binding;ATP hydrolysis activity;single-stranded DNA helicase activity	GO:0003677;GO:0003697;GO:0005515;GO:0005524;GO:0016887;GO:0017116	1.0	d6e9881a-5521-11e7-8f50-0ac135e8bacf	E2F transcription factor network											
chr12:25398284:C/T	KRAS p.Gly12Asp						chr12	25398284	C	T	151		Yes	KRAS	ENST00000256078.9	missense_variant	2.0	c.35G>A	p.Gly12Asp	25245350							0.0	0.0	Colon Cancer, Colorectal Cancer, Hairy Cell Leukemia, Lung Cancer, Lung Non-small Cell Carcinoma, Malignant Exocrine Pancreas Neoplasm, Melanoma, Multiple Myeloma, Ovarian Cancer, Pancreatic Cancer, Pancreatic Carcinoma, Pancreatic Ductal Carcinoma, Skin Squamous Cell Carcinoma, Thyroid Gland Carcinoma	79.0	162.0	While the KRAS G12 region is a widely studied recurrent region in cancer, its impact on clinical action is still actively debated. Often associated with tumors that are wild-type for other drivers (EGFR and ALK specifically), the prognosis for patients with this mutation seems to be worse than the KRAS wild-type cohort in patients with colorectal and pancreatic cancer, however this hypothesis is in need of further validation. This mutation, along with the mutations affecting the neighboring G13 position, may result in a less responsive tumor when treated with first-generation TKI's like gefitinib. The NCCN guidelines for colorectal cancer contain recommendations that the targeted therapies cetuximab and panitumumab should only be used in the context of wild type KRAS. However, cetuximab treatment was shown to extend survival in a single cohort of colorectal patients with G12D mutations. Overall, the interpretation for KRAS mutations in most clinical scenarios is still undecided.	COSV55497369	"[[""large intestine"", 9173], [""pancreas"", 3544], [""lung"", 1419], [""biliary tract"", 481], [""ovary"", 429], [""haematopoietic and lymphoid tissue"", 364], [""endometrium"", 276], [""stomach"", 135], [""small intestine"", 117], [""peritoneum"", 95], [""cervix"", 56], [""skin"", 55], [""urinary tract"", 48], [""thyroid"", 46], [""upper aerodigestive tract"", 40], [""soft tissue"", 31], [""prostate"", 25], [""breast"", 25], [""liver"", 24], [""NS"", 24], [""gastrointestinal tract (site indeterminate)"", 21], [""oesophagus"", 18], [""kidney"", 12], [""central nervous system"", 12], [""testis"", 7], [""eye"", 3], [""penis"", 3], [""genital tract"", 3], [""pleura"", 2], [""bone"", 2], [""salivary gland"", 1], [""autonomic ganglia"", 1]]"	16492.0	ENST00000556131.1	G12D	Exact Match	Pathogenic	Human Phenotype Ontology:HP:0100031,MONDO:MONDO:0015074,MeSH:D013964,MedGen:C0040136,Orphanet:100087|MedGen:C4302356|.|MedGen:C3661900|Human Phenotype Ontology:HP:0012126,MONDO:MONDO:0001056,MeSH:D013274,MedGen:C0024623,OMIM:613659|MONDO:MONDO:0013074,MedGen:C0406612,OMIM:613001,Orphanet:2396|Human Phenotype Ontology:HP:0002408,MONDO:MONDO:0007154,MedGen:C0917804,OMIM:108010,Orphanet:46724|MONDO:MONDO:0013767,MedGen:C2674723,OMIM:614470,Orphanet:268114|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|Human Phenotype Ontology:HP:0010815,MedGen:C3854181|Human Phenotype Ontology:HP:0010817,MONDO:MONDO:0008097,MedGen:C4552097,OMIM:163200,Orphanet:2612|MONDO:MONDO:0005192,MeSH:C562463,MedGen:C0235974,OMIM:260350,Orphanet:1333,Orphanet:217074|MONDO:MONDO:0020783,MedGen:C4747394,OMIM:608354,Orphanet:137667,Orphanet:90307|Human Phenotype Ontology:HP:0030358,MONDO:MONDO:0005233,MeSH:D002289,MedGen:C0007131|Human Phenotype Ontology:HP:0010816,MONDO:MONDO:0008093,MedGen:C0334082,OMIM:162900,Orphanet:79414|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267,OMIM:167000|Human Phenotype Ontology:HP:0001914,Human Phenotype Ontology:HP:0004808,Human Phenotype Ontology:HP:0004843,Human Phenotype Ontology:HP:0005516,Human Phenotype Ontology:HP:0006724,Human Phenotype Ontology:HP:0006728,MONDO:MONDO:0018874,MeSH:D015470,MedGen:C0023467,OMIM:601626,Orphanet:519|MONDO:MONDO:0005138,MedGen:C0684249|MONDO:MONDO:0006096,MedGen:C0349579|MONDO:MONDO:0006193,MedGen:C1516855|Human Phenotype Ontology:HP:0100834,MONDO:MONDO:0005335,MeSH:D015179,MedGen:C0009404|Human Phenotype Ontology:HP:0012209,MONDO:MONDO:0011908,MedGen:C0349639,OMIM:607785,Orphanet:86834	Thyroid tumor|Primary low grade serous adenocarcinoma of ovary|Vascular Tumors Including Pyogenic Granuloma|not provided|Gastric cancer|Encephalocraniocutaneous lipomatosis|Cerebral arteriovenous malformation|Autoimmune lymphoproliferative syndrome type 4|RASopathy|Nevus sebaceous|Linear nevus sebaceous syndrome|Carcinoma of pancreas|Capillary malformation-arteriovenous malformation 1|Non-small cell lung carcinoma|Epidermal nevus|Neoplasm of ovary|Acute myeloid leukemia|Lung carcinoma|Atypical endometrial hyperplasia|Endometrial hyperplasia without atypia|Neoplasm of the large intestine|Juvenile myelomonocytic leukemia	criteria provided, multiple submitters, no conflicts	12582.0		MAPK cascade;positive regulation of protein phosphorylation;Ras protein signal transduction;visual learning;gene expression;positive regulation of gene expression;glial cell proliferation;Rac protein signal transduction;forebrain astrocyte development;actin cytoskeleton organization;negative regulation of epithelial cell differentiation;regulation of synaptic transmission, GABAergic;positive regulation of Rac protein signal transduction;skeletal muscle cell differentiation;negative regulation of neuron apoptotic process;regulation of long-term neuronal synaptic plasticity;homeostasis of number of cells within a tissue;striated muscle cell differentiation;neuron apoptotic process;positive regulation of glial cell proliferation;epithelial tube branching involved in lung morphogenesis;type I pneumocyte differentiation	GO:0000165;GO:0001934;GO:0007265;GO:0008542;GO:0010467;GO:0010628;GO:0014009;GO:0016601;GO:0021897;GO:0030036;GO:0030857;GO:0032228;GO:0035022;GO:0035914;GO:0043524;GO:0048169;GO:0048873;GO:0051146;GO:0051402;GO:0060252;GO:0060441;GO:0060509	Golgi membrane;cytoplasm;mitochondrial outer membrane;endoplasmic reticulum membrane;cytosol;plasma membrane;focal adhesion;cytoplasmic side of plasma membrane;membrane	GO:0000139;GO:0005737;GO:0005741;GO:0005789;GO:0005829;GO:0005886;GO:0005925;GO:0009898;GO:0016020	GTPase activity;G protein activity;protein binding;GTP binding;GDP binding;protein-membrane adaptor activity;protein-containing complex binding	GO:0003924;GO:0003925;GO:0005515;GO:0005525;GO:0019003;GO:0043495;GO:0044877	21.0	3be95afa-5521-11e7-8f50-0ac135e8bacf,3c88330c-5521-11e7-8f50-0ac135e8bacf,412efed6-5521-11e7-8f50-0ac135e8bacf,4362cec8-5521-11e7-8f50-0ac135e8bacf,576974d6-5521-11e7-8f50-0ac135e8bacf,65205a00-5521-11e7-8f50-0ac135e8bacf,720b3c92-5521-11e7-8f50-0ac135e8bacf,78974324-5521-11e7-8f50-0ac135e8bacf,7ac7dec6-5521-11e7-8f50-0ac135e8bacf,898a6694-5521-11e7-8f50-0ac135e8bacf,8f640d10-5521-11e7-8f50-0ac135e8bacf,95fd0bec-5521-11e7-8f50-0ac135e8bacf,a59cd558-5521-11e7-8f50-0ac135e8bacf,b7824902-5521-11e7-8f50-0ac135e8bacf,c70366de-5521-11e7-8f50-0ac135e8bacf,c92b28e0-5521-11e7-8f50-0ac135e8bacf,ce49e3cc-5521-11e7-8f50-0ac135e8bacf,da3d4700-5521-11e7-8f50-0ac135e8bacf,e1b66caa-5521-11e7-8f50-0ac135e8bacf,e4e93610-5521-11e7-8f50-0ac135e8bacf,ef96f9ea-5521-11e7-8f50-0ac135e8bacf	Trk receptor signaling mediated by the MAPK pathway,Trk receptor signaling mediated by PI3K and PLC-gamma,TCR signaling in naive CD8 T cells,TCR signaling in naive CD4 T cells,SHP2 signaling,Regulation of Ras family activation,Ras signaling in the CD4 TCR pathway,Plasma membrane estrogen receptor signaling,PDGFR-beta signaling pathway,Neurotrophic factor-mediated Trk receptor signaling,mTOR signaling pathway,Internalization of ErbB1,IL2-mediated signaling events,GMCSF-mediated signaling events,ErbB2ErbB3 signaling events,ErbB1 downstream signaling,EPHB forward signaling,Downstream signaling in naive CD8 T cells,CXCR3-mediated signaling events,Class I PI3K signaling events,C-MYB transcription factor network	rs121913529		1.39585e-05	0.0	0.0	0.0	0.0	0.0	3.09761e-05	0.0	0.0
chr15:41275014:T/G	INO80 intron_variant		4.0	0.6439570695286981	True	0.4666666666666667	chr15	41275014	T	G	147			INO80	ENST00000648947.1	intron_variant		c.4453+46A>C		40982816	0.2434105431309904	0.3320726172465961	0.2492795389048991	0.0069444444444444	0.3797216699801193	0.2229038854805726													Benign	MedGen:CN169374	not specified	criteria provided, single submitter	2688187.0		mitotic sister chromatid segregation;telomere maintenance;double-strand break repair via homologous recombination;regulation of DNA replication;DNA repair;regulation of DNA repair;double-strand break repair;chromatin remodeling;DNA-templated transcription;positive regulation of nuclear cell cycle DNA replication;positive regulation of cell growth;regulation of chromosome organization;cellular response to UV;positive regulation of DNA repair;positive regulation of DNA-templated transcription;positive regulation of transcription by RNA polymerase II;regulation of embryonic development;spindle assembly;cell division;regulation of cell cycle;regulation of DNA strand elongation;UV-damage excision repair;cellular response to ionizing radiation;positive regulation of telomere maintenance in response to DNA damage;regulation of G1/S transition of mitotic cell cycle	GO:0000070;GO:0000723;GO:0000724;GO:0006275;GO:0006281;GO:0006282;GO:0006302;GO:0006338;GO:0006351;GO:0010571;GO:0030307;GO:0033044;GO:0034644;GO:0045739;GO:0045893;GO:0045944;GO:0045995;GO:0051225;GO:0051301;GO:0051726;GO:0060382;GO:0070914;GO:0071479;GO:1904507;GO:2000045	nucleus;nucleoplasm;spindle;cytosol;microtubule;nuclear body;Ino80 complex	GO:0005634;GO:0005654;GO:0005819;GO:0005829;GO:0005874;GO:0016604;GO:0031011	DNA binding;actin binding;protein binding;ATP binding;ATP-dependent activity, acting on DNA;ATP hydrolysis activity;histone binding;alpha-tubulin binding;ATP-dependent chromatin remodeler activity	GO:0003677;GO:0003779;GO:0005515;GO:0005524;GO:0008094;GO:0016887;GO:0042393;GO:0043014;GO:0140658				rs7173954	rs7173954	0.339693	0.330109	0.433957	0.0083014	0.367152	0.270555	0.370354	0.321263	0.236721
chr22:29130458:T/C	CHEK2 p.Glu84=				True	0.5	chr22	29130458	T	C	139		Yes	CHEK2	ENST00000404276.6	synonymous_variant	2.0	c.252A>G	p.Glu84=	28734470	0.0427316293929712	0.0544629349470499	0.0144092219020172	0.0863095238095238	0.0168986083499005	0.0286298568507157							COSV60417575	"[[""prostate"", 32], [""meninges"", 11], [""stomach"", 1], [""lung"", 1]]"	45.0	ENST00000382565.5	E84%3D	Exact Match	Benign	MedGen:CN239278|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0007254,MedGen:C0006142	CHEK2-Related Cancer Susceptibility|Hereditary cancer-predisposing syndrome|not specified|not provided|Hereditary breast ovarian cancer syndrome|Familial cancer of breast|Malignant tumor of breast	criteria provided, multiple submitters, no conflicts	142139.0		DNA damage checkpoint signaling;G2/M transition of mitotic cell cycle;double-strand break repair;regulation of DNA-templated transcription;protein phosphorylation;DNA damage response;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;intrinsic apoptotic signaling pathway in response to DNA damage;protein catabolic process;mitotic intra-S DNA damage checkpoint signaling;regulation of protein catabolic process;signal transduction in response to DNA damage;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;mitotic DNA damage checkpoint signaling;positive regulation of DNA-templated transcription;protein autophosphorylation;protein stabilization;cell division;thymocyte apoptotic process;cellular response to gamma radiation;mitotic spindle assembly;replicative senescence;regulation of signal transduction by p53 class mediator;regulation of autophagosome assembly	GO:0000077;GO:0000086;GO:0006302;GO:0006355;GO:0006468;GO:0006974;GO:0006977;GO:0006978;GO:0008630;GO:0030163;GO:0031573;GO:0042176;GO:0042770;GO:0042771;GO:0044773;GO:0045893;GO:0046777;GO:0050821;GO:0051301;GO:0070242;GO:0071480;GO:0090307;GO:0090399;GO:1901796;GO:2000785	chromosome, telomeric region;nucleus;nucleoplasm;cytoplasm;Golgi apparatus;PML body	GO:0000781;GO:0005634;GO:0005654;GO:0005737;GO:0005794;GO:0016605	protein serine/threonine kinase activity;protein binding;ATP binding;protein kinase binding;ubiquitin protein ligase binding;identical protein binding;protein homodimerization activity;metal ion binding;protein serine kinase activity	GO:0004674;GO:0005515;GO:0005524;GO:0019901;GO:0031625;GO:0042802;GO:0042803;GO:0046872;GO:0106310	4.0	76f15b4e-5521-11e7-8f50-0ac135e8bacf,81be3ee4-5521-11e7-8f50-0ac135e8bacf,bddf504e-5521-11e7-8f50-0ac135e8bacf,f9c7eca4-5521-11e7-8f50-0ac135e8bacf	PLK3 signaling events,p53 pathway,FOXM1 transcription factor network,ATM pathway	rs1805129	rs1805129	0.0400587	0.0654239	0.0895118	0.0911425	0.0254482	0.0213033	0.0255585	0.0327715	0.0387442
chr14:105242966:T/C	AKT1 intron_variant		6.0	0.4664598681659558	True	0.36	chr14	105242966	T	C	120			AKT1	ENST00000349310.7	intron_variant		c.287+30A>G		104776629	0.5964456869009584	0.7360060514372163	0.5518731988472623	0.6547619047619048	0.3727634194831014	0.6094069529652352							COSV62573175	"[[""meninges"", 85], [""lung"", 2], [""breast"", 1], [""liver"", 1]]"	89.0	ENST00000402615.6	?	Exact Match	Benign	MedGen:C3661900	not provided	criteria provided, single submitter	1272355.0		osteoblast differentiation;maternal placenta development;positive regulation of protein phosphorylation;positive regulation of endothelial cell proliferation;cell migration involved in sprouting angiogenesis;sphingosine-1-phosphate receptor signaling pathway;glycogen biosynthetic process;regulation of glycogen biosynthetic process;glucose metabolic process;regulation of translation;protein phosphorylation;negative regulation of protein kinase activity;protein import into nucleus;nitric oxide biosynthetic process;activation-induced cell death of T cells;inflammatory response;response to oxidative stress;signal transduction;epidermal growth factor receptor signaling pathway;G protein-coupled receptor signaling pathway;canonical NF-kappaB signal transduction;cell population proliferation;insulin receptor signaling pathway;apoptotic mitochondrial changes;response to heat;gene expression;negative regulation of autophagy;positive regulation of endothelial cell migration;positive regulation of gene expression;negative regulation of gene expression;negative regulation of long-chain fatty acid import across plasma membrane;fibroblast migration;positive regulation of fibroblast migration;positive regulation of sodium ion transport;positive regulation of glucose metabolic process;negative regulation of endopeptidase activity;regulation of neuron projection development;negative regulation of macroautophagy;phosphorylation;protein ubiquitination;peptidyl-serine phosphorylation;peptidyl-threonine phosphorylation;virus-mediated perturbation of host defense response;cytokine-mediated signaling pathway;mammalian oogenesis stage;cell differentiation;positive regulation of cell growth;regulation of cell migration;positive regulation of cell migration;T cell costimulation;negative regulation of protein ubiquitination;regulation of myelination;lipopolysaccharide-mediated signaling pathway;TOR signaling;negative regulation of fatty acid beta-oxidation;positive regulation of endodeoxyribonuclease activity;negative regulation of protein binding;response to food;peripheral nervous system myelin maintenance;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;cellular response to insulin stimulus;positive regulation of peptidyl-serine phosphorylation;response to fluid shear stress;cellular response to reactive oxygen species;intracellular signal transduction;interleukin-18-mediated signaling pathway;cellular response to vascular endothelial growth factor stimulus;cellular response to decreased oxygen levels;non-canonical NF-kappaB signal transduction;glucose homeostasis;regulation of apoptotic process;negative regulation of apoptotic process;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;proteasome-mediated ubiquitin-dependent protein catabolic process;anoikis;regulation of mRNA stability;phosphatidylinositol 3-kinase/protein kinase B signal transduction;positive regulation of blood vessel endothelial cell migration;positive regulation of nitric oxide biosynthetic process;positive regulation of fat cell differentiation;positive regulation of glycogen biosynthetic process;positive regulation of cyclin-dependent protein serine/threonine kinase activity;negative regulation of Notch signaling pathway;negative regulation of proteolysis;positive regulation of DNA-templated transcription;positive regulation of transcription by RNA polymerase II;positive regulation of glucose import;positive regulation of organ growth;protein autophosphorylation;positive regulation of lipid biosynthetic process;insulin-like growth factor receptor signaling pathway;behavioral response to pain;positive regulation of smooth muscle cell proliferation;positive regulation of nitric-oxide synthase activity;positive regulation of DNA-binding transcription factor activity;striated muscle cell differentiation;positive regulation of protein metabolic process;excitatory postsynaptic potential;response to growth hormone;mammary gland epithelial cell differentiation;labyrinthine layer blood vessel development;response to UV-A;response to growth factor;cellular response to cadmium ion;cellular response to tumor necrosis factor;cellular response to epidermal growth factor stimulus;cellular response to prostaglandin E stimulus;negative regulation of protein serine/threonine kinase activity;establishment of protein localization to mitochondrion;maintenance of protein location in mitochondrion;negative regulation of release of cytochrome c from mitochondria;cellular response to granulocyte macrophage colony-stimulating factor stimulus;execution phase of apoptosis;regulation of postsynapse organization;regulation of tRNA methylation;cellular response to oxidised low-density lipoprotein particle stimulus;negative regulation of protein localization to lysosome;negative regulation of cGAS/STING signaling pathway;positive regulation of G1/S transition of mitotic cell cycle;positive regulation of protein localization to nucleus;cellular response to peptide;regulation of signal transduction by p53 class mediator;negative regulation of cilium assembly;negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway;negative regulation of leukocyte cell-cell adhesion;positive regulation of protein localization to plasma membrane;positive regulation of I-kappaB phosphorylation;positive regulation of TORC1 signaling;positive regulation of protein localization to endoplasmic reticulum;cellular response to nerve growth factor stimulus;response to insulin-like growth factor stimulus;positive regulation of protein localization to cell surface;regulation of type B pancreatic cell development;negative regulation of lymphocyte migration;negative regulation of extrinsic apoptotic signaling pathway in absence of ligand	GO:0001649;GO:0001893;GO:0001934;GO:0001938;GO:0002042;GO:0003376;GO:0005978;GO:0005979;GO:0006006;GO:0006417;GO:0006468;GO:0006469;GO:0006606;GO:0006809;GO:0006924;GO:0006954;GO:0006979;GO:0007165;GO:0007173;GO:0007186;GO:0007249;GO:0008283;GO:0008286;GO:0008637;GO:0009408;GO:0010467;GO:0010507;GO:0010595;GO:0010628;GO:0010629;GO:0010748;GO:0010761;GO:0010763;GO:0010765;GO:0010907;GO:0010951;GO:0010975;GO:0016242;GO:0016310;GO:0016567;GO:0018105;GO:0018107;GO:0019049;GO:0019221;GO:0022605;GO:0030154;GO:0030307;GO:0030334;GO:0030335;GO:0031295;GO:0031397;GO:0031641;GO:0031663;GO:0031929;GO:0031999;GO:0032079;GO:0032091;GO:0032094;GO:0032287;GO:0032436;GO:0032869;GO:0033138;GO:0034405;GO:0034614;GO:0035556;GO:0035655;GO:0035924;GO:0036294;GO:0038061;GO:0042593;GO:0042981;GO:0043066;GO:0043154;GO:0043161;GO:0043276;GO:0043488;GO:0043491;GO:0043536;GO:0045429;GO:0045600;GO:0045725;GO:0045737;GO:0045746;GO:0045861;GO:0045893;GO:0045944;GO:0046326;GO:0046622;GO:0046777;GO:0046889;GO:0048009;GO:0048266;GO:0048661;GO:0051000;GO:0051091;GO:0051146;GO:0051247;GO:0060079;GO:0060416;GO:0060644;GO:0060716;GO:0070141;GO:0070848;GO:0071276;GO:0071356;GO:0071364;GO:0071380;GO:0071901;GO:0072655;GO:0072656;GO:0090201;GO:0097011;GO:0097194;GO:0099175;GO:0110002;GO:0140052;GO:0150033;GO:0160049;GO:1900087;GO:1900182;GO:1901653;GO:1901796;GO:1902018;GO:1902176;GO:1903038;GO:1903078;GO:1903721;GO:1904263;GO:1905552;GO:1990090;GO:1990418;GO:2000010;GO:2000074;GO:2000402;GO:2001240	nucleus;nucleoplasm;cytoplasm;mitochondrial intermembrane space;spindle;cytosol;plasma membrane;cell-cell junction;cell cortex;microtubule cytoskeleton;membrane;lamellipodium;vesicle;protein-containing complex;ciliary basal body;postsynapse;glutamatergic synapse	GO:0005634;GO:0005654;GO:0005737;GO:0005758;GO:0005819;GO:0005829;GO:0005886;GO:0005911;GO:0005938;GO:0015630;GO:0016020;GO:0030027;GO:0031982;GO:0032991;GO:0036064;GO:0098794;GO:0098978	protein kinase activity;protein serine/threonine kinase activity;protein serine/threonine/tyrosine kinase activity;protein binding;calmodulin binding;ATP binding;phosphatidylinositol-3,4,5-trisphosphate binding;kinase activity;enzyme binding;protein kinase binding;nitric-oxide synthase regulator activity;protein serine/threonine kinase inhibitor activity;identical protein binding;protein homodimerization activity;phosphatidylinositol-3,4-bisphosphate binding;14-3-3 protein binding;potassium channel activator activity;protein serine kinase activity	GO:0004672;GO:0004674;GO:0004712;GO:0005515;GO:0005516;GO:0005524;GO:0005547;GO:0016301;GO:0019899;GO:0019901;GO:0030235;GO:0030291;GO:0042802;GO:0042803;GO:0043325;GO:0071889;GO:0099104;GO:0106310	59.0	05bf4684-5522-11e7-8f50-0ac135e8bacf,326486c4-5521-11e7-8f50-0ac135e8bacf,32ff1916-5521-11e7-8f50-0ac135e8bacf,3c88330c-5521-11e7-8f50-0ac135e8bacf,3e718c82-5521-11e7-8f50-0ac135e8bacf,412efed6-5521-11e7-8f50-0ac135e8bacf,4362cec8-5521-11e7-8f50-0ac135e8bacf,4c90f780-5521-11e7-8f50-0ac135e8bacf,4e9e0592-5521-11e7-8f50-0ac135e8bacf,4fc2fd96-5521-11e7-8f50-0ac135e8bacf,50509798-5521-11e7-8f50-0ac135e8bacf,5189b3dc-5521-11e7-8f50-0ac135e8bacf,5aadca6c-5521-11e7-8f50-0ac135e8bacf,5fa96cf8-5521-11e7-8f50-0ac135e8bacf,603902ca-5521-11e7-8f50-0ac135e8bacf,68975856-5521-11e7-8f50-0ac135e8bacf,71848060-5521-11e7-8f50-0ac135e8bacf,78974324-5521-11e7-8f50-0ac135e8bacf,7f189a50-5521-11e7-8f50-0ac135e8bacf,81be3ee4-5521-11e7-8f50-0ac135e8bacf,854f7c00-5521-11e7-8f50-0ac135e8bacf,8daf7f38-5521-11e7-8f50-0ac135e8bacf,8f640d10-5521-11e7-8f50-0ac135e8bacf,924f9444-5521-11e7-8f50-0ac135e8bacf,9697501e-5521-11e7-8f50-0ac135e8bacf,98ad85f0-5521-11e7-8f50-0ac135e8bacf,99c67004-5521-11e7-8f50-0ac135e8bacf,9a5d0ab6-5521-11e7-8f50-0ac135e8bacf,9c711da8-5521-11e7-8f50-0ac135e8bacf,9d03247a-5521-11e7-8f50-0ac135e8bacf,9d979c4c-5521-11e7-8f50-0ac135e8bacf,a04a1220-5521-11e7-8f50-0ac135e8bacf,a8411a5c-5521-11e7-8f50-0ac135e8bacf,ad8f70c4-5521-11e7-8f50-0ac135e8bacf,afa50a56-5521-11e7-8f50-0ac135e8bacf,b354a4de-5521-11e7-8f50-0ac135e8bacf,b568dee0-5521-11e7-8f50-0ac135e8bacf,bb3d7c4a-5521-11e7-8f50-0ac135e8bacf,bd570d7c-5521-11e7-8f50-0ac135e8bacf,be728fa0-5521-11e7-8f50-0ac135e8bacf,bf958bd4-5521-11e7-8f50-0ac135e8bacf,c02fa8f6-5521-11e7-8f50-0ac135e8bacf,c24171f8-5521-11e7-8f50-0ac135e8bacf,c70366de-5521-11e7-8f50-0ac135e8bacf,c92b28e0-5521-11e7-8f50-0ac135e8bacf,d306cfa2-5521-11e7-8f50-0ac135e8bacf,d8fe5e5c-5521-11e7-8f50-0ac135e8bacf,d992af1e-5521-11e7-8f50-0ac135e8bacf,df93b3b8-5521-11e7-8f50-0ac135e8bacf,e1b66caa-5521-11e7-8f50-0ac135e8bacf,e3c4b33c-5521-11e7-8f50-0ac135e8bacf,e4e93610-5521-11e7-8f50-0ac135e8bacf,e6f69242-5521-11e7-8f50-0ac135e8bacf,e803e396-5521-11e7-8f50-0ac135e8bacf,eb41826c-5521-11e7-8f50-0ac135e8bacf,ebd732be-5521-11e7-8f50-0ac135e8bacf,f47e9f46-5521-11e7-8f50-0ac135e8bacf,f823645e-5521-11e7-8f50-0ac135e8bacf,ff43bbb2-5521-11e7-8f50-0ac135e8bacf	a6b1 and a6b4 Integrin signaling,VEGFR3 signaling in lymphatic endothelium,VEGFR1 specific signals,Trk receptor signaling mediated by PI3K and PLC-gamma,Thromboxane A2 receptor signaling,TCR signaling in naive CD8 T cells,TCR signaling in naive CD4 T cells,Signaling events mediated by VEGFR1 and VEGFR2,Signaling events mediated by the Hedgehog family,Signaling events mediated by Stem cell factor receptor (c-Kit),Signaling events mediated by PTP1B,Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met),S1P3 pathway,Retinoic acid receptors-mediated signaling,Regulation of Telomerase,Regulation of nuclear SMAD23 signaling,Reelin signaling pathway,Plasma membrane estrogen receptor signaling,p75(NTR)-mediated signaling,p53 pathway,Nongenotropic Androgen signaling,NephrinNeph1 signaling in the kidney podocyte,mTOR signaling pathway,LPA receptor mediated events,Integrins in angiogenesis,Integrin-linked kinase signaling,Insulin-mediated glucose transport,Insulin Pathway,IL8- and CXCR2-mediated signaling events,IL8- and CXCR1-mediated signaling events,IL6-mediated signaling events,IL4-mediated signaling events,IL2 signaling events mediated by PI3K,IGF1 pathway,IFN-gamma pathway,HIF-1-alpha transcription factor network,Hedgehog signaling events mediated by Gli proteins,Glucocorticoid receptor regulatory network,FoxO family signaling,FOXA2 and FOXA3 transcription factor networks,FGF signaling pathway,Fc-epsilon receptor I signaling in mast cells,FAS (CD95) signaling pathway,ErbB2ErbB3 signaling events,ErbB1 downstream signaling,Endothelins,E-cadherin signaling in the nascent adherens junction,E-cadherin signaling in keratinocytes,CXCR4-mediated signaling events,CXCR3-mediated signaling events,Coregulation of Androgen receptor activity,Class I PI3K signaling events,Class I PI3K signaling events mediated by Akt,Ceramide signaling pathway,CD40CD40L signaling,Caspase Cascade in Apoptosis,BCR signaling pathway,Aurora A signaling,Angiopoietin receptor Tie2-mediated signaling	rs2494735	rs2494735	0.489056	0.703129	0.327815	0.649649	0.40555	0.517204	0.355075	0.480948	0.584262
chr2:148675003:T/G	ACVR2A intron_variant		8.0	0.1398201144726083			chr2	148675003	T	G	120			ACVR2A	ENST00000241416.12	intron_variant		c.816+8T>G		147917434																									gastrulation with mouth forming second;positive regulation of protein phosphorylation;protein phosphorylation;cell surface receptor protein serine/threonine kinase signaling pathway;spermatogenesis;determination of left/right symmetry;mesoderm development;anterior/posterior pattern specification;positive regulation of bone mineralization;BMP signaling pathway;activin receptor signaling pathway;positive regulation of activin receptor signaling pathway;odontogenesis of dentin-containing tooth;sperm ejaculation;penile erection;regulation of nitric oxide biosynthetic process;positive regulation of erythrocyte differentiation;positive regulation of osteoblast differentiation;positive regulation of transcription by RNA polymerase II;embryonic skeletal system development;Sertoli cell proliferation;positive regulation of SMAD protein signal transduction;cellular response to growth factor stimulus;cellular response to BMP stimulus	GO:0001702;GO:0001934;GO:0006468;GO:0007178;GO:0007283;GO:0007368;GO:0007498;GO:0009952;GO:0030501;GO:0030509;GO:0032924;GO:0032927;GO:0042475;GO:0042713;GO:0043084;GO:0045428;GO:0045648;GO:0045669;GO:0045944;GO:0048706;GO:0060011;GO:0060391;GO:0071363;GO:0071773	cytoplasm;plasma membrane;cell surface;inhibin-betaglycan-ActRII complex;receptor complex;activin receptor complex	GO:0005737;GO:0005886;GO:0009986;GO:0034673;GO:0043235;GO:0048179	protein serine/threonine kinase activity;transmembrane receptor protein serine/threonine kinase activity;protein binding;ATP binding;coreceptor activity;activin receptor activity;growth factor binding;PDZ domain binding;inhibin binding;metal ion binding;activin binding;BMP receptor activity	GO:0004674;GO:0004675;GO:0005515;GO:0005524;GO:0015026;GO:0017002;GO:0019838;GO:0030165;GO:0034711;GO:0046872;GO:0048185;GO:0098821	1.0	05263ad2-5522-11e7-8f50-0ac135e8bacf	ALK1 signaling events											
chr3:41275107:T/C	CTNNB1 p.Ser425Pro		8.0	0.1108045977011494			chr3	41275107	T	C	115		Yes	CTNNB1	ENST00000349496.11	missense_variant	9.0	c.1273T>C	p.Ser425Pro	41233616							1.6e-06	0.0241																	negative regulation of transcription by RNA polymerase II;MAPK cascade;protein polyubiquitination;embryonic axis specification;branching involved in blood vessel morphogenesis;osteoblast differentiation;branching involved in ureteric bud morphogenesis;in utero embryonic development;gastrulation with mouth forming second;cell fate specification;endodermal cell fate commitment;neuron migration;epithelial to mesenchymal transition;neural plate development;positive regulation of neuroblast proliferation;positive regulation of mesenchymal cell proliferation;chondrocyte differentiation;lens morphogenesis in camera-type eye;outflow tract morphogenesis;regulation of secondary heart field cardioblast proliferation;metanephros morphogenesis;negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis;transcription by RNA polymerase II;cell adhesion;cell-matrix adhesion;chemical synaptic transmission;ectoderm development;glial cell fate determination;neuroblast proliferation;positive regulation of cell population proliferation;negative regulation of cell population proliferation;fibroblast growth factor receptor signaling pathway;response to xenobiotic stimulus;anterior/posterior axis specification;dorsal/ventral axis specification;proximal/distal pattern formation;positive regulation of gene expression;negative regulation of gene expression;positive regulation of epithelial to mesenchymal transition;positive regulation of heparan sulfate proteoglycan biosynthetic process;negative regulation of angiogenesis;stem cell population maintenance;layer formation in cerebral cortex;hypothalamus development;central nervous system vasculogenesis;osteoclast differentiation;male genitalia development;hindbrain development;regulation of centriole-centriole cohesion;pancreas development;hair follicle morphogenesis;regulation of protein ubiquitination;regulation of myelination;positive regulation of telomere maintenance via telomerase;negative regulation of chondrocyte differentiation;response to estradiol;positive regulation of transcription elongation by RNA polymerase II;T cell differentiation in thymus;negative regulation of protein sumoylation;adherens junction assembly;protein localization to cell surface;embryonic heart tube development;genitalia morphogenesis;embryonic forelimb morphogenesis;embryonic hindlimb morphogenesis;hair cell differentiation;detection of muscle stretch;embryonic skeletal limb joint morphogenesis;astrocyte-dopaminergic neuron signaling;regulation of T cell proliferation;odontogenesis of dentin-containing tooth;embryonic digit morphogenesis;positive regulation of apoptotic process;negative regulation of apoptotic process;proteasome-mediated ubiquitin-dependent protein catabolic process;positive regulation of MAPK cascade;positive regulation of neuron apoptotic process;canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation;bone resorption;positive regulation of cell differentiation;positive regulation of endothelial cell differentiation;positive regulation of osteoblast differentiation;negative regulation of osteoclast differentiation;positive regulation of fibroblast growth factor receptor signaling pathway;regulation of angiogenesis;negative regulation of DNA-templated transcription;positive regulation of DNA-templated transcription;positive regulation of transcription by RNA polymerase II;negative regulation of mitotic cell cycle, embryonic;regulation of fibroblast proliferation;cell maturation;synaptic vesicle transport;thymus development;oocyte development;embryonic foregut morphogenesis;positive regulation of skeletal muscle tissue development;regulation of smooth muscle cell proliferation;neuron fate determination;oligodendrocyte differentiation;negative regulation of oligodendrocyte differentiation;regulation of neurogenesis;synapse organization;smooth muscle cell differentiation;myoblast proliferation;regulation of timing of anagen;regulation of synapse assembly;oviduct development;canonical Wnt signaling pathway;trachea formation;epithelial tube branching involved in lung morphogenesis;lung-associated mesenchyme development;lung epithelial cell differentiation;lung induction;epithelial cell differentiation involved in prostate gland development;epithelial cell proliferation involved in prostate gland development;positive regulation of epithelial cell proliferation involved in prostate gland development;hair follicle placode formation;establishment of blood-brain barrier;mesenchymal cell proliferation involved in lung development;positive regulation of branching involved in lung morphogenesis;endothelial tube morphogenesis;fungiform papilla formation;sympathetic ganglion development;cranial ganglion development;regulation of centromeric sister chromatid cohesion;cellular response to growth factor stimulus;cellular response to indole-3-methanol;renal vesicle formation;renal inner medulla development;renal outer medulla development;nephron tubule formation;stem cell proliferation;regulation of nephron tubule epithelial cell differentiation;mesenchymal stem cell differentiation;negative regulation of canonical Wnt signaling pathway;regulation of calcium ion import;acinar cell differentiation;synaptic vesicle clustering;apoptotic signaling pathway;cell-cell adhesion;positive regulation of odontoblast differentiation;negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway;cranial skeletal system development;midbrain dopaminergic neuron differentiation;neuron projection extension;embryonic brain development;dorsal root ganglion development;establishment of blood-retinal barrier;regulation of protein localization to cell surface;positive regulation of determination of dorsal identity;positive regulation of myoblast proliferation;positive regulation of stem cell proliferation	GO:0000122;GO:0000165;GO:0000209;GO:0000578;GO:0001569;GO:0001649;GO:0001658;GO:0001701;GO:0001702;GO:0001708;GO:0001711;GO:0001764;GO:0001837;GO:0001840;GO:0002052;GO:0002053;GO:0002062;GO:0002089;GO:0003151;GO:0003266;GO:0003338;GO:0003340;GO:0006366;GO:0007155;GO:0007160;GO:0007268;GO:0007398;GO:0007403;GO:0007405;GO:0008284;GO:0008285;GO:0008543;GO:0009410;GO:0009948;GO:0009950;GO:0009954;GO:0010628;GO:0010629;GO:0010718;GO:0010909;GO:0016525;GO:0019827;GO:0021819;GO:0021854;GO:0022009;GO:0030316;GO:0030539;GO:0030902;GO:0030997;GO:0031016;GO:0031069;GO:0031396;GO:0031641;GO:0032212;GO:0032331;GO:0032355;GO:0032968;GO:0033077;GO:0033234;GO:0034333;GO:0034394;GO:0035050;GO:0035112;GO:0035115;GO:0035116;GO:0035315;GO:0035995;GO:0036023;GO:0036520;GO:0042129;GO:0042475;GO:0042733;GO:0043065;GO:0043066;GO:0043161;GO:0043410;GO:0043525;GO:0044338;GO:0045453;GO:0045597;GO:0045603;GO:0045669;GO:0045671;GO:0045743;GO:0045765;GO:0045892;GO:0045893;GO:0045944;GO:0045976;GO:0048145;GO:0048469;GO:0048489;GO:0048538;GO:0048599;GO:0048617;GO:0048643;GO:0048660;GO:0048664;GO:0048709;GO:0048715;GO:0050767;GO:0050808;GO:0051145;GO:0051450;GO:0051884;GO:0051963;GO:0060066;GO:0060070;GO:0060440;GO:0060441;GO:0060484;GO:0060487;GO:0060492;GO:0060742;GO:0060767;GO:0060769;GO:0060789;GO:0060856;GO:0060916;GO:0061047;GO:0061154;GO:0061198;GO:0061549;GO:0061550;GO:0070602;GO:0071363;GO:0071681;GO:0072033;GO:0072053;GO:0072054;GO:0072079;GO:0072089;GO:0072182;GO:0072497;GO:0090090;GO:0090279;GO:0090425;GO:0097091;GO:0097190;GO:0098609;GO:1901331;GO:1903377;GO:1904888;GO:1904948;GO:1990138;GO:1990403;GO:1990791;GO:1990963;GO:2000008;GO:2000017;GO:2000288;GO:2000648	euchromatin;spindle pole;nucleus;nucleoplasm;transcription regulator complex;cytoplasm;centrosome;cytosol;plasma membrane;cell-cell junction;adherens junction;fascia adherens;bicellular tight junction;focal adhesion;cell cortex;membrane;basolateral plasma membrane;apicolateral plasma membrane;lateral plasma membrane;catenin complex;flotillin complex;Z disc;lamellipodium;cell junction;beta-catenin destruction complex;microvillus membrane;protein-containing complex;protein-DNA complex;Scrib-APC-beta-catenin complex;presynaptic membrane;apical part of cell;synapse;postsynaptic membrane;perinuclear region of cytoplasm;extracellular exosome;beta-catenin-TCF7L2 complex;cell periphery;Schaffer collateral - CA1 synapse;presynaptic active zone cytoplasmic component;glutamatergic synapse;postsynaptic density, intracellular component;beta-catenin-ICAT complex;beta-catenin-TCF complex;Wnt signalosome	GO:0000791;GO:0000922;GO:0005634;GO:0005654;GO:0005667;GO:0005737;GO:0005813;GO:0005829;GO:0005886;GO:0005911;GO:0005912;GO:0005916;GO:0005923;GO:0005925;GO:0005938;GO:0016020;GO:0016323;GO:0016327;GO:0016328;GO:0016342;GO:0016600;GO:0030018;GO:0030027;GO:0030054;GO:0030877;GO:0031528;GO:0032991;GO:0032993;GO:0034750;GO:0042734;GO:0045177;GO:0045202;GO:0045211;GO:0048471;GO:0070062;GO:0070369;GO:0071944;GO:0098685;GO:0098831;GO:0098978;GO:0099092;GO:1990711;GO:1990907;GO:1990909	transcription coregulator binding;transcription corepressor binding;chromatin binding;transcription coactivator activity;signaling receptor binding;protein binding;nuclear receptor binding;enzyme binding;kinase binding;protein kinase binding;protein phosphatase binding;nuclear estrogen receptor binding;ubiquitin protein ligase binding;transmembrane transporter binding;alpha-catenin binding;cadherin binding;SMAD binding;RNA polymerase II-specific DNA-binding transcription factor binding;I-SMAD binding;disordered domain specific binding;DNA-binding transcription factor binding	GO:0001221;GO:0001222;GO:0003682;GO:0003713;GO:0005102;GO:0005515;GO:0016922;GO:0019899;GO:0019900;GO:0019901;GO:0019903;GO:0030331;GO:0031625;GO:0044325;GO:0045294;GO:0045296;GO:0046332;GO:0061629;GO:0070411;GO:0097718;GO:0140297	20.0	408a0c44-5521-11e7-8f50-0ac135e8bacf,49ac7526-5521-11e7-8f50-0ac135e8bacf,4c90f780-5521-11e7-8f50-0ac135e8bacf,5189b3dc-5521-11e7-8f50-0ac135e8bacf,6aae5178-5521-11e7-8f50-0ac135e8bacf,73325776-5521-11e7-8f50-0ac135e8bacf,7455058a-5521-11e7-8f50-0ac135e8bacf,74f0d05c-5521-11e7-8f50-0ac135e8bacf,8e3d8e6c-5521-11e7-8f50-0ac135e8bacf,8ed3dafe-5521-11e7-8f50-0ac135e8bacf,98ad85f0-5521-11e7-8f50-0ac135e8bacf,bd570d7c-5521-11e7-8f50-0ac135e8bacf,d8fe5e5c-5521-11e7-8f50-0ac135e8bacf,d992af1e-5521-11e7-8f50-0ac135e8bacf,def3ca36-5521-11e7-8f50-0ac135e8bacf,e3c4b33c-5521-11e7-8f50-0ac135e8bacf,e92d968a-5521-11e7-8f50-0ac135e8bacf,ecb0a2d0-5521-11e7-8f50-0ac135e8bacf,fae73f58-5521-11e7-8f50-0ac135e8bacf,fd2c9b80-5521-11e7-8f50-0ac135e8bacf	TGF-beta receptor signaling,Stabilization and expansion of the E-cadherin adherens junction,Signaling events mediated by VEGFR1 and VEGFR2,Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met),Regulation of nuclear beta catenin signaling and target gene transcription,RAC1 signaling pathway,Presenilin action in Notch and Wnt signaling,Posttranslational regulation of adherens junction stability and dissassembly,Nectin adhesion pathway,N-cadherin signaling events,Integrin-linked kinase signaling,FoxO family signaling,E-cadherin signaling in the nascent adherens junction,E-cadherin signaling in keratinocytes,Degradation of beta catenin,Coregulation of Androgen receptor activity,CDC42 signaling events,Canonical Wnt signaling pathway,Arf6 trafficking events,AP-1 transcription factor network											
chr9:137293761:G/A	RXRA intron_variant		7.0	0.0409669330592365	True	0.5714285714285714	chr9	137293761	G	A	113			RXRA	ENST00000481739.2	intron_variant		c.279+33G>A		134401915	0.7709664536741214	0.9236006051437216	0.6959654178674352	0.7708333333333334	0.7584493041749503	0.630879345603272																			negative regulation of transcription by RNA polymerase II;positive regulation of thyroid hormone mediated signaling pathway;hormone-mediated signaling pathway;positive regulation of cholesterol efflux;cell differentiation;positive regulation of bone mineralization;positive regulation of transporter activity;response to retinoic acid;peroxisome proliferator activated receptor signaling pathway;mRNA transcription by RNA polymerase II;steroid hormone mediated signaling pathway;positive regulation of DNA-templated transcription;positive regulation of transcription by RNA polymerase II;retinoic acid receptor signaling pathway;anatomical structure development;positive regulation of vitamin D receptor signaling pathway	GO:0000122;GO:0002157;GO:0009755;GO:0010875;GO:0030154;GO:0030501;GO:0032411;GO:0032526;GO:0035357;GO:0042789;GO:0043401;GO:0045893;GO:0045944;GO:0048384;GO:0048856;GO:0070564	chromatin;nucleus;nucleoplasm;transcription regulator complex;mitochondrion;cytosol;receptor complex;RNA polymerase II transcription regulator complex	GO:0000785;GO:0005634;GO:0005654;GO:0005667;GO:0005739;GO:0005829;GO:0043235;GO:0090575	transcription cis-regulatory region binding;RNA polymerase II transcription regulatory region sequence-specific DNA binding;RNA polymerase II cis-regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;transcription coregulator binding;retinoic acid binding;double-stranded DNA binding;DNA-binding transcription factor activity;nuclear steroid receptor activity;nuclear receptor activity;protein binding;zinc ion binding;enzyme binding;peptide binding;identical protein binding;nuclear vitamin D receptor binding;sequence-specific DNA binding;retinoic acid-responsive element binding;DNA binding domain binding;LBD domain binding;vitamin D response element binding;sequence-specific double-stranded DNA binding	GO:0000976;GO:0000977;GO:0000978;GO:0000981;GO:0001221;GO:0001972;GO:0003690;GO:0003700;GO:0003707;GO:0004879;GO:0005515;GO:0008270;GO:0019899;GO:0042277;GO:0042802;GO:0042809;GO:0043565;GO:0044323;GO:0050692;GO:0050693;GO:0070644;GO:1990837	4.0	05bf4684-5522-11e7-8f50-0ac135e8bacf,5c7718c2-5521-11e7-8f50-0ac135e8bacf,5fa96cf8-5521-11e7-8f50-0ac135e8bacf,6f7a316e-5521-11e7-8f50-0ac135e8bacf	a6b1 and a6b4 Integrin signaling,RXR and RAR heterodimerization with other nuclear receptor,Retinoic acid receptors-mediated signaling,Regulation of Androgen receptor activity	rs2234753	rs2234753	0.800268	0.910094	0.697471	0.782832	0.781987	0.707808	0.764978	0.788765	0.626239
chr17:7801776:C/T	CHD3 intron_variant		1.0	0.62569558101473	True	0.525	chr17	7801776	C	T	104			CHD3	ENST00000330494.12	intron_variant		c.2052-38C>T		7898458	0.1926916932907348	0.077912254160363	0.1945244956772334	0.3402777777777778	0.1550695825049702	0.2331288343558282							COSV57879008	"[[""lung"", 1], [""kidney"", 1], [""haematopoietic and lymphoid tissue"", 1]]"	3.0	ENST00000358181.8	?	Exact Match							negative regulation of transcription by RNA polymerase II;chromatin remodeling;regulation of DNA-templated transcription;spindle organization;centrosome cycle;regulation of cell fate specification;negative regulation of DNA-templated transcription;positive regulation of DNA-templated transcription;regulation of stem cell differentiation	GO:0000122;GO:0006338;GO:0006355;GO:0007051;GO:0007098;GO:0042659;GO:0045892;GO:0045893;GO:2000736	chromatin;nucleus;nucleoplasm;nucleolus;cytoplasm;centrosome;NuRD complex;PML body;centriolar satellite	GO:0000785;GO:0005634;GO:0005654;GO:0005730;GO:0005737;GO:0005813;GO:0016581;GO:0016605;GO:0034451	transcription cis-regulatory region binding;DNA binding;chromatin binding;RNA binding;helicase activity;protein binding;ATP binding;zinc ion binding;ATP hydrolysis activity;histone binding;ATP-dependent chromatin remodeler activity	GO:0000976;GO:0003677;GO:0003682;GO:0003723;GO:0004386;GO:0005515;GO:0005524;GO:0008270;GO:0016887;GO:0042393;GO:0140658	1.0	54bc0812-5521-11e7-8f50-0ac135e8bacf	Signaling events mediated by HDAC Class I	rs58909711	rs58909711	0.151335	0.100563	0.116727	0.364044	0.200747	0.195965	0.152756	0.155784	0.256427
chr18:19756856:C/T	GATA6 intron_variant		1.0	0.5193935119887165		0.5925925925925926	chr18	19756856	C	T	104			GATA6	ENST00000269216.9	intron_variant		c.1136-60C>T		22176895	0.0253594249201277	0.0015128593040847	0.0345821325648415	0.0198412698412698	0.040755467196819	0.0408997955010225																			negative regulation of transcription by RNA polymerase II;in utero embryonic development;liver development;sebaceous gland cell differentiation;regulation of antimicrobial humoral response;outflow tract septum morphogenesis;atrioventricular node development;sinoatrial node development;type B pancreatic cell differentiation;pancreatic A cell differentiation;phospholipid metabolic process;endodermal cell fate determination;male gonad development;response to xenobiotic stimulus;response to toxic substance;gene expression;positive regulation of cardiac muscle cell apoptotic process;cardiac muscle hypertrophy in response to stress;positive regulation of BMP signaling pathway;epithelial cell differentiation;response to retinoic acid;negative regulation of transforming growth factor beta1 production;negative regulation of transforming growth factor beta2 production;tube morphogenesis;atrioventricular canal development;odontogenesis of dentin-containing tooth;negative regulation of apoptotic process;response to estrogen;cell fate commitment;positive regulation of angiogenesis;negative regulation of DNA-templated transcription;positive regulation of DNA-templated transcription;positive regulation of transcription by RNA polymerase II;animal organ formation;stem cell differentiation;smooth muscle cell differentiation;response to cAMP;cardiac muscle cell differentiation;cardiac muscle cell proliferation;positive regulation of cardiac muscle cell proliferation;heart contraction;lung saccule development;club cell differentiation;type II pneumocyte differentiation;intestinal epithelial cell differentiation;cardiac vascular smooth muscle cell differentiation;G1 to G0 transition involved in cell differentiation;response to growth factor;cellular response to gonadotropin stimulus;cellular response to hypoxia;cellular response to BMP stimulus;skin epidermis development;positive regulation of cardiac muscle myoblast proliferation;negative regulation of miRNA transcription;negative regulation of sebum secreting cell proliferation	GO:0000122;GO:0001701;GO:0001889;GO:0001949;GO:0002759;GO:0003148;GO:0003162;GO:0003163;GO:0003309;GO:0003310;GO:0006644;GO:0007493;GO:0008584;GO:0009410;GO:0009636;GO:0010467;GO:0010666;GO:0014898;GO:0030513;GO:0030855;GO:0032526;GO:0032911;GO:0032912;GO:0035239;GO:0036302;GO:0042475;GO:0043066;GO:0043627;GO:0045165;GO:0045766;GO:0045892;GO:0045893;GO:0045944;GO:0048645;GO:0048863;GO:0051145;GO:0051591;GO:0055007;GO:0060038;GO:0060045;GO:0060047;GO:0060430;GO:0060486;GO:0060510;GO:0060575;GO:0060947;GO:0070315;GO:0070848;GO:0071371;GO:0071456;GO:0071773;GO:0098773;GO:0110024;GO:1902894;GO:1904003	chromatin;nucleus;nucleoplasm;transcription regulator complex;nuclear membrane	GO:0000785;GO:0005634;GO:0005654;GO:0005667;GO:0031965	transcription cis-regulatory region binding;RNA polymerase II cis-regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;transcription coactivator binding;chromatin binding;DNA-binding transcription factor activity;protein binding;zinc ion binding;protein kinase binding;NFAT protein binding;DNA-binding transcription factor binding;sequence-specific double-stranded DNA binding	GO:0000976;GO:0000978;GO:0000981;GO:0001223;GO:0003682;GO:0003700;GO:0005515;GO:0008270;GO:0019901;GO:0051525;GO:0140297;GO:1990837	1.0	841dd9cc-5521-11e7-8f50-0ac135e8bacf	Notch-mediated HESHEY network	rs3764504	rs3764504	0.0308609	0.00922887	0.0966867	0.0233078	0.0340844	0.0284731	0.0409554	0.0352832	0.0541694
chr11:92577070:T/C	FAT3 intron_variant		6.0	0.0304118268215417	True		chr11	92577070	T	C	95			FAT3	ENST00000409404.6	intron_variant		c.10567-30T>C		92843904	0.386182108626198	0.2980332829046899	0.4164265129682997	0.4474206349206349	0.4105367793240557	0.3957055214723926							COSV53115691	"[[""breast"", 1], [""haematopoietic and lymphoid tissue"", 1]]"	2.0	ENST00000409404.6	?	Exact Match							homophilic cell adhesion via plasma membrane adhesion molecules;retina layer formation;dendrite development;cell morphogenesis involved in neuron differentiation;cell-cell adhesion;interneuron migration;negative regulation of dendrite development	GO:0007156;GO:0010842;GO:0016358;GO:0048667;GO:0098609;GO:1904936;GO:2000171	plasma membrane;dendrite	GO:0005886;GO:0030425	calcium ion binding	GO:0005509				rs4753419	rs4753419	0.389743	0.325999	0.473827	0.450192	0.446541	0.442203	0.404534	0.396086	0.384363
chr1:27099487:T/G	ARID1A intron_variant		8.0	0.1889644746787604			chr1	27099487	T	G	93			ARID1A	ENST00000324856.13	intron_variant		c.3715+9T>G		26772996																									nucleosome disassembly;chromatin remodeling;regulation of transcription by RNA polymerase II;nervous system development;regulation of mitotic metaphase/anaphase transition;intracellular estrogen receptor signaling pathway;androgen receptor signaling pathway;intracellular glucocorticoid receptor signaling pathway;positive regulation of T cell differentiation;positive regulation of cell differentiation;positive regulation of myoblast differentiation;transcription initiation-coupled chromatin remodeling;positive regulation of DNA-templated transcription;regulation of G0 to G1 transition;positive regulation of stem cell population maintenance;regulation of G1/S transition of mitotic cell cycle;positive regulation of double-strand break repair;regulation of nucleotide-excision repair	GO:0006337;GO:0006338;GO:0006357;GO:0007399;GO:0030071;GO:0030520;GO:0030521;GO:0042921;GO:0045582;GO:0045597;GO:0045663;GO:0045815;GO:0045893;GO:0070316;GO:1902459;GO:2000045;GO:2000781;GO:2000819	chromatin;nucleus;nucleoplasm;SWI/SNF complex;brahma complex;npBAF complex;nBAF complex;bBAF complex	GO:0000785;GO:0005634;GO:0005654;GO:0016514;GO:0035060;GO:0071564;GO:0071565;GO:0140092	DNA binding;transcription coactivator activity;protein binding;nuclear receptor binding;nucleosome binding	GO:0003677;GO:0003713;GO:0005515;GO:0016922;GO:0031491														
chr6:7229619:G/A	RREB1 p.Ala429=		4.0	0.0380818053596615	True	0.6451612903225806	chr6	7229619	G	A	90		Yes	RREB1	ENST00000379938.7	synonymous_variant	10.0	c.1287G>A	p.Ala429=	7229386	0.2034744408945687	0.3350983358547655	0.1714697406340057	0.0416666666666666	0.3081510934393638	0.107361963190184							COSV58566718	"[[""large intestine"", 1]]"	1.0	ENST00000379938.6	A429%3D	Exact Match	Benign		RREB1-related condition	criteria provided, single submitter	3059500.0		negative regulation of transcription by RNA polymerase II;regulation of DNA-templated transcription;regulation of transcription by RNA polymerase II;transcription by RNA polymerase II;positive regulation of epithelial cell migration;positive regulation of mammary gland epithelial cell proliferation;positive regulation of DNA-templated transcription;positive regulation of transcription by RNA polymerase II;positive regulation of brown fat cell differentiation;positive regulation of substrate adhesion-dependent cell spreading;positive regulation of wound healing, spreading of epidermal cells;positive regulation of lamellipodium morphogenesis	GO:0000122;GO:0006355;GO:0006357;GO:0006366;GO:0010634;GO:0033601;GO:0045893;GO:0045944;GO:0090336;GO:1900026;GO:1903691;GO:2000394	fibrillar center;nucleus;cytoplasm;nuclear body;nuclear speck;extracellular exosome	GO:0001650;GO:0005634;GO:0005737;GO:0016604;GO:0016607;GO:0070062	RNA polymerase II transcription regulatory region sequence-specific DNA binding;RNA polymerase II cis-regulatory region sequence-specific DNA binding;DNA-binding transcription activator activity, RNA polymerase II-specific;metal ion binding	GO:0000977;GO:0000978;GO:0001228;GO:0046872				rs12192672	rs12192672	0.279537	0.309702	0.23012	0.0393978	0.359183	0.186007	0.289699	0.253724	0.118922
chr9:101894998:T/C	TGFBR1 p.Met184Thr		8.0	0.2316789862724392			chr9	101894998	T	C	77		Yes	TGFBR1	ENST00000374994.9	missense_variant	3.0	c.551T>C	p.Met184Thr	99132716							0.00289	0.0355											Uncertain significance	MONDO:MONDO:0018954,MedGen:C2697932,OMIM:PS609192,Orphanet:60030	Loeys-Dietz syndrome	criteria provided, single submitter	3074454.0		skeletal system development;in utero embryonic development;kidney development;blastocyst development;epithelial to mesenchymal transition;endothelial cell proliferation;negative regulation of endothelial cell proliferation;positive regulation of endothelial cell proliferation;lens development in camera-type eye;ventricular trabecula myocardium morphogenesis;ventricular compact myocardium morphogenesis;proepicardium development;regulation of DNA-templated transcription;protein phosphorylation;apoptotic process;signal transduction;transforming growth factor beta receptor signaling pathway;nervous system development;heart development;positive regulation of cell population proliferation;germ cell migration;male gonad development;post-embryonic development;anterior/posterior pattern specification;positive regulation of gene expression;regulation of epithelial to mesenchymal transition;positive regulation of epithelial to mesenchymal transition;peptidyl-serine phosphorylation;collagen fibril organization;positive regulation of cell growth;positive regulation of cell migration;negative regulation of cell migration;regulation of protein ubiquitination;negative regulation of chondrocyte differentiation;activin receptor signaling pathway;intracellular signal transduction;myofibroblast differentiation;wound healing;endothelial cell activation;extracellular structure organization;endothelial cell migration;positive regulation of DNA-templated transcription;filopodium assembly;thymus development;neuron fate commitment;embryonic cranial skeleton morphogenesis;skeletal system morphogenesis;mesenchymal cell differentiation;artery morphogenesis;cell motility;positive regulation of filopodium assembly;positive regulation of stress fiber assembly;regulation of cell cycle;positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction;parathyroid gland development;roof of mouth development;pharyngeal system development;regulation of cardiac muscle cell proliferation;cardiac epithelial to mesenchymal transition;positive regulation of SMAD protein signal transduction;ventricular septum morphogenesis;angiogenesis involved in coronary vascular morphogenesis;coronary artery morphogenesis;response to cholesterol;cellular response to growth factor stimulus;cellular response to transforming growth factor beta stimulus;positive regulation of extracellular matrix assembly;positive regulation of mesenchymal stem cell proliferation;positive regulation of vasculature development;positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation;positive regulation of tight junction disassembly;epicardium morphogenesis;positive regulation of apoptotic signaling pathway;negative regulation of extrinsic apoptotic signaling pathway	GO:0001501;GO:0001701;GO:0001822;GO:0001824;GO:0001837;GO:0001935;GO:0001937;GO:0001938;GO:0002088;GO:0003222;GO:0003223;GO:0003342;GO:0006355;GO:0006468;GO:0006915;GO:0007165;GO:0007179;GO:0007399;GO:0007507;GO:0008284;GO:0008354;GO:0008584;GO:0009791;GO:0009952;GO:0010628;GO:0010717;GO:0010718;GO:0018105;GO:0030199;GO:0030307;GO:0030335;GO:0030336;GO:0031396;GO:0032331;GO:0032924;GO:0035556;GO:0036446;GO:0042060;GO:0042118;GO:0043062;GO:0043542;GO:0045893;GO:0046847;GO:0048538;GO:0048663;GO:0048701;GO:0048705;GO:0048762;GO:0048844;GO:0048870;GO:0051491;GO:0051496;GO:0051726;GO:0051897;GO:0060017;GO:0060021;GO:0060037;GO:0060043;GO:0060317;GO:0060391;GO:0060412;GO:0060978;GO:0060982;GO:0070723;GO:0071363;GO:0071560;GO:1901203;GO:1902462;GO:1904018;GO:1905007;GO:1905075;GO:1905223;GO:2001235;GO:2001237	nucleus;endosome;plasma membrane;bicellular tight junction;cell surface;receptor complex;membrane raft;activin receptor complex;transforming growth factor beta ligand-receptor complex	GO:0005634;GO:0005768;GO:0005886;GO:0005923;GO:0009986;GO:0043235;GO:0045121;GO:0048179;GO:0070021	protein kinase activity;protein serine/threonine kinase activity;transmembrane receptor protein serine/threonine kinase activity;transforming growth factor beta receptor activity;transforming growth factor beta receptor activity, type I;type II transforming growth factor beta receptor binding;protein binding;ATP binding;activin receptor activity, type I;growth factor binding;ubiquitin protein ligase binding;SMAD binding;metal ion binding;activin binding;transforming growth factor beta binding;I-SMAD binding	GO:0004672;GO:0004674;GO:0004675;GO:0005024;GO:0005025;GO:0005114;GO:0005515;GO:0005524;GO:0016361;GO:0019838;GO:0031625;GO:0046332;GO:0046872;GO:0048185;GO:0050431;GO:0070411	4.0	05263ad2-5522-11e7-8f50-0ac135e8bacf,408a0c44-5521-11e7-8f50-0ac135e8bacf,ba907368-5521-11e7-8f50-0ac135e8bacf,f23376be-5521-11e7-8f50-0ac135e8bacf	ALK1 signaling events,TGF-beta receptor signaling,Glypican 1 network,Beta5 beta6 beta7 and beta8 integrin cell surface interactions											
chr2:48028287:A/G	MSH6 p.Ala1055=		8.0	0.0428722280887011			chr2	48028287	A	G	72		Yes	MSH6	ENST00000234420.10	synonymous_variant	4.0	c.3165A>G	p.Ala1055=	47801148																			Likely benign	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0005835,MedGen:C4552100,Orphanet:144|MeSH:D003123,MedGen:C0009405	Hereditary cancer-predisposing syndrome|Lynch syndrome|Hereditary nonpolyposis colorectal neoplasms	criteria provided, multiple submitters, no conflicts	485870.0		meiotic mismatch repair;DNA repair;mismatch repair;spermatogenesis;determination of adult lifespan;intrinsic apoptotic signaling pathway in response to DNA damage;response to UV;somatic hypermutation of immunoglobulin genes;somatic recombination of immunoglobulin gene segments;maintenance of DNA repeat elements;isotype switching;negative regulation of DNA recombination;positive regulation of helicase activity;intrinsic apoptotic signaling pathway	GO:0000710;GO:0006281;GO:0006298;GO:0007283;GO:0008340;GO:0008630;GO:0009411;GO:0016446;GO:0016447;GO:0043570;GO:0045190;GO:0045910;GO:0051096;GO:0097193	chromatin;nucleus;nucleoplasm;Golgi apparatus;cytosol;MutSalpha complex;intracellular membrane-bounded organelle	GO:0000785;GO:0005634;GO:0005654;GO:0005794;GO:0005829;GO:0032301;GO:0043231	magnesium ion binding;four-way junction DNA binding;chromatin binding;double-stranded DNA binding;protein binding;ATP binding;ATP-dependent activity, acting on DNA;enzyme binding;mismatched DNA binding;guanine/thymine mispair binding;single guanine insertion binding;single thymine insertion binding;oxidized purine DNA binding;MutLalpha complex binding;methylated histone binding;protein homodimerization activity;ADP binding;ATP-dependent DNA damage sensor activity	GO:0000287;GO:0000400;GO:0003682;GO:0003690;GO:0005515;GO:0005524;GO:0008094;GO:0019899;GO:0030983;GO:0032137;GO:0032142;GO:0032143;GO:0032357;GO:0032405;GO:0035064;GO:0042803;GO:0043531;GO:0140664				rs1553414590										
chr2:232577214:T/C	PTMA p.Ala117=		8.0	0.081805359661495			chr2	232577214	T	C	70		Yes	PTMA	ENST00000410064.5	synonymous_variant	4.0	c.351T>C	p.Ala117=	231712504																									DNA-templated transcription;negative regulation of apoptotic process;positive regulation of transcription by RNA polymerase II	GO:0006351;GO:0043066;GO:0045944	nucleus;nucleoplasm;cytosol	GO:0005634;GO:0005654;GO:0005829	protein binding;histone binding;DNA-binding transcription factor binding	GO:0005515;GO:0042393;GO:0140297	1.0	3814fa62-5521-11e7-8f50-0ac135e8bacf	Validated targets of C-MYC transcriptional activation	rs1490087180										
chr2:48028287:A/T	MSH6 p.Ala1055=		8.0	0.0338504936530324			chr2	48028287	A	T	64		Yes	MSH6	ENST00000234420.10	synonymous_variant	4.0	c.3165A>T	p.Ala1055=	47801148																									meiotic mismatch repair;DNA repair;mismatch repair;spermatogenesis;determination of adult lifespan;intrinsic apoptotic signaling pathway in response to DNA damage;response to UV;somatic hypermutation of immunoglobulin genes;somatic recombination of immunoglobulin gene segments;maintenance of DNA repeat elements;isotype switching;negative regulation of DNA recombination;positive regulation of helicase activity;intrinsic apoptotic signaling pathway	GO:0000710;GO:0006281;GO:0006298;GO:0007283;GO:0008340;GO:0008630;GO:0009411;GO:0016446;GO:0016447;GO:0043570;GO:0045190;GO:0045910;GO:0051096;GO:0097193	chromatin;nucleus;nucleoplasm;Golgi apparatus;cytosol;MutSalpha complex;intracellular membrane-bounded organelle	GO:0000785;GO:0005634;GO:0005654;GO:0005794;GO:0005829;GO:0032301;GO:0043231	magnesium ion binding;four-way junction DNA binding;chromatin binding;double-stranded DNA binding;protein binding;ATP binding;ATP-dependent activity, acting on DNA;enzyme binding;mismatched DNA binding;guanine/thymine mispair binding;single guanine insertion binding;single thymine insertion binding;oxidized purine DNA binding;MutLalpha complex binding;methylated histone binding;protein homodimerization activity;ADP binding;ATP-dependent DNA damage sensor activity	GO:0000287;GO:0000400;GO:0003682;GO:0003690;GO:0005515;GO:0005524;GO:0008094;GO:0019899;GO:0030983;GO:0032137;GO:0032142;GO:0032143;GO:0032357;GO:0032405;GO:0035064;GO:0042803;GO:0043531;GO:0140664														
chr12:133252796:C/G	POLE intron_variant		7.0	0.1074716535228196	True	0.55	chr12	133252796	C	G	58			POLE	ENST00000320574.10	intron_variant		c.910-6G>C		132676210	0.571685303514377	0.6452344931921331	0.5561959654178674	0.3353174603174603	0.6998011928429424	0.5950920245398773							COSV57680623	"[[""haematopoietic and lymphoid tissue"", 1], [""lung"", 1], [""breast"", 1]]"	3.0	ENST00000320574.9	?	Exact Match	Benign	MONDO:MONDO:0014058,MedGen:C3554576,OMIM:615139,Orphanet:352712|MONDO:MONDO:0014038,MedGen:C3554460,OMIM:615083,Orphanet:220460|MONDO:MONDO:0032684,MedGen:C5193036,OMIM:618336|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MedGen:CN169374	Facial dysmorphism-immunodeficiency-livedo-short stature syndrome|Colorectal cancer, susceptibility to, 12|Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency|Hereditary cancer-predisposing syndrome|not provided|not specified	criteria provided, multiple submitters, no conflicts	380209.0		G1/S transition of mitotic cell cycle;mitotic cell cycle;DNA synthesis involved in DNA repair;DNA replication;DNA-templated DNA replication;leading strand elongation;base-excision repair, gap-filling;nucleotide-excision repair, DNA gap filling;DNA replication proofreading;embryonic organ development	GO:0000082;GO:0000278;GO:0000731;GO:0006260;GO:0006261;GO:0006272;GO:0006287;GO:0006297;GO:0045004;GO:0048568	nucleus;nucleoplasm;plasma membrane;epsilon DNA polymerase complex	GO:0005634;GO:0005654;GO:0005886;GO:0008622	nucleotide binding;DNA binding;chromatin binding;DNA-directed DNA polymerase activity;protein binding;zinc ion binding;single-stranded DNA 3'-5' DNA exonuclease activity;4 iron, 4 sulfur cluster binding	GO:0000166;GO:0003677;GO:0003682;GO:0003887;GO:0005515;GO:0008270;GO:0008310;GO:0051539				rs4077170	rs4077170	0.653238	0.634372	0.778748	0.297893	0.601515	0.58899	0.69939	0.642924	0.602429
chr3:52437892:T/A	BAP1 p.Thr423=		8.0	0.1043294614572333			chr3	52437892	T	A	56		Yes	BAP1	ENST00000460680.6	synonymous_variant	13.0	c.1269A>T	p.Thr423=	52403876																									mitotic cell cycle;regulation of cell growth;in utero embryonic development;tissue homeostasis;thrombocyte differentiation;chromatin remodeling;ubiquitin-dependent protein catabolic process;negative regulation of cell population proliferation;response to inorganic substance;gene expression;protein deubiquitination;neutrophil differentiation;myeloid cell apoptotic process;monoubiquitinated protein deubiquitination;common myeloid progenitor cell proliferation;protein modification process;platelet morphogenesis;erythrocyte maturation;nucleate erythrocyte differentiation;negative regulation of DNA-templated transcription;regulation of inflammatory response;regulation of cell cycle;hematopoietic stem cell homeostasis;macrophage homeostasis;neuron cellular homeostasis;leukocyte proliferation;protein K48-linked deubiquitination;regulation of cytokine production involved in inflammatory response;positive regulation of protein targeting to mitochondrion	GO:0000278;GO:0001558;GO:0001701;GO:0001894;GO:0002574;GO:0006338;GO:0006511;GO:0008285;GO:0010035;GO:0010467;GO:0016579;GO:0030223;GO:0033028;GO:0035520;GO:0035726;GO:0036211;GO:0036344;GO:0043249;GO:0043363;GO:0045892;GO:0050727;GO:0051726;GO:0061484;GO:0061519;GO:0070050;GO:0070661;GO:0071108;GO:1900015;GO:1903955	nucleus;nucleoplasm;cytoplasm;cytosol;PR-DUB complex	GO:0005634;GO:0005654;GO:0005737;GO:0005829;GO:0035517	chromatin binding;cysteine-type deubiquitinase activity;protein binding;peptidase activity;chromatin DNA binding;histone H2A deubiquitinase activity	GO:0003682;GO:0004843;GO:0005515;GO:0008233;GO:0031490;GO:0140950														
chr11:107880049:T/C	CUL5 5_prime_UTR_variant	23.0	8.0	0.0589198036006546			chr11	107880049	T	C	55			CUL5	ENST00000393094.7	5_prime_UTR_variant	1.0	c.-26T>C		108009323																									G1/S transition of mitotic cell cycle;protein ubiquitination;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;ERBB2 signaling pathway;calcium ion transmembrane transport;intrinsic apoptotic signaling pathway	GO:0000082;GO:0016567;GO:0031146;GO:0038128;GO:0070588;GO:0097193	nucleus;cytosol;SCF ubiquitin ligase complex;Cul5-RING ubiquitin ligase complex;site of DNA damage	GO:0005634;GO:0005829;GO:0019005;GO:0031466;GO:0090734	ubiquitin-protein transferase activity;calcium channel activity;protein binding;protein-macromolecule adaptor activity;ubiquitin protein ligase binding;signaling receptor activity	GO:0004842;GO:0005262;GO:0005515;GO:0030674;GO:0031625;GO:0038023														
chr3:30648618:T/G	TGFBR2 intron_variant		8.0	0.0588716271463614			chr3	30648618	T	G	55			TGFBR2	ENST00000295754.10	intron_variant		c.94+149T>G		30607126																									blood vessel development;branching involved in blood vessel morphogenesis;vasculogenesis;in utero embryonic development;epithelial to mesenchymal transition;heart looping;positive regulation of mesenchymal cell proliferation;lens development in camera-type eye;positive regulation of tolerance induction to self antigen;positive regulation of B cell tolerance induction;positive regulation of T cell tolerance induction;outflow tract septum morphogenesis;membranous septum morphogenesis;outflow tract morphogenesis;aortic valve morphogenesis;atrioventricular valve morphogenesis;tricuspid valve morphogenesis;cardiac left ventricle morphogenesis;endocardial cushion fusion;growth plate cartilage chondrocyte growth;protein phosphorylation;apoptotic process;transforming growth factor beta receptor signaling pathway;Notch signaling pathway;smoothened signaling pathway;gastrulation;brain development;heart development;positive regulation of cell population proliferation;response to xenobiotic stimulus;regulation of gene expression;positive regulation of epithelial cell migration;positive regulation of epithelial to mesenchymal transition;activation of protein kinase activity;activin receptor signaling pathway;embryonic hemopoiesis;aorta morphogenesis;regulation of cell population proliferation;myeloid dendritic cell differentiation;positive regulation of angiogenesis;embryonic cranial skeleton morphogenesis;artery morphogenesis;positive regulation of NK T cell differentiation;roof of mouth development;positive regulation of SMAD protein signal transduction;SMAD protein signal transduction;ventricular septum morphogenesis;bronchus morphogenesis;trachea formation;mammary gland morphogenesis;lung lobe morphogenesis;Langerhans cell differentiation;secondary palate development;response to cholesterol;cellular response to growth factor stimulus;regulation of stem cell proliferation;positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation;cell proliferation involved in endocardial cushion morphogenesis;superior endocardial cushion morphogenesis;inferior endocardial cushion morphogenesis;lens fiber cell apoptotic process;miRNA transport;positive regulation of reactive oxygen species metabolic process;positive regulation of CD4-positive, alpha-beta T cell proliferation;regulation of stem cell differentiation	GO:0001568;GO:0001569;GO:0001570;GO:0001701;GO:0001837;GO:0001947;GO:0002053;GO:0002088;GO:0002651;GO:0002663;GO:0002666;GO:0003148;GO:0003149;GO:0003151;GO:0003180;GO:0003181;GO:0003186;GO:0003214;GO:0003274;GO:0003430;GO:0006468;GO:0006915;GO:0007179;GO:0007219;GO:0007224;GO:0007369;GO:0007420;GO:0007507;GO:0008284;GO:0009410;GO:0010468;GO:0010634;GO:0010718;GO:0032147;GO:0032924;GO:0035162;GO:0035909;GO:0042127;GO:0043011;GO:0045766;GO:0048701;GO:0048844;GO:0051138;GO:0060021;GO:0060391;GO:0060395;GO:0060412;GO:0060434;GO:0060440;GO:0060443;GO:0060463;GO:0061520;GO:0062009;GO:0070723;GO:0071363;GO:0072091;GO:1905007;GO:1905315;GO:1905316;GO:1905317;GO:1990086;GO:1990428;GO:2000379;GO:2000563;GO:2000736	extracellular region;cytosol;plasma membrane;caveola;external side of plasma membrane;membrane;receptor complex;membrane raft;transforming growth factor beta ligand-receptor complex	GO:0005576;GO:0005829;GO:0005886;GO:0005901;GO:0009897;GO:0016020;GO:0043235;GO:0045121;GO:0070021	transmembrane receptor protein serine/threonine kinase activity;transforming growth factor beta receptor activity;transforming growth factor beta receptor activity, type II;protein binding;ATP binding;glycosaminoglycan binding;activin receptor activity;kinase activator activity;type I transforming growth factor beta receptor binding;SMAD binding;metal ion binding;activin binding;transforming growth factor beta binding;molecular adaptor activity	GO:0004675;GO:0005024;GO:0005026;GO:0005515;GO:0005524;GO:0005539;GO:0017002;GO:0019209;GO:0034713;GO:0046332;GO:0046872;GO:0048185;GO:0050431;GO:0060090	5.0	05263ad2-5522-11e7-8f50-0ac135e8bacf,408a0c44-5521-11e7-8f50-0ac135e8bacf,9697501e-5521-11e7-8f50-0ac135e8bacf,ba907368-5521-11e7-8f50-0ac135e8bacf,f2ca3880-5521-11e7-8f50-0ac135e8bacf	ALK1 signaling events,TGF-beta receptor signaling,Integrins in angiogenesis,Glypican 1 network,Beta3 integrin cell surface interactions											
chr3:52442632:G/A	BAP1 intron_variant		8.0	0.0593103448275862			chr3	52442632	G	A	52			BAP1	ENST00000460680.6	intron_variant		c.123-10C>T		52408616																			Likely benign	MONDO:MONDO:0013692,MedGen:C3280492,OMIM:614327,Orphanet:289539	BAP1-related tumor predisposition syndrome	criteria provided, single submitter	2049841.0		mitotic cell cycle;regulation of cell growth;in utero embryonic development;tissue homeostasis;thrombocyte differentiation;chromatin remodeling;ubiquitin-dependent protein catabolic process;negative regulation of cell population proliferation;response to inorganic substance;gene expression;protein deubiquitination;neutrophil differentiation;myeloid cell apoptotic process;monoubiquitinated protein deubiquitination;common myeloid progenitor cell proliferation;protein modification process;platelet morphogenesis;erythrocyte maturation;nucleate erythrocyte differentiation;negative regulation of DNA-templated transcription;regulation of inflammatory response;regulation of cell cycle;hematopoietic stem cell homeostasis;macrophage homeostasis;neuron cellular homeostasis;leukocyte proliferation;protein K48-linked deubiquitination;regulation of cytokine production involved in inflammatory response;positive regulation of protein targeting to mitochondrion	GO:0000278;GO:0001558;GO:0001701;GO:0001894;GO:0002574;GO:0006338;GO:0006511;GO:0008285;GO:0010035;GO:0010467;GO:0016579;GO:0030223;GO:0033028;GO:0035520;GO:0035726;GO:0036211;GO:0036344;GO:0043249;GO:0043363;GO:0045892;GO:0050727;GO:0051726;GO:0061484;GO:0061519;GO:0070050;GO:0070661;GO:0071108;GO:1900015;GO:1903955	nucleus;nucleoplasm;cytoplasm;cytosol;PR-DUB complex	GO:0005634;GO:0005654;GO:0005737;GO:0005829;GO:0035517	chromatin binding;cysteine-type deubiquitinase activity;protein binding;peptidase activity;chromatin DNA binding;histone H2A deubiquitinase activity	GO:0003682;GO:0004843;GO:0005515;GO:0008233;GO:0031490;GO:0140950				rs1420847667										
chr6:157522037:C/A	ARID1B p.Gln1477Lys		8.0	0.0628150445909267			chr6	157522037	C	A	52		Yes	ARID1B	ENST00000636930.1	missense_variant	18.0	c.4429C>A	p.Gln1477Lys	157200903							0.00829	0.247																	response to ischemia;chromatin remodeling;regulation of transcription by RNA polymerase II;nervous system development;regulation of mitotic metaphase/anaphase transition;positive regulation of T cell differentiation;positive regulation of cell differentiation;positive regulation of myoblast differentiation;transcription initiation-coupled chromatin remodeling;positive regulation of DNA-templated transcription;regulation of G0 to G1 transition;cellular response to angiotensin;regulation of G1/S transition of mitotic cell cycle;positive regulation of double-strand break repair;regulation of nucleotide-excision repair	GO:0002931;GO:0006338;GO:0006357;GO:0007399;GO:0030071;GO:0045582;GO:0045597;GO:0045663;GO:0045815;GO:0045893;GO:0070316;GO:1904385;GO:2000045;GO:2000781;GO:2000819	chromatin;nucleoplasm;cytosol;plasma membrane;SWI/SNF complex;brahma complex;npBAF complex;nBAF complex;bBAF complex	GO:0000785;GO:0005654;GO:0005829;GO:0005886;GO:0016514;GO:0035060;GO:0071564;GO:0071565;GO:0140092	DNA binding;transcription coactivator activity;protein binding;nucleosome binding	GO:0003677;GO:0003713;GO:0005515;GO:0031491														
chr10:88677081:T/C	BMPR1A p.Leu289Pro		8.0	0.0763218390804597			chr10	88677081	T	C	49		Yes	BMPR1A	ENST00000372037.7	missense_variant	9.0	c.866T>C	p.Leu289Pro	86917324							0.000454	0.141																	angiogenesis;osteoblast differentiation;in utero embryonic development;mesoderm formation;somitogenesis;Mullerian duct regression;positive regulation of mesenchymal cell proliferation;chondrocyte differentiation;outflow tract septum morphogenesis;outflow tract morphogenesis;cardiac conduction system development;atrioventricular valve development;mitral valve morphogenesis;tricuspid valve morphogenesis;endocardial cushion morphogenesis;cardiac right ventricle morphogenesis;ventricular trabecula myocardium morphogenesis;ventricular compact myocardium morphogenesis;endocardial cushion formation;protein phosphorylation;immune response;transforming growth factor beta receptor signaling pathway;ectoderm development;dorsal/ventral axis specification;dorsal/ventral pattern formation;positive regulation of gene expression;negative regulation of gene expression;regulation of cardiac muscle cell apoptotic process;neural crest cell development;negative regulation of smooth muscle cell migration;central nervous system neuron differentiation;pituitary gland development;neural plate mediolateral regionalization;lung development;positive regulation of bone mineralization;BMP signaling pathway;positive regulation of transforming growth factor beta2 production;somatic stem cell population maintenance;hindlimb morphogenesis;dorsal aorta morphogenesis;odontogenesis of dentin-containing tooth;embryonic digit morphogenesis;positive regulation of osteoblast differentiation;positive regulation of transcription by RNA polymerase II;paraxial mesoderm structural organization;lateral mesoderm development;regulation of lateral mesodermal cell fate specification;mesendoderm development;embryonic organ development;developmental growth;epithelial cell proliferation;positive regulation of epithelial cell proliferation;negative regulation of neurogenesis;negative regulation of muscle cell differentiation;roof of mouth development;regulation of cardiac muscle cell proliferation;positive regulation of cardiac muscle cell proliferation;positive regulation of SMAD protein signal transduction;ventricular septum morphogenesis;heart formation;atrioventricular node cell development;pharyngeal arch artery morphogenesis;cellular response to growth factor stimulus;cellular response to BMP stimulus;positive regulation of miRNA transcription;positive regulation of cardiac ventricle development;positive regulation of vascular associated smooth muscle cell proliferation;fibrous ring of heart morphogenesis;regulation of neural crest cell differentiation;regulation of cellular senescence	GO:0001525;GO:0001649;GO:0001701;GO:0001707;GO:0001756;GO:0001880;GO:0002053;GO:0002062;GO:0003148;GO:0003151;GO:0003161;GO:0003171;GO:0003183;GO:0003186;GO:0003203;GO:0003215;GO:0003222;GO:0003223;GO:0003272;GO:0006468;GO:0006955;GO:0007179;GO:0007398;GO:0009950;GO:0009953;GO:0010628;GO:0010629;GO:0010665;GO:0014032;GO:0014912;GO:0021953;GO:0021983;GO:0021998;GO:0030324;GO:0030501;GO:0030509;GO:0032915;GO:0035019;GO:0035137;GO:0035912;GO:0042475;GO:0042733;GO:0045669;GO:0045944;GO:0048352;GO:0048368;GO:0048378;GO:0048382;GO:0048568;GO:0048589;GO:0050673;GO:0050679;GO:0050768;GO:0051148;GO:0060021;GO:0060043;GO:0060045;GO:0060391;GO:0060412;GO:0060914;GO:0060928;GO:0061626;GO:0071363;GO:0071773;GO:1902895;GO:1904414;GO:1904707;GO:1905285;GO:1905292;GO:2000772	plasma membrane;caveola;external side of plasma membrane;membrane;dendrite;neuronal cell body;receptor complex;HFE-transferrin receptor complex	GO:0005886;GO:0005901;GO:0009897;GO:0016020;GO:0030425;GO:0043025;GO:0043235;GO:1990712	protein serine/threonine kinase activity;transmembrane receptor protein serine/threonine kinase activity;transforming growth factor beta receptor activity, type I;protein binding;ATP binding;BMP binding;protein homodimerization activity;SMAD binding;metal ion binding;BMP receptor activity	GO:0004674;GO:0004675;GO:0005025;GO:0005515;GO:0005524;GO:0036122;GO:0042803;GO:0046332;GO:0046872;GO:0098821	1.0	f1ae1a1c-5521-11e7-8f50-0ac135e8bacf	BMP receptor signaling											
chr5:138240137:T/G	CTNNA1 intron_variant		8.0	0.1101259916005599			chr5	138240137	T	G	46			CTNNA1	ENST00000302763.12	intron_variant		c.1389+7T>G		138904448																									ovarian follicle development;cell adhesion;establishment or maintenance of cell polarity;smoothened signaling pathway;integrin-mediated signaling pathway;neuroblast proliferation;negative regulation of neuroblast proliferation;protein localization;male gonad development;gap junction assembly;cell migration;axon regeneration;odontogenesis of dentin-containing tooth;apical junction assembly;response to estrogen;positive regulation of smoothened signaling pathway;cellular response to indole-3-methanol;epithelial cell-cell adhesion;extrinsic apoptotic signaling pathway in absence of ligand;cell-cell adhesion;negative regulation of protein localization to nucleus;negative regulation of cell motility;negative regulation of integrin-mediated signaling pathway;negative regulation of extrinsic apoptotic signaling pathway in absence of ligand;positive regulation of extrinsic apoptotic signaling pathway in absence of ligand	GO:0001541;GO:0007155;GO:0007163;GO:0007224;GO:0007229;GO:0007405;GO:0007406;GO:0008104;GO:0008584;GO:0016264;GO:0016477;GO:0031103;GO:0042475;GO:0043297;GO:0043627;GO:0045880;GO:0071681;GO:0090136;GO:0097192;GO:0098609;GO:1900181;GO:2000146;GO:2001045;GO:2001240;GO:2001241	acrosomal vesicle;nucleus;cytosol;plasma membrane;cell-cell junction;adherens junction;zonula adherens;focal adhesion;intercalated disc;actin cytoskeleton;catenin complex;flotillin complex;lamellipodium;cell junction;intracellular membrane-bounded organelle	GO:0001669;GO:0005634;GO:0005829;GO:0005886;GO:0005911;GO:0005912;GO:0005915;GO:0005925;GO:0014704;GO:0015629;GO:0016342;GO:0016600;GO:0030027;GO:0030054;GO:0043231	RNA binding;structural molecule activity;protein binding;beta-catenin binding;vinculin binding;identical protein binding;gamma-catenin binding;cadherin binding;actin filament binding	GO:0003723;GO:0005198;GO:0005515;GO:0008013;GO:0017166;GO:0042802;GO:0045295;GO:0045296;GO:0051015	11.0	49ac7526-5521-11e7-8f50-0ac135e8bacf,4c90f780-5521-11e7-8f50-0ac135e8bacf,5189b3dc-5521-11e7-8f50-0ac135e8bacf,73325776-5521-11e7-8f50-0ac135e8bacf,74f0d05c-5521-11e7-8f50-0ac135e8bacf,8e3d8e6c-5521-11e7-8f50-0ac135e8bacf,8ed3dafe-5521-11e7-8f50-0ac135e8bacf,d8fe5e5c-5521-11e7-8f50-0ac135e8bacf,d992af1e-5521-11e7-8f50-0ac135e8bacf,e92d968a-5521-11e7-8f50-0ac135e8bacf,fae73f58-5521-11e7-8f50-0ac135e8bacf	Stabilization and expansion of the E-cadherin adherens junction,Signaling events mediated by VEGFR1 and VEGFR2,Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met),RAC1 signaling pathway,Posttranslational regulation of adherens junction stability and dissassembly,Nectin adhesion pathway,N-cadherin signaling events,E-cadherin signaling in the nascent adherens junction,E-cadherin signaling in keratinocytes,CDC42 signaling events,Arf6 trafficking events											
chrX:53565683:A/ACTCT	HUWE1 intron_variant		4.0	0.3180535966149506			chrX	53565683	A	ACTCT	45			HUWE1	ENST00000262854.11	intron_variant		c.11878+112_11878+113insAGAG		53538726																			Benign	MedGen:C3661900	not provided	criteria provided, single submitter	1287062.0		protein polyubiquitination;base-excision repair;chromatin remodeling;ubiquitin-dependent protein catabolic process;protein monoubiquitination;Golgi organization;negative regulation of mitochondrial fusion;cell differentiation;positive regulation of protein ubiquitination;circadian regulation of gene expression;membrane fusion;positive regulation of mitophagy in response to mitochondrial depolarization;positive regulation of protein targeting to mitochondrion	GO:0000209;GO:0006284;GO:0006338;GO:0006511;GO:0006513;GO:0007030;GO:0010637;GO:0030154;GO:0031398;GO:0032922;GO:0061025;GO:0098779;GO:1903955	Golgi membrane;extracellular region;nucleus;nucleoplasm;cytoplasm;mitochondrion;cytosol;membrane;secretory granule lumen;extracellular exosome;ficolin-1-rich granule lumen	GO:0000139;GO:0005576;GO:0005634;GO:0005654;GO:0005737;GO:0005739;GO:0005829;GO:0016020;GO:0034774;GO:0070062;GO:1904813	DNA binding;RNA binding;ubiquitin-protein transferase activity;protein binding;ubiquitin protein ligase activity;histone ubiquitin ligase activity	GO:0003677;GO:0003723;GO:0004842;GO:0005515;GO:0061630;GO:0140852	2.0	3814fa62-5521-11e7-8f50-0ac135e8bacf,81be3ee4-5521-11e7-8f50-0ac135e8bacf	Validated targets of C-MYC transcriptional activation,p53 pathway			0.173415	0.0621098	0.26341	0.30611	0.127081	0.193766	0.229215	0.184853	0.233375
chr5:37038842:T/C	NIPBL splice_site_variant		8.0	0.14227309893704			chr5	37038842	T	C	44			NIPBL	ENST00000282516.13	splice_site_variant	35.0	c.6108+2T>C		37038740																			Pathogenic	MONDO:MONDO:0007387,MedGen:C4551851,OMIM:122470,Orphanet:199	Cornelia de Lange syndrome 1	criteria provided, single submitter	211653.0		mitotic sister chromatid segregation;negative regulation of transcription by RNA polymerase II;metanephros development;heart morphogenesis;outflow tract morphogenesis;chromatin remodeling;DNA damage response;mitotic sister chromatid cohesion;brain development;sensory perception of sound;protein localization;establishment of mitotic sister chromatid cohesion;maintenance of mitotic sister chromatid cohesion;somatic stem cell population maintenance;embryonic forelimb morphogenesis;forelimb morphogenesis;external genitalia morphogenesis;positive regulation of multicellular organism growth;ear morphogenesis;regulation of hair cycle;fat cell differentiation;positive regulation of ossification;positive regulation of transcription by RNA polymerase II;regulation of embryonic development;embryonic digestive tract morphogenesis;digestive tract development;developmental growth;eye morphogenesis;regulation of developmental growth;embryonic viscerocranium morphogenesis;cognition;face morphogenesis;gallbladder development;uterus morphogenesis;mitotic cohesin loading;establishment of protein localization to chromatin;cellular response to X-ray;replication-born double-strand break repair via sister chromatid exchange;positive regulation of neuron migration	GO:0000070;GO:0000122;GO:0001656;GO:0003007;GO:0003151;GO:0006338;GO:0006974;GO:0007064;GO:0007420;GO:0007605;GO:0008104;GO:0034087;GO:0034088;GO:0035019;GO:0035115;GO:0035136;GO:0035261;GO:0040018;GO:0042471;GO:0042634;GO:0045444;GO:0045778;GO:0045944;GO:0045995;GO:0048557;GO:0048565;GO:0048589;GO:0048592;GO:0048638;GO:0048703;GO:0050890;GO:0060325;GO:0061010;GO:0061038;GO:0061780;GO:0071169;GO:0071481;GO:1990414;GO:2001224	chromatin;nucleus;nucleoplasm;cytosol;integrator complex;SMC loading complex;intracellular membrane-bounded organelle;extracellular exosome;Scc2-Scc4 cohesin loading complex	GO:0000785;GO:0005634;GO:0005654;GO:0005829;GO:0032039;GO:0032116;GO:0043231;GO:0070062;GO:0090694	chromatin binding;transcription corepressor activity;protein binding;mediator complex binding;histone deacetylase binding;cohesin loader activity;chromo shadow domain binding;promoter-specific chromatin binding	GO:0003682;GO:0003714;GO:0005515;GO:0036033;GO:0042826;GO:0061775;GO:0070087;GO:1990841				rs797045775										
chr12:56481710:T/C	ERBB3 intron_variant		8.0	0.0561774023231256			chr12	56481710	T	C	37			ERBB3	ENST00000267101.7	intron_variant		c.732+13T>C		56087926																									endocardial cushion development;negative regulation of cell adhesion;signal transduction;cell surface receptor protein tyrosine kinase signaling pathway;multicellular organism development;peripheral nervous system development;heart development;positive regulation of cell population proliferation;negative regulation of signal transduction;positive regulation of gene expression;Schwann cell differentiation;Schwann cell development;cranial nerve development;neurogenesis;positive regulation of kinase activity;ERBB2-ERBB3 signaling pathway;wound healing;regulation of cell population proliferation;myelination;negative regulation of apoptotic process;phosphatidylinositol 3-kinase/protein kinase B signal transduction;negative regulation of neuron apoptotic process;negative regulation of secretion;neuron apoptotic process;positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction;positive regulation of cardiac muscle tissue development;positive regulation of calcineurin-NFAT signaling cascade;motor neuron apoptotic process;extrinsic apoptotic signaling pathway in absence of ligand;negative regulation of motor neuron apoptotic process	GO:0003197;GO:0007162;GO:0007165;GO:0007169;GO:0007275;GO:0007422;GO:0007507;GO:0008284;GO:0009968;GO:0010628;GO:0014037;GO:0014044;GO:0021545;GO:0022008;GO:0033674;GO:0038133;GO:0042060;GO:0042127;GO:0042552;GO:0043066;GO:0043491;GO:0043524;GO:0051048;GO:0051402;GO:0051897;GO:0055025;GO:0070886;GO:0097049;GO:0097192;GO:2000672	extracellular space;plasma membrane;basal plasma membrane;basolateral plasma membrane;apical plasma membrane;lateral plasma membrane;ERBB3:ERBB2 complex;receptor complex	GO:0005615;GO:0005886;GO:0009925;GO:0016323;GO:0016324;GO:0016328;GO:0038143;GO:0043235	protein tyrosine kinase activity;transmembrane signaling receptor activity;protein binding;ATP binding;growth factor binding;protein tyrosine kinase activator activity;ubiquitin protein ligase binding;neuregulin receptor activity;neuregulin binding;identical protein binding;ErbB-3 class receptor binding;protein heterodimerization activity	GO:0004713;GO:0004888;GO:0005515;GO:0005524;GO:0019838;GO:0030296;GO:0031625;GO:0038131;GO:0038132;GO:0042802;GO:0043125;GO:0046982	3.0	05bf4684-5522-11e7-8f50-0ac135e8bacf,c70366de-5521-11e7-8f50-0ac135e8bacf,cb348d72-5521-11e7-8f50-0ac135e8bacf	a6b1 and a6b4 Integrin signaling,ErbB2ErbB3 signaling events,ErbB receptor signaling network											
chr3:196198874:T/C	RNF168 p.Glu511Gly		8.0	0.0905272981801213			chr3	196198874	T	C	36		Yes	RNF168	ENST00000318037.3	missense_variant	6.0	c.1532A>G	p.Glu511Gly	196472003							0.393	0.473																	double-strand break repair;double-strand break repair via nonhomologous end joining;ubiquitin-dependent protein catabolic process;DNA damage response;response to ionizing radiation;protein ubiquitination;negative regulation of transcription elongation by RNA polymerase II;interstrand cross-link repair;epigenetic regulation of gene expression;isotype switching;positive regulation of DNA repair;protein K63-linked ubiquitination;double-strand break repair via classical nonhomologous end joining;DNA repair-dependent chromatin remodeling	GO:0006302;GO:0006303;GO:0006511;GO:0006974;GO:0010212;GO:0016567;GO:0034244;GO:0036297;GO:0040029;GO:0045190;GO:0045739;GO:0070534;GO:0097680;GO:0140861	ubiquitin ligase complex;nucleus;nucleoplasm;cytosol;protein-containing complex;site of double-strand break	GO:0000151;GO:0005634;GO:0005654;GO:0005829;GO:0032991;GO:0035861	chromatin binding;ubiquitin-protein transferase activity;protein binding;nucleosome binding;histone binding;ubiquitin binding;metal ion binding;K63-linked polyubiquitin modification-dependent protein binding;histone ubiquitin ligase activity;histone H2AK15 ubiquitin ligase activity	GO:0003682;GO:0004842;GO:0005515;GO:0031491;GO:0042393;GO:0043130;GO:0046872;GO:0070530;GO:0140852;GO:0140858														
chr18:19780824:G/A	GATA6 3_prime_UTR_variant		8.0	0.0329461457233368			chr18	19780824	G	A	36			GATA6	ENST00000269216.9	3_prime_UTR_variant	7.0	c.*38G>A		22200861													COSV99333318	"[[""lung"", 1]]"	1.0	ENST00000581694.1	?	Genomic Location							negative regulation of transcription by RNA polymerase II;in utero embryonic development;liver development;sebaceous gland cell differentiation;regulation of antimicrobial humoral response;outflow tract septum morphogenesis;atrioventricular node development;sinoatrial node development;type B pancreatic cell differentiation;pancreatic A cell differentiation;phospholipid metabolic process;endodermal cell fate determination;male gonad development;response to xenobiotic stimulus;response to toxic substance;gene expression;positive regulation of cardiac muscle cell apoptotic process;cardiac muscle hypertrophy in response to stress;positive regulation of BMP signaling pathway;epithelial cell differentiation;response to retinoic acid;negative regulation of transforming growth factor beta1 production;negative regulation of transforming growth factor beta2 production;tube morphogenesis;atrioventricular canal development;odontogenesis of dentin-containing tooth;negative regulation of apoptotic process;response to estrogen;cell fate commitment;positive regulation of angiogenesis;negative regulation of DNA-templated transcription;positive regulation of DNA-templated transcription;positive regulation of transcription by RNA polymerase II;animal organ formation;stem cell differentiation;smooth muscle cell differentiation;response to cAMP;cardiac muscle cell differentiation;cardiac muscle cell proliferation;positive regulation of cardiac muscle cell proliferation;heart contraction;lung saccule development;club cell differentiation;type II pneumocyte differentiation;intestinal epithelial cell differentiation;cardiac vascular smooth muscle cell differentiation;G1 to G0 transition involved in cell differentiation;response to growth factor;cellular response to gonadotropin stimulus;cellular response to hypoxia;cellular response to BMP stimulus;skin epidermis development;positive regulation of cardiac muscle myoblast proliferation;negative regulation of miRNA transcription;negative regulation of sebum secreting cell proliferation	GO:0000122;GO:0001701;GO:0001889;GO:0001949;GO:0002759;GO:0003148;GO:0003162;GO:0003163;GO:0003309;GO:0003310;GO:0006644;GO:0007493;GO:0008584;GO:0009410;GO:0009636;GO:0010467;GO:0010666;GO:0014898;GO:0030513;GO:0030855;GO:0032526;GO:0032911;GO:0032912;GO:0035239;GO:0036302;GO:0042475;GO:0043066;GO:0043627;GO:0045165;GO:0045766;GO:0045892;GO:0045893;GO:0045944;GO:0048645;GO:0048863;GO:0051145;GO:0051591;GO:0055007;GO:0060038;GO:0060045;GO:0060047;GO:0060430;GO:0060486;GO:0060510;GO:0060575;GO:0060947;GO:0070315;GO:0070848;GO:0071371;GO:0071456;GO:0071773;GO:0098773;GO:0110024;GO:1902894;GO:1904003	chromatin;nucleus;nucleoplasm;transcription regulator complex;nuclear membrane	GO:0000785;GO:0005634;GO:0005654;GO:0005667;GO:0031965	transcription cis-regulatory region binding;RNA polymerase II cis-regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;transcription coactivator binding;chromatin binding;DNA-binding transcription factor activity;protein binding;zinc ion binding;protein kinase binding;NFAT protein binding;DNA-binding transcription factor binding;sequence-specific double-stranded DNA binding	GO:0000976;GO:0000978;GO:0000981;GO:0001223;GO:0003682;GO:0003700;GO:0005515;GO:0008270;GO:0019901;GO:0051525;GO:0140297;GO:1990837	1.0	841dd9cc-5521-11e7-8f50-0ac135e8bacf	Notch-mediated HESHEY network											
chr19:47491354:C/A	ARHGAP35 intron_variant		7.0	0.0113350310260906			chr19	47491354	C	A	34			ARHGAP35	ENST00000672722.1	intron_variant		c.3904+31C>A		46988097																									neural tube closure;Rho protein signal transduction;axon guidance;axonal fasciculation;regulation of actin polymerization or depolymerization;regulation of cell shape;regulation of cell size;positive regulation of neuron projection development;cell migration;central nervous system neuron axonogenesis;mammary gland development;forebrain development;establishment or maintenance of actin cytoskeleton polarity;regulation of actin cytoskeleton organization;negative regulation of Rho protein signal transduction;camera-type eye development;negative regulation of vascular permeability;wound healing, spreading of cells;positive regulation of cilium assembly;regulation of axonogenesis;regulation of small GTPase mediated signal transduction;neuron projection guidance	GO:0001843;GO:0007266;GO:0007411;GO:0007413;GO:0008064;GO:0008360;GO:0008361;GO:0010976;GO:0016477;GO:0021955;GO:0030879;GO:0030900;GO:0030950;GO:0032956;GO:0035024;GO:0043010;GO:0043116;GO:0044319;GO:0045724;GO:0050770;GO:0051056;GO:0097485	nucleus;cytosol;plasma membrane;actin cytoskeleton;ciliary basal body	GO:0005634;GO:0005829;GO:0005886;GO:0015629;GO:0036064	DNA binding;GTPase activity;GTPase activator activity;GTP binding;phospholipid binding	GO:0003677;GO:0003924;GO:0005096;GO:0005525;GO:0005543	5.0	55522d94-5521-11e7-8f50-0ac135e8bacf,576974d6-5521-11e7-8f50-0ac135e8bacf,60f3521c-5521-11e7-8f50-0ac135e8bacf,7ac7dec6-5521-11e7-8f50-0ac135e8bacf,d0573ffe-5521-11e7-8f50-0ac135e8bacf	Signaling events mediated by focal adhesion kinase,SHP2 signaling,Regulation of RhoA activity,PDGFR-beta signaling pathway,EPHA2 forward signaling											
chr17:7579929:G/A	TP53 5_prime_UTR_variant		8.0	0.0627362055933484			chr17	7579929	G	A	33			TP53	ENST00000269305.8	5_prime_UTR_variant	2.0	c.-17C>T		7676611													COSV99407046	"[[""large intestine"", 1]]"	1.0	ENST00000455263.6	?	Exact Match							negative regulation of transcription by RNA polymerase II;mitophagy;in utero embryonic development;somitogenesis;release of cytochrome c from mitochondria;hematopoietic progenitor cell differentiation;T cell proliferation involved in immune response;B cell lineage commitment;T cell lineage commitment;response to ischemia;nucleotide-excision repair;double-strand break repair;regulation of DNA-templated transcription;regulation of transcription by RNA polymerase II;protein import into nucleus;autophagy;DNA damage response;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;ER overload response;transforming growth factor beta receptor signaling pathway;Ras protein signal transduction;gastrulation;neuroblast proliferation;negative regulation of neuroblast proliferation;protein localization;negative regulation of DNA replication;negative regulation of cell population proliferation;determination of adult lifespan;mRNA transcription;rRNA transcription;response to salt stress;response to inorganic substance;response to X-ray;response to gamma radiation;positive regulation of gene expression;cardiac muscle cell apoptotic process;positive regulation of cardiac muscle cell apoptotic process;glial cell proliferation;viral process;glucose catabolic process to lactate via pyruvate;cerebellum development;negative regulation of cell growth;DNA damage response, signal transduction by p53 class mediator;negative regulation of transforming growth factor beta receptor signaling pathway;mitotic G1 DNA damage checkpoint signaling;negative regulation of telomere maintenance via telomerase;T cell differentiation in thymus;tumor necrosis factor-mediated signaling pathway;regulation of tissue remodeling;cellular response to UV;multicellular organism growth;positive regulation of mitochondrial membrane permeability;cellular response to glucose starvation;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;regulation of apoptotic process;positive regulation of apoptotic process;negative regulation of apoptotic process;entrainment of circadian clock by photoperiod;mitochondrial DNA repair;regulation of DNA damage response, signal transduction by p53 class mediator;positive regulation of neuron apoptotic process;transcription initiation-coupled chromatin remodeling;negative regulation of proteolysis;negative regulation of DNA-templated transcription;positive regulation of DNA-templated transcription;positive regulation of RNA polymerase II transcription preinitiation complex assembly;positive regulation of transcription by RNA polymerase II;response to antibiotic;fibroblast proliferation;negative regulation of fibroblast proliferation;circadian behavior;bone marrow development;embryonic organ development;positive regulation of peptidyl-tyrosine phosphorylation;protein stabilization;negative regulation of helicase activity;protein tetramerization;chromosome organization;neuron apoptotic process;regulation of cell cycle;hematopoietic stem cell differentiation;negative regulation of glial cell proliferation;type II interferon-mediated signaling pathway;cardiac septum morphogenesis;positive regulation of programmed necrotic cell death;protein-containing complex assembly;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;thymocyte apoptotic process;positive regulation of thymocyte apoptotic process;necroptotic process;cellular response to hypoxia;cellular response to xenobiotic stimulus;cellular response to ionizing radiation;cellular response to gamma radiation;cellular response to UV-C;stem cell proliferation;signal transduction by p53 class mediator;intrinsic apoptotic signaling pathway by p53 class mediator;reactive oxygen species metabolic process;cellular response to actinomycin D;positive regulation of release of cytochrome c from mitochondria;cellular senescence;replicative senescence;oxidative stress-induced premature senescence;intrinsic apoptotic signaling pathway;oligodendrocyte apoptotic process;positive regulation of execution phase of apoptosis;negative regulation of mitophagy;regulation of mitochondrial membrane permeability involved in apoptotic process;regulation of intrinsic apoptotic signaling pathway by p53 class mediator;regulation of cell cycle G2/M phase transition;positive regulation of miRNA transcription;negative regulation of G1 to G0 transition;negative regulation of miRNA processing;negative regulation of glucose catabolic process to lactate via pyruvate;negative regulation of pentose-phosphate shunt;intrinsic apoptotic signaling pathway in response to hypoxia;regulation of fibroblast apoptotic process;negative regulation of reactive oxygen species metabolic process;positive regulation of reactive oxygen species metabolic process;negative regulation of stem cell proliferation;positive regulation of cellular senescence;positive regulation of intrinsic apoptotic signaling pathway	GO:0000122;GO:0000423;GO:0001701;GO:0001756;GO:0001836;GO:0002244;GO:0002309;GO:0002326;GO:0002360;GO:0002931;GO:0006289;GO:0006302;GO:0006355;GO:0006357;GO:0006606;GO:0006914;GO:0006974;GO:0006977;GO:0006978;GO:0006983;GO:0007179;GO:0007265;GO:0007369;GO:0007405;GO:0007406;GO:0008104;GO:0008156;GO:0008285;GO:0008340;GO:0009299;GO:0009303;GO:0009651;GO:0010035;GO:0010165;GO:0010332;GO:0010628;GO:0010659;GO:0010666;GO:0014009;GO:0016032;GO:0019661;GO:0021549;GO:0030308;GO:0030330;GO:0030512;GO:0031571;GO:0032211;GO:0033077;GO:0033209;GO:0034103;GO:0034644;GO:0035264;GO:0035794;GO:0042149;GO:0042771;GO:0042981;GO:0043065;GO:0043066;GO:0043153;GO:0043504;GO:0043516;GO:0043525;GO:0045815;GO:0045861;GO:0045892;GO:0045893;GO:0045899;GO:0045944;GO:0046677;GO:0048144;GO:0048147;GO:0048512;GO:0048539;GO:0048568;GO:0050731;GO:0050821;GO:0051097;GO:0051262;GO:0051276;GO:0051402;GO:0051726;GO:0060218;GO:0060253;GO:0060333;GO:0060411;GO:0062100;GO:0065003;GO:0070059;GO:0070242;GO:0070245;GO:0070266;GO:0071456;GO:0071466;GO:0071479;GO:0071480;GO:0071494;GO:0072089;GO:0072331;GO:0072332;GO:0072593;GO:0072717;GO:0090200;GO:0090398;GO:0090399;GO:0090403;GO:0097193;GO:0097252;GO:1900119;GO:1901525;GO:1902108;GO:1902253;GO:1902749;GO:1902895;GO:1903451;GO:1903799;GO:1904024;GO:1905856;GO:1990144;GO:2000269;GO:2000378;GO:2000379;GO:2000647;GO:2000774;GO:2001244	chromatin;nucleus;nucleoplasm;replication fork;transcription regulator complex;nucleolus;cytoplasm;mitochondrion;mitochondrial matrix;endoplasmic reticulum;centrosome;cytosol;nuclear matrix;nuclear body;PML body;transcription repressor complex;protein-containing complex;site of double-strand break;germ cell nucleus	GO:0000785;GO:0005634;GO:0005654;GO:0005657;GO:0005667;GO:0005730;GO:0005737;GO:0005739;GO:0005759;GO:0005783;GO:0005813;GO:0005829;GO:0016363;GO:0016604;GO:0016605;GO:0017053;GO:0032991;GO:0035861;GO:0043073	transcription cis-regulatory region binding;RNA polymerase II cis-regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;cis-regulatory region sequence-specific DNA binding;core promoter sequence-specific DNA binding;TFIID-class transcription factor complex binding;DNA-binding transcription repressor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;protease binding;p53 binding;DNA binding;chromatin binding;DNA-binding transcription factor activity;mRNA 3'-UTR binding;copper ion binding;protein binding;zinc ion binding;enzyme binding;receptor tyrosine kinase binding;ubiquitin protein ligase binding;histone deacetylase regulator activity;ATP-dependent DNA/DNA annealing activity;identical protein binding;histone deacetylase binding;protein heterodimerization activity;protein-folding chaperone binding;protein phosphatase 2A binding;RNA polymerase II-specific DNA-binding transcription factor binding;14-3-3 protein binding;MDM2/MDM4 family protein binding;disordered domain specific binding;general transcription initiation factor binding;molecular function activator activity;promoter-specific chromatin binding	GO:0000976;GO:0000978;GO:0000981;GO:0000987;GO:0001046;GO:0001094;GO:0001227;GO:0001228;GO:0002020;GO:0002039;GO:0003677;GO:0003682;GO:0003700;GO:0003730;GO:0005507;GO:0005515;GO:0008270;GO:0019899;GO:0030971;GO:0031625;GO:0035033;GO:0036310;GO:0042802;GO:0042826;GO:0046982;GO:0051087;GO:0051721;GO:0061629;GO:0071889;GO:0097371;GO:0097718;GO:0140296;GO:0140677;GO:1990841	13.0	3814fa62-5521-11e7-8f50-0ac135e8bacf,4b62628c-5521-11e7-8f50-0ac135e8bacf,538cfdee-5521-11e7-8f50-0ac135e8bacf,76f15b4e-5521-11e7-8f50-0ac135e8bacf,7f189a50-5521-11e7-8f50-0ac135e8bacf,81be3ee4-5521-11e7-8f50-0ac135e8bacf,945aa686-5521-11e7-8f50-0ac135e8bacf,b1ac7318-5521-11e7-8f50-0ac135e8bacf,bb3d7c4a-5521-11e7-8f50-0ac135e8bacf,dce0a1a4-5521-11e7-8f50-0ac135e8bacf,f6898a78-5521-11e7-8f50-0ac135e8bacf,f823645e-5521-11e7-8f50-0ac135e8bacf,fd2c9b80-5521-11e7-8f50-0ac135e8bacf	Validated targets of C-MYC transcriptional activation,Signaling mediated by p38-alpha and p38-beta,Signaling events mediated by HDAC Class III,PLK3 signaling events,p75(NTR)-mediated signaling,p53 pathway,LKB1 signaling events,Hypoxic and oxygen homeostasis regulation of HIF-1-alpha,Glucocorticoid receptor regulatory network,Direct p53 effectors,BARD1 signaling events,Aurora A signaling,AP-1 transcription factor network											
chr6:157528402:A/G	ARID1B p.Ser2083Gly		8.0	0.0363218390804597			chr6	157528402	A	G	31		Yes	ARID1B	ENST00000636930.1	missense_variant	20.0	c.6247A>G	p.Ser2083Gly	157207268							0.00574	0.236					COSV51652846	"[[""haematopoietic and lymphoid tissue"", 2]]"	2.0	ENST00000635849.1	S2043R	Genomic Location	Uncertain significance	MONDO:MONDO:0007617,MedGen:C3281201,OMIM:135900,Orphanet:1465	Coffin-Siris syndrome 1	no assertion criteria provided	3066079.0		response to ischemia;chromatin remodeling;regulation of transcription by RNA polymerase II;nervous system development;regulation of mitotic metaphase/anaphase transition;positive regulation of T cell differentiation;positive regulation of cell differentiation;positive regulation of myoblast differentiation;transcription initiation-coupled chromatin remodeling;positive regulation of DNA-templated transcription;regulation of G0 to G1 transition;cellular response to angiotensin;regulation of G1/S transition of mitotic cell cycle;positive regulation of double-strand break repair;regulation of nucleotide-excision repair	GO:0002931;GO:0006338;GO:0006357;GO:0007399;GO:0030071;GO:0045582;GO:0045597;GO:0045663;GO:0045815;GO:0045893;GO:0070316;GO:1904385;GO:2000045;GO:2000781;GO:2000819	chromatin;nucleoplasm;cytosol;plasma membrane;SWI/SNF complex;brahma complex;npBAF complex;nBAF complex;bBAF complex	GO:0000785;GO:0005654;GO:0005829;GO:0005886;GO:0016514;GO:0035060;GO:0071564;GO:0071565;GO:0140092	DNA binding;transcription coactivator activity;protein binding;nucleosome binding	GO:0003677;GO:0003713;GO:0005515;GO:0031491				rs746220769										
chr10:88659907:CA/C	BMPR1A intron_variant		8.0	0.0294358135731807			chr10	88659907	CA	C	30			BMPR1A	ENST00000372037.7	intron_variant		c.530+28del		86900151																									angiogenesis;osteoblast differentiation;in utero embryonic development;mesoderm formation;somitogenesis;Mullerian duct regression;positive regulation of mesenchymal cell proliferation;chondrocyte differentiation;outflow tract septum morphogenesis;outflow tract morphogenesis;cardiac conduction system development;atrioventricular valve development;mitral valve morphogenesis;tricuspid valve morphogenesis;endocardial cushion morphogenesis;cardiac right ventricle morphogenesis;ventricular trabecula myocardium morphogenesis;ventricular compact myocardium morphogenesis;endocardial cushion formation;protein phosphorylation;immune response;transforming growth factor beta receptor signaling pathway;ectoderm development;dorsal/ventral axis specification;dorsal/ventral pattern formation;positive regulation of gene expression;negative regulation of gene expression;regulation of cardiac muscle cell apoptotic process;neural crest cell development;negative regulation of smooth muscle cell migration;central nervous system neuron differentiation;pituitary gland development;neural plate mediolateral regionalization;lung development;positive regulation of bone mineralization;BMP signaling pathway;positive regulation of transforming growth factor beta2 production;somatic stem cell population maintenance;hindlimb morphogenesis;dorsal aorta morphogenesis;odontogenesis of dentin-containing tooth;embryonic digit morphogenesis;positive regulation of osteoblast differentiation;positive regulation of transcription by RNA polymerase II;paraxial mesoderm structural organization;lateral mesoderm development;regulation of lateral mesodermal cell fate specification;mesendoderm development;embryonic organ development;developmental growth;epithelial cell proliferation;positive regulation of epithelial cell proliferation;negative regulation of neurogenesis;negative regulation of muscle cell differentiation;roof of mouth development;regulation of cardiac muscle cell proliferation;positive regulation of cardiac muscle cell proliferation;positive regulation of SMAD protein signal transduction;ventricular septum morphogenesis;heart formation;atrioventricular node cell development;pharyngeal arch artery morphogenesis;cellular response to growth factor stimulus;cellular response to BMP stimulus;positive regulation of miRNA transcription;positive regulation of cardiac ventricle development;positive regulation of vascular associated smooth muscle cell proliferation;fibrous ring of heart morphogenesis;regulation of neural crest cell differentiation;regulation of cellular senescence	GO:0001525;GO:0001649;GO:0001701;GO:0001707;GO:0001756;GO:0001880;GO:0002053;GO:0002062;GO:0003148;GO:0003151;GO:0003161;GO:0003171;GO:0003183;GO:0003186;GO:0003203;GO:0003215;GO:0003222;GO:0003223;GO:0003272;GO:0006468;GO:0006955;GO:0007179;GO:0007398;GO:0009950;GO:0009953;GO:0010628;GO:0010629;GO:0010665;GO:0014032;GO:0014912;GO:0021953;GO:0021983;GO:0021998;GO:0030324;GO:0030501;GO:0030509;GO:0032915;GO:0035019;GO:0035137;GO:0035912;GO:0042475;GO:0042733;GO:0045669;GO:0045944;GO:0048352;GO:0048368;GO:0048378;GO:0048382;GO:0048568;GO:0048589;GO:0050673;GO:0050679;GO:0050768;GO:0051148;GO:0060021;GO:0060043;GO:0060045;GO:0060391;GO:0060412;GO:0060914;GO:0060928;GO:0061626;GO:0071363;GO:0071773;GO:1902895;GO:1904414;GO:1904707;GO:1905285;GO:1905292;GO:2000772	plasma membrane;caveola;external side of plasma membrane;membrane;dendrite;neuronal cell body;receptor complex;HFE-transferrin receptor complex	GO:0005886;GO:0005901;GO:0009897;GO:0016020;GO:0030425;GO:0043025;GO:0043235;GO:1990712	protein serine/threonine kinase activity;transmembrane receptor protein serine/threonine kinase activity;transforming growth factor beta receptor activity, type I;protein binding;ATP binding;BMP binding;protein homodimerization activity;SMAD binding;metal ion binding;BMP receptor activity	GO:0004674;GO:0004675;GO:0005025;GO:0005515;GO:0005524;GO:0036122;GO:0042803;GO:0046332;GO:0046872;GO:0098821	1.0	f1ae1a1c-5521-11e7-8f50-0ac135e8bacf	BMP receptor signaling											
chr2:203329711:T/C	BMPR2 intron_variant		8.0	0.044428772919605			chr2	203329711	T	C	30			BMPR2	ENST00000374580.10	intron_variant		c.247+9T>C		202464988																									blood vessel development;osteoblast differentiation;mesoderm formation;maternal placenta development;endothelial cell proliferation;lymphangiogenesis;blood vessel remodeling;chondrocyte development;negative regulation of systemic arterial blood pressure;outflow tract septum morphogenesis;outflow tract morphogenesis;aortic valve development;pulmonary valve development;atrioventricular valve morphogenesis;mitral valve morphogenesis;tricuspid valve morphogenesis;endocardial cushion development;negative regulation of cell proliferation involved in heart valve morphogenesis;protein phosphorylation;cell surface receptor protein serine/threonine kinase signaling pathway;cellular response to starvation;anterior/posterior pattern specification;positive regulation of gene expression;positive regulation of epithelial cell migration;regulation of lung blood pressure;proteoglycan biosynthetic process;negative regulation of cell growth;positive regulation of bone mineralization;BMP signaling pathway;activin receptor signaling pathway;regulation of cell population proliferation;positive regulation of osteoblast differentiation;positive regulation of ossification;negative regulation of vasoconstriction;positive regulation of transcription by RNA polymerase II;lung alveolus development;negative regulation of smooth muscle cell proliferation;cardiac muscle tissue development;positive regulation of axon extension involved in axon guidance;negative regulation of muscle cell differentiation;limb development;endochondral bone morphogenesis;positive regulation of SMAD protein signal transduction;ventricular septum morphogenesis;atrial septum morphogenesis;lung vasculature development;lymphatic endothelial cell differentiation;artery development;venous blood vessel development;positive regulation of cartilage development;retina vasculature development in camera-type eye;pharyngeal arch artery morphogenesis;cellular response to growth factor stimulus;cellular response to BMP stimulus;endothelial cell apoptotic process;negative regulation of chondrocyte proliferation;semi-lunar valve development	GO:0001568;GO:0001649;GO:0001707;GO:0001893;GO:0001935;GO:0001946;GO:0001974;GO:0002063;GO:0003085;GO:0003148;GO:0003151;GO:0003176;GO:0003177;GO:0003181;GO:0003183;GO:0003186;GO:0003197;GO:0003252;GO:0006468;GO:0007178;GO:0009267;GO:0009952;GO:0010628;GO:0010634;GO:0014916;GO:0030166;GO:0030308;GO:0030501;GO:0030509;GO:0032924;GO:0042127;GO:0045669;GO:0045778;GO:0045906;GO:0045944;GO:0048286;GO:0048662;GO:0048738;GO:0048842;GO:0051148;GO:0060173;GO:0060350;GO:0060391;GO:0060412;GO:0060413;GO:0060426;GO:0060836;GO:0060840;GO:0060841;GO:0061036;GO:0061298;GO:0061626;GO:0071363;GO:0071773;GO:0072577;GO:1902731;GO:1905314	extracellular space;nucleoplasm;plasma membrane;caveola;clathrin-coated pit;adherens junction;basal plasma membrane;cell surface;postsynaptic density;apical plasma membrane;axon;dendrite;neuronal cell body;receptor complex	GO:0005615;GO:0005654;GO:0005886;GO:0005901;GO:0005905;GO:0005912;GO:0009925;GO:0009986;GO:0014069;GO:0016324;GO:0030424;GO:0030425;GO:0043025;GO:0043235	transforming growth factor beta receptor activity;protein binding;ATP binding;activin receptor activity, type II;growth factor binding;BMP binding;cadherin binding;metal ion binding;BMP receptor activity;protein tyrosine kinase binding	GO:0005024;GO:0005515;GO:0005524;GO:0016362;GO:0019838;GO:0036122;GO:0045296;GO:0046872;GO:0098821;GO:1990782	3.0	049349a0-5522-11e7-8f50-0ac135e8bacf,05263ad2-5522-11e7-8f50-0ac135e8bacf,f1ae1a1c-5521-11e7-8f50-0ac135e8bacf	ALK2 signaling events,ALK1 signaling events,BMP receptor signaling											
chr5:68667308:T/C	RAD17 5_prime_UTR_variant		8.0	0.0148095909732016			chr5	68667308	T	C	28			RAD17	ENST00000354868.10	5_prime_UTR_variant	3.0	c.-252T>C		69371481																									DNA replication checkpoint signaling;DNA damage checkpoint signaling;DNA repair;chromatin organization;DNA damage response;negative regulation of DNA replication;mitotic intra-S DNA damage checkpoint signaling;mitotic DNA replication checkpoint signaling;regulation of phosphorylation;protein localization to site of double-strand break	GO:0000076;GO:0000077;GO:0006281;GO:0006325;GO:0006974;GO:0008156;GO:0031573;GO:0033314;GO:0042325;GO:1990166	chromosome, telomeric region;nucleus;nucleoplasm;nucleolus;Rad17 RFC-like complex;site of double-strand break	GO:0000781;GO:0005634;GO:0005654;GO:0005730;GO:0031389;GO:0035861	chromatin binding;DNA clamp loader activity;protein binding;ATP binding;chromatin-protein adaptor activity	GO:0003682;GO:0003689;GO:0005515;GO:0005524;GO:0140463	3.0	c45e106a-5521-11e7-8f50-0ac135e8bacf,f93a0482-5521-11e7-8f50-0ac135e8bacf,f9c7eca4-5521-11e7-8f50-0ac135e8bacf	Fanconi anemia pathway,ATR signaling pathway,ATM pathway											
chr2:148672905:T/G	ACVR2A splice_site_variant		8.0	0.1055966209081309			chr2	148672905	T	G	27			ACVR2A	ENST00000241416.12	splice_site_variant	6.0	c.672+2T>G		147915336																									gastrulation with mouth forming second;positive regulation of protein phosphorylation;protein phosphorylation;cell surface receptor protein serine/threonine kinase signaling pathway;spermatogenesis;determination of left/right symmetry;mesoderm development;anterior/posterior pattern specification;positive regulation of bone mineralization;BMP signaling pathway;activin receptor signaling pathway;positive regulation of activin receptor signaling pathway;odontogenesis of dentin-containing tooth;sperm ejaculation;penile erection;regulation of nitric oxide biosynthetic process;positive regulation of erythrocyte differentiation;positive regulation of osteoblast differentiation;positive regulation of transcription by RNA polymerase II;embryonic skeletal system development;Sertoli cell proliferation;positive regulation of SMAD protein signal transduction;cellular response to growth factor stimulus;cellular response to BMP stimulus	GO:0001702;GO:0001934;GO:0006468;GO:0007178;GO:0007283;GO:0007368;GO:0007498;GO:0009952;GO:0030501;GO:0030509;GO:0032924;GO:0032927;GO:0042475;GO:0042713;GO:0043084;GO:0045428;GO:0045648;GO:0045669;GO:0045944;GO:0048706;GO:0060011;GO:0060391;GO:0071363;GO:0071773	cytoplasm;plasma membrane;cell surface;inhibin-betaglycan-ActRII complex;receptor complex;activin receptor complex	GO:0005737;GO:0005886;GO:0009986;GO:0034673;GO:0043235;GO:0048179	protein serine/threonine kinase activity;transmembrane receptor protein serine/threonine kinase activity;protein binding;ATP binding;coreceptor activity;activin receptor activity;growth factor binding;PDZ domain binding;inhibin binding;metal ion binding;activin binding;BMP receptor activity	GO:0004674;GO:0004675;GO:0005515;GO:0005524;GO:0015026;GO:0017002;GO:0019838;GO:0030165;GO:0034711;GO:0046872;GO:0048185;GO:0098821	1.0	05263ad2-5522-11e7-8f50-0ac135e8bacf	ALK1 signaling events	rs1573706664										
chr2:48028281:T/C	MSH6 p.Cys1053=	2.0	8.0	0.0173178458289334			chr2	48028281	T	C	26		Yes	MSH6	ENST00000234420.10	synonymous_variant	4.0	c.3159T>C	p.Cys1053=	47801142																			Likely benign	MeSH:D003123,MedGen:C0009405|MONDO:MONDO:0005835,MedGen:C4552100,Orphanet:144|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Hereditary nonpolyposis colorectal neoplasms|Lynch syndrome|Hereditary cancer-predisposing syndrome	criteria provided, multiple submitters, no conflicts	416147.0		meiotic mismatch repair;DNA repair;mismatch repair;spermatogenesis;determination of adult lifespan;intrinsic apoptotic signaling pathway in response to DNA damage;response to UV;somatic hypermutation of immunoglobulin genes;somatic recombination of immunoglobulin gene segments;maintenance of DNA repeat elements;isotype switching;negative regulation of DNA recombination;positive regulation of helicase activity;intrinsic apoptotic signaling pathway	GO:0000710;GO:0006281;GO:0006298;GO:0007283;GO:0008340;GO:0008630;GO:0009411;GO:0016446;GO:0016447;GO:0043570;GO:0045190;GO:0045910;GO:0051096;GO:0097193	chromatin;nucleus;nucleoplasm;Golgi apparatus;cytosol;MutSalpha complex;intracellular membrane-bounded organelle	GO:0000785;GO:0005634;GO:0005654;GO:0005794;GO:0005829;GO:0032301;GO:0043231	magnesium ion binding;four-way junction DNA binding;chromatin binding;double-stranded DNA binding;protein binding;ATP binding;ATP-dependent activity, acting on DNA;enzyme binding;mismatched DNA binding;guanine/thymine mispair binding;single guanine insertion binding;single thymine insertion binding;oxidized purine DNA binding;MutLalpha complex binding;methylated histone binding;protein homodimerization activity;ADP binding;ATP-dependent DNA damage sensor activity	GO:0000287;GO:0000400;GO:0003682;GO:0003690;GO:0005515;GO:0005524;GO:0008094;GO:0019899;GO:0030983;GO:0032137;GO:0032142;GO:0032143;GO:0032357;GO:0032405;GO:0035064;GO:0042803;GO:0043531;GO:0140664				rs767021188		2.79193e-05	7.1364e-05	0.0	0.0	0.0	0.0	0.0	0.000464253	0.0
chr15:67073257:C/T	SMAD6 intron_variant		8.0	0.0725623582766439			chr15	67073257	C	T	26			SMAD6	ENST00000288840.10	intron_variant		c.953-78C>T		66780919																									ureteric bud development;outflow tract septum morphogenesis;aortic valve morphogenesis;mitral valve morphogenesis;pulmonary valve morphogenesis;ventricular septum development;regulation of transcription by RNA polymerase II;immune response;transforming growth factor beta receptor signaling pathway;zygotic specification of dorsal/ventral axis;negative regulation of cell population proliferation;anatomical structure morphogenesis;cell differentiation;negative regulation of ossification;BMP signaling pathway;negative regulation of transforming growth factor beta receptor signaling pathway;negative regulation of BMP signaling pathway;cell-substrate adhesion;response to lipopolysaccharide;negative regulation of activin receptor signaling pathway;response to laminar fluid shear stress;aorta development;negative regulation of apoptotic process;response to estrogen;fat cell differentiation;negative regulation of osteoblast differentiation;negative regulation of SMAD protein signal transduction;SMAD protein signal transduction;coronary vasculature development;positive regulation of miRNA transcription	GO:0001657;GO:0003148;GO:0003180;GO:0003183;GO:0003184;GO:0003281;GO:0006357;GO:0006955;GO:0007179;GO:0007352;GO:0008285;GO:0009653;GO:0030154;GO:0030279;GO:0030509;GO:0030512;GO:0030514;GO:0031589;GO:0032496;GO:0032926;GO:0034616;GO:0035904;GO:0043066;GO:0043627;GO:0045444;GO:0045668;GO:0060392;GO:0060395;GO:0060976;GO:1902895	chromatin;nucleus;nucleoplasm;cytoplasm;Golgi apparatus;cytosol;nuclear body;protein-containing complex;heteromeric SMAD protein complex	GO:0000785;GO:0005634;GO:0005654;GO:0005737;GO:0005794;GO:0005829;GO:0016604;GO:0032991;GO:0071144	transcription cis-regulatory region binding;chromatin binding;protein binding;ubiquitin protein ligase binding;type I transforming growth factor beta receptor binding;identical protein binding;metal ion binding;co-SMAD binding;I-SMAD binding;R-SMAD binding;type I activin receptor binding;protein sequestering activity;transcription regulator inhibitor activity	GO:0000976;GO:0003682;GO:0005515;GO:0031625;GO:0034713;GO:0042802;GO:0046872;GO:0070410;GO:0070411;GO:0070412;GO:0070698;GO:0140311;GO:0140416	1.0	f1ae1a1c-5521-11e7-8f50-0ac135e8bacf	BMP receptor signaling											
chr19:10252697:G/A	DNMT1 intron_variant		8.0	0.0430399379604497			chr19	10252697	G	A	25			DNMT1	ENST00000359526.9	intron_variant		c.3309+7C>T		10142021																									negative regulation of transcription by RNA polymerase II;DNA methylation-dependent heterochromatin formation;DNA-templated transcription;positive regulation of gene expression;negative regulation of gene expression;methylation;epigenetic programming of gene expression;negative regulation of gene expression via chromosomal CpG island methylation;cellular response to amino acid stimulus;chromosomal DNA methylation maintenance following DNA replication;cellular response to bisphenol A;positive regulation of vascular associated smooth muscle cell proliferation;negative regulation of vascular associated smooth muscle cell apoptotic process;negative regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching	GO:0000122;GO:0006346;GO:0006351;GO:0010628;GO:0010629;GO:0032259;GO:0043045;GO:0044027;GO:0071230;GO:0141119;GO:1903926;GO:1904707;GO:1905460;GO:1905931	female germ cell nucleus;nucleus;nucleoplasm;replication fork;pericentric heterochromatin	GO:0001674;GO:0005634;GO:0005654;GO:0005657;GO:0005721	DNA binding;RNA binding;DNA (cytosine-5-)-methyltransferase activity;protein binding;zinc ion binding;methyl-CpG binding;DNA-methyltransferase activity;promoter-specific chromatin binding	GO:0003677;GO:0003723;GO:0003886;GO:0005515;GO:0008270;GO:0008327;GO:0009008;GO:1990841	1.0	6309aefe-5521-11e7-8f50-0ac135e8bacf	Regulation of retinoblastoma protein	rs1321247231										
chr11:107880054:C/T	CUL5 5_prime_UTR_variant	2.0	8.0	0.0204857444561774			chr11	107880054	C	T	24			CUL5	ENST00000393094.7	5_prime_UTR_variant	1.0	c.-21C>T		108009328																									G1/S transition of mitotic cell cycle;protein ubiquitination;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;ERBB2 signaling pathway;calcium ion transmembrane transport;intrinsic apoptotic signaling pathway	GO:0000082;GO:0016567;GO:0031146;GO:0038128;GO:0070588;GO:0097193	nucleus;cytosol;SCF ubiquitin ligase complex;Cul5-RING ubiquitin ligase complex;site of DNA damage	GO:0005634;GO:0005829;GO:0019005;GO:0031466;GO:0090734	ubiquitin-protein transferase activity;calcium channel activity;protein binding;protein-macromolecule adaptor activity;ubiquitin protein ligase binding;signaling receptor activity	GO:0004842;GO:0005262;GO:0005515;GO:0030674;GO:0031625;GO:0038023														
chr11:107880051:T/C	CUL5 5_prime_UTR_variant		8.0	0.0494192185850052			chr11	107880051	T	C	24			CUL5	ENST00000393094.7	5_prime_UTR_variant	1.0	c.-24T>C		108009325																									G1/S transition of mitotic cell cycle;protein ubiquitination;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;ERBB2 signaling pathway;calcium ion transmembrane transport;intrinsic apoptotic signaling pathway	GO:0000082;GO:0016567;GO:0031146;GO:0038128;GO:0070588;GO:0097193	nucleus;cytosol;SCF ubiquitin ligase complex;Cul5-RING ubiquitin ligase complex;site of DNA damage	GO:0005634;GO:0005829;GO:0019005;GO:0031466;GO:0090734	ubiquitin-protein transferase activity;calcium channel activity;protein binding;protein-macromolecule adaptor activity;ubiquitin protein ligase binding;signaling receptor activity	GO:0004842;GO:0005262;GO:0005515;GO:0030674;GO:0031625;GO:0038023				rs1054183723		6.97954e-06	2.37914e-05	0.0	0.0	0.0	0.0	0.0	0.0	0.0
chr20:57415540:A/T	GNAS p.Thr127Ser		8.0	0.045839210155148			chr20	57415540	A	T	23		Yes	GNAS	ENST00000313949.11	missense_variant	1.0	c.379A>T	p.Thr127Ser	58840485							0.118	0.0304																	adenylate cyclase-activating G protein-coupled receptor signaling pathway;adenylate cyclase-activating dopamine receptor signaling pathway;sensory perception of chemical stimulus;developmental growth;bone development;platelet aggregation;positive regulation of cold-induced thermogenesis	GO:0007189;GO:0007191;GO:0007606;GO:0048589;GO:0060348;GO:0070527;GO:0120162	cytoplasm;cytosol;heterotrimeric G-protein complex;membrane;apical plasma membrane;extracellular exosome	GO:0005737;GO:0005829;GO:0005834;GO:0016020;GO:0016324;GO:0070062	GTPase activity;insulin-like growth factor receptor binding;protein binding;GTP binding;adenylate cyclase activator activity;G-protein beta/gamma-subunit complex binding;beta-2 adrenergic receptor binding;D1 dopamine receptor binding;mu-type opioid receptor binding;ionotropic glutamate receptor binding;metal ion binding;corticotropin-releasing hormone receptor 1 binding	GO:0003924;GO:0005159;GO:0005515;GO:0005525;GO:0010856;GO:0031683;GO:0031698;GO:0031748;GO:0031852;GO:0035255;GO:0046872;GO:0051430	4.0	72929504-5521-11e7-8f50-0ac135e8bacf,78974324-5521-11e7-8f50-0ac135e8bacf,916de6d2-5521-11e7-8f50-0ac135e8bacf,d306cfa2-5521-11e7-8f50-0ac135e8bacf	Rapid glucocorticoid signaling,Plasma membrane estrogen receptor signaling,LPA4-mediated signaling events,Endothelins											
chr1:11205104:T/A	MTOR splice_site_variant		8.0	0.0504071345482745			chr1	11205104	T	A	22			MTOR	ENST00000361445.9	splice_site_variant	33.0	c.4687-2A>T		11145047													COSV63868472	"[[""large intestine"", 2]]"	2.0	ENST00000361445.8	?	Genomic Location							regulation of cell growth;T-helper 1 cell lineage commitment;heart morphogenesis;heart valve morphogenesis;energy reserve metabolic process;'de novo' pyrimidine nucleobase biosynthetic process;protein phosphorylation;inflammatory response;DNA damage response;cytoskeleton organization;lysosome organization;germ cell development;response to nutrient;regulation of cell size;cellular response to starvation;response to heat;post-embryonic development;negative regulation of autophagy;positive regulation of lamellipodium assembly;positive regulation of gene expression;positive regulation of epithelial to mesenchymal transition;positive regulation of myotube differentiation;macroautophagy;regulation of macroautophagy;negative regulation of macroautophagy;phosphorylation;peptidyl-serine phosphorylation;neuronal action potential;protein catabolic process;positive regulation of cell growth;positive regulation of actin filament polymerization;T cell costimulation;ruffle organization;regulation of myelination;protein destabilization;response to nutrient levels;cellular response to nutrient levels;cellular response to nutrient;TOR signaling;positive regulation of phosphoprotein phosphatase activity;cellular response to insulin stimulus;regulation of actin cytoskeleton organization;calcineurin-NFAT signaling cascade;cellular response to amino acid starvation;multicellular organism growth;TORC1 signaling;regulation of circadian rhythm;negative regulation of apoptotic process;response to amino acid;anoikis;regulation of osteoclast differentiation;positive regulation of translation;negative regulation of cell size;positive regulation of glycolytic process;positive regulation of transcription by RNA polymerase III;positive regulation of translational initiation;protein autophosphorylation;positive regulation of lipid biosynthetic process;behavioral response to pain;rhythmic process;oligodendrocyte differentiation;positive regulation of oligodendrocyte differentiation;positive regulation of peptidyl-tyrosine phosphorylation;voluntary musculoskeletal movement;positive regulation of stress fiber assembly;positive regulation of keratinocyte migration;nucleus localization;positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction;cardiac muscle cell development;cardiac muscle contraction;cellular response to methionine;negative regulation of calcineurin-NFAT signaling cascade;cellular response to amino acid stimulus;cellular response to L-leucine;cellular response to hypoxia;cellular response to osmotic stress;regulation of membrane permeability;regulation of cellular response to heat;negative regulation of protein localization to nucleus;regulation of signal transduction by p53 class mediator;positive regulation of transcription of nucleolar large rRNA by RNA polymerase I;positive regulation of wound healing, spreading of epidermal cells;regulation of locomotor rhythm;positive regulation of cytoplasmic translational initiation;negative regulation of lysosome organization;positive regulation of pentose-phosphate shunt;cellular response to leucine starvation;regulation of autophagosome assembly	GO:0001558;GO:0002296;GO:0003007;GO:0003179;GO:0006112;GO:0006207;GO:0006468;GO:0006954;GO:0006974;GO:0007010;GO:0007040;GO:0007281;GO:0007584;GO:0008361;GO:0009267;GO:0009408;GO:0009791;GO:0010507;GO:0010592;GO:0010628;GO:0010718;GO:0010831;GO:0016236;GO:0016241;GO:0016242;GO:0016310;GO:0018105;GO:0019228;GO:0030163;GO:0030307;GO:0030838;GO:0031295;GO:0031529;GO:0031641;GO:0031648;GO:0031667;GO:0031669;GO:0031670;GO:0031929;GO:0032516;GO:0032869;GO:0032956;GO:0033173;GO:0034198;GO:0035264;GO:0038202;GO:0042752;GO:0043066;GO:0043200;GO:0043276;GO:0045670;GO:0045727;GO:0045792;GO:0045821;GO:0045945;GO:0045948;GO:0046777;GO:0046889;GO:0048266;GO:0048511;GO:0048709;GO:0048714;GO:0050731;GO:0050882;GO:0051496;GO:0051549;GO:0051647;GO:0051897;GO:0055013;GO:0060048;GO:0061431;GO:0070885;GO:0071230;GO:0071233;GO:0071456;GO:0071470;GO:0090559;GO:1900034;GO:1900181;GO:1901796;GO:1901838;GO:1903691;GO:1904059;GO:1904690;GO:1905672;GO:1905857;GO:1990253;GO:2000785	Golgi membrane;nucleus;nuclear envelope;nucleoplasm;cytoplasm;mitochondrial outer membrane;lysosome;lysosomal membrane;endoplasmic reticulum membrane;cytosol;endomembrane system;membrane;PML body;dendrite;TORC1 complex;TORC2 complex;phagocytic vesicle	GO:0000139;GO:0005634;GO:0005635;GO:0005654;GO:0005737;GO:0005741;GO:0005764;GO:0005765;GO:0005789;GO:0005829;GO:0012505;GO:0016020;GO:0016605;GO:0030425;GO:0031931;GO:0031932;GO:0045335	RNA polymerase III type 1 promoter sequence-specific DNA binding;RNA polymerase III type 2 promoter sequence-specific DNA binding;RNA polymerase III type 3 promoter sequence-specific DNA binding;TFIIIC-class transcription factor complex binding;protein kinase activity;protein serine/threonine kinase activity;protein binding;ATP binding;kinase activity;identical protein binding;ribosome binding;phosphoprotein binding;protein serine kinase activity	GO:0001002;GO:0001003;GO:0001006;GO:0001156;GO:0004672;GO:0004674;GO:0005515;GO:0005524;GO:0016301;GO:0042802;GO:0043022;GO:0051219;GO:0106310	15.0	5189b3dc-5521-11e7-8f50-0ac135e8bacf,603902ca-5521-11e7-8f50-0ac135e8bacf,8f640d10-5521-11e7-8f50-0ac135e8bacf,945aa686-5521-11e7-8f50-0ac135e8bacf,a04a1220-5521-11e7-8f50-0ac135e8bacf,a8411a5c-5521-11e7-8f50-0ac135e8bacf,aa5b6ede-5521-11e7-8f50-0ac135e8bacf,afa50a56-5521-11e7-8f50-0ac135e8bacf,c70366de-5521-11e7-8f50-0ac135e8bacf,c92b28e0-5521-11e7-8f50-0ac135e8bacf,d5aa2a46-5521-11e7-8f50-0ac135e8bacf,df93b3b8-5521-11e7-8f50-0ac135e8bacf,e1b66caa-5521-11e7-8f50-0ac135e8bacf,e6f69242-5521-11e7-8f50-0ac135e8bacf,e92d968a-5521-11e7-8f50-0ac135e8bacf	Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met),Regulation of Telomerase,mTOR signaling pathway,LKB1 signaling events,IL4-mediated signaling events,IL2 signaling events mediated by PI3K,IL12-mediated signaling events,IFN-gamma pathway,ErbB2ErbB3 signaling events,ErbB1 downstream signaling,EGFR-dependent Endothelin signaling events,CXCR4-mediated signaling events,CXCR3-mediated signaling events,Class I PI3K signaling events mediated by Akt,CDC42 signaling events											
chr20:40739077:C/A	PTPRT p.Trp1072Cys		8.0	0.026165167620605			chr20	40739077	C	A	22		Yes	PTPRT	ENST00000373193.7	missense_variant	24.0	c.3216G>T	p.Trp1072Cys	42110437							0.353	0.364					COSV61965861	"[[""lung"", 1]]"	1.0	ENST00000373193.7	W1069C	Exact Match							protein dephosphorylation;cell adhesion;homophilic cell adhesion via plasma membrane adhesion molecules;signal transduction;cell surface receptor protein tyrosine kinase signaling pathway;negative regulation of cell migration;peptidyl-tyrosine dephosphorylation;regulation of synapse organization;cellular response to interleukin-6;negative regulation of receptor signaling pathway via STAT;peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity	GO:0006470;GO:0007155;GO:0007156;GO:0007165;GO:0007169;GO:0030336;GO:0035335;GO:0050807;GO:0071354;GO:1904893;GO:1990264	plasma membrane;cell surface;membrane;postsynaptic density membrane;glutamatergic synapse	GO:0005886;GO:0009986;GO:0016020;GO:0098839;GO:0098978	protein tyrosine phosphatase activity;transmembrane receptor protein tyrosine phosphatase activity;protein binding;beta-catenin binding;thiolester hydrolase activity;protein phosphatase binding;protein homodimerization activity;alpha-catenin binding;gamma-catenin binding;cadherin binding;alpha-actinin binding;delta-catenin binding;STAT family protein binding	GO:0004725;GO:0005001;GO:0005515;GO:0008013;GO:0016790;GO:0019903;GO:0042803;GO:0045294;GO:0045295;GO:0045296;GO:0051393;GO:0070097;GO:0097677														
chr2:203395682:G/A	BMPR2 intron_variant		8.0	0.0656810982048574			chr2	203395682	G	A	21			BMPR2	ENST00000374580.10	intron_variant		c.1128+5G>A		202530959																									blood vessel development;osteoblast differentiation;mesoderm formation;maternal placenta development;endothelial cell proliferation;lymphangiogenesis;blood vessel remodeling;chondrocyte development;negative regulation of systemic arterial blood pressure;outflow tract septum morphogenesis;outflow tract morphogenesis;aortic valve development;pulmonary valve development;atrioventricular valve morphogenesis;mitral valve morphogenesis;tricuspid valve morphogenesis;endocardial cushion development;negative regulation of cell proliferation involved in heart valve morphogenesis;protein phosphorylation;cell surface receptor protein serine/threonine kinase signaling pathway;cellular response to starvation;anterior/posterior pattern specification;positive regulation of gene expression;positive regulation of epithelial cell migration;regulation of lung blood pressure;proteoglycan biosynthetic process;negative regulation of cell growth;positive regulation of bone mineralization;BMP signaling pathway;activin receptor signaling pathway;regulation of cell population proliferation;positive regulation of osteoblast differentiation;positive regulation of ossification;negative regulation of vasoconstriction;positive regulation of transcription by RNA polymerase II;lung alveolus development;negative regulation of smooth muscle cell proliferation;cardiac muscle tissue development;positive regulation of axon extension involved in axon guidance;negative regulation of muscle cell differentiation;limb development;endochondral bone morphogenesis;positive regulation of SMAD protein signal transduction;ventricular septum morphogenesis;atrial septum morphogenesis;lung vasculature development;lymphatic endothelial cell differentiation;artery development;venous blood vessel development;positive regulation of cartilage development;retina vasculature development in camera-type eye;pharyngeal arch artery morphogenesis;cellular response to growth factor stimulus;cellular response to BMP stimulus;endothelial cell apoptotic process;negative regulation of chondrocyte proliferation;semi-lunar valve development	GO:0001568;GO:0001649;GO:0001707;GO:0001893;GO:0001935;GO:0001946;GO:0001974;GO:0002063;GO:0003085;GO:0003148;GO:0003151;GO:0003176;GO:0003177;GO:0003181;GO:0003183;GO:0003186;GO:0003197;GO:0003252;GO:0006468;GO:0007178;GO:0009267;GO:0009952;GO:0010628;GO:0010634;GO:0014916;GO:0030166;GO:0030308;GO:0030501;GO:0030509;GO:0032924;GO:0042127;GO:0045669;GO:0045778;GO:0045906;GO:0045944;GO:0048286;GO:0048662;GO:0048738;GO:0048842;GO:0051148;GO:0060173;GO:0060350;GO:0060391;GO:0060412;GO:0060413;GO:0060426;GO:0060836;GO:0060840;GO:0060841;GO:0061036;GO:0061298;GO:0061626;GO:0071363;GO:0071773;GO:0072577;GO:1902731;GO:1905314	extracellular space;nucleoplasm;plasma membrane;caveola;clathrin-coated pit;adherens junction;basal plasma membrane;cell surface;postsynaptic density;apical plasma membrane;axon;dendrite;neuronal cell body;receptor complex	GO:0005615;GO:0005654;GO:0005886;GO:0005901;GO:0005905;GO:0005912;GO:0009925;GO:0009986;GO:0014069;GO:0016324;GO:0030424;GO:0030425;GO:0043025;GO:0043235	transforming growth factor beta receptor activity;protein binding;ATP binding;activin receptor activity, type II;growth factor binding;BMP binding;cadherin binding;metal ion binding;BMP receptor activity;protein tyrosine kinase binding	GO:0005024;GO:0005515;GO:0005524;GO:0016362;GO:0019838;GO:0036122;GO:0045296;GO:0046872;GO:0098821;GO:1990782	3.0	049349a0-5522-11e7-8f50-0ac135e8bacf,05263ad2-5522-11e7-8f50-0ac135e8bacf,f1ae1a1c-5521-11e7-8f50-0ac135e8bacf	ALK2 signaling events,ALK1 signaling events,BMP receptor signaling											
chr11:107880058:A/G	CUL5 5_prime_UTR_variant	1.0	8.0	0.0547833197056418			chr11	107880058	A	G	21			CUL5	ENST00000393094.7	5_prime_UTR_variant	1.0	c.-17A>G		108009332																									G1/S transition of mitotic cell cycle;protein ubiquitination;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;ERBB2 signaling pathway;calcium ion transmembrane transport;intrinsic apoptotic signaling pathway	GO:0000082;GO:0016567;GO:0031146;GO:0038128;GO:0070588;GO:0097193	nucleus;cytosol;SCF ubiquitin ligase complex;Cul5-RING ubiquitin ligase complex;site of DNA damage	GO:0005634;GO:0005829;GO:0019005;GO:0031466;GO:0090734	ubiquitin-protein transferase activity;calcium channel activity;protein binding;protein-macromolecule adaptor activity;ubiquitin protein ligase binding;signaling receptor activity	GO:0004842;GO:0005262;GO:0005515;GO:0030674;GO:0031625;GO:0038023														
chr5:68667300:A/G	RAD17 5_prime_UTR_variant		8.0	0.0074661689220718			chr5	68667300	A	G	21			RAD17	ENST00000354868.10	5_prime_UTR_variant	3.0	c.-260A>G		69371473																									DNA replication checkpoint signaling;DNA damage checkpoint signaling;DNA repair;chromatin organization;DNA damage response;negative regulation of DNA replication;mitotic intra-S DNA damage checkpoint signaling;mitotic DNA replication checkpoint signaling;regulation of phosphorylation;protein localization to site of double-strand break	GO:0000076;GO:0000077;GO:0006281;GO:0006325;GO:0006974;GO:0008156;GO:0031573;GO:0033314;GO:0042325;GO:1990166	chromosome, telomeric region;nucleus;nucleoplasm;nucleolus;Rad17 RFC-like complex;site of double-strand break	GO:0000781;GO:0005634;GO:0005654;GO:0005730;GO:0031389;GO:0035861	chromatin binding;DNA clamp loader activity;protein binding;ATP binding;chromatin-protein adaptor activity	GO:0003682;GO:0003689;GO:0005515;GO:0005524;GO:0140463	3.0	c45e106a-5521-11e7-8f50-0ac135e8bacf,f93a0482-5521-11e7-8f50-0ac135e8bacf,f9c7eca4-5521-11e7-8f50-0ac135e8bacf	Fanconi anemia pathway,ATR signaling pathway,ATM pathway											
chr1:209969799:T/C	IRF6 p.Arg91=		8.0	0.0550070521861777			chr1	209969799	T	C	20		Yes	IRF6	ENST00000367021.8	synonymous_variant	4.0	c.273A>G	p.Arg91=	209796454																									immune system process;regulation of transcription by RNA polymerase II;negative regulation of cell population proliferation;negative regulation of keratinocyte proliferation;keratinocyte differentiation;keratinocyte proliferation;positive regulation of DNA-templated transcription;positive regulation of transcription by RNA polymerase II;cell development;roof of mouth development;limb development;mammary gland epithelial cell differentiation;stem cell proliferation;cranial skeletal system development;negative regulation of stem cell proliferation	GO:0002376;GO:0006357;GO:0008285;GO:0010839;GO:0030216;GO:0043616;GO:0045893;GO:0045944;GO:0048468;GO:0060021;GO:0060173;GO:0060644;GO:0072089;GO:1904888;GO:2000647	chromatin;nucleus;cytoplasm;cytosol;extracellular exosome	GO:0000785;GO:0005634;GO:0005737;GO:0005829;GO:0070062	RNA polymerase II cis-regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA binding;DNA-binding transcription factor activity;protein binding;sequence-specific DNA binding;sequence-specific double-stranded DNA binding	GO:0000978;GO:0000981;GO:0001228;GO:0003677;GO:0003700;GO:0005515;GO:0043565;GO:1990837	3.0	67f1a274-5521-11e7-8f50-0ac135e8bacf,82e49678-5521-11e7-8f50-0ac135e8bacf,e88bd848-5521-11e7-8f50-0ac135e8bacf	Regulation of p38-alpha and p38-beta,p38 MAPK signaling pathway,Cellular roles of Anthrax toxin											
chr10:88659649:T/A	BMPR1A splice_site_variant		8.0	0.016285381930981			chr10	88659649	T	A	19			BMPR1A	ENST00000372037.7	splice_site_variant	7.0	c.430+2T>A		86899892																									angiogenesis;osteoblast differentiation;in utero embryonic development;mesoderm formation;somitogenesis;Mullerian duct regression;positive regulation of mesenchymal cell proliferation;chondrocyte differentiation;outflow tract septum morphogenesis;outflow tract morphogenesis;cardiac conduction system development;atrioventricular valve development;mitral valve morphogenesis;tricuspid valve morphogenesis;endocardial cushion morphogenesis;cardiac right ventricle morphogenesis;ventricular trabecula myocardium morphogenesis;ventricular compact myocardium morphogenesis;endocardial cushion formation;protein phosphorylation;immune response;transforming growth factor beta receptor signaling pathway;ectoderm development;dorsal/ventral axis specification;dorsal/ventral pattern formation;positive regulation of gene expression;negative regulation of gene expression;regulation of cardiac muscle cell apoptotic process;neural crest cell development;negative regulation of smooth muscle cell migration;central nervous system neuron differentiation;pituitary gland development;neural plate mediolateral regionalization;lung development;positive regulation of bone mineralization;BMP signaling pathway;positive regulation of transforming growth factor beta2 production;somatic stem cell population maintenance;hindlimb morphogenesis;dorsal aorta morphogenesis;odontogenesis of dentin-containing tooth;embryonic digit morphogenesis;positive regulation of osteoblast differentiation;positive regulation of transcription by RNA polymerase II;paraxial mesoderm structural organization;lateral mesoderm development;regulation of lateral mesodermal cell fate specification;mesendoderm development;embryonic organ development;developmental growth;epithelial cell proliferation;positive regulation of epithelial cell proliferation;negative regulation of neurogenesis;negative regulation of muscle cell differentiation;roof of mouth development;regulation of cardiac muscle cell proliferation;positive regulation of cardiac muscle cell proliferation;positive regulation of SMAD protein signal transduction;ventricular septum morphogenesis;heart formation;atrioventricular node cell development;pharyngeal arch artery morphogenesis;cellular response to growth factor stimulus;cellular response to BMP stimulus;positive regulation of miRNA transcription;positive regulation of cardiac ventricle development;positive regulation of vascular associated smooth muscle cell proliferation;fibrous ring of heart morphogenesis;regulation of neural crest cell differentiation;regulation of cellular senescence	GO:0001525;GO:0001649;GO:0001701;GO:0001707;GO:0001756;GO:0001880;GO:0002053;GO:0002062;GO:0003148;GO:0003151;GO:0003161;GO:0003171;GO:0003183;GO:0003186;GO:0003203;GO:0003215;GO:0003222;GO:0003223;GO:0003272;GO:0006468;GO:0006955;GO:0007179;GO:0007398;GO:0009950;GO:0009953;GO:0010628;GO:0010629;GO:0010665;GO:0014032;GO:0014912;GO:0021953;GO:0021983;GO:0021998;GO:0030324;GO:0030501;GO:0030509;GO:0032915;GO:0035019;GO:0035137;GO:0035912;GO:0042475;GO:0042733;GO:0045669;GO:0045944;GO:0048352;GO:0048368;GO:0048378;GO:0048382;GO:0048568;GO:0048589;GO:0050673;GO:0050679;GO:0050768;GO:0051148;GO:0060021;GO:0060043;GO:0060045;GO:0060391;GO:0060412;GO:0060914;GO:0060928;GO:0061626;GO:0071363;GO:0071773;GO:1902895;GO:1904414;GO:1904707;GO:1905285;GO:1905292;GO:2000772	plasma membrane;caveola;external side of plasma membrane;membrane;dendrite;neuronal cell body;receptor complex;HFE-transferrin receptor complex	GO:0005886;GO:0005901;GO:0009897;GO:0016020;GO:0030425;GO:0043025;GO:0043235;GO:1990712	protein serine/threonine kinase activity;transmembrane receptor protein serine/threonine kinase activity;transforming growth factor beta receptor activity, type I;protein binding;ATP binding;BMP binding;protein homodimerization activity;SMAD binding;metal ion binding;BMP receptor activity	GO:0004674;GO:0004675;GO:0005025;GO:0005515;GO:0005524;GO:0036122;GO:0042803;GO:0046332;GO:0046872;GO:0098821	1.0	f1ae1a1c-5521-11e7-8f50-0ac135e8bacf	BMP receptor signaling											
chr14:75514742:G/A	MLH3 p.Ala539=		8.0	0.0143466459868165			chr14	75514742	G	A	19		Yes	MLH3	ENST00000355774.6	synonymous_variant	2.0	c.1617C>T	p.Ala539=	75048039																									mismatch repair;synaptonemal complex assembly;reciprocal meiotic recombination;male meiotic nuclear division;female meiosis I;protein localization	GO:0006298;GO:0007130;GO:0007131;GO:0007140;GO:0007144;GO:0008104	synaptonemal complex;male germ cell nucleus;nucleus;nucleoplasm;chiasma;mismatch repair complex	GO:0000795;GO:0001673;GO:0005634;GO:0005654;GO:0005712;GO:0032300	chromatin binding;satellite DNA binding;protein binding;ATP binding;ATP hydrolysis activity;centromeric DNA binding;mismatched DNA binding;ATP-dependent DNA damage sensor activity	GO:0003682;GO:0003696;GO:0005515;GO:0005524;GO:0016887;GO:0019237;GO:0030983;GO:0140664														
chr8:128752922:G/C	MYC p.Arg361Ser		8.0	0.0119887165021156			chr8	128752922	G	C	18		Yes	MYC	ENST00000621592.7	missense_variant	3.0	c.1083G>C	p.Arg361Ser	127740676							0.00192	0.211																	G1/S transition of mitotic cell cycle;negative regulation of transcription by RNA polymerase II;MAPK cascade;branching involved in ureteric bud morphogenesis;positive regulation of mesenchymal cell proliferation;chromatin remodeling;regulation of transcription by RNA polymerase II;intracellular iron ion homeostasis;DNA damage response;positive regulation of cell population proliferation;response to xenobiotic stimulus;response to gamma radiation;regulation of gene expression;regulation of cell cycle process;positive regulation of gene expression;regulation of telomere maintenance;negative regulation of stress-activated MAPK cascade;protein-DNA complex disassembly;cellular response to UV;negative regulation of apoptotic process;positive regulation of cysteine-type endopeptidase activity involved in apoptotic process;negative regulation of gene expression via chromosomal CpG island methylation;fibroblast apoptotic process;negative regulation of monocyte differentiation;positive regulation of DNA-templated transcription;positive regulation of transcription by RNA polymerase II;positive regulation of fibroblast proliferation;negative regulation of fibroblast proliferation;positive regulation of epithelial cell proliferation;chromosome organization;negative regulation of cell division;positive regulation of telomerase activity;negative regulation of transcription initiation by RNA polymerase II;ERK1 and ERK2 cascade;response to growth factor;cellular response to hypoxia;cellular response to xenobiotic stimulus;positive regulation of metanephric cap mesenchymal cell proliferation;positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator;positive regulation of miRNA transcription;regulation of somatic stem cell population maintenance	GO:0000082;GO:0000122;GO:0000165;GO:0001658;GO:0002053;GO:0006338;GO:0006357;GO:0006879;GO:0006974;GO:0008284;GO:0009410;GO:0010332;GO:0010468;GO:0010564;GO:0010628;GO:0032204;GO:0032873;GO:0032986;GO:0034644;GO:0043066;GO:0043280;GO:0044027;GO:0044346;GO:0045656;GO:0045893;GO:0045944;GO:0048146;GO:0048147;GO:0050679;GO:0051276;GO:0051782;GO:0051973;GO:0060633;GO:0070371;GO:0070848;GO:0071456;GO:0071466;GO:0090096;GO:1902255;GO:1902895;GO:1904672	chromatin;nucleus;nucleoplasm;nucleolus;cytoplasm;protein-containing complex;Myc-Max complex;RNA polymerase II transcription repressor complex	GO:0000785;GO:0005634;GO:0005654;GO:0005730;GO:0005737;GO:0032991;GO:0071943;GO:0090571	RNA polymerase II cis-regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;core promoter sequence-specific DNA binding;transcription coregulator binding;DNA-binding transcription repressor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA binding;protein binding;identical protein binding;protein-containing complex binding;protein dimerization activity;E-box binding;DNA-binding transcription factor binding;SCF ubiquitin ligase complex binding	GO:0000978;GO:0000981;GO:0001046;GO:0001221;GO:0001227;GO:0001228;GO:0003677;GO:0005515;GO:0042802;GO:0044877;GO:0046983;GO:0070888;GO:0140297;GO:1905761	21.0	35f28f90-5521-11e7-8f50-0ac135e8bacf,3814fa62-5521-11e7-8f50-0ac135e8bacf,3ab9dba6-5521-11e7-8f50-0ac135e8bacf,603902ca-5521-11e7-8f50-0ac135e8bacf,68975856-5521-11e7-8f50-0ac135e8bacf,6aae5178-5521-11e7-8f50-0ac135e8bacf,7455058a-5521-11e7-8f50-0ac135e8bacf,7ac7dec6-5521-11e7-8f50-0ac135e8bacf,812903c2-5521-11e7-8f50-0ac135e8bacf,84be116e-5521-11e7-8f50-0ac135e8bacf,945aa686-5521-11e7-8f50-0ac135e8bacf,9d979c4c-5521-11e7-8f50-0ac135e8bacf,a59cd558-5521-11e7-8f50-0ac135e8bacf,a7ad3eca-5521-11e7-8f50-0ac135e8bacf,a8411a5c-5521-11e7-8f50-0ac135e8bacf,bddf504e-5521-11e7-8f50-0ac135e8bacf,d6e9881a-5521-11e7-8f50-0ac135e8bacf,eb41826c-5521-11e7-8f50-0ac135e8bacf,eef8e528-5521-11e7-8f50-0ac135e8bacf,ef96f9ea-5521-11e7-8f50-0ac135e8bacf,fd2c9b80-5521-11e7-8f50-0ac135e8bacf	Validated targets of C-MYC transcriptional repression,Validated targets of C-MYC transcriptional activation,Validated nuclear estrogen receptor alpha network,Regulation of Telomerase,Regulation of nuclear SMAD23 signaling,Regulation of nuclear beta catenin signaling and target gene transcription,Presenilin action in Notch and Wnt signaling,PDGFR-beta signaling pathway,p73 transcription factor network,Notch signaling pathway,LKB1 signaling events,IL6-mediated signaling events,IL2-mediated signaling events,IL2 signaling events mediated by STAT5,IL2 signaling events mediated by PI3K,FOXM1 transcription factor network,E2F transcription factor network,CD40CD40L signaling,C-MYC pathway,C-MYB transcription factor network,AP-1 transcription factor network											
chr8:70971077:T/G	PRDM14 p.Glu395Ala		8.0	0.0468965517241379			chr8	70971077	T	G	17		Yes	PRDM14	ENST00000276594.3	missense_variant	6.0	c.1184A>C	p.Glu395Ala	70058842							0.706	0.688																	negative regulation of transcription by RNA polymerase II;cell morphogenesis;cell fate specification;inner cell mass cell fate commitment;regulation of transcription by RNA polymerase II;germ cell development;embryo implantation;fibroblast growth factor receptor signaling pathway;fertilization;germ-line stem cell population maintenance;methylation;epigenetic regulation of gene expression;negative regulation of fibroblast growth factor receptor signaling pathway;homeostasis of number of cells within a tissue;positive regulation of flagellated sperm motility;positive regulation of stem cell population maintenance	GO:0000122;GO:0000902;GO:0001708;GO:0001827;GO:0006357;GO:0007281;GO:0007566;GO:0008543;GO:0009566;GO:0030718;GO:0032259;GO:0040029;GO:0040037;GO:0048873;GO:1902093;GO:1902459	nucleus;nucleoplasm;intracellular membrane-bounded organelle	GO:0005634;GO:0005654;GO:0043231	RNA polymerase II transcription regulatory region sequence-specific DNA binding;RNA binding;protein binding;methyltransferase activity;chromatin DNA binding;metal ion binding	GO:0000977;GO:0003723;GO:0005515;GO:0008168;GO:0031490;GO:0046872						6.9772e-06	0.0	0.0	0.0	0.0	0.0	1.54837e-05	0.0	0.0
chr2:48028285:G/A	MSH6 p.Ala1055Thr		8.0	0.0176304654442877			chr2	48028285	G	A	17		Yes	MSH6	ENST00000234420.10	missense_variant	4.0	c.3163G>A	p.Ala1055Thr	47801146							0.0439	0.425					COSV52276308	"[[""large intestine"", 2], [""pancreas"", 1], [""small intestine"", 1]]"	4.0	ENST00000538136.1	A1055T	Exact Match	Conflicting classifications of pathogenicity	MeSH:D003123,MedGen:C0009405|MONDO:MONDO:0010159,MedGen:C5399763,OMIM:276300,Orphanet:252202|MONDO:MONDO:0013710,MedGen:C1833477,OMIM:614350,Orphanet:144|Human Phenotype Ontology:HP:0012114,MONDO:MONDO:0002447,MedGen:C0476089,OMIM:608089|MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900	Hereditary nonpolyposis colorectal neoplasms|Mismatch repair cancer syndrome 1|Lynch syndrome 5|Endometrial carcinoma|not specified|Hereditary cancer-predisposing syndrome|not provided	criteria provided, conflicting classifications	89342.0	Uncertain significance(8)|Likely benign(1)	meiotic mismatch repair;DNA repair;mismatch repair;spermatogenesis;determination of adult lifespan;intrinsic apoptotic signaling pathway in response to DNA damage;response to UV;somatic hypermutation of immunoglobulin genes;somatic recombination of immunoglobulin gene segments;maintenance of DNA repeat elements;isotype switching;negative regulation of DNA recombination;positive regulation of helicase activity;intrinsic apoptotic signaling pathway	GO:0000710;GO:0006281;GO:0006298;GO:0007283;GO:0008340;GO:0008630;GO:0009411;GO:0016446;GO:0016447;GO:0043570;GO:0045190;GO:0045910;GO:0051096;GO:0097193	chromatin;nucleus;nucleoplasm;Golgi apparatus;cytosol;MutSalpha complex;intracellular membrane-bounded organelle	GO:0000785;GO:0005634;GO:0005654;GO:0005794;GO:0005829;GO:0032301;GO:0043231	magnesium ion binding;four-way junction DNA binding;chromatin binding;double-stranded DNA binding;protein binding;ATP binding;ATP-dependent activity, acting on DNA;enzyme binding;mismatched DNA binding;guanine/thymine mispair binding;single guanine insertion binding;single thymine insertion binding;oxidized purine DNA binding;MutLalpha complex binding;methylated histone binding;protein homodimerization activity;ADP binding;ATP-dependent DNA damage sensor activity	GO:0000287;GO:0000400;GO:0003682;GO:0003690;GO:0005515;GO:0005524;GO:0008094;GO:0019899;GO:0030983;GO:0032137;GO:0032142;GO:0032143;GO:0032357;GO:0032405;GO:0035064;GO:0042803;GO:0043531;GO:0140664				rs587779254		2.09442e-05	7.14082e-05	0.0	0.0	0.0	0.0	0.0	0.0	0.0
chr18:46476191:A/G	SMAD7 p.Cys202Arg	1.0	5.0	0.0074424592474034			chr18	46476191	A	G	17		Yes	SMAD7	ENST00000262158.7	missense_variant	1.0	c.604T>C	p.Cys202Arg	48949821							0.0492	0.221																	negative regulation of transcription by RNA polymerase II;ureteric bud development;negative regulation of T cell cytokine production;regulation of transcription by RNA polymerase II;transforming growth factor beta receptor signaling pathway;anatomical structure morphogenesis;regulation of epithelial to mesenchymal transition;negative regulation of epithelial to mesenchymal transition;negative regulation of peptidyl-threonine phosphorylation;negative regulation of transcription by competitive promoter binding;positive regulation of cell-cell adhesion;cell differentiation;negative regulation of ossification;negative regulation of cell migration;negative regulation of transforming growth factor beta receptor signaling pathway;negative regulation of BMP signaling pathway;negative regulation of protein ubiquitination;protein-containing complex localization;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;negative regulation of activin receptor signaling pathway;negative regulation of peptidyl-serine phosphorylation;adherens junction assembly;response to laminar fluid shear stress;artery morphogenesis;protein stabilization;negative regulation of ubiquitin-protein transferase activity;ventricular cardiac muscle tissue morphogenesis;regulation of cardiac muscle contraction;regulation of ventricular cardiac muscle cell membrane depolarization;negative regulation of SMAD protein signal transduction;SMAD protein signal transduction;ventricular septum morphogenesis;cellular response to transforming growth factor beta stimulus;negative regulation of chondrocyte proliferation;positive regulation of chondrocyte hypertrophy;cellular response to leukemia inhibitory factor;negative regulation of T-helper 17 type immune response;negative regulation of T-helper 17 cell differentiation	GO:0000122;GO:0001657;GO:0002725;GO:0006357;GO:0007179;GO:0009653;GO:0010717;GO:0010719;GO:0010801;GO:0010944;GO:0022409;GO:0030154;GO:0030279;GO:0030336;GO:0030512;GO:0030514;GO:0031397;GO:0031503;GO:0032436;GO:0032926;GO:0033137;GO:0034333;GO:0034616;GO:0048844;GO:0050821;GO:0051444;GO:0055010;GO:0055117;GO:0060373;GO:0060392;GO:0060395;GO:0060412;GO:0071560;GO:1902731;GO:1903043;GO:1990830;GO:2000317;GO:2000320	chromatin;fibrillar center;nucleus;nucleoplasm;cytoplasm;centrosome;cytosol;plasma membrane;adherens junction;protein-containing complex;heteromeric SMAD protein complex	GO:0000785;GO:0001650;GO:0005634;GO:0005654;GO:0005737;GO:0005813;GO:0005829;GO:0005886;GO:0005912;GO:0032991;GO:0071144	transcription corepressor activity;protein binding;collagen binding;beta-catenin binding;ubiquitin protein ligase binding;type I transforming growth factor beta receptor binding;metal ion binding;I-SMAD binding;activin receptor binding;transcription regulator inhibitor activity;ubiquitin-like ligase-substrate adaptor activity	GO:0003714;GO:0005515;GO:0005518;GO:0008013;GO:0031625;GO:0034713;GO:0046872;GO:0070411;GO:0070697;GO:0140416;GO:1990756	6.0	05263ad2-5522-11e7-8f50-0ac135e8bacf,408a0c44-5521-11e7-8f50-0ac135e8bacf,54bc0812-5521-11e7-8f50-0ac135e8bacf,68975856-5521-11e7-8f50-0ac135e8bacf,afa50a56-5521-11e7-8f50-0ac135e8bacf,f1ae1a1c-5521-11e7-8f50-0ac135e8bacf	ALK1 signaling events,TGF-beta receptor signaling,Signaling events mediated by HDAC Class I,Regulation of nuclear SMAD23 signaling,IFN-gamma pathway,BMP receptor signaling											
chr15:66996383:C/T	SMAD6 p.Pro263Ser		7.0	0.0160858688266259			chr15	66996383	C	T	16		Yes	SMAD6	ENST00000288840.10	missense_variant	1.0	c.787C>T	p.Pro263Ser	66704045							0.111	0.173											Uncertain significance	MeSH:D030342,MedGen:C0950123|MedGen:C3661900|MONDO:MONDO:0013902,MedGen:C3542024,OMIM:614823	Inborn genetic diseases|not provided|Aortic valve disease 2	criteria provided, multiple submitters, no conflicts	1017896.0		ureteric bud development;outflow tract septum morphogenesis;aortic valve morphogenesis;mitral valve morphogenesis;pulmonary valve morphogenesis;ventricular septum development;regulation of transcription by RNA polymerase II;immune response;transforming growth factor beta receptor signaling pathway;zygotic specification of dorsal/ventral axis;negative regulation of cell population proliferation;anatomical structure morphogenesis;cell differentiation;negative regulation of ossification;BMP signaling pathway;negative regulation of transforming growth factor beta receptor signaling pathway;negative regulation of BMP signaling pathway;cell-substrate adhesion;response to lipopolysaccharide;negative regulation of activin receptor signaling pathway;response to laminar fluid shear stress;aorta development;negative regulation of apoptotic process;response to estrogen;fat cell differentiation;negative regulation of osteoblast differentiation;negative regulation of SMAD protein signal transduction;SMAD protein signal transduction;coronary vasculature development;positive regulation of miRNA transcription	GO:0001657;GO:0003148;GO:0003180;GO:0003183;GO:0003184;GO:0003281;GO:0006357;GO:0006955;GO:0007179;GO:0007352;GO:0008285;GO:0009653;GO:0030154;GO:0030279;GO:0030509;GO:0030512;GO:0030514;GO:0031589;GO:0032496;GO:0032926;GO:0034616;GO:0035904;GO:0043066;GO:0043627;GO:0045444;GO:0045668;GO:0060392;GO:0060395;GO:0060976;GO:1902895	chromatin;nucleus;nucleoplasm;cytoplasm;Golgi apparatus;cytosol;nuclear body;protein-containing complex;heteromeric SMAD protein complex	GO:0000785;GO:0005634;GO:0005654;GO:0005737;GO:0005794;GO:0005829;GO:0016604;GO:0032991;GO:0071144	transcription cis-regulatory region binding;chromatin binding;protein binding;ubiquitin protein ligase binding;type I transforming growth factor beta receptor binding;identical protein binding;metal ion binding;co-SMAD binding;I-SMAD binding;R-SMAD binding;type I activin receptor binding;protein sequestering activity;transcription regulator inhibitor activity	GO:0000976;GO:0003682;GO:0005515;GO:0031625;GO:0034713;GO:0042802;GO:0046872;GO:0070410;GO:0070411;GO:0070412;GO:0070698;GO:0140311;GO:0140416	1.0	f1ae1a1c-5521-11e7-8f50-0ac135e8bacf	BMP receptor signaling	rs1382712515										
chr17:56435885:G/T	RNF43 p.Leu418Met		5.0	0.0189515430659379	True	0.5	chr17	56435885	G	T	16		Yes	RNF43	ENST00000407977.6	missense_variant	9.0	c.1252C>A	p.Leu418Met	58358524	0.3995607028753993	0.4009077155824508	0.4668587896253602	0.4494047619047619	0.3290258449304175	0.3711656441717792	0.131	0.0259					COSV68456749	"[[""soft tissue"", 6], [""lung"", 3], [""small intestine"", 2], [""thymus"", 1], [""breast"", 1], [""thyroid"", 1]]"	14.0	ENST00000584437.5	L418M	Exact Match	Benign	MedGen:CN169374|MedGen:C3661900	not specified|not provided	criteria provided, multiple submitters, no conflicts	403384.0		ubiquitin-dependent protein catabolic process;Wnt signaling pathway;protein ubiquitination;negative regulation of Wnt signaling pathway;Wnt receptor catabolic process;stem cell proliferation	GO:0006511;GO:0016055;GO:0016567;GO:0030178;GO:0038018;GO:0072089	nuclear envelope;endoplasmic reticulum membrane;plasma membrane	GO:0005635;GO:0005789;GO:0005886	ubiquitin-protein transferase activity;frizzled binding;protein binding;metal ion binding;ubiquitin protein ligase activity	GO:0004842;GO:0005109;GO:0005515;GO:0046872;GO:0061630	1.0	812903c2-5521-11e7-8f50-0ac135e8bacf	p73 transcription factor network	rs2526374	rs2526374	0.377293	0.39959	0.33082	0.450767	0.320142	0.436145	0.359278	0.387803	0.367126
chr12:49424234:G/A	KMT2D intron_variant						chr12	49424234	G	A	16			KMT2D	ENST00000301067.11	intron_variant		c.13840-12C>T		49030451																									oocyte growth;regulation of DNA-templated transcription;positive regulation of cell population proliferation;heterochromatin formation;methylation;positive regulation of intracellular estrogen receptor signaling pathway;response to estrogen;positive regulation of transcription by RNA polymerase II;oogenesis;beta-catenin-TCF complex assembly	GO:0001555;GO:0006355;GO:0008284;GO:0031507;GO:0032259;GO:0033148;GO:0043627;GO:0045944;GO:0048477;GO:1904837	nucleus;nucleoplasm;MLL3/4 complex	GO:0005634;GO:0005654;GO:0044666	transcription cis-regulatory region binding;DNA binding;transcription coactivator activity;protein binding;histone H3K4 methyltransferase activity;metal ion binding;histone H3K4 monomethyltransferase activity;histone H3K4 trimethyltransferase activity	GO:0000976;GO:0003677;GO:0003713;GO:0005515;GO:0042800;GO:0046872;GO:0140945;GO:0140999														
chr11:108123678:T/C	ATM intron_variant		8.0	0.009693679720822			chr11	108123678	T	C	16			ATM	ENST00000278616.8	intron_variant		c.1898+39T>C		108252951																									DNA damage checkpoint signaling;pexophagy;telomere maintenance;double-strand break repair via homologous recombination;DNA double-strand break processing;ovarian follicle development;response to hypoxia;somitogenesis;pre-B cell allelic exclusion;double-strand break repair;double-strand break repair via nonhomologous end joining;chromatin remodeling;protein phosphorylation;DNA damage response;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;mitotic spindle assembly checkpoint signaling;mitotic G2 DNA damage checkpoint signaling;reciprocal meiotic recombination;male meiotic nuclear division;female meiotic nuclear division;signal transduction;brain development;heart development;determination of adult lifespan;intrinsic apoptotic signaling pathway in response to DNA damage;post-embryonic development;response to ionizing radiation;regulation of autophagy;positive regulation of gene expression;peptidyl-serine phosphorylation;positive regulation of cell migration;negative regulation of B cell proliferation;regulation of telomere maintenance via telomerase;positive regulation of telomere maintenance via telomerase;V(D)J recombination;cellular response to reactive oxygen species;multicellular organism growth;phosphatidylinositol-3-phosphate biosynthetic process;peptidyl-serine autophosphorylation;lipoprotein catabolic process;signal transduction in response to DNA damage;regulation of apoptotic process;positive regulation of apoptotic process;positive regulation of DNA damage response, signal transduction by p53 class mediator;positive regulation of neuron apoptotic process;meiotic telomere clustering;positive regulation of cell adhesion;positive regulation of transcription by RNA polymerase II;protein autophosphorylation;thymus development;oocyte development;neuron apoptotic process;regulation of cell cycle;regulation of telomerase activity;histone mRNA catabolic process;cellular response to retinoic acid;cellular response to gamma radiation;cellular response to X-ray;cellular response to nitrosative stress;cellular senescence;replicative senescence;establishment of RNA localization to telomere;establishment of protein-containing complex localization to telomere;regulation of cellular response to heat;regulation of signal transduction by p53 class mediator;positive regulation of DNA catabolic process;regulation of microglial cell activation;negative regulation of TORC1 signaling;negative regulation of telomere capping;positive regulation of telomere maintenance via telomere lengthening;positive regulation of telomerase catalytic core complex assembly;regulation of autophagosome assembly	GO:0000077;GO:0000425;GO:0000723;GO:0000724;GO:0000729;GO:0001541;GO:0001666;GO:0001756;GO:0002331;GO:0006302;GO:0006303;GO:0006338;GO:0006468;GO:0006974;GO:0006977;GO:0007094;GO:0007095;GO:0007131;GO:0007140;GO:0007143;GO:0007165;GO:0007420;GO:0007507;GO:0008340;GO:0008630;GO:0009791;GO:0010212;GO:0010506;GO:0010628;GO:0018105;GO:0030335;GO:0030889;GO:0032210;GO:0032212;GO:0033151;GO:0034614;GO:0035264;GO:0036092;GO:0036289;GO:0042159;GO:0042770;GO:0042981;GO:0043065;GO:0043517;GO:0043525;GO:0045141;GO:0045785;GO:0045944;GO:0046777;GO:0048538;GO:0048599;GO:0051402;GO:0051726;GO:0051972;GO:0071044;GO:0071300;GO:0071480;GO:0071481;GO:0071500;GO:0090398;GO:0090399;GO:0097694;GO:0097695;GO:1900034;GO:1901796;GO:1903626;GO:1903978;GO:1904262;GO:1904354;GO:1904358;GO:1904884;GO:2000785	chromosome, telomeric region;nucleus;nucleoplasm;nucleolus;cytoplasm;peroxisomal matrix;centrosome;spindle;cytosol;cytoplasmic vesicle;site of double-strand break;intracellular membrane-bounded organelle;DNA repair complex	GO:0000781;GO:0005634;GO:0005654;GO:0005730;GO:0005737;GO:0005782;GO:0005813;GO:0005819;GO:0005829;GO:0031410;GO:0035861;GO:0043231;GO:1990391	DNA binding;protein serine/threonine kinase activity;DNA-dependent protein kinase activity;protein binding;ATP binding;1-phosphatidylinositol-3-kinase activity;histone H2AXS139 kinase activity;identical protein binding;protein-containing complex binding;protein serine kinase activity	GO:0003677;GO:0004674;GO:0004677;GO:0005515;GO:0005524;GO:0016303;GO:0035979;GO:0042802;GO:0044877;GO:0106310	10.0	34a994cc-5521-11e7-8f50-0ac135e8bacf,603902ca-5521-11e7-8f50-0ac135e8bacf,76f15b4e-5521-11e7-8f50-0ac135e8bacf,81be3ee4-5521-11e7-8f50-0ac135e8bacf,82e49678-5521-11e7-8f50-0ac135e8bacf,c45e106a-5521-11e7-8f50-0ac135e8bacf,d6e9881a-5521-11e7-8f50-0ac135e8bacf,ed3cb632-5521-11e7-8f50-0ac135e8bacf,f6898a78-5521-11e7-8f50-0ac135e8bacf,f9c7eca4-5521-11e7-8f50-0ac135e8bacf	Validated transcriptional targets of deltaNp63 isoforms,Regulation of Telomerase,PLK3 signaling events,p53 pathway,p38 MAPK signaling pathway,Fanconi anemia pathway,E2F transcription factor network,Canonical NF-kappaB pathway,BARD1 signaling events,ATM pathway											
chr18:46476193:A/G	SMAD7 p.Leu201Pro		6.0	0.0026186579378068			chr18	46476193	A	G	15		Yes	SMAD7	ENST00000262158.7	missense_variant	1.0	c.602T>C	p.Leu201Pro	48949823							0.0213	0.155																	negative regulation of transcription by RNA polymerase II;ureteric bud development;negative regulation of T cell cytokine production;regulation of transcription by RNA polymerase II;transforming growth factor beta receptor signaling pathway;anatomical structure morphogenesis;regulation of epithelial to mesenchymal transition;negative regulation of epithelial to mesenchymal transition;negative regulation of peptidyl-threonine phosphorylation;negative regulation of transcription by competitive promoter binding;positive regulation of cell-cell adhesion;cell differentiation;negative regulation of ossification;negative regulation of cell migration;negative regulation of transforming growth factor beta receptor signaling pathway;negative regulation of BMP signaling pathway;negative regulation of protein ubiquitination;protein-containing complex localization;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;negative regulation of activin receptor signaling pathway;negative regulation of peptidyl-serine phosphorylation;adherens junction assembly;response to laminar fluid shear stress;artery morphogenesis;protein stabilization;negative regulation of ubiquitin-protein transferase activity;ventricular cardiac muscle tissue morphogenesis;regulation of cardiac muscle contraction;regulation of ventricular cardiac muscle cell membrane depolarization;negative regulation of SMAD protein signal transduction;SMAD protein signal transduction;ventricular septum morphogenesis;cellular response to transforming growth factor beta stimulus;negative regulation of chondrocyte proliferation;positive regulation of chondrocyte hypertrophy;cellular response to leukemia inhibitory factor;negative regulation of T-helper 17 type immune response;negative regulation of T-helper 17 cell differentiation	GO:0000122;GO:0001657;GO:0002725;GO:0006357;GO:0007179;GO:0009653;GO:0010717;GO:0010719;GO:0010801;GO:0010944;GO:0022409;GO:0030154;GO:0030279;GO:0030336;GO:0030512;GO:0030514;GO:0031397;GO:0031503;GO:0032436;GO:0032926;GO:0033137;GO:0034333;GO:0034616;GO:0048844;GO:0050821;GO:0051444;GO:0055010;GO:0055117;GO:0060373;GO:0060392;GO:0060395;GO:0060412;GO:0071560;GO:1902731;GO:1903043;GO:1990830;GO:2000317;GO:2000320	chromatin;fibrillar center;nucleus;nucleoplasm;cytoplasm;centrosome;cytosol;plasma membrane;adherens junction;protein-containing complex;heteromeric SMAD protein complex	GO:0000785;GO:0001650;GO:0005634;GO:0005654;GO:0005737;GO:0005813;GO:0005829;GO:0005886;GO:0005912;GO:0032991;GO:0071144	transcription corepressor activity;protein binding;collagen binding;beta-catenin binding;ubiquitin protein ligase binding;type I transforming growth factor beta receptor binding;metal ion binding;I-SMAD binding;activin receptor binding;transcription regulator inhibitor activity;ubiquitin-like ligase-substrate adaptor activity	GO:0003714;GO:0005515;GO:0005518;GO:0008013;GO:0031625;GO:0034713;GO:0046872;GO:0070411;GO:0070697;GO:0140416;GO:1990756	6.0	05263ad2-5522-11e7-8f50-0ac135e8bacf,408a0c44-5521-11e7-8f50-0ac135e8bacf,54bc0812-5521-11e7-8f50-0ac135e8bacf,68975856-5521-11e7-8f50-0ac135e8bacf,afa50a56-5521-11e7-8f50-0ac135e8bacf,f1ae1a1c-5521-11e7-8f50-0ac135e8bacf	ALK1 signaling events,TGF-beta receptor signaling,Signaling events mediated by HDAC Class I,Regulation of nuclear SMAD23 signaling,IFN-gamma pathway,BMP receptor signaling											
chr11:118344817:A/C	KMT2A p.Pro981=		7.0	0.0049817200966156			chr11	118344817	A	C	15		Yes	KMT2A	ENST00000534358.7	synonymous_variant	3.0	c.2943A>C	p.Pro981=	118474102													COSV63290679	"[[""liver"", 1]]"	1.0	ENST00000534358.5	P981%3D	Genomic Location							apoptotic process;visual learning;post-embryonic development;anterior/posterior pattern specification;methylation;circadian regulation of gene expression;embryonic hemopoiesis;exploration behavior;response to potassium ion;protein modification process;T-helper 2 cell differentiation;transcription initiation-coupled chromatin remodeling;positive regulation of DNA-templated transcription;positive regulation of transcription by RNA polymerase II;fibroblast proliferation;negative regulation of fibroblast proliferation;regulation of short-term neuronal synaptic plasticity;spleen development;homeostasis of number of cells within a tissue;membrane depolarization;definitive hemopoiesis;protein-containing complex assembly;cellular response to transforming growth factor beta stimulus;negative regulation of DNA methylation-dependent heterochromatin formation	GO:0006915;GO:0008542;GO:0009791;GO:0009952;GO:0032259;GO:0032922;GO:0035162;GO:0035640;GO:0035864;GO:0036211;GO:0045064;GO:0045815;GO:0045893;GO:0045944;GO:0048144;GO:0048147;GO:0048172;GO:0048536;GO:0048873;GO:0051899;GO:0060216;GO:0065003;GO:0071560;GO:0090310	nucleus;nucleoplasm;cytosol;histone methyltransferase complex;MLL1 complex	GO:0005634;GO:0005654;GO:0005829;GO:0035097;GO:0071339	minor groove of adenine-thymine-rich DNA binding;chromatin binding;protein binding;zinc ion binding;histone H3K4 methyltransferase activity;identical protein binding;protein homodimerization activity;unmethylated CpG binding;lysine-acetylated histone binding;protein-cysteine methyltransferase activity;histone H3K4 monomethyltransferase activity;histone H3K4 trimethyltransferase activity	GO:0003680;GO:0003682;GO:0005515;GO:0008270;GO:0042800;GO:0042802;GO:0042803;GO:0045322;GO:0070577;GO:0106363;GO:0140945;GO:0140999														
chr17:41276223:T/A	BRCA1 intron_variant		8.0	0.0137931034482758			chr17	41276223	T	A	15			BRCA1	ENST00000357654.9	intron_variant		c.-19-91A>T		43124206																									double-strand break repair via homologous recombination;DNA repair;regulation of DNA repair;postreplication repair;double-strand break repair;regulation of transcription by RNA polymerase II;fatty acid biosynthetic process;DNA damage response;chromosome segregation;mitotic G2 DNA damage checkpoint signaling;centrosome cycle;sex-chromosome dosage compensation;intrinsic apoptotic signaling pathway in response to DNA damage;response to ionizing radiation;positive regulation of vascular endothelial growth factor production;positive regulation of gene expression;protein ubiquitination;negative regulation of cell growth;negative regulation of intracellular estrogen receptor signaling pathway;homologous recombination;chordate embryonic development;negative regulation of gene expression via chromosomal CpG island methylation;mitotic G2/M transition checkpoint;negative regulation of fatty acid biosynthetic process;positive regulation of DNA repair;positive regulation of angiogenesis;negative regulation of cell cycle;negative regulation of DNA-templated transcription;positive regulation of DNA-templated transcription;positive regulation of transcription by RNA polymerase II;negative regulation of centriole replication;regulation of cell cycle;protein autoubiquitination;random inactivation of X chromosome;cellular response to tumor necrosis factor;cellular response to ionizing radiation;cellular response to indole-3-methanol;protein K6-linked ubiquitination;DNA strand resection involved in replication fork processing;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors;regulation of DNA damage checkpoint;negative regulation of reactive oxygen species metabolic process	GO:0000724;GO:0006281;GO:0006282;GO:0006301;GO:0006302;GO:0006357;GO:0006633;GO:0006974;GO:0007059;GO:0007095;GO:0007098;GO:0007549;GO:0008630;GO:0010212;GO:0010575;GO:0010628;GO:0016567;GO:0030308;GO:0033147;GO:0035825;GO:0043009;GO:0044027;GO:0044818;GO:0045717;GO:0045739;GO:0045766;GO:0045786;GO:0045892;GO:0045893;GO:0045944;GO:0046600;GO:0051726;GO:0051865;GO:0060816;GO:0071356;GO:0071479;GO:0071681;GO:0085020;GO:0110025;GO:1902042;GO:2000001;GO:2000378	ubiquitin ligase complex;nuclear ubiquitin ligase complex;lateral element;gamma-tubulin ring complex;male germ cell nucleus;XY body;nucleus;nucleoplasm;chromosome;cytoplasm;plasma membrane;nuclear body;BRCA1-BARD1 complex;protein-containing complex;intracellular non-membrane-bounded organelle;BRCA1-A complex;BRCA1-B complex;BRCA1-C complex;DNA repair complex;ribonucleoprotein complex	GO:0000151;GO:0000152;GO:0000800;GO:0000931;GO:0001673;GO:0001741;GO:0005634;GO:0005654;GO:0005694;GO:0005737;GO:0005886;GO:0016604;GO:0031436;GO:0032991;GO:0043232;GO:0070531;GO:0070532;GO:0070533;GO:1990391;GO:1990904	transcription cis-regulatory region binding;DNA-binding transcription activator activity;p53 binding;DNA binding;damaged DNA binding;transcription coactivator activity;RNA binding;ubiquitin-protein transferase activity;protein binding;zinc ion binding;tubulin binding;enzyme binding;ubiquitin protein ligase binding;identical protein binding;RNA polymerase binding	GO:0000976;GO:0001216;GO:0002039;GO:0003677;GO:0003684;GO:0003713;GO:0003723;GO:0004842;GO:0005515;GO:0008270;GO:0015631;GO:0019899;GO:0031625;GO:0042802;GO:0070063	10.0	35f28f90-5521-11e7-8f50-0ac135e8bacf,3ab9dba6-5521-11e7-8f50-0ac135e8bacf,bf04bd82-5521-11e7-8f50-0ac135e8bacf,c45e106a-5521-11e7-8f50-0ac135e8bacf,d6e9881a-5521-11e7-8f50-0ac135e8bacf,e3c4b33c-5521-11e7-8f50-0ac135e8bacf,f6898a78-5521-11e7-8f50-0ac135e8bacf,f823645e-5521-11e7-8f50-0ac135e8bacf,f9c7eca4-5521-11e7-8f50-0ac135e8bacf,fa553886-5521-11e7-8f50-0ac135e8bacf	Validated targets of C-MYC transcriptional repression,Validated nuclear estrogen receptor alpha network,FOXA1 transcription factor network,Fanconi anemia pathway,E2F transcription factor network,Coregulation of Androgen receptor activity,BARD1 signaling events,Aurora A signaling,ATM pathway,ATF-2 transcription factor network											
chr15:67430456:G/A	SMAD3 intron_variant		8.0	0.0244280728964715			chr15	67430456	G	A	14			SMAD3	ENST00000327367.9	intron_variant		c.207-26777G>A		67138118																									negative regulation of transcription by RNA polymerase II;ureteric bud development;response to hypoxia;in utero embryonic development;mesoderm formation;somitogenesis;liver development;heart looping;osteoblast development;immune system development;regulation of DNA-templated transcription;regulation of transcription by RNA polymerase II;activation of cysteine-type endopeptidase activity involved in apoptotic process;immune response;transforming growth factor beta receptor signaling pathway;JNK cascade;endoderm development;cell population proliferation;negative regulation of cell population proliferation;anatomical structure morphogenesis;embryonic pattern specification;positive regulation of gene expression;negative regulation of gene expression;positive regulation of epithelial to mesenchymal transition;regulation of striated muscle tissue development;regulation of transforming growth factor beta receptor signaling pathway;signal transduction involved in regulation of gene expression;cell differentiation;negative regulation of cell growth;adrenal gland development;positive regulation of cell migration;positive regulation of bone mineralization;thyroid gland development;primary miRNA processing;positive regulation of chondrocyte differentiation;positive regulation of interleukin-1 beta production;regulation of transforming growth factor beta2 production;positive regulation of transforming growth factor beta3 production;activin receptor signaling pathway;negative regulation of osteoblast proliferation;nodal signaling pathway;wound healing;T cell activation;negative regulation of protein catabolic process;positive regulation of protein import into nucleus;negative regulation of apoptotic process;cell-cell junction organization;positive regulation of nitric oxide biosynthetic process;negative regulation of fat cell differentiation;negative regulation of osteoblast differentiation;positive regulation of DNA-templated transcription;positive regulation of transcription by RNA polymerase II;paraxial mesoderm morphogenesis;developmental growth;embryonic foregut morphogenesis;embryonic cranial skeleton morphogenesis;regulation of epithelial cell proliferation;negative regulation of inflammatory response;regulation of immune response;protein stabilization;positive regulation of positive chemotaxis;positive regulation of DNA-binding transcription factor activity;negative regulation of cytosolic calcium ion concentration;positive regulation of stress fiber assembly;positive regulation of focal adhesion assembly;pericardium development;transdifferentiation;SMAD protein signal transduction;negative regulation of wound healing;negative regulation of lung blood pressure;lens fiber cell differentiation;cellular response to glucose stimulus;cellular response to transforming growth factor beta stimulus;positive regulation of canonical Wnt signaling pathway;extrinsic apoptotic signaling pathway;cellular response to virus;positive regulation of extracellular matrix assembly;regulation of miRNA transcription;negative regulation of miRNA transcription;positive regulation of miRNA transcription;negative regulation of cardiac muscle hypertrophy in response to stress;response to angiotensin	GO:0000122;GO:0001657;GO:0001666;GO:0001701;GO:0001707;GO:0001756;GO:0001889;GO:0001947;GO:0002076;GO:0002520;GO:0006355;GO:0006357;GO:0006919;GO:0006955;GO:0007179;GO:0007254;GO:0007492;GO:0008283;GO:0008285;GO:0009653;GO:0009880;GO:0010628;GO:0010629;GO:0010718;GO:0016202;GO:0017015;GO:0023019;GO:0030154;GO:0030308;GO:0030325;GO:0030335;GO:0030501;GO:0030878;GO:0031053;GO:0032332;GO:0032731;GO:0032909;GO:0032916;GO:0032924;GO:0033689;GO:0038092;GO:0042060;GO:0042110;GO:0042177;GO:0042307;GO:0043066;GO:0045216;GO:0045429;GO:0045599;GO:0045668;GO:0045893;GO:0045944;GO:0048340;GO:0048589;GO:0048617;GO:0048701;GO:0050678;GO:0050728;GO:0050776;GO:0050821;GO:0050927;GO:0051091;GO:0051481;GO:0051496;GO:0051894;GO:0060039;GO:0060290;GO:0060395;GO:0061045;GO:0061767;GO:0070306;GO:0071333;GO:0071560;GO:0090263;GO:0097191;GO:0098586;GO:1901203;GO:1902893;GO:1902894;GO:1902895;GO:1903243;GO:1990776	chromatin;nucleus;nuclear inner membrane;nucleoplasm;transcription regulator complex;cytoplasm;cytosol;plasma membrane;receptor complex;SMAD protein complex;heteromeric SMAD protein complex	GO:0000785;GO:0005634;GO:0005637;GO:0005654;GO:0005667;GO:0005737;GO:0005829;GO:0005886;GO:0043235;GO:0071141;GO:0071144	transcription cis-regulatory region binding;RNA polymerase II cis-regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;cis-regulatory region sequence-specific DNA binding;DNA-binding transcription repressor activity;transcription corepressor binding;transcription coactivator binding;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA binding;DNA-binding transcription factor activity;transforming growth factor beta receptor binding;protein binding;collagen binding;beta-catenin binding;zinc ion binding;nuclear receptor binding;DEAD/H-box RNA helicase binding;protein kinase binding;phosphatase binding;chromatin DNA binding;ubiquitin protein ligase binding;nuclear mineralocorticoid receptor binding;sterol response element binding;nuclear glucocorticoid receptor binding;identical protein binding;protein homodimerization activity;ubiquitin binding;bHLH transcription factor binding;sequence-specific DNA binding;RNA polymerase II-specific DNA-binding transcription factor binding;co-SMAD binding;I-SMAD binding;R-SMAD binding;DNA-binding transcription factor binding;promoter-specific chromatin binding	GO:0000976;GO:0000978;GO:0000981;GO:0000987;GO:0001217;GO:0001222;GO:0001223;GO:0001228;GO:0003677;GO:0003700;GO:0005160;GO:0005515;GO:0005518;GO:0008013;GO:0008270;GO:0016922;GO:0017151;GO:0019901;GO:0019902;GO:0031490;GO:0031625;GO:0031962;GO:0032810;GO:0035259;GO:0042802;GO:0042803;GO:0043130;GO:0043425;GO:0043565;GO:0061629;GO:0070410;GO:0070411;GO:0070412;GO:0140297;GO:1990841	7.0	35f28f90-5521-11e7-8f50-0ac135e8bacf,3814fa62-5521-11e7-8f50-0ac135e8bacf,408a0c44-5521-11e7-8f50-0ac135e8bacf,603902ca-5521-11e7-8f50-0ac135e8bacf,68975856-5521-11e7-8f50-0ac135e8bacf,6cb6085a-5521-11e7-8f50-0ac135e8bacf,b354a4de-5521-11e7-8f50-0ac135e8bacf	Validated targets of C-MYC transcriptional repression,Validated targets of C-MYC transcriptional activation,TGF-beta receptor signaling,Regulation of Telomerase,Regulation of nuclear SMAD23 signaling,Regulation of cytoplasmic and nuclear SMAD23 signaling,HIF-1-alpha transcription factor network											
chr11:107880060:T/C	CUL5 5_prime_UTR_variant		8.0	0.0468085106382978			chr11	107880060	T	C	13			CUL5	ENST00000393094.7	5_prime_UTR_variant	1.0	c.-15T>C		108009334																									G1/S transition of mitotic cell cycle;protein ubiquitination;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;ERBB2 signaling pathway;calcium ion transmembrane transport;intrinsic apoptotic signaling pathway	GO:0000082;GO:0016567;GO:0031146;GO:0038128;GO:0070588;GO:0097193	nucleus;cytosol;SCF ubiquitin ligase complex;Cul5-RING ubiquitin ligase complex;site of DNA damage	GO:0005634;GO:0005829;GO:0019005;GO:0031466;GO:0090734	ubiquitin-protein transferase activity;calcium channel activity;protein binding;protein-macromolecule adaptor activity;ubiquitin protein ligase binding;signaling receptor activity	GO:0004842;GO:0005262;GO:0005515;GO:0030674;GO:0031625;GO:0038023														
chr5:38953546:A/G	RICTOR intron_variant		7.0	0.0244632198360098			chr5	38953546	A	G	13			RICTOR	ENST00000357387.8	intron_variant		c.2790+17T>C		38953444																									positive regulation of endothelial cell proliferation;cytoskeleton organization;embryo development ending in birth or egg hatching;regulation of gene expression;peptidyl-serine phosphorylation;actin cytoskeleton organization;positive regulation of cell growth;positive regulation of actin filament polymerization;cellular response to nutrient levels;positive regulation of TOR signaling;regulation of actin cytoskeleton organization;regulation of peptidyl-serine phosphorylation;TORC2 signaling;negative regulation of apoptotic process;regulation of inflammatory response;positive regulation of peptidyl-tyrosine phosphorylation;regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction;positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction;regulation of establishment of cell polarity	GO:0001938;GO:0007010;GO:0009792;GO:0010468;GO:0018105;GO:0030036;GO:0030307;GO:0030838;GO:0031669;GO:0032008;GO:0032956;GO:0033135;GO:0038203;GO:0043066;GO:0050727;GO:0050731;GO:0051896;GO:0051897;GO:2000114	Golgi apparatus;cytosol;TORC2 complex	GO:0005794;GO:0005829;GO:0031932	protein binding;protein kinase binding;ribosome binding;protein serine/threonine kinase activator activity;molecular adaptor activity	GO:0005515;GO:0019901;GO:0043022;GO:0043539;GO:0060090	6.0	8f640d10-5521-11e7-8f50-0ac135e8bacf,98ad85f0-5521-11e7-8f50-0ac135e8bacf,c92b28e0-5521-11e7-8f50-0ac135e8bacf,df93b3b8-5521-11e7-8f50-0ac135e8bacf,e1b66caa-5521-11e7-8f50-0ac135e8bacf,e6f69242-5521-11e7-8f50-0ac135e8bacf	mTOR signaling pathway,Integrin-linked kinase signaling,ErbB1 downstream signaling,CXCR4-mediated signaling events,CXCR3-mediated signaling events,Class I PI3K signaling events mediated by Akt											
chr14:75514737:A/T	MLH3 p.Ile541Asn		8.0	0.0148095909732016			chr14	75514737	A	T	11		Yes	MLH3	ENST00000355774.6	missense_variant	2.0	c.1622T>A	p.Ile541Asn	75048034							0.338	0.543																	mismatch repair;synaptonemal complex assembly;reciprocal meiotic recombination;male meiotic nuclear division;female meiosis I;protein localization	GO:0006298;GO:0007130;GO:0007131;GO:0007140;GO:0007144;GO:0008104	synaptonemal complex;male germ cell nucleus;nucleus;nucleoplasm;chiasma;mismatch repair complex	GO:0000795;GO:0001673;GO:0005634;GO:0005654;GO:0005712;GO:0032300	chromatin binding;satellite DNA binding;protein binding;ATP binding;ATP hydrolysis activity;centromeric DNA binding;mismatched DNA binding;ATP-dependent DNA damage sensor activity	GO:0003682;GO:0003696;GO:0005515;GO:0005524;GO:0016887;GO:0019237;GO:0030983;GO:0140664														
chr6:7230380:A/C	RREB1 p.Lys683Thr		8.0	0.0155355682747342			chr6	7230380	A	C	11		Yes	RREB1	ENST00000379938.7	missense_variant	10.0	c.2048A>C	p.Lys683Thr	7230147							0.285	0.0185																	negative regulation of transcription by RNA polymerase II;regulation of DNA-templated transcription;regulation of transcription by RNA polymerase II;transcription by RNA polymerase II;positive regulation of epithelial cell migration;positive regulation of mammary gland epithelial cell proliferation;positive regulation of DNA-templated transcription;positive regulation of transcription by RNA polymerase II;positive regulation of brown fat cell differentiation;positive regulation of substrate adhesion-dependent cell spreading;positive regulation of wound healing, spreading of epidermal cells;positive regulation of lamellipodium morphogenesis	GO:0000122;GO:0006355;GO:0006357;GO:0006366;GO:0010634;GO:0033601;GO:0045893;GO:0045944;GO:0090336;GO:1900026;GO:1903691;GO:2000394	fibrillar center;nucleus;cytoplasm;nuclear body;nuclear speck;extracellular exosome	GO:0001650;GO:0005634;GO:0005737;GO:0016604;GO:0016607;GO:0070062	RNA polymerase II transcription regulatory region sequence-specific DNA binding;RNA polymerase II cis-regulatory region sequence-specific DNA binding;DNA-binding transcription activator activity, RNA polymerase II-specific;metal ion binding	GO:0000977;GO:0000978;GO:0001228;GO:0046872														
chr6:7229435:G/C	RREB1 p.Gly368Ala		7.0	0.0205008530847602			chr6	7229435	G	C	11		Yes	RREB1	ENST00000379938.7	missense_variant	10.0	c.1103G>C	p.Gly368Ala	7229202							0.297	0.0275																	negative regulation of transcription by RNA polymerase II;regulation of DNA-templated transcription;regulation of transcription by RNA polymerase II;transcription by RNA polymerase II;positive regulation of epithelial cell migration;positive regulation of mammary gland epithelial cell proliferation;positive regulation of DNA-templated transcription;positive regulation of transcription by RNA polymerase II;positive regulation of brown fat cell differentiation;positive regulation of substrate adhesion-dependent cell spreading;positive regulation of wound healing, spreading of epidermal cells;positive regulation of lamellipodium morphogenesis	GO:0000122;GO:0006355;GO:0006357;GO:0006366;GO:0010634;GO:0033601;GO:0045893;GO:0045944;GO:0090336;GO:1900026;GO:1903691;GO:2000394	fibrillar center;nucleus;cytoplasm;nuclear body;nuclear speck;extracellular exosome	GO:0001650;GO:0005634;GO:0005737;GO:0016604;GO:0016607;GO:0070062	RNA polymerase II transcription regulatory region sequence-specific DNA binding;RNA polymerase II cis-regulatory region sequence-specific DNA binding;DNA-binding transcription activator activity, RNA polymerase II-specific;metal ion binding	GO:0000977;GO:0000978;GO:0001228;GO:0046872														
chr11:107920803:T/C	CUL5 intron_variant		8.0	0.0289314045730284			chr11	107920803	T	C	11			CUL5	ENST00000393094.7	intron_variant		c.411+10T>C		108050076																									G1/S transition of mitotic cell cycle;protein ubiquitination;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;ERBB2 signaling pathway;calcium ion transmembrane transport;intrinsic apoptotic signaling pathway	GO:0000082;GO:0016567;GO:0031146;GO:0038128;GO:0070588;GO:0097193	nucleus;cytosol;SCF ubiquitin ligase complex;Cul5-RING ubiquitin ligase complex;site of DNA damage	GO:0005634;GO:0005829;GO:0019005;GO:0031466;GO:0090734	ubiquitin-protein transferase activity;calcium channel activity;protein binding;protein-macromolecule adaptor activity;ubiquitin protein ligase binding;signaling receptor activity	GO:0004842;GO:0005262;GO:0005515;GO:0030674;GO:0031625;GO:0038023														
chr2:203384920:A/G	BMPR2 p.Arg321=		4.0	0.0013999066728884			chr2	203384920	A	G	11		Yes	BMPR2	ENST00000374580.10	synonymous_variant	7.0	c.963A>G	p.Arg321=	202520197																									blood vessel development;osteoblast differentiation;mesoderm formation;maternal placenta development;endothelial cell proliferation;lymphangiogenesis;blood vessel remodeling;chondrocyte development;negative regulation of systemic arterial blood pressure;outflow tract septum morphogenesis;outflow tract morphogenesis;aortic valve development;pulmonary valve development;atrioventricular valve morphogenesis;mitral valve morphogenesis;tricuspid valve morphogenesis;endocardial cushion development;negative regulation of cell proliferation involved in heart valve morphogenesis;protein phosphorylation;cell surface receptor protein serine/threonine kinase signaling pathway;cellular response to starvation;anterior/posterior pattern specification;positive regulation of gene expression;positive regulation of epithelial cell migration;regulation of lung blood pressure;proteoglycan biosynthetic process;negative regulation of cell growth;positive regulation of bone mineralization;BMP signaling pathway;activin receptor signaling pathway;regulation of cell population proliferation;positive regulation of osteoblast differentiation;positive regulation of ossification;negative regulation of vasoconstriction;positive regulation of transcription by RNA polymerase II;lung alveolus development;negative regulation of smooth muscle cell proliferation;cardiac muscle tissue development;positive regulation of axon extension involved in axon guidance;negative regulation of muscle cell differentiation;limb development;endochondral bone morphogenesis;positive regulation of SMAD protein signal transduction;ventricular septum morphogenesis;atrial septum morphogenesis;lung vasculature development;lymphatic endothelial cell differentiation;artery development;venous blood vessel development;positive regulation of cartilage development;retina vasculature development in camera-type eye;pharyngeal arch artery morphogenesis;cellular response to growth factor stimulus;cellular response to BMP stimulus;endothelial cell apoptotic process;negative regulation of chondrocyte proliferation;semi-lunar valve development	GO:0001568;GO:0001649;GO:0001707;GO:0001893;GO:0001935;GO:0001946;GO:0001974;GO:0002063;GO:0003085;GO:0003148;GO:0003151;GO:0003176;GO:0003177;GO:0003181;GO:0003183;GO:0003186;GO:0003197;GO:0003252;GO:0006468;GO:0007178;GO:0009267;GO:0009952;GO:0010628;GO:0010634;GO:0014916;GO:0030166;GO:0030308;GO:0030501;GO:0030509;GO:0032924;GO:0042127;GO:0045669;GO:0045778;GO:0045906;GO:0045944;GO:0048286;GO:0048662;GO:0048738;GO:0048842;GO:0051148;GO:0060173;GO:0060350;GO:0060391;GO:0060412;GO:0060413;GO:0060426;GO:0060836;GO:0060840;GO:0060841;GO:0061036;GO:0061298;GO:0061626;GO:0071363;GO:0071773;GO:0072577;GO:1902731;GO:1905314	extracellular space;nucleoplasm;plasma membrane;caveola;clathrin-coated pit;adherens junction;basal plasma membrane;cell surface;postsynaptic density;apical plasma membrane;axon;dendrite;neuronal cell body;receptor complex	GO:0005615;GO:0005654;GO:0005886;GO:0005901;GO:0005905;GO:0005912;GO:0009925;GO:0009986;GO:0014069;GO:0016324;GO:0030424;GO:0030425;GO:0043025;GO:0043235	transforming growth factor beta receptor activity;protein binding;ATP binding;activin receptor activity, type II;growth factor binding;BMP binding;cadherin binding;metal ion binding;BMP receptor activity;protein tyrosine kinase binding	GO:0005024;GO:0005515;GO:0005524;GO:0016362;GO:0019838;GO:0036122;GO:0045296;GO:0046872;GO:0098821;GO:1990782	3.0	049349a0-5522-11e7-8f50-0ac135e8bacf,05263ad2-5522-11e7-8f50-0ac135e8bacf,f1ae1a1c-5521-11e7-8f50-0ac135e8bacf	ALK2 signaling events,ALK1 signaling events,BMP receptor signaling											
chr11:64572681:G/A	MEN1 intron_variant		6.0	0.0169252468265162			chr11	64572681	G	A	10			MEN1	ENST00000450708.6	intron_variant		c.1186-11C>T		64805209													COSV105128552	"[[""skin"", 1]]"	1.0	ENST00000377313.5	?	Exact Match							negative regulation of transcription by RNA polymerase II;MAPK cascade;negative regulation of protein phosphorylation;osteoblast development;DNA repair;regulation of transcription by RNA polymerase II;DNA damage response;negative regulation of cell population proliferation;response to UV;response to gamma radiation;positive regulation of transforming growth factor beta receptor signaling pathway;negative regulation of DNA-binding transcription factor activity;T-helper 2 cell differentiation;negative regulation of osteoblast differentiation;negative regulation of cyclin-dependent protein serine/threonine kinase activity;negative regulation of cell cycle;transcription initiation-coupled chromatin remodeling;negative regulation of DNA-templated transcription;positive regulation of transcription by RNA polymerase II;negative regulation of JNK cascade;negative regulation of telomerase activity	GO:0000122;GO:0000165;GO:0001933;GO:0002076;GO:0006281;GO:0006357;GO:0006974;GO:0008285;GO:0009411;GO:0010332;GO:0030511;GO:0043433;GO:0045064;GO:0045668;GO:0045736;GO:0045786;GO:0045815;GO:0045892;GO:0045944;GO:0046329;GO:0051974	chromosome, telomeric region;chromatin;nucleus;nucleoplasm;cytoplasm;endoplasmic reticulum lumen;cytosol;nuclear matrix;transcription repressor complex;cleavage furrow;protein-containing complex;histone methyltransferase complex;MLL1/2 complex;MLL1 complex	GO:0000781;GO:0000785;GO:0005634;GO:0005654;GO:0005737;GO:0005788;GO:0005829;GO:0016363;GO:0017053;GO:0032154;GO:0032991;GO:0035097;GO:0044665;GO:0071339	four-way junction DNA binding;Y-form DNA binding;transcription cis-regulatory region binding;chromatin binding;double-stranded DNA binding;protein binding;protein-macromolecule adaptor activity;phosphoprotein binding;R-SMAD binding	GO:0000400;GO:0000403;GO:0000976;GO:0003682;GO:0003690;GO:0005515;GO:0030674;GO:0051219;GO:0070412				rs772464417		6.97885e-06	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.000328515
chr2:48028282:A/G	MSH6 p.Ile1054Val		8.0	0.0156282998944033			chr2	48028282	A	G	10		Yes	MSH6	ENST00000234420.10	missense_variant	4.0	c.3160A>G	p.Ile1054Val	47801143							0.00859	0.414					COSV52286890	"[[""breast"", 2], [""lung"", 1]]"	3.0	ENST00000538136.1	I1054F	Genomic Location	Conflicting classifications of pathogenicity	MeSH:D003123,MedGen:C0009405|MONDO:MONDO:0005835,MedGen:C4552100,Orphanet:144|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Hereditary nonpolyposis colorectal neoplasms|Lynch syndrome|Hereditary cancer-predisposing syndrome	criteria provided, conflicting classifications	525847.0	Uncertain significance(3)|Likely benign(1)	meiotic mismatch repair;DNA repair;mismatch repair;spermatogenesis;determination of adult lifespan;intrinsic apoptotic signaling pathway in response to DNA damage;response to UV;somatic hypermutation of immunoglobulin genes;somatic recombination of immunoglobulin gene segments;maintenance of DNA repeat elements;isotype switching;negative regulation of DNA recombination;positive regulation of helicase activity;intrinsic apoptotic signaling pathway	GO:0000710;GO:0006281;GO:0006298;GO:0007283;GO:0008340;GO:0008630;GO:0009411;GO:0016446;GO:0016447;GO:0043570;GO:0045190;GO:0045910;GO:0051096;GO:0097193	chromatin;nucleus;nucleoplasm;Golgi apparatus;cytosol;MutSalpha complex;intracellular membrane-bounded organelle	GO:0000785;GO:0005634;GO:0005654;GO:0005794;GO:0005829;GO:0032301;GO:0043231	magnesium ion binding;four-way junction DNA binding;chromatin binding;double-stranded DNA binding;protein binding;ATP binding;ATP-dependent activity, acting on DNA;enzyme binding;mismatched DNA binding;guanine/thymine mispair binding;single guanine insertion binding;single thymine insertion binding;oxidized purine DNA binding;MutLalpha complex binding;methylated histone binding;protein homodimerization activity;ADP binding;ATP-dependent DNA damage sensor activity	GO:0000287;GO:0000400;GO:0003682;GO:0003690;GO:0005515;GO:0005524;GO:0008094;GO:0019899;GO:0030983;GO:0032137;GO:0032142;GO:0032143;GO:0032357;GO:0032405;GO:0035064;GO:0042803;GO:0043531;GO:0140664				rs267608075										
chr4:96036956:C/A	BMPR1B intron_variant		7.0	0.0041578679260989			chr4	96036956	C	A	10			BMPR1B	ENST00000515059.6	intron_variant		c.349+18C>A		95115805																									cartilage condensation;ovarian cumulus expansion;osteoblast differentiation;eye development;chondrocyte development;protein phosphorylation;inflammatory response;dorsal/ventral pattern formation;positive regulation of gene expression;central nervous system neuron differentiation;proteoglycan biosynthetic process;positive regulation of bone mineralization;BMP signaling pathway;retinal ganglion cell axon guidance;positive regulation of chondrocyte differentiation;ovulation cycle;positive regulation of osteoblast differentiation;positive regulation of transcription by RNA polymerase II;retina development in camera-type eye;endochondral bone morphogenesis;positive regulation of cartilage development;cellular response to growth factor stimulus;cellular response to BMP stimulus;positive regulation of extrinsic apoptotic signaling pathway via death domain receptors;negative regulation of chondrocyte proliferation	GO:0001502;GO:0001550;GO:0001649;GO:0001654;GO:0002063;GO:0006468;GO:0006954;GO:0009953;GO:0010628;GO:0021953;GO:0030166;GO:0030501;GO:0030509;GO:0031290;GO:0032332;GO:0042698;GO:0045669;GO:0045944;GO:0060041;GO:0060350;GO:0061036;GO:0071363;GO:0071773;GO:1902043;GO:1902731	plasma membrane;dendrite;neuronal cell body;receptor complex;HFE-transferrin receptor complex	GO:0005886;GO:0030425;GO:0043025;GO:0043235;GO:1990712	protein serine/threonine kinase activity;transmembrane receptor protein serine/threonine kinase activity;transmembrane signaling receptor activity;transforming growth factor beta receptor activity, type I;protein binding;ATP binding;BMP binding;SMAD binding;metal ion binding;BMP receptor activity	GO:0004674;GO:0004675;GO:0004888;GO:0005025;GO:0005515;GO:0005524;GO:0036122;GO:0046332;GO:0046872;GO:0098821	1.0	f1ae1a1c-5521-11e7-8f50-0ac135e8bacf	BMP receptor signaling											
chr16:133240:A/G	MPG p.Asn164Asp		6.0	0.0020998600093327			chr16	133240	A	G	10		Yes	MPG	ENST00000356432.7	missense_variant	3.0	c.490A>G	p.Asn164Asp	83241							0.328	0.241																	base-excision repair;DNA alkylation repair;depurination	GO:0006284;GO:0006307;GO:0045007	nucleoplasm;cytosol;mitochondrial nucleoid	GO:0005654;GO:0005829;GO:0042645	damaged DNA binding;alkylbase DNA N-glycosylase activity;protein binding;DNA-3-methyladenine glycosylase activity;DNA N-glycosylase activity;DNA-7-methylguanine glycosylase activity;DNA-7-methyladenine glycosylase activity;DNA-3-methylguanine glycosylase activity	GO:0003684;GO:0003905;GO:0005515;GO:0008725;GO:0019104;GO:0043916;GO:0052821;GO:0052822	1.0	3ab9dba6-5521-11e7-8f50-0ac135e8bacf	Validated nuclear estrogen receptor alpha network											
chr11:108192156:T/C	ATM intron_variant		8.0	0.0075585789871504			chr11	108192156	T	C	9			ATM	ENST00000278616.8	intron_variant		c.6572+9T>C		108321429																									DNA damage checkpoint signaling;pexophagy;telomere maintenance;double-strand break repair via homologous recombination;DNA double-strand break processing;ovarian follicle development;response to hypoxia;somitogenesis;pre-B cell allelic exclusion;double-strand break repair;double-strand break repair via nonhomologous end joining;chromatin remodeling;protein phosphorylation;DNA damage response;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;mitotic spindle assembly checkpoint signaling;mitotic G2 DNA damage checkpoint signaling;reciprocal meiotic recombination;male meiotic nuclear division;female meiotic nuclear division;signal transduction;brain development;heart development;determination of adult lifespan;intrinsic apoptotic signaling pathway in response to DNA damage;post-embryonic development;response to ionizing radiation;regulation of autophagy;positive regulation of gene expression;peptidyl-serine phosphorylation;positive regulation of cell migration;negative regulation of B cell proliferation;regulation of telomere maintenance via telomerase;positive regulation of telomere maintenance via telomerase;V(D)J recombination;cellular response to reactive oxygen species;multicellular organism growth;phosphatidylinositol-3-phosphate biosynthetic process;peptidyl-serine autophosphorylation;lipoprotein catabolic process;signal transduction in response to DNA damage;regulation of apoptotic process;positive regulation of apoptotic process;positive regulation of DNA damage response, signal transduction by p53 class mediator;positive regulation of neuron apoptotic process;meiotic telomere clustering;positive regulation of cell adhesion;positive regulation of transcription by RNA polymerase II;protein autophosphorylation;thymus development;oocyte development;neuron apoptotic process;regulation of cell cycle;regulation of telomerase activity;histone mRNA catabolic process;cellular response to retinoic acid;cellular response to gamma radiation;cellular response to X-ray;cellular response to nitrosative stress;cellular senescence;replicative senescence;establishment of RNA localization to telomere;establishment of protein-containing complex localization to telomere;regulation of cellular response to heat;regulation of signal transduction by p53 class mediator;positive regulation of DNA catabolic process;regulation of microglial cell activation;negative regulation of TORC1 signaling;negative regulation of telomere capping;positive regulation of telomere maintenance via telomere lengthening;positive regulation of telomerase catalytic core complex assembly;regulation of autophagosome assembly	GO:0000077;GO:0000425;GO:0000723;GO:0000724;GO:0000729;GO:0001541;GO:0001666;GO:0001756;GO:0002331;GO:0006302;GO:0006303;GO:0006338;GO:0006468;GO:0006974;GO:0006977;GO:0007094;GO:0007095;GO:0007131;GO:0007140;GO:0007143;GO:0007165;GO:0007420;GO:0007507;GO:0008340;GO:0008630;GO:0009791;GO:0010212;GO:0010506;GO:0010628;GO:0018105;GO:0030335;GO:0030889;GO:0032210;GO:0032212;GO:0033151;GO:0034614;GO:0035264;GO:0036092;GO:0036289;GO:0042159;GO:0042770;GO:0042981;GO:0043065;GO:0043517;GO:0043525;GO:0045141;GO:0045785;GO:0045944;GO:0046777;GO:0048538;GO:0048599;GO:0051402;GO:0051726;GO:0051972;GO:0071044;GO:0071300;GO:0071480;GO:0071481;GO:0071500;GO:0090398;GO:0090399;GO:0097694;GO:0097695;GO:1900034;GO:1901796;GO:1903626;GO:1903978;GO:1904262;GO:1904354;GO:1904358;GO:1904884;GO:2000785	chromosome, telomeric region;nucleus;nucleoplasm;nucleolus;cytoplasm;peroxisomal matrix;centrosome;spindle;cytosol;cytoplasmic vesicle;site of double-strand break;intracellular membrane-bounded organelle;DNA repair complex	GO:0000781;GO:0005634;GO:0005654;GO:0005730;GO:0005737;GO:0005782;GO:0005813;GO:0005819;GO:0005829;GO:0031410;GO:0035861;GO:0043231;GO:1990391	DNA binding;protein serine/threonine kinase activity;DNA-dependent protein kinase activity;protein binding;ATP binding;1-phosphatidylinositol-3-kinase activity;histone H2AXS139 kinase activity;identical protein binding;protein-containing complex binding;protein serine kinase activity	GO:0003677;GO:0004674;GO:0004677;GO:0005515;GO:0005524;GO:0016303;GO:0035979;GO:0042802;GO:0044877;GO:0106310	10.0	34a994cc-5521-11e7-8f50-0ac135e8bacf,603902ca-5521-11e7-8f50-0ac135e8bacf,76f15b4e-5521-11e7-8f50-0ac135e8bacf,81be3ee4-5521-11e7-8f50-0ac135e8bacf,82e49678-5521-11e7-8f50-0ac135e8bacf,c45e106a-5521-11e7-8f50-0ac135e8bacf,d6e9881a-5521-11e7-8f50-0ac135e8bacf,ed3cb632-5521-11e7-8f50-0ac135e8bacf,f6898a78-5521-11e7-8f50-0ac135e8bacf,f9c7eca4-5521-11e7-8f50-0ac135e8bacf	Validated transcriptional targets of deltaNp63 isoforms,Regulation of Telomerase,PLK3 signaling events,p53 pathway,p38 MAPK signaling pathway,Fanconi anemia pathway,E2F transcription factor network,Canonical NF-kappaB pathway,BARD1 signaling events,ATM pathway											
chr17:56438277:G/A	RNF43 p.Ala239Val		8.0	0.0317512274959083			chr17	56438277	G	A	9		Yes	RNF43	ENST00000407977.6	missense_variant	7.0	c.716C>T	p.Ala239Val	58360916							0.00709	0.0249																	ubiquitin-dependent protein catabolic process;Wnt signaling pathway;protein ubiquitination;negative regulation of Wnt signaling pathway;Wnt receptor catabolic process;stem cell proliferation	GO:0006511;GO:0016055;GO:0016567;GO:0030178;GO:0038018;GO:0072089	nuclear envelope;endoplasmic reticulum membrane;plasma membrane	GO:0005635;GO:0005789;GO:0005886	ubiquitin-protein transferase activity;frizzled binding;protein binding;metal ion binding;ubiquitin protein ligase activity	GO:0004842;GO:0005109;GO:0005515;GO:0046872;GO:0061630	1.0	812903c2-5521-11e7-8f50-0ac135e8bacf	p73 transcription factor network	rs1449453586		6.97681e-06	2.37801e-05	0.0	0.0	0.0	0.0	0.0	0.0	0.0
chr12:49424235:G/T	KMT2D intron_variant						chr12	49424235	G	T	9			KMT2D	ENST00000301067.11	intron_variant		c.13840-13C>A		49030452																									oocyte growth;regulation of DNA-templated transcription;positive regulation of cell population proliferation;heterochromatin formation;methylation;positive regulation of intracellular estrogen receptor signaling pathway;response to estrogen;positive regulation of transcription by RNA polymerase II;oogenesis;beta-catenin-TCF complex assembly	GO:0001555;GO:0006355;GO:0008284;GO:0031507;GO:0032259;GO:0033148;GO:0043627;GO:0045944;GO:0048477;GO:1904837	nucleus;nucleoplasm;MLL3/4 complex	GO:0005634;GO:0005654;GO:0044666	transcription cis-regulatory region binding;DNA binding;transcription coactivator activity;protein binding;histone H3K4 methyltransferase activity;metal ion binding;histone H3K4 monomethyltransferase activity;histone H3K4 trimethyltransferase activity	GO:0000976;GO:0003677;GO:0003713;GO:0005515;GO:0042800;GO:0046872;GO:0140945;GO:0140999														
chr4:96036803:A/G	BMPR1B intron_variant		8.0	0.0170321978534764			chr4	96036803	A	G	9			BMPR1B	ENST00000515059.6	intron_variant		c.247-33A>G		95115652																									cartilage condensation;ovarian cumulus expansion;osteoblast differentiation;eye development;chondrocyte development;protein phosphorylation;inflammatory response;dorsal/ventral pattern formation;positive regulation of gene expression;central nervous system neuron differentiation;proteoglycan biosynthetic process;positive regulation of bone mineralization;BMP signaling pathway;retinal ganglion cell axon guidance;positive regulation of chondrocyte differentiation;ovulation cycle;positive regulation of osteoblast differentiation;positive regulation of transcription by RNA polymerase II;retina development in camera-type eye;endochondral bone morphogenesis;positive regulation of cartilage development;cellular response to growth factor stimulus;cellular response to BMP stimulus;positive regulation of extrinsic apoptotic signaling pathway via death domain receptors;negative regulation of chondrocyte proliferation	GO:0001502;GO:0001550;GO:0001649;GO:0001654;GO:0002063;GO:0006468;GO:0006954;GO:0009953;GO:0010628;GO:0021953;GO:0030166;GO:0030501;GO:0030509;GO:0031290;GO:0032332;GO:0042698;GO:0045669;GO:0045944;GO:0060041;GO:0060350;GO:0061036;GO:0071363;GO:0071773;GO:1902043;GO:1902731	plasma membrane;dendrite;neuronal cell body;receptor complex;HFE-transferrin receptor complex	GO:0005886;GO:0030425;GO:0043025;GO:0043235;GO:1990712	protein serine/threonine kinase activity;transmembrane receptor protein serine/threonine kinase activity;transmembrane signaling receptor activity;transforming growth factor beta receptor activity, type I;protein binding;ATP binding;BMP binding;SMAD binding;metal ion binding;BMP receptor activity	GO:0004674;GO:0004675;GO:0004888;GO:0005025;GO:0005515;GO:0005524;GO:0036122;GO:0046332;GO:0046872;GO:0098821	1.0	f1ae1a1c-5521-11e7-8f50-0ac135e8bacf	BMP receptor signaling											
chr9:101900369:A/G	TGFBR1 p.Lys268Arg		8.0	0.0112834978843441			chr9	101900369	A	G	9		Yes	TGFBR1	ENST00000374994.9	missense_variant	4.0	c.803A>G	p.Lys268Arg	99138087							0.00543	0.0416																	skeletal system development;in utero embryonic development;kidney development;blastocyst development;epithelial to mesenchymal transition;endothelial cell proliferation;negative regulation of endothelial cell proliferation;positive regulation of endothelial cell proliferation;lens development in camera-type eye;ventricular trabecula myocardium morphogenesis;ventricular compact myocardium morphogenesis;proepicardium development;regulation of DNA-templated transcription;protein phosphorylation;apoptotic process;signal transduction;transforming growth factor beta receptor signaling pathway;nervous system development;heart development;positive regulation of cell population proliferation;germ cell migration;male gonad development;post-embryonic development;anterior/posterior pattern specification;positive regulation of gene expression;regulation of epithelial to mesenchymal transition;positive regulation of epithelial to mesenchymal transition;peptidyl-serine phosphorylation;collagen fibril organization;positive regulation of cell growth;positive regulation of cell migration;negative regulation of cell migration;regulation of protein ubiquitination;negative regulation of chondrocyte differentiation;activin receptor signaling pathway;intracellular signal transduction;myofibroblast differentiation;wound healing;endothelial cell activation;extracellular structure organization;endothelial cell migration;positive regulation of DNA-templated transcription;filopodium assembly;thymus development;neuron fate commitment;embryonic cranial skeleton morphogenesis;skeletal system morphogenesis;mesenchymal cell differentiation;artery morphogenesis;cell motility;positive regulation of filopodium assembly;positive regulation of stress fiber assembly;regulation of cell cycle;positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction;parathyroid gland development;roof of mouth development;pharyngeal system development;regulation of cardiac muscle cell proliferation;cardiac epithelial to mesenchymal transition;positive regulation of SMAD protein signal transduction;ventricular septum morphogenesis;angiogenesis involved in coronary vascular morphogenesis;coronary artery morphogenesis;response to cholesterol;cellular response to growth factor stimulus;cellular response to transforming growth factor beta stimulus;positive regulation of extracellular matrix assembly;positive regulation of mesenchymal stem cell proliferation;positive regulation of vasculature development;positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation;positive regulation of tight junction disassembly;epicardium morphogenesis;positive regulation of apoptotic signaling pathway;negative regulation of extrinsic apoptotic signaling pathway	GO:0001501;GO:0001701;GO:0001822;GO:0001824;GO:0001837;GO:0001935;GO:0001937;GO:0001938;GO:0002088;GO:0003222;GO:0003223;GO:0003342;GO:0006355;GO:0006468;GO:0006915;GO:0007165;GO:0007179;GO:0007399;GO:0007507;GO:0008284;GO:0008354;GO:0008584;GO:0009791;GO:0009952;GO:0010628;GO:0010717;GO:0010718;GO:0018105;GO:0030199;GO:0030307;GO:0030335;GO:0030336;GO:0031396;GO:0032331;GO:0032924;GO:0035556;GO:0036446;GO:0042060;GO:0042118;GO:0043062;GO:0043542;GO:0045893;GO:0046847;GO:0048538;GO:0048663;GO:0048701;GO:0048705;GO:0048762;GO:0048844;GO:0048870;GO:0051491;GO:0051496;GO:0051726;GO:0051897;GO:0060017;GO:0060021;GO:0060037;GO:0060043;GO:0060317;GO:0060391;GO:0060412;GO:0060978;GO:0060982;GO:0070723;GO:0071363;GO:0071560;GO:1901203;GO:1902462;GO:1904018;GO:1905007;GO:1905075;GO:1905223;GO:2001235;GO:2001237	nucleus;endosome;plasma membrane;bicellular tight junction;cell surface;receptor complex;membrane raft;activin receptor complex;transforming growth factor beta ligand-receptor complex	GO:0005634;GO:0005768;GO:0005886;GO:0005923;GO:0009986;GO:0043235;GO:0045121;GO:0048179;GO:0070021	protein kinase activity;protein serine/threonine kinase activity;transmembrane receptor protein serine/threonine kinase activity;transforming growth factor beta receptor activity;transforming growth factor beta receptor activity, type I;type II transforming growth factor beta receptor binding;protein binding;ATP binding;activin receptor activity, type I;growth factor binding;ubiquitin protein ligase binding;SMAD binding;metal ion binding;activin binding;transforming growth factor beta binding;I-SMAD binding	GO:0004672;GO:0004674;GO:0004675;GO:0005024;GO:0005025;GO:0005114;GO:0005515;GO:0005524;GO:0016361;GO:0019838;GO:0031625;GO:0046332;GO:0046872;GO:0048185;GO:0050431;GO:0070411	4.0	05263ad2-5522-11e7-8f50-0ac135e8bacf,408a0c44-5521-11e7-8f50-0ac135e8bacf,ba907368-5521-11e7-8f50-0ac135e8bacf,f23376be-5521-11e7-8f50-0ac135e8bacf	ALK1 signaling events,TGF-beta receptor signaling,Glypican 1 network,Beta5 beta6 beta7 and beta8 integrin cell surface interactions											
chr17:15989703:GC/G	NCOR1 p.Leu1024PhefsTer29		5.0	0.0033180462889919			chr17	15989703	GC	G	8		Yes	NCOR1	ENST00000268712.8	frameshift_truncation	23.0	c.3069del	p.Leu1024PhefsTer29	16086390																									negative regulation of transcription by RNA polymerase II;chromatin organization;locomotor rhythm;negative regulation of glycolytic process;negative regulation of DNA-templated transcription;negative regulation of fatty acid metabolic process;negative regulation of JNK cascade;spindle assembly;negative regulation of androgen receptor signaling pathway;negative regulation of miRNA transcription	GO:0000122;GO:0006325;GO:0045475;GO:0045820;GO:0045892;GO:0045922;GO:0046329;GO:0051225;GO:0060766;GO:1902894	histone deacetylase complex;chromatin;nucleus;nucleoplasm;cytosol;membrane;transcription repressor complex;mitotic spindle	GO:0000118;GO:0000785;GO:0005634;GO:0005654;GO:0005829;GO:0016020;GO:0017053;GO:0072686	transcription cis-regulatory region binding;transcription corepressor activity;protein binding;nuclear receptor binding;histone deacetylase binding;nuclear thyroid hormone receptor binding;RNA polymerase II-specific DNA-binding transcription factor binding	GO:0000976;GO:0003714;GO:0005515;GO:0016922;GO:0042826;GO:0046966;GO:0061629	7.0	3ab9dba6-5521-11e7-8f50-0ac135e8bacf,54bc0812-5521-11e7-8f50-0ac135e8bacf,68975856-5521-11e7-8f50-0ac135e8bacf,841dd9cc-5521-11e7-8f50-0ac135e8bacf,84be116e-5521-11e7-8f50-0ac135e8bacf,c4ed581c-5521-11e7-8f50-0ac135e8bacf,ef96f9ea-5521-11e7-8f50-0ac135e8bacf	Validated nuclear estrogen receptor alpha network,Signaling events mediated by HDAC Class I,Regulation of nuclear SMAD23 signaling,Notch-mediated HESHEY network,Notch signaling pathway,ErbB4 signaling events,C-MYB transcription factor network											
chr1:27106926:C/T	ARID1A p.Ser2179=		6.0	0.0042553191489361			chr1	27106926	C	T	8		Yes	ARID1A	ENST00000324856.13	synonymous_variant	20.0	c.6537C>T	p.Ser2179=	26780435																									nucleosome disassembly;chromatin remodeling;regulation of transcription by RNA polymerase II;nervous system development;regulation of mitotic metaphase/anaphase transition;intracellular estrogen receptor signaling pathway;androgen receptor signaling pathway;intracellular glucocorticoid receptor signaling pathway;positive regulation of T cell differentiation;positive regulation of cell differentiation;positive regulation of myoblast differentiation;transcription initiation-coupled chromatin remodeling;positive regulation of DNA-templated transcription;regulation of G0 to G1 transition;positive regulation of stem cell population maintenance;regulation of G1/S transition of mitotic cell cycle;positive regulation of double-strand break repair;regulation of nucleotide-excision repair	GO:0006337;GO:0006338;GO:0006357;GO:0007399;GO:0030071;GO:0030520;GO:0030521;GO:0042921;GO:0045582;GO:0045597;GO:0045663;GO:0045815;GO:0045893;GO:0070316;GO:1902459;GO:2000045;GO:2000781;GO:2000819	chromatin;nucleus;nucleoplasm;SWI/SNF complex;brahma complex;npBAF complex;nBAF complex;bBAF complex	GO:0000785;GO:0005634;GO:0005654;GO:0016514;GO:0035060;GO:0071564;GO:0071565;GO:0140092	DNA binding;transcription coactivator activity;protein binding;nuclear receptor binding;nucleosome binding	GO:0003677;GO:0003713;GO:0005515;GO:0016922;GO:0031491														
chr18:46476196:C/T	SMAD7 p.Arg200Gln		1.0	0.5034013605442177			chr18	46476196	C	T	8		Yes	SMAD7	ENST00000262158.7	missense_variant	1.0	c.599G>A	p.Arg200Gln	48949826							0.0937	0.299																	negative regulation of transcription by RNA polymerase II;ureteric bud development;negative regulation of T cell cytokine production;regulation of transcription by RNA polymerase II;transforming growth factor beta receptor signaling pathway;anatomical structure morphogenesis;regulation of epithelial to mesenchymal transition;negative regulation of epithelial to mesenchymal transition;negative regulation of peptidyl-threonine phosphorylation;negative regulation of transcription by competitive promoter binding;positive regulation of cell-cell adhesion;cell differentiation;negative regulation of ossification;negative regulation of cell migration;negative regulation of transforming growth factor beta receptor signaling pathway;negative regulation of BMP signaling pathway;negative regulation of protein ubiquitination;protein-containing complex localization;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;negative regulation of activin receptor signaling pathway;negative regulation of peptidyl-serine phosphorylation;adherens junction assembly;response to laminar fluid shear stress;artery morphogenesis;protein stabilization;negative regulation of ubiquitin-protein transferase activity;ventricular cardiac muscle tissue morphogenesis;regulation of cardiac muscle contraction;regulation of ventricular cardiac muscle cell membrane depolarization;negative regulation of SMAD protein signal transduction;SMAD protein signal transduction;ventricular septum morphogenesis;cellular response to transforming growth factor beta stimulus;negative regulation of chondrocyte proliferation;positive regulation of chondrocyte hypertrophy;cellular response to leukemia inhibitory factor;negative regulation of T-helper 17 type immune response;negative regulation of T-helper 17 cell differentiation	GO:0000122;GO:0001657;GO:0002725;GO:0006357;GO:0007179;GO:0009653;GO:0010717;GO:0010719;GO:0010801;GO:0010944;GO:0022409;GO:0030154;GO:0030279;GO:0030336;GO:0030512;GO:0030514;GO:0031397;GO:0031503;GO:0032436;GO:0032926;GO:0033137;GO:0034333;GO:0034616;GO:0048844;GO:0050821;GO:0051444;GO:0055010;GO:0055117;GO:0060373;GO:0060392;GO:0060395;GO:0060412;GO:0071560;GO:1902731;GO:1903043;GO:1990830;GO:2000317;GO:2000320	chromatin;fibrillar center;nucleus;nucleoplasm;cytoplasm;centrosome;cytosol;plasma membrane;adherens junction;protein-containing complex;heteromeric SMAD protein complex	GO:0000785;GO:0001650;GO:0005634;GO:0005654;GO:0005737;GO:0005813;GO:0005829;GO:0005886;GO:0005912;GO:0032991;GO:0071144	transcription corepressor activity;protein binding;collagen binding;beta-catenin binding;ubiquitin protein ligase binding;type I transforming growth factor beta receptor binding;metal ion binding;I-SMAD binding;activin receptor binding;transcription regulator inhibitor activity;ubiquitin-like ligase-substrate adaptor activity	GO:0003714;GO:0005515;GO:0005518;GO:0008013;GO:0031625;GO:0034713;GO:0046872;GO:0070411;GO:0070697;GO:0140416;GO:1990756	6.0	05263ad2-5522-11e7-8f50-0ac135e8bacf,408a0c44-5521-11e7-8f50-0ac135e8bacf,54bc0812-5521-11e7-8f50-0ac135e8bacf,68975856-5521-11e7-8f50-0ac135e8bacf,afa50a56-5521-11e7-8f50-0ac135e8bacf,f1ae1a1c-5521-11e7-8f50-0ac135e8bacf	ALK1 signaling events,TGF-beta receptor signaling,Signaling events mediated by HDAC Class I,Regulation of nuclear SMAD23 signaling,IFN-gamma pathway,BMP receptor signaling	rs779292276										
chr14:23393384:T/G	PRMT5 p.Asn403Thr		8.0	0.0252035672741372			chr14	23393384	T	G	8		Yes	PRMT5	ENST00000324366.13	missense_variant	12.0	c.1208A>C	p.Asn403Thr	22924175							0.2	0.189																	spliceosomal snRNP assembly;chromatin remodeling;DNA-templated transcription termination;regulation of DNA-templated transcription;regulation of mitotic nuclear division;peptidyl-arginine methylation;circadian regulation of gene expression;peptidyl-arginine N-methylation;endothelial cell activation;negative regulation of gene expression via chromosomal CpG island methylation;negative regulation of cell differentiation;negative regulation of DNA-templated transcription;positive regulation of mRNA splicing, via spliceosome;positive regulation of oligodendrocyte differentiation;regulation of ERK1 and ERK2 cascade;Golgi ribbon formation;liver regeneration;regulation of signal transduction by p53 class mediator;positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway	GO:0000387;GO:0006338;GO:0006353;GO:0006355;GO:0007088;GO:0018216;GO:0032922;GO:0035246;GO:0042118;GO:0044027;GO:0045596;GO:0045892;GO:0048026;GO:0048714;GO:0070372;GO:0090161;GO:0097421;GO:1901796;GO:1904992	chromatin;nucleus;nucleoplasm;cytoplasm;Golgi apparatus;cytosol;methylosome;histone methyltransferase complex	GO:0000785;GO:0005634;GO:0005654;GO:0005737;GO:0005794;GO:0005829;GO:0034709;GO:0035097	p53 binding;transcription corepressor activity;protein binding;methyltransferase activity;methyl-CpG binding;histone arginine N-methyltransferase activity;protein-arginine N-methyltransferase activity;protein-arginine omega-N symmetric methyltransferase activity;histone methyltransferase activity;identical protein binding;ribonucleoprotein complex binding;histone H4R3 methyltransferase activity;protein heterodimerization activity;E-box binding;histone H3 methyltransferase activity	GO:0002039;GO:0003714;GO:0005515;GO:0008168;GO:0008327;GO:0008469;GO:0016274;GO:0035243;GO:0042054;GO:0042802;GO:0043021;GO:0044020;GO:0046982;GO:0070888;GO:0140938	3.0	54bc0812-5521-11e7-8f50-0ac135e8bacf,81be3ee4-5521-11e7-8f50-0ac135e8bacf,d6e9881a-5521-11e7-8f50-0ac135e8bacf	Signaling events mediated by HDAC Class I,p53 pathway,E2F transcription factor network											
chr11:108206690:T/G	ATM splice_site_variant		8.0	0.0108019639934533			chr11	108206690	T	G	8			ATM	ENST00000278616.8	splice_site_variant	57.0	c.8268+2T>G		108335963																									DNA damage checkpoint signaling;pexophagy;telomere maintenance;double-strand break repair via homologous recombination;DNA double-strand break processing;ovarian follicle development;response to hypoxia;somitogenesis;pre-B cell allelic exclusion;double-strand break repair;double-strand break repair via nonhomologous end joining;chromatin remodeling;protein phosphorylation;DNA damage response;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;mitotic spindle assembly checkpoint signaling;mitotic G2 DNA damage checkpoint signaling;reciprocal meiotic recombination;male meiotic nuclear division;female meiotic nuclear division;signal transduction;brain development;heart development;determination of adult lifespan;intrinsic apoptotic signaling pathway in response to DNA damage;post-embryonic development;response to ionizing radiation;regulation of autophagy;positive regulation of gene expression;peptidyl-serine phosphorylation;positive regulation of cell migration;negative regulation of B cell proliferation;regulation of telomere maintenance via telomerase;positive regulation of telomere maintenance via telomerase;V(D)J recombination;cellular response to reactive oxygen species;multicellular organism growth;phosphatidylinositol-3-phosphate biosynthetic process;peptidyl-serine autophosphorylation;lipoprotein catabolic process;signal transduction in response to DNA damage;regulation of apoptotic process;positive regulation of apoptotic process;positive regulation of DNA damage response, signal transduction by p53 class mediator;positive regulation of neuron apoptotic process;meiotic telomere clustering;positive regulation of cell adhesion;positive regulation of transcription by RNA polymerase II;protein autophosphorylation;thymus development;oocyte development;neuron apoptotic process;regulation of cell cycle;regulation of telomerase activity;histone mRNA catabolic process;cellular response to retinoic acid;cellular response to gamma radiation;cellular response to X-ray;cellular response to nitrosative stress;cellular senescence;replicative senescence;establishment of RNA localization to telomere;establishment of protein-containing complex localization to telomere;regulation of cellular response to heat;regulation of signal transduction by p53 class mediator;positive regulation of DNA catabolic process;regulation of microglial cell activation;negative regulation of TORC1 signaling;negative regulation of telomere capping;positive regulation of telomere maintenance via telomere lengthening;positive regulation of telomerase catalytic core complex assembly;regulation of autophagosome assembly	GO:0000077;GO:0000425;GO:0000723;GO:0000724;GO:0000729;GO:0001541;GO:0001666;GO:0001756;GO:0002331;GO:0006302;GO:0006303;GO:0006338;GO:0006468;GO:0006974;GO:0006977;GO:0007094;GO:0007095;GO:0007131;GO:0007140;GO:0007143;GO:0007165;GO:0007420;GO:0007507;GO:0008340;GO:0008630;GO:0009791;GO:0010212;GO:0010506;GO:0010628;GO:0018105;GO:0030335;GO:0030889;GO:0032210;GO:0032212;GO:0033151;GO:0034614;GO:0035264;GO:0036092;GO:0036289;GO:0042159;GO:0042770;GO:0042981;GO:0043065;GO:0043517;GO:0043525;GO:0045141;GO:0045785;GO:0045944;GO:0046777;GO:0048538;GO:0048599;GO:0051402;GO:0051726;GO:0051972;GO:0071044;GO:0071300;GO:0071480;GO:0071481;GO:0071500;GO:0090398;GO:0090399;GO:0097694;GO:0097695;GO:1900034;GO:1901796;GO:1903626;GO:1903978;GO:1904262;GO:1904354;GO:1904358;GO:1904884;GO:2000785	chromosome, telomeric region;nucleus;nucleoplasm;nucleolus;cytoplasm;peroxisomal matrix;centrosome;spindle;cytosol;cytoplasmic vesicle;site of double-strand break;intracellular membrane-bounded organelle;DNA repair complex	GO:0000781;GO:0005634;GO:0005654;GO:0005730;GO:0005737;GO:0005782;GO:0005813;GO:0005819;GO:0005829;GO:0031410;GO:0035861;GO:0043231;GO:1990391	DNA binding;protein serine/threonine kinase activity;DNA-dependent protein kinase activity;protein binding;ATP binding;1-phosphatidylinositol-3-kinase activity;histone H2AXS139 kinase activity;identical protein binding;protein-containing complex binding;protein serine kinase activity	GO:0003677;GO:0004674;GO:0004677;GO:0005515;GO:0005524;GO:0016303;GO:0035979;GO:0042802;GO:0044877;GO:0106310	10.0	34a994cc-5521-11e7-8f50-0ac135e8bacf,603902ca-5521-11e7-8f50-0ac135e8bacf,76f15b4e-5521-11e7-8f50-0ac135e8bacf,81be3ee4-5521-11e7-8f50-0ac135e8bacf,82e49678-5521-11e7-8f50-0ac135e8bacf,c45e106a-5521-11e7-8f50-0ac135e8bacf,d6e9881a-5521-11e7-8f50-0ac135e8bacf,ed3cb632-5521-11e7-8f50-0ac135e8bacf,f6898a78-5521-11e7-8f50-0ac135e8bacf,f9c7eca4-5521-11e7-8f50-0ac135e8bacf	Validated transcriptional targets of deltaNp63 isoforms,Regulation of Telomerase,PLK3 signaling events,p53 pathway,p38 MAPK signaling pathway,Fanconi anemia pathway,E2F transcription factor network,Canonical NF-kappaB pathway,BARD1 signaling events,ATM pathway											
chr12:52385777:G/A	ACVR1B p.Glu464=		8.0	0.0058919803600654			chr12	52385777	G	A	8		Yes	ACVR1B	ENST00000257963.9	synonymous_variant	8.0	c.1392G>A	p.Glu464=	51991993																									G1/S transition of mitotic cell cycle;in utero embryonic development;hair follicle development;regulation of DNA-templated transcription;protein phosphorylation;signal transduction;cell surface receptor protein serine/threonine kinase signaling pathway;nervous system development;positive regulation of gene expression;negative regulation of gene expression;peptidyl-threonine phosphorylation;negative regulation of cell growth;activin receptor signaling pathway;positive regulation of activin receptor signaling pathway;nodal signaling pathway;positive regulation of erythrocyte differentiation;protein autophosphorylation;cellular response to growth factor stimulus;extrinsic apoptotic signaling pathway;positive regulation of trophoblast cell migration	GO:0000082;GO:0001701;GO:0001942;GO:0006355;GO:0006468;GO:0007165;GO:0007178;GO:0007399;GO:0010628;GO:0010629;GO:0018107;GO:0030308;GO:0032924;GO:0032927;GO:0038092;GO:0045648;GO:0046777;GO:0071363;GO:0097191;GO:1901165	cytosol;plasma membrane;cell surface;receptor complex;activin receptor complex	GO:0005829;GO:0005886;GO:0009986;GO:0043235;GO:0048179	protein serine/threonine kinase activity;transmembrane receptor protein serine/threonine kinase activity;protein binding;ATP binding;activin receptor activity, type I;activin receptor activity;growth factor binding;ubiquitin protein ligase binding;inhibin binding;SMAD binding;metal ion binding;activin binding;I-SMAD binding	GO:0004674;GO:0004675;GO:0005515;GO:0005524;GO:0016361;GO:0017002;GO:0019838;GO:0031625;GO:0034711;GO:0046332;GO:0046872;GO:0048185;GO:0070411														
chr1:11308104:G/A	MTOR p.His296=		8.0	0.0197461212976022			chr1	11308104	G	A	8		Yes	MTOR	ENST00000361445.9	synonymous_variant	7.0	c.888C>T	p.His296=	11248047																			Likely benign	MedGen:C3661900	not provided	criteria provided, single submitter	772960.0		regulation of cell growth;T-helper 1 cell lineage commitment;heart morphogenesis;heart valve morphogenesis;energy reserve metabolic process;'de novo' pyrimidine nucleobase biosynthetic process;protein phosphorylation;inflammatory response;DNA damage response;cytoskeleton organization;lysosome organization;germ cell development;response to nutrient;regulation of cell size;cellular response to starvation;response to heat;post-embryonic development;negative regulation of autophagy;positive regulation of lamellipodium assembly;positive regulation of gene expression;positive regulation of epithelial to mesenchymal transition;positive regulation of myotube differentiation;macroautophagy;regulation of macroautophagy;negative regulation of macroautophagy;phosphorylation;peptidyl-serine phosphorylation;neuronal action potential;protein catabolic process;positive regulation of cell growth;positive regulation of actin filament polymerization;T cell costimulation;ruffle organization;regulation of myelination;protein destabilization;response to nutrient levels;cellular response to nutrient levels;cellular response to nutrient;TOR signaling;positive regulation of phosphoprotein phosphatase activity;cellular response to insulin stimulus;regulation of actin cytoskeleton organization;calcineurin-NFAT signaling cascade;cellular response to amino acid starvation;multicellular organism growth;TORC1 signaling;regulation of circadian rhythm;negative regulation of apoptotic process;response to amino acid;anoikis;regulation of osteoclast differentiation;positive regulation of translation;negative regulation of cell size;positive regulation of glycolytic process;positive regulation of transcription by RNA polymerase III;positive regulation of translational initiation;protein autophosphorylation;positive regulation of lipid biosynthetic process;behavioral response to pain;rhythmic process;oligodendrocyte differentiation;positive regulation of oligodendrocyte differentiation;positive regulation of peptidyl-tyrosine phosphorylation;voluntary musculoskeletal movement;positive regulation of stress fiber assembly;positive regulation of keratinocyte migration;nucleus localization;positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction;cardiac muscle cell development;cardiac muscle contraction;cellular response to methionine;negative regulation of calcineurin-NFAT signaling cascade;cellular response to amino acid stimulus;cellular response to L-leucine;cellular response to hypoxia;cellular response to osmotic stress;regulation of membrane permeability;regulation of cellular response to heat;negative regulation of protein localization to nucleus;regulation of signal transduction by p53 class mediator;positive regulation of transcription of nucleolar large rRNA by RNA polymerase I;positive regulation of wound healing, spreading of epidermal cells;regulation of locomotor rhythm;positive regulation of cytoplasmic translational initiation;negative regulation of lysosome organization;positive regulation of pentose-phosphate shunt;cellular response to leucine starvation;regulation of autophagosome assembly	GO:0001558;GO:0002296;GO:0003007;GO:0003179;GO:0006112;GO:0006207;GO:0006468;GO:0006954;GO:0006974;GO:0007010;GO:0007040;GO:0007281;GO:0007584;GO:0008361;GO:0009267;GO:0009408;GO:0009791;GO:0010507;GO:0010592;GO:0010628;GO:0010718;GO:0010831;GO:0016236;GO:0016241;GO:0016242;GO:0016310;GO:0018105;GO:0019228;GO:0030163;GO:0030307;GO:0030838;GO:0031295;GO:0031529;GO:0031641;GO:0031648;GO:0031667;GO:0031669;GO:0031670;GO:0031929;GO:0032516;GO:0032869;GO:0032956;GO:0033173;GO:0034198;GO:0035264;GO:0038202;GO:0042752;GO:0043066;GO:0043200;GO:0043276;GO:0045670;GO:0045727;GO:0045792;GO:0045821;GO:0045945;GO:0045948;GO:0046777;GO:0046889;GO:0048266;GO:0048511;GO:0048709;GO:0048714;GO:0050731;GO:0050882;GO:0051496;GO:0051549;GO:0051647;GO:0051897;GO:0055013;GO:0060048;GO:0061431;GO:0070885;GO:0071230;GO:0071233;GO:0071456;GO:0071470;GO:0090559;GO:1900034;GO:1900181;GO:1901796;GO:1901838;GO:1903691;GO:1904059;GO:1904690;GO:1905672;GO:1905857;GO:1990253;GO:2000785	Golgi membrane;nucleus;nuclear envelope;nucleoplasm;cytoplasm;mitochondrial outer membrane;lysosome;lysosomal membrane;endoplasmic reticulum membrane;cytosol;endomembrane system;membrane;PML body;dendrite;TORC1 complex;TORC2 complex;phagocytic vesicle	GO:0000139;GO:0005634;GO:0005635;GO:0005654;GO:0005737;GO:0005741;GO:0005764;GO:0005765;GO:0005789;GO:0005829;GO:0012505;GO:0016020;GO:0016605;GO:0030425;GO:0031931;GO:0031932;GO:0045335	RNA polymerase III type 1 promoter sequence-specific DNA binding;RNA polymerase III type 2 promoter sequence-specific DNA binding;RNA polymerase III type 3 promoter sequence-specific DNA binding;TFIIIC-class transcription factor complex binding;protein kinase activity;protein serine/threonine kinase activity;protein binding;ATP binding;kinase activity;identical protein binding;ribosome binding;phosphoprotein binding;protein serine kinase activity	GO:0001002;GO:0001003;GO:0001006;GO:0001156;GO:0004672;GO:0004674;GO:0005515;GO:0005524;GO:0016301;GO:0042802;GO:0043022;GO:0051219;GO:0106310	15.0	5189b3dc-5521-11e7-8f50-0ac135e8bacf,603902ca-5521-11e7-8f50-0ac135e8bacf,8f640d10-5521-11e7-8f50-0ac135e8bacf,945aa686-5521-11e7-8f50-0ac135e8bacf,a04a1220-5521-11e7-8f50-0ac135e8bacf,a8411a5c-5521-11e7-8f50-0ac135e8bacf,aa5b6ede-5521-11e7-8f50-0ac135e8bacf,afa50a56-5521-11e7-8f50-0ac135e8bacf,c70366de-5521-11e7-8f50-0ac135e8bacf,c92b28e0-5521-11e7-8f50-0ac135e8bacf,d5aa2a46-5521-11e7-8f50-0ac135e8bacf,df93b3b8-5521-11e7-8f50-0ac135e8bacf,e1b66caa-5521-11e7-8f50-0ac135e8bacf,e6f69242-5521-11e7-8f50-0ac135e8bacf,e92d968a-5521-11e7-8f50-0ac135e8bacf	Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met),Regulation of Telomerase,mTOR signaling pathway,LKB1 signaling events,IL4-mediated signaling events,IL2 signaling events mediated by PI3K,IL12-mediated signaling events,IFN-gamma pathway,ErbB2ErbB3 signaling events,ErbB1 downstream signaling,EGFR-dependent Endothelin signaling events,CXCR4-mediated signaling events,CXCR3-mediated signaling events,Class I PI3K signaling events mediated by Akt,CDC42 signaling events	rs754711973										
chr15:67457335:A/G	SMAD3 p.Leu103=		3.0	0.0034940659283609	True		chr15	67457335	A	G	7		Yes	SMAD3	ENST00000327367.9	synonymous_variant	2.0	c.309A>G	p.Leu103=	67164997	0.8340654952076677	0.8668683812405447	0.9135446685878964	0.7619047619047619	0.8608349900596421	0.7801635991820041	0.0115	0.272					COSV59284976	"[[""lung"", 1]]"	1.0	ENST00000559092.1	L103%3D	Exact Match	Benign	Human Phenotype Ontology:HP:0012727,MONDO:MONDO:0005396,MedGen:C0162872|MedGen:CN169374|MONDO:MONDO:0013426,MedGen:C3151087,OMIM:613795,Orphanet:284984|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387	Thoracic aortic aneurysm|not specified|Aneurysm-osteoarthritis syndrome|Familial thoracic aortic aneurysm and aortic dissection	criteria provided, multiple submitters, no conflicts	139217.0		negative regulation of transcription by RNA polymerase II;ureteric bud development;response to hypoxia;in utero embryonic development;mesoderm formation;somitogenesis;liver development;heart looping;osteoblast development;immune system development;regulation of DNA-templated transcription;regulation of transcription by RNA polymerase II;activation of cysteine-type endopeptidase activity involved in apoptotic process;immune response;transforming growth factor beta receptor signaling pathway;JNK cascade;endoderm development;cell population proliferation;negative regulation of cell population proliferation;anatomical structure morphogenesis;embryonic pattern specification;positive regulation of gene expression;negative regulation of gene expression;positive regulation of epithelial to mesenchymal transition;regulation of striated muscle tissue development;regulation of transforming growth factor beta receptor signaling pathway;signal transduction involved in regulation of gene expression;cell differentiation;negative regulation of cell growth;adrenal gland development;positive regulation of cell migration;positive regulation of bone mineralization;thyroid gland development;primary miRNA processing;positive regulation of chondrocyte differentiation;positive regulation of interleukin-1 beta production;regulation of transforming growth factor beta2 production;positive regulation of transforming growth factor beta3 production;activin receptor signaling pathway;negative regulation of osteoblast proliferation;nodal signaling pathway;wound healing;T cell activation;negative regulation of protein catabolic process;positive regulation of protein import into nucleus;negative regulation of apoptotic process;cell-cell junction organization;positive regulation of nitric oxide biosynthetic process;negative regulation of fat cell differentiation;negative regulation of osteoblast differentiation;positive regulation of DNA-templated transcription;positive regulation of transcription by RNA polymerase II;paraxial mesoderm morphogenesis;developmental growth;embryonic foregut morphogenesis;embryonic cranial skeleton morphogenesis;regulation of epithelial cell proliferation;negative regulation of inflammatory response;regulation of immune response;protein stabilization;positive regulation of positive chemotaxis;positive regulation of DNA-binding transcription factor activity;negative regulation of cytosolic calcium ion concentration;positive regulation of stress fiber assembly;positive regulation of focal adhesion assembly;pericardium development;transdifferentiation;SMAD protein signal transduction;negative regulation of wound healing;negative regulation of lung blood pressure;lens fiber cell differentiation;cellular response to glucose stimulus;cellular response to transforming growth factor beta stimulus;positive regulation of canonical Wnt signaling pathway;extrinsic apoptotic signaling pathway;cellular response to virus;positive regulation of extracellular matrix assembly;regulation of miRNA transcription;negative regulation of miRNA transcription;positive regulation of miRNA transcription;negative regulation of cardiac muscle hypertrophy in response to stress;response to angiotensin	GO:0000122;GO:0001657;GO:0001666;GO:0001701;GO:0001707;GO:0001756;GO:0001889;GO:0001947;GO:0002076;GO:0002520;GO:0006355;GO:0006357;GO:0006919;GO:0006955;GO:0007179;GO:0007254;GO:0007492;GO:0008283;GO:0008285;GO:0009653;GO:0009880;GO:0010628;GO:0010629;GO:0010718;GO:0016202;GO:0017015;GO:0023019;GO:0030154;GO:0030308;GO:0030325;GO:0030335;GO:0030501;GO:0030878;GO:0031053;GO:0032332;GO:0032731;GO:0032909;GO:0032916;GO:0032924;GO:0033689;GO:0038092;GO:0042060;GO:0042110;GO:0042177;GO:0042307;GO:0043066;GO:0045216;GO:0045429;GO:0045599;GO:0045668;GO:0045893;GO:0045944;GO:0048340;GO:0048589;GO:0048617;GO:0048701;GO:0050678;GO:0050728;GO:0050776;GO:0050821;GO:0050927;GO:0051091;GO:0051481;GO:0051496;GO:0051894;GO:0060039;GO:0060290;GO:0060395;GO:0061045;GO:0061767;GO:0070306;GO:0071333;GO:0071560;GO:0090263;GO:0097191;GO:0098586;GO:1901203;GO:1902893;GO:1902894;GO:1902895;GO:1903243;GO:1990776	chromatin;nucleus;nuclear inner membrane;nucleoplasm;transcription regulator complex;cytoplasm;cytosol;plasma membrane;receptor complex;SMAD protein complex;heteromeric SMAD protein complex	GO:0000785;GO:0005634;GO:0005637;GO:0005654;GO:0005667;GO:0005737;GO:0005829;GO:0005886;GO:0043235;GO:0071141;GO:0071144	transcription cis-regulatory region binding;RNA polymerase II cis-regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;cis-regulatory region sequence-specific DNA binding;DNA-binding transcription repressor activity;transcription corepressor binding;transcription coactivator binding;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA binding;DNA-binding transcription factor activity;transforming growth factor beta receptor binding;protein binding;collagen binding;beta-catenin binding;zinc ion binding;nuclear receptor binding;DEAD/H-box RNA helicase binding;protein kinase binding;phosphatase binding;chromatin DNA binding;ubiquitin protein ligase binding;nuclear mineralocorticoid receptor binding;sterol response element binding;nuclear glucocorticoid receptor binding;identical protein binding;protein homodimerization activity;ubiquitin binding;bHLH transcription factor binding;sequence-specific DNA binding;RNA polymerase II-specific DNA-binding transcription factor binding;co-SMAD binding;I-SMAD binding;R-SMAD binding;DNA-binding transcription factor binding;promoter-specific chromatin binding	GO:0000976;GO:0000978;GO:0000981;GO:0000987;GO:0001217;GO:0001222;GO:0001223;GO:0001228;GO:0003677;GO:0003700;GO:0005160;GO:0005515;GO:0005518;GO:0008013;GO:0008270;GO:0016922;GO:0017151;GO:0019901;GO:0019902;GO:0031490;GO:0031625;GO:0031962;GO:0032810;GO:0035259;GO:0042802;GO:0042803;GO:0043130;GO:0043425;GO:0043565;GO:0061629;GO:0070410;GO:0070411;GO:0070412;GO:0140297;GO:1990841	7.0	35f28f90-5521-11e7-8f50-0ac135e8bacf,3814fa62-5521-11e7-8f50-0ac135e8bacf,408a0c44-5521-11e7-8f50-0ac135e8bacf,603902ca-5521-11e7-8f50-0ac135e8bacf,68975856-5521-11e7-8f50-0ac135e8bacf,6cb6085a-5521-11e7-8f50-0ac135e8bacf,b354a4de-5521-11e7-8f50-0ac135e8bacf	Validated targets of C-MYC transcriptional repression,Validated targets of C-MYC transcriptional activation,TGF-beta receptor signaling,Regulation of Telomerase,Regulation of nuclear SMAD23 signaling,Regulation of cytoplasmic and nuclear SMAD23 signaling,HIF-1-alpha transcription factor network	rs1065080	rs1065080	0.871884	0.862352	0.839952	0.755754	0.863619	0.911227	0.882008	0.873259	0.790545
chr6:35425761:G/T	FANCE p.Gln323His						chr6	35425761	G	T	7		Yes	FANCE	ENST00000229769.3	missense_variant	4.0	c.969G>T	p.Gln323His	35457984							0.14	0.33					COSV57691262	"[[""lung"", 1]]"	1.0	ENST00000229769.2	Q323H	Exact Match							interstrand cross-link repair	GO:0036297	chromatin;nucleus;nucleoplasm;chromosome;centrosome;cytosol;Fanconi anaemia nuclear complex	GO:0000785;GO:0005634;GO:0005654;GO:0005694;GO:0005813;GO:0005829;GO:0043240	molecular_function	GO:0003674	2.0	c45e106a-5521-11e7-8f50-0ac135e8bacf,f6898a78-5521-11e7-8f50-0ac135e8bacf	Fanconi anemia pathway,BARD1 signaling events											
chr17:7801724:G/A	CHD3 intron_variant		8.0	0.005641748942172			chr17	7801724	G	A	7			CHD3	ENST00000330494.12	intron_variant		c.2052-90G>A		7898406																									negative regulation of transcription by RNA polymerase II;chromatin remodeling;regulation of DNA-templated transcription;spindle organization;centrosome cycle;regulation of cell fate specification;negative regulation of DNA-templated transcription;positive regulation of DNA-templated transcription;regulation of stem cell differentiation	GO:0000122;GO:0006338;GO:0006355;GO:0007051;GO:0007098;GO:0042659;GO:0045892;GO:0045893;GO:2000736	chromatin;nucleus;nucleoplasm;nucleolus;cytoplasm;centrosome;NuRD complex;PML body;centriolar satellite	GO:0000785;GO:0005634;GO:0005654;GO:0005730;GO:0005737;GO:0005813;GO:0016581;GO:0016605;GO:0034451	transcription cis-regulatory region binding;DNA binding;chromatin binding;RNA binding;helicase activity;protein binding;ATP binding;zinc ion binding;ATP hydrolysis activity;histone binding;ATP-dependent chromatin remodeler activity	GO:0000976;GO:0003677;GO:0003682;GO:0003723;GO:0004386;GO:0005515;GO:0005524;GO:0008270;GO:0016887;GO:0042393;GO:0140658	1.0	54bc0812-5521-11e7-8f50-0ac135e8bacf	Signaling events mediated by HDAC Class I	rs1405339881		6.97924e-06	0.0	0.0	0.0	0.0	0.0	1.54895e-05	0.0	0.0
chr4:1807291:G/C	FGFR3 p.Ala516Pro		8.0	0.0059770114942528			chr4	1807291	G	C	7		Yes	FGFR3	ENST00000340107.8	missense_variant	12.0	c.1546G>C	p.Ala516Pro	1805564							9.45e-05	0.207																	MAPK cascade;skeletal system development;endochondral ossification;chondrocyte differentiation;endochondral bone growth;cell surface receptor protein tyrosine kinase signaling pathway;cell surface receptor signaling pathway via JAK-STAT;cell-cell signaling;multicellular organism development;positive regulation of cell population proliferation;fibroblast growth factor receptor signaling pathway;positive regulation of phospholipase activity;bone mineralization;positive regulation of kinase activity;chondrocyte proliferation;positive regulation of tyrosine phosphorylation of STAT protein;positive regulation of MAPK cascade;negative regulation of developmental growth;positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction;bone morphogenesis;positive regulation of ERK1 and ERK2 cascade;bone maturation;fibroblast growth factor receptor apoptotic signaling pathway	GO:0000165;GO:0001501;GO:0001958;GO:0002062;GO:0003416;GO:0007169;GO:0007259;GO:0007267;GO:0007275;GO:0008284;GO:0008543;GO:0010518;GO:0030282;GO:0033674;GO:0035988;GO:0042531;GO:0043410;GO:0048640;GO:0051897;GO:0060349;GO:0070374;GO:0070977;GO:1902178	extracellular region;endoplasmic reticulum;Golgi apparatus;plasma membrane;focal adhesion;cell surface;transport vesicle;receptor complex	GO:0005576;GO:0005783;GO:0005794;GO:0005886;GO:0005925;GO:0009986;GO:0030133;GO:0043235	protein tyrosine kinase activity;fibroblast growth factor receptor activity;protein binding;ATP binding;fibroblast growth factor binding;identical protein binding	GO:0004713;GO:0005007;GO:0005515;GO:0005524;GO:0017134;GO:0042802	6.0	45f18ffc-5521-11e7-8f50-0ac135e8bacf,4679d2ce-5521-11e7-8f50-0ac135e8bacf,470c27c0-5521-11e7-8f50-0ac135e8bacf,576974d6-5521-11e7-8f50-0ac135e8bacf,bf958bd4-5521-11e7-8f50-0ac135e8bacf,d641d668-5521-11e7-8f50-0ac135e8bacf	Syndecan-3-mediated signaling events,Syndecan-2-mediated signaling events,Syndecan-1-mediated signaling events,SHP2 signaling,FGF signaling pathway,Effects of Botulinum toxin											
chr1:120483295:G/A	NOTCH2 p.Cys1022=		8.0	0.005641748942172			chr1	120483295	G	A	7		Yes	NOTCH2	ENST00000256646.7	synonymous_variant	19.0	c.3066C>T	p.Cys1022=	119940672																									negative regulation of transcription by RNA polymerase II;in utero embryonic development;cell fate determination;heart looping;morphogenesis of an epithelial sheet;marginal zone B cell differentiation;inflammatory response to antigenic stimulus;atrioventricular node development;pulmonary valve morphogenesis;apoptotic process;humoral immune response;Notch signaling pathway;nervous system development;axon guidance;animal organ morphogenesis;negative regulation of gene expression;positive regulation of keratinocyte proliferation;hemopoiesis;embryonic limb morphogenesis;BMP signaling pathway;positive regulation of BMP signaling pathway;multicellular organism growth;intracellular signal transduction;intrahepatic bile duct development;wound healing;defense response to bacterium;myeloid dendritic cell differentiation;positive regulation of apoptotic process;negative regulation of apoptotic process;positive regulation of osteoclast differentiation;positive regulation of transcription by RNA polymerase II;positive regulation of Ras protein signal transduction;bone remodeling;positive regulation of smooth muscle cell differentiation;atrial septum morphogenesis;placenta blood vessel development;ciliary body morphogenesis;positive regulation of ERK1 and ERK2 cascade;left/right axis specification;cellular response to tumor cell;proximal tubule development;podocyte development;glomerular capillary formation;hepatocyte proliferation;positive regulation of miRNA transcription;cholangiocyte proliferation;regulation of osteoclast development	GO:0000122;GO:0001701;GO:0001709;GO:0001947;GO:0002011;GO:0002315;GO:0002437;GO:0003162;GO:0003184;GO:0006915;GO:0006959;GO:0007219;GO:0007399;GO:0007411;GO:0009887;GO:0010629;GO:0010838;GO:0030097;GO:0030326;GO:0030509;GO:0030513;GO:0035264;GO:0035556;GO:0035622;GO:0042060;GO:0042742;GO:0043011;GO:0043065;GO:0043066;GO:0045672;GO:0045944;GO:0046579;GO:0046849;GO:0051152;GO:0060413;GO:0060674;GO:0061073;GO:0070374;GO:0070986;GO:0071228;GO:0072014;GO:0072015;GO:0072104;GO:0072574;GO:1902895;GO:1990705;GO:2001204	Golgi membrane;extracellular region;nucleus;nucleoplasm;endoplasmic reticulum membrane;plasma membrane;cilium;cell surface;membrane;receptor complex	GO:0000139;GO:0005576;GO:0005634;GO:0005654;GO:0005789;GO:0005886;GO:0005929;GO:0009986;GO:0016020;GO:0043235	cis-regulatory region sequence-specific DNA binding;DNA-binding transcription activator activity, RNA polymerase II-specific;calcium ion binding;protein binding;enzyme binding;signaling receptor activity;NF-kappaB binding	GO:0000987;GO:0001228;GO:0005509;GO:0005515;GO:0019899;GO:0038023;GO:0051059	1.0	84be116e-5521-11e7-8f50-0ac135e8bacf	Notch signaling pathway											
chr6:27840057:C/A	H3C11 p.Gly13Cys		7.0	0.0028736807232109			chr6	27840057	C	A	6		Yes	H3C11	ENST00000616365.1	missense_variant	1.0	c.37G>T	p.Gly13Cys	27872279							0.0765	0.322																																				
chr7:40172760:T/C	MPLKIP p.Glu146=		4.0	0.0027142303218301			chr7	40172760	T	C	6		Yes	MPLKIP	ENST00000306984.8	synonymous_variant	2.0	c.438A>G	p.Glu146=	40133161																									cell division	GO:0051301	nucleus;nucleoplasm;cytoplasm;Golgi apparatus;centrosome;midbody;intracellular membrane-bounded organelle	GO:0005634;GO:0005654;GO:0005737;GO:0005794;GO:0005813;GO:0030496;GO:0043231	protein binding	GO:0005515														
chr5:1266608:A/G	TERT p.Pro875=		8.0	0.0059134107708553			chr5	1266608	A	G	6		Yes	TERT	ENST00000310581.10	synonymous_variant	10.0	c.2625T>C	p.Pro875=	1266493																									telomere maintenance;RNA-templated transcription;RNA-templated DNA biosynthetic process;telomere maintenance via telomerase;mitochondrion organization;negative regulation of gene expression;DNA strand elongation;positive regulation of Wnt signaling pathway;siRNA processing;regulation of protein stability;positive regulation of protein binding;positive regulation of hair cycle;negative regulation of neuron apoptotic process;positive regulation of angiogenesis;positive regulation of glucose import;response to cadmium ion;positive regulation of nitric-oxide synthase activity;establishment of protein localization to telomere;cellular response to hypoxia;DNA biosynthetic process;replicative senescence;siRNA transcription;positive regulation of G1/S transition of mitotic cell cycle;positive regulation of miRNA transcription;positive regulation of transdifferentiation;positive regulation of vascular associated smooth muscle cell proliferation;positive regulation of protein localization to nucleolus;positive regulation of vascular associated smooth muscle cell migration;negative regulation of endothelial cell apoptotic process;positive regulation of stem cell proliferation;negative regulation of cellular senescence;negative regulation of extrinsic apoptotic signaling pathway in absence of ligand	GO:0000723;GO:0001172;GO:0006278;GO:0007004;GO:0007005;GO:0010629;GO:0022616;GO:0030177;GO:0030422;GO:0031647;GO:0032092;GO:0042635;GO:0043524;GO:0045766;GO:0046326;GO:0046686;GO:0051000;GO:0070200;GO:0071456;GO:0071897;GO:0090399;GO:0140745;GO:1900087;GO:1902895;GO:1903620;GO:1904707;GO:1904751;GO:1904754;GO:2000352;GO:2000648;GO:2000773;GO:2001240	telomerase catalytic core complex;chromosome, telomeric region;nuclear telomere cap complex;nucleus;nucleoplasm;telomerase holoenzyme complex;nucleolus;cytosol;plasma membrane;PML body;nuclear speck;RNA-directed RNA polymerase complex;mitochondrial nucleoid;TERT-RMRP complex	GO:0000333;GO:0000781;GO:0000783;GO:0005634;GO:0005654;GO:0005697;GO:0005730;GO:0005829;GO:0005886;GO:0016605;GO:0016607;GO:0031379;GO:0042645;GO:1990572	tRNA binding;transcription coactivator binding;DNA binding;telomerase activity;telomerase RNA reverse transcriptase activity;RNA binding;RNA-directed DNA polymerase activity;RNA-dependent RNA polymerase activity;protein binding;telomeric DNA binding;identical protein binding;protein homodimerization activity;metal ion binding;protein-folding chaperone binding;telomerase RNA binding;template-free RNA nucleotidyltransferase	GO:0000049;GO:0001223;GO:0003677;GO:0003720;GO:0003721;GO:0003723;GO:0003964;GO:0003968;GO:0005515;GO:0042162;GO:0042802;GO:0042803;GO:0046872;GO:0051087;GO:0070034;GO:0098680	5.0	3814fa62-5521-11e7-8f50-0ac135e8bacf,603902ca-5521-11e7-8f50-0ac135e8bacf,6aae5178-5521-11e7-8f50-0ac135e8bacf,a8411a5c-5521-11e7-8f50-0ac135e8bacf,b354a4de-5521-11e7-8f50-0ac135e8bacf	Validated targets of C-MYC transcriptional activation,Regulation of Telomerase,Regulation of nuclear beta catenin signaling and target gene transcription,IL2 signaling events mediated by PI3K,HIF-1-alpha transcription factor network											
chr19:36223076:G/C	KMT2B intron_variant		5.0	0.0019513646987597			chr19	36223076	G	C	6			KMT2B	ENST00000420124.3	intron_variant		c.5666-40G>C		35732175																									chromatin remodeling;methylation;positive regulation of DNA-templated transcription	GO:0006338;GO:0032259;GO:0045893	nucleus;nucleoplasm;histone methyltransferase complex;MLL1/2 complex	GO:0005634;GO:0005654;GO:0035097;GO:0044665	protein binding;zinc ion binding;histone H3K4 methyltransferase activity;unmethylated CpG binding;histone H3K4 monomethyltransferase activity;histone H3K4 trimethyltransferase activity	GO:0005515;GO:0008270;GO:0042800;GO:0045322;GO:0140945;GO:0140999														
chr7:154746135:T/G	PAXIP1 splice_site_variant		8.0	0.0089942763695829			chr7	154746135	T	G	6			PAXIP1	ENST00000404141.6	splice_site_variant	16.0	c.2653-2A>C		154954425																									vasculogenesis;DNA repair;DNA recombination;chromatin remodeling;response to ionizing radiation;DNA damage response, signal transduction by p53 class mediator;positive regulation of protein ubiquitination;negative regulation of DNA-binding transcription factor activity;endothelial cell migration;positive regulation of isotype switching;positive regulation of isotype switching to IgG isotypes;positive regulation of transcription initiation by RNA polymerase II;adipose tissue development;chorion development;regulation of cell cycle G2/M phase transition	GO:0001570;GO:0006281;GO:0006310;GO:0006338;GO:0010212;GO:0030330;GO:0031398;GO:0043433;GO:0043542;GO:0045830;GO:0048304;GO:0060261;GO:0060612;GO:0060717;GO:1902749	nucleus;nucleoplasm;chromosome;nuclear matrix;histone methyltransferase complex;MLL3/4 complex	GO:0005634;GO:0005654;GO:0005694;GO:0016363;GO:0035097;GO:0044666	protein binding	GO:0005515														
chr20:40733334:CA/C	PTPRT p.Asp1160GlufsTer48		4.0	0.0016366612111292			chr20	40733334	CA	C	6		Yes	PTPRT	ENST00000373193.7	frameshift_truncation	26.0	c.3480del	p.Asp1160GlufsTer48	42104695																									protein dephosphorylation;cell adhesion;homophilic cell adhesion via plasma membrane adhesion molecules;signal transduction;cell surface receptor protein tyrosine kinase signaling pathway;negative regulation of cell migration;peptidyl-tyrosine dephosphorylation;regulation of synapse organization;cellular response to interleukin-6;negative regulation of receptor signaling pathway via STAT;peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity	GO:0006470;GO:0007155;GO:0007156;GO:0007165;GO:0007169;GO:0030336;GO:0035335;GO:0050807;GO:0071354;GO:1904893;GO:1990264	plasma membrane;cell surface;membrane;postsynaptic density membrane;glutamatergic synapse	GO:0005886;GO:0009986;GO:0016020;GO:0098839;GO:0098978	protein tyrosine phosphatase activity;transmembrane receptor protein tyrosine phosphatase activity;protein binding;beta-catenin binding;thiolester hydrolase activity;protein phosphatase binding;protein homodimerization activity;alpha-catenin binding;gamma-catenin binding;cadherin binding;alpha-actinin binding;delta-catenin binding;STAT family protein binding	GO:0004725;GO:0005001;GO:0005515;GO:0008013;GO:0016790;GO:0019903;GO:0042803;GO:0045294;GO:0045295;GO:0045296;GO:0051393;GO:0070097;GO:0097677														
chr9:101911587:A/G	TGFBR1 p.Ter504=		8.0	0.0046529662659945			chr9	101911587	A	G	6		Yes	TGFBR1	ENST00000374994.9	stop_retained_variant	9.0	c.1512A>G	p.Ter504=	99149305																			Likely benign	MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387	Familial thoracic aortic aneurysm and aortic dissection	criteria provided, single submitter	924239.0		skeletal system development;in utero embryonic development;kidney development;blastocyst development;epithelial to mesenchymal transition;endothelial cell proliferation;negative regulation of endothelial cell proliferation;positive regulation of endothelial cell proliferation;lens development in camera-type eye;ventricular trabecula myocardium morphogenesis;ventricular compact myocardium morphogenesis;proepicardium development;regulation of DNA-templated transcription;protein phosphorylation;apoptotic process;signal transduction;transforming growth factor beta receptor signaling pathway;nervous system development;heart development;positive regulation of cell population proliferation;germ cell migration;male gonad development;post-embryonic development;anterior/posterior pattern specification;positive regulation of gene expression;regulation of epithelial to mesenchymal transition;positive regulation of epithelial to mesenchymal transition;peptidyl-serine phosphorylation;collagen fibril organization;positive regulation of cell growth;positive regulation of cell migration;negative regulation of cell migration;regulation of protein ubiquitination;negative regulation of chondrocyte differentiation;activin receptor signaling pathway;intracellular signal transduction;myofibroblast differentiation;wound healing;endothelial cell activation;extracellular structure organization;endothelial cell migration;positive regulation of DNA-templated transcription;filopodium assembly;thymus development;neuron fate commitment;embryonic cranial skeleton morphogenesis;skeletal system morphogenesis;mesenchymal cell differentiation;artery morphogenesis;cell motility;positive regulation of filopodium assembly;positive regulation of stress fiber assembly;regulation of cell cycle;positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction;parathyroid gland development;roof of mouth development;pharyngeal system development;regulation of cardiac muscle cell proliferation;cardiac epithelial to mesenchymal transition;positive regulation of SMAD protein signal transduction;ventricular septum morphogenesis;angiogenesis involved in coronary vascular morphogenesis;coronary artery morphogenesis;response to cholesterol;cellular response to growth factor stimulus;cellular response to transforming growth factor beta stimulus;positive regulation of extracellular matrix assembly;positive regulation of mesenchymal stem cell proliferation;positive regulation of vasculature development;positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation;positive regulation of tight junction disassembly;epicardium morphogenesis;positive regulation of apoptotic signaling pathway;negative regulation of extrinsic apoptotic signaling pathway	GO:0001501;GO:0001701;GO:0001822;GO:0001824;GO:0001837;GO:0001935;GO:0001937;GO:0001938;GO:0002088;GO:0003222;GO:0003223;GO:0003342;GO:0006355;GO:0006468;GO:0006915;GO:0007165;GO:0007179;GO:0007399;GO:0007507;GO:0008284;GO:0008354;GO:0008584;GO:0009791;GO:0009952;GO:0010628;GO:0010717;GO:0010718;GO:0018105;GO:0030199;GO:0030307;GO:0030335;GO:0030336;GO:0031396;GO:0032331;GO:0032924;GO:0035556;GO:0036446;GO:0042060;GO:0042118;GO:0043062;GO:0043542;GO:0045893;GO:0046847;GO:0048538;GO:0048663;GO:0048701;GO:0048705;GO:0048762;GO:0048844;GO:0048870;GO:0051491;GO:0051496;GO:0051726;GO:0051897;GO:0060017;GO:0060021;GO:0060037;GO:0060043;GO:0060317;GO:0060391;GO:0060412;GO:0060978;GO:0060982;GO:0070723;GO:0071363;GO:0071560;GO:1901203;GO:1902462;GO:1904018;GO:1905007;GO:1905075;GO:1905223;GO:2001235;GO:2001237	nucleus;endosome;plasma membrane;bicellular tight junction;cell surface;receptor complex;membrane raft;activin receptor complex;transforming growth factor beta ligand-receptor complex	GO:0005634;GO:0005768;GO:0005886;GO:0005923;GO:0009986;GO:0043235;GO:0045121;GO:0048179;GO:0070021	protein kinase activity;protein serine/threonine kinase activity;transmembrane receptor protein serine/threonine kinase activity;transforming growth factor beta receptor activity;transforming growth factor beta receptor activity, type I;type II transforming growth factor beta receptor binding;protein binding;ATP binding;activin receptor activity, type I;growth factor binding;ubiquitin protein ligase binding;SMAD binding;metal ion binding;activin binding;transforming growth factor beta binding;I-SMAD binding	GO:0004672;GO:0004674;GO:0004675;GO:0005024;GO:0005025;GO:0005114;GO:0005515;GO:0005524;GO:0016361;GO:0019838;GO:0031625;GO:0046332;GO:0046872;GO:0048185;GO:0050431;GO:0070411	4.0	05263ad2-5522-11e7-8f50-0ac135e8bacf,408a0c44-5521-11e7-8f50-0ac135e8bacf,ba907368-5521-11e7-8f50-0ac135e8bacf,f23376be-5521-11e7-8f50-0ac135e8bacf	ALK1 signaling events,TGF-beta receptor signaling,Glypican 1 network,Beta5 beta6 beta7 and beta8 integrin cell surface interactions											
chr20:40733333:G/T	PTPRT p.Ala1161Asp		4.0	0.0015509887553315			chr20	40733333	G	T	6		Yes	PTPRT	ENST00000373193.7	missense_variant	26.0	c.3482C>A	p.Ala1161Asp	42104693							0.393	0.46																	protein dephosphorylation;cell adhesion;homophilic cell adhesion via plasma membrane adhesion molecules;signal transduction;cell surface receptor protein tyrosine kinase signaling pathway;negative regulation of cell migration;peptidyl-tyrosine dephosphorylation;regulation of synapse organization;cellular response to interleukin-6;negative regulation of receptor signaling pathway via STAT;peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity	GO:0006470;GO:0007155;GO:0007156;GO:0007165;GO:0007169;GO:0030336;GO:0035335;GO:0050807;GO:0071354;GO:1904893;GO:1990264	plasma membrane;cell surface;membrane;postsynaptic density membrane;glutamatergic synapse	GO:0005886;GO:0009986;GO:0016020;GO:0098839;GO:0098978	protein tyrosine phosphatase activity;transmembrane receptor protein tyrosine phosphatase activity;protein binding;beta-catenin binding;thiolester hydrolase activity;protein phosphatase binding;protein homodimerization activity;alpha-catenin binding;gamma-catenin binding;cadherin binding;alpha-actinin binding;delta-catenin binding;STAT family protein binding	GO:0004725;GO:0005001;GO:0005515;GO:0008013;GO:0016790;GO:0019903;GO:0042803;GO:0045294;GO:0045295;GO:0045296;GO:0051393;GO:0070097;GO:0097677														
chrX:70349824:T/C	MED12 intron_variant						chrX	70349824	T	C	6			MED12	ENST00000374080.8	intron_variant		c.3868-61T>C		71129974																									neural tube closure;endoderm development;heart development;oligodendrocyte development;Schwann cell development;protein ubiquitination;spinal cord development;somatic stem cell population maintenance;post-anal tail morphogenesis;positive regulation of DNA-templated transcription;positive regulation of transcription by RNA polymerase II;embryonic neurocranium morphogenesis;Wnt signaling pathway, planar cell polarity pathway;positive regulation of transcription initiation by RNA polymerase II;axis elongation involved in somitogenesis;embryonic brain development	GO:0001843;GO:0007492;GO:0007507;GO:0014003;GO:0014044;GO:0016567;GO:0021510;GO:0035019;GO:0036342;GO:0045893;GO:0045944;GO:0048702;GO:0060071;GO:0060261;GO:0090245;GO:1990403	ubiquitin ligase complex;nucleus;nucleoplasm;membrane;mediator complex;CKM complex	GO:0000151;GO:0005634;GO:0005654;GO:0016020;GO:0016592;GO:1990508	RNA polymerase II cis-regulatory region sequence-specific DNA binding;chromatin binding;transcription coregulator activity;transcription coactivator activity;protein binding;beta-catenin binding;transcription factor binding;nuclear receptor coactivator activity;nuclear vitamin D receptor binding;nuclear thyroid hormone receptor binding;ubiquitin protein ligase activity	GO:0000978;GO:0003682;GO:0003712;GO:0003713;GO:0005515;GO:0008013;GO:0008134;GO:0030374;GO:0042809;GO:0046966;GO:0061630	1.0	6aae5178-5521-11e7-8f50-0ac135e8bacf	Regulation of nuclear beta catenin signaling and target gene transcription	rs866584169		9.56105e-06	0.0	0.0	0.0	0.0	0.0	1.99235e-05	0.0	0.0
chr1:39781328:C/T	MACF1 p.Asp1175=		5.0	0.002195860204298			chr1	39781328	C	T	6		Yes	MACF1	ENST00000567887.5	synonymous_variant	27.0	c.3525C>T	p.Asp1175=	39315656																									regulation of epithelial cell migration;Wnt signaling pathway;positive regulation of Wnt signaling pathway;regulation of cell migration;regulation of microtubule-based process;wound healing;Golgi to plasma membrane protein transport;intermediate filament cytoskeleton organization;positive regulation of axon extension;regulation of focal adhesion assembly;regulation of neuron projection arborization	GO:0010632;GO:0016055;GO:0030177;GO:0030334;GO:0032886;GO:0042060;GO:0043001;GO:0045104;GO:0045773;GO:0051893;GO:0150011	cytoplasm;Golgi apparatus;cytoskeleton;microtubule;intermediate filament;plasma membrane;actin cytoskeleton;membrane;ruffle membrane	GO:0005737;GO:0005794;GO:0005856;GO:0005874;GO:0005882;GO:0005886;GO:0015629;GO:0016020;GO:0032587	RNA binding;actin binding;structural molecule activity;calcium ion binding;protein binding;cadherin binding;microtubule minus-end binding;actin filament binding	GO:0003723;GO:0003779;GO:0005198;GO:0005509;GO:0005515;GO:0045296;GO:0051011;GO:0051015				rs763617504		6.98061e-06	2.37937e-05	0.0	0.0	0.0	0.0	0.0	0.0	0.0
chr1:11308111:A/T	MTOR p.Leu294Gln		7.0	0.0028210447663335			chr1	11308111	A	T	6		Yes	MTOR	ENST00000361445.9	missense_variant	7.0	c.881T>A	p.Leu294Gln	11248054							0.00102	0.054																	regulation of cell growth;T-helper 1 cell lineage commitment;heart morphogenesis;heart valve morphogenesis;energy reserve metabolic process;'de novo' pyrimidine nucleobase biosynthetic process;protein phosphorylation;inflammatory response;DNA damage response;cytoskeleton organization;lysosome organization;germ cell development;response to nutrient;regulation of cell size;cellular response to starvation;response to heat;post-embryonic development;negative regulation of autophagy;positive regulation of lamellipodium assembly;positive regulation of gene expression;positive regulation of epithelial to mesenchymal transition;positive regulation of myotube differentiation;macroautophagy;regulation of macroautophagy;negative regulation of macroautophagy;phosphorylation;peptidyl-serine phosphorylation;neuronal action potential;protein catabolic process;positive regulation of cell growth;positive regulation of actin filament polymerization;T cell costimulation;ruffle organization;regulation of myelination;protein destabilization;response to nutrient levels;cellular response to nutrient levels;cellular response to nutrient;TOR signaling;positive regulation of phosphoprotein phosphatase activity;cellular response to insulin stimulus;regulation of actin cytoskeleton organization;calcineurin-NFAT signaling cascade;cellular response to amino acid starvation;multicellular organism growth;TORC1 signaling;regulation of circadian rhythm;negative regulation of apoptotic process;response to amino acid;anoikis;regulation of osteoclast differentiation;positive regulation of translation;negative regulation of cell size;positive regulation of glycolytic process;positive regulation of transcription by RNA polymerase III;positive regulation of translational initiation;protein autophosphorylation;positive regulation of lipid biosynthetic process;behavioral response to pain;rhythmic process;oligodendrocyte differentiation;positive regulation of oligodendrocyte differentiation;positive regulation of peptidyl-tyrosine phosphorylation;voluntary musculoskeletal movement;positive regulation of stress fiber assembly;positive regulation of keratinocyte migration;nucleus localization;positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction;cardiac muscle cell development;cardiac muscle contraction;cellular response to methionine;negative regulation of calcineurin-NFAT signaling cascade;cellular response to amino acid stimulus;cellular response to L-leucine;cellular response to hypoxia;cellular response to osmotic stress;regulation of membrane permeability;regulation of cellular response to heat;negative regulation of protein localization to nucleus;regulation of signal transduction by p53 class mediator;positive regulation of transcription of nucleolar large rRNA by RNA polymerase I;positive regulation of wound healing, spreading of epidermal cells;regulation of locomotor rhythm;positive regulation of cytoplasmic translational initiation;negative regulation of lysosome organization;positive regulation of pentose-phosphate shunt;cellular response to leucine starvation;regulation of autophagosome assembly	GO:0001558;GO:0002296;GO:0003007;GO:0003179;GO:0006112;GO:0006207;GO:0006468;GO:0006954;GO:0006974;GO:0007010;GO:0007040;GO:0007281;GO:0007584;GO:0008361;GO:0009267;GO:0009408;GO:0009791;GO:0010507;GO:0010592;GO:0010628;GO:0010718;GO:0010831;GO:0016236;GO:0016241;GO:0016242;GO:0016310;GO:0018105;GO:0019228;GO:0030163;GO:0030307;GO:0030838;GO:0031295;GO:0031529;GO:0031641;GO:0031648;GO:0031667;GO:0031669;GO:0031670;GO:0031929;GO:0032516;GO:0032869;GO:0032956;GO:0033173;GO:0034198;GO:0035264;GO:0038202;GO:0042752;GO:0043066;GO:0043200;GO:0043276;GO:0045670;GO:0045727;GO:0045792;GO:0045821;GO:0045945;GO:0045948;GO:0046777;GO:0046889;GO:0048266;GO:0048511;GO:0048709;GO:0048714;GO:0050731;GO:0050882;GO:0051496;GO:0051549;GO:0051647;GO:0051897;GO:0055013;GO:0060048;GO:0061431;GO:0070885;GO:0071230;GO:0071233;GO:0071456;GO:0071470;GO:0090559;GO:1900034;GO:1900181;GO:1901796;GO:1901838;GO:1903691;GO:1904059;GO:1904690;GO:1905672;GO:1905857;GO:1990253;GO:2000785	Golgi membrane;nucleus;nuclear envelope;nucleoplasm;cytoplasm;mitochondrial outer membrane;lysosome;lysosomal membrane;endoplasmic reticulum membrane;cytosol;endomembrane system;membrane;PML body;dendrite;TORC1 complex;TORC2 complex;phagocytic vesicle	GO:0000139;GO:0005634;GO:0005635;GO:0005654;GO:0005737;GO:0005741;GO:0005764;GO:0005765;GO:0005789;GO:0005829;GO:0012505;GO:0016020;GO:0016605;GO:0030425;GO:0031931;GO:0031932;GO:0045335	RNA polymerase III type 1 promoter sequence-specific DNA binding;RNA polymerase III type 2 promoter sequence-specific DNA binding;RNA polymerase III type 3 promoter sequence-specific DNA binding;TFIIIC-class transcription factor complex binding;protein kinase activity;protein serine/threonine kinase activity;protein binding;ATP binding;kinase activity;identical protein binding;ribosome binding;phosphoprotein binding;protein serine kinase activity	GO:0001002;GO:0001003;GO:0001006;GO:0001156;GO:0004672;GO:0004674;GO:0005515;GO:0005524;GO:0016301;GO:0042802;GO:0043022;GO:0051219;GO:0106310	15.0	5189b3dc-5521-11e7-8f50-0ac135e8bacf,603902ca-5521-11e7-8f50-0ac135e8bacf,8f640d10-5521-11e7-8f50-0ac135e8bacf,945aa686-5521-11e7-8f50-0ac135e8bacf,a04a1220-5521-11e7-8f50-0ac135e8bacf,a8411a5c-5521-11e7-8f50-0ac135e8bacf,aa5b6ede-5521-11e7-8f50-0ac135e8bacf,afa50a56-5521-11e7-8f50-0ac135e8bacf,c70366de-5521-11e7-8f50-0ac135e8bacf,c92b28e0-5521-11e7-8f50-0ac135e8bacf,d5aa2a46-5521-11e7-8f50-0ac135e8bacf,df93b3b8-5521-11e7-8f50-0ac135e8bacf,e1b66caa-5521-11e7-8f50-0ac135e8bacf,e6f69242-5521-11e7-8f50-0ac135e8bacf,e92d968a-5521-11e7-8f50-0ac135e8bacf	Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met),Regulation of Telomerase,mTOR signaling pathway,LKB1 signaling events,IL4-mediated signaling events,IL2 signaling events mediated by PI3K,IL12-mediated signaling events,IFN-gamma pathway,ErbB2ErbB3 signaling events,ErbB1 downstream signaling,EGFR-dependent Endothelin signaling events,CXCR4-mediated signaling events,CXCR3-mediated signaling events,Class I PI3K signaling events mediated by Akt,CDC42 signaling events											
chr1:27056289:C/T	ARID1A p.Arg429Trp		7.0	0.0023652951779847			chr1	27056289	C	T	6		Yes	ARID1A	ENST00000324856.13	missense_variant	2.0	c.1285C>T	p.Arg429Trp	26729798							0.000914	0.00672																	nucleosome disassembly;chromatin remodeling;regulation of transcription by RNA polymerase II;nervous system development;regulation of mitotic metaphase/anaphase transition;intracellular estrogen receptor signaling pathway;androgen receptor signaling pathway;intracellular glucocorticoid receptor signaling pathway;positive regulation of T cell differentiation;positive regulation of cell differentiation;positive regulation of myoblast differentiation;transcription initiation-coupled chromatin remodeling;positive regulation of DNA-templated transcription;regulation of G0 to G1 transition;positive regulation of stem cell population maintenance;regulation of G1/S transition of mitotic cell cycle;positive regulation of double-strand break repair;regulation of nucleotide-excision repair	GO:0006337;GO:0006338;GO:0006357;GO:0007399;GO:0030071;GO:0030520;GO:0030521;GO:0042921;GO:0045582;GO:0045597;GO:0045663;GO:0045815;GO:0045893;GO:0070316;GO:1902459;GO:2000045;GO:2000781;GO:2000819	chromatin;nucleus;nucleoplasm;SWI/SNF complex;brahma complex;npBAF complex;nBAF complex;bBAF complex	GO:0000785;GO:0005634;GO:0005654;GO:0016514;GO:0035060;GO:0071564;GO:0071565;GO:0140092	DNA binding;transcription coactivator activity;protein binding;nuclear receptor binding;nucleosome binding	GO:0003677;GO:0003713;GO:0005515;GO:0016922;GO:0031491				rs993324701										
chr13:32914443:A/G	BRCA2 p.Lys1984Arg		7.0	0.0051390146652206			chr13	32914443	A	G	6		Yes	BRCA2	ENST00000380152.7	missense_variant	11.0	c.5951A>G	p.Lys1984Arg	32340306							0.0313	0.315																	telomere maintenance via recombination;double-strand break repair via homologous recombination;oocyte maturation;inner cell mass cell proliferation;nucleotide-excision repair;double-strand break repair;chromatin remodeling;regulation of DNA-templated transcription;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;male meiosis I;spermatogenesis;brain development;female gonad development;response to X-ray;response to UV-C;response to gamma radiation;regulation of cytokinesis;negative regulation of mammary gland epithelial cell proliferation;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;positive regulation of DNA-templated transcription;positive regulation of mitotic cell cycle;centrosome duplication;establishment of protein localization to telomere;hematopoietic stem cell proliferation;cellular response to ionizing radiation;cellular senescence;mitotic recombination-dependent replication fork processing;regulation of DNA damage checkpoint	GO:0000722;GO:0000724;GO:0001556;GO:0001833;GO:0006289;GO:0006302;GO:0006338;GO:0006355;GO:0006978;GO:0007141;GO:0007283;GO:0007420;GO:0008585;GO:0010165;GO:0010225;GO:0010332;GO:0032465;GO:0033600;GO:0042771;GO:0045893;GO:0045931;GO:0051298;GO:0070200;GO:0071425;GO:0071479;GO:0090398;GO:1990426;GO:2000001	nuclear ubiquitin ligase complex;chromosome, telomeric region;lateral element;nucleus;nucleoplasm;centrosome;cytosol;secretory granule;protein-containing complex;BRCA2-MAGE-D1 complex;DNA repair complex	GO:0000152;GO:0000781;GO:0000800;GO:0005634;GO:0005654;GO:0005813;GO:0005829;GO:0030141;GO:0032991;GO:0033593;GO:1990391	protease binding;single-stranded DNA binding;histone acetyltransferase activity;protein binding;histone H3 acetyltransferase activity;histone H4 acetyltransferase activity;identical protein binding;gamma-tubulin binding	GO:0002020;GO:0003697;GO:0004402;GO:0005515;GO:0010484;GO:0010485;GO:0042802;GO:0043015	5.0	34a994cc-5521-11e7-8f50-0ac135e8bacf,812903c2-5521-11e7-8f50-0ac135e8bacf,bddf504e-5521-11e7-8f50-0ac135e8bacf,c45e106a-5521-11e7-8f50-0ac135e8bacf,f93a0482-5521-11e7-8f50-0ac135e8bacf	Validated transcriptional targets of deltaNp63 isoforms,p73 transcription factor network,FOXM1 transcription factor network,Fanconi anemia pathway,ATR signaling pathway	rs781732299										
chr14:75514734:A/G	MLH3 p.Leu542Ser		2.0	0.0013093289689034			chr14	75514734	A	G	5		Yes	MLH3	ENST00000355774.6	missense_variant	2.0	c.1625T>C	p.Leu542Ser	75048031							0.333	0.61																	mismatch repair;synaptonemal complex assembly;reciprocal meiotic recombination;male meiotic nuclear division;female meiosis I;protein localization	GO:0006298;GO:0007130;GO:0007131;GO:0007140;GO:0007144;GO:0008104	synaptonemal complex;male germ cell nucleus;nucleus;nucleoplasm;chiasma;mismatch repair complex	GO:0000795;GO:0001673;GO:0005634;GO:0005654;GO:0005712;GO:0032300	chromatin binding;satellite DNA binding;protein binding;ATP binding;ATP hydrolysis activity;centromeric DNA binding;mismatched DNA binding;ATP-dependent DNA damage sensor activity	GO:0003682;GO:0003696;GO:0005515;GO:0005524;GO:0016887;GO:0019237;GO:0030983;GO:0140664														
chr18:19751450:C/T	GATA6 p.Phe115=						chr18	19751450	C	T	5		Yes	GATA6	ENST00000269216.9	synonymous_variant	2.0	c.345C>T	p.Phe115=	22171489																									negative regulation of transcription by RNA polymerase II;in utero embryonic development;liver development;sebaceous gland cell differentiation;regulation of antimicrobial humoral response;outflow tract septum morphogenesis;atrioventricular node development;sinoatrial node development;type B pancreatic cell differentiation;pancreatic A cell differentiation;phospholipid metabolic process;endodermal cell fate determination;male gonad development;response to xenobiotic stimulus;response to toxic substance;gene expression;positive regulation of cardiac muscle cell apoptotic process;cardiac muscle hypertrophy in response to stress;positive regulation of BMP signaling pathway;epithelial cell differentiation;response to retinoic acid;negative regulation of transforming growth factor beta1 production;negative regulation of transforming growth factor beta2 production;tube morphogenesis;atrioventricular canal development;odontogenesis of dentin-containing tooth;negative regulation of apoptotic process;response to estrogen;cell fate commitment;positive regulation of angiogenesis;negative regulation of DNA-templated transcription;positive regulation of DNA-templated transcription;positive regulation of transcription by RNA polymerase II;animal organ formation;stem cell differentiation;smooth muscle cell differentiation;response to cAMP;cardiac muscle cell differentiation;cardiac muscle cell proliferation;positive regulation of cardiac muscle cell proliferation;heart contraction;lung saccule development;club cell differentiation;type II pneumocyte differentiation;intestinal epithelial cell differentiation;cardiac vascular smooth muscle cell differentiation;G1 to G0 transition involved in cell differentiation;response to growth factor;cellular response to gonadotropin stimulus;cellular response to hypoxia;cellular response to BMP stimulus;skin epidermis development;positive regulation of cardiac muscle myoblast proliferation;negative regulation of miRNA transcription;negative regulation of sebum secreting cell proliferation	GO:0000122;GO:0001701;GO:0001889;GO:0001949;GO:0002759;GO:0003148;GO:0003162;GO:0003163;GO:0003309;GO:0003310;GO:0006644;GO:0007493;GO:0008584;GO:0009410;GO:0009636;GO:0010467;GO:0010666;GO:0014898;GO:0030513;GO:0030855;GO:0032526;GO:0032911;GO:0032912;GO:0035239;GO:0036302;GO:0042475;GO:0043066;GO:0043627;GO:0045165;GO:0045766;GO:0045892;GO:0045893;GO:0045944;GO:0048645;GO:0048863;GO:0051145;GO:0051591;GO:0055007;GO:0060038;GO:0060045;GO:0060047;GO:0060430;GO:0060486;GO:0060510;GO:0060575;GO:0060947;GO:0070315;GO:0070848;GO:0071371;GO:0071456;GO:0071773;GO:0098773;GO:0110024;GO:1902894;GO:1904003	chromatin;nucleus;nucleoplasm;transcription regulator complex;nuclear membrane	GO:0000785;GO:0005634;GO:0005654;GO:0005667;GO:0031965	transcription cis-regulatory region binding;RNA polymerase II cis-regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;transcription coactivator binding;chromatin binding;DNA-binding transcription factor activity;protein binding;zinc ion binding;protein kinase binding;NFAT protein binding;DNA-binding transcription factor binding;sequence-specific double-stranded DNA binding	GO:0000976;GO:0000978;GO:0000981;GO:0001223;GO:0003682;GO:0003700;GO:0005515;GO:0008270;GO:0019901;GO:0051525;GO:0140297;GO:1990837	1.0	841dd9cc-5521-11e7-8f50-0ac135e8bacf	Notch-mediated HESHEY network	rs1270313711										
chrX:47430317:T/C	ARAF p.Leu531Pro		3.0	0.0012729496194506			chrX	47430317	T	C	5		Yes	ARAF	ENST00000377045.9	missense_variant	15.0	c.1592T>C	p.Leu531Pro	47570918							0.0039	0.0653																	MAPK cascade;regulation of TOR signaling;regulation of proteasomal ubiquitin-dependent protein catabolic process;positive regulation of peptidyl-serine phosphorylation;protein modification process;negative regulation of apoptotic process	GO:0000165;GO:0032006;GO:0032434;GO:0033138;GO:0036211;GO:0043066	cellular_component;mitochondrion;cytosol	GO:0005575;GO:0005739;GO:0005829	protein kinase activity;protein serine/threonine kinase activity;MAP kinase kinase kinase activity;protein binding;ATP binding;metal ion binding;protein serine kinase activity	GO:0004672;GO:0004674;GO:0004709;GO:0005515;GO:0005524;GO:0046872;GO:0106310														
chr14:75514610:T/C	MLH3 p.Lys583=		1.0	0.5003167898627244			chr14	75514610	T	C	5		Yes	MLH3	ENST00000355774.6	synonymous_variant	2.0	c.1749A>G	p.Lys583=	75047907																									mismatch repair;synaptonemal complex assembly;reciprocal meiotic recombination;male meiotic nuclear division;female meiosis I;protein localization	GO:0006298;GO:0007130;GO:0007131;GO:0007140;GO:0007144;GO:0008104	synaptonemal complex;male germ cell nucleus;nucleus;nucleoplasm;chiasma;mismatch repair complex	GO:0000795;GO:0001673;GO:0005634;GO:0005654;GO:0005712;GO:0032300	chromatin binding;satellite DNA binding;protein binding;ATP binding;ATP hydrolysis activity;centromeric DNA binding;mismatched DNA binding;ATP-dependent DNA damage sensor activity	GO:0003682;GO:0003696;GO:0005515;GO:0005524;GO:0016887;GO:0019237;GO:0030983;GO:0140664														
chr11:64573843:G/A	MEN1 intron_variant		7.0	0.0047275728555996			chr11	64573843	G	A	5			MEN1	ENST00000450708.6	intron_variant		c.913-3C>T		64806371																									negative regulation of transcription by RNA polymerase II;MAPK cascade;negative regulation of protein phosphorylation;osteoblast development;DNA repair;regulation of transcription by RNA polymerase II;DNA damage response;negative regulation of cell population proliferation;response to UV;response to gamma radiation;positive regulation of transforming growth factor beta receptor signaling pathway;negative regulation of DNA-binding transcription factor activity;T-helper 2 cell differentiation;negative regulation of osteoblast differentiation;negative regulation of cyclin-dependent protein serine/threonine kinase activity;negative regulation of cell cycle;transcription initiation-coupled chromatin remodeling;negative regulation of DNA-templated transcription;positive regulation of transcription by RNA polymerase II;negative regulation of JNK cascade;negative regulation of telomerase activity	GO:0000122;GO:0000165;GO:0001933;GO:0002076;GO:0006281;GO:0006357;GO:0006974;GO:0008285;GO:0009411;GO:0010332;GO:0030511;GO:0043433;GO:0045064;GO:0045668;GO:0045736;GO:0045786;GO:0045815;GO:0045892;GO:0045944;GO:0046329;GO:0051974	chromosome, telomeric region;chromatin;nucleus;nucleoplasm;cytoplasm;endoplasmic reticulum lumen;cytosol;nuclear matrix;transcription repressor complex;cleavage furrow;protein-containing complex;histone methyltransferase complex;MLL1/2 complex;MLL1 complex	GO:0000781;GO:0000785;GO:0005634;GO:0005654;GO:0005737;GO:0005788;GO:0005829;GO:0016363;GO:0017053;GO:0032154;GO:0032991;GO:0035097;GO:0044665;GO:0071339	four-way junction DNA binding;Y-form DNA binding;transcription cis-regulatory region binding;chromatin binding;double-stranded DNA binding;protein binding;protein-macromolecule adaptor activity;phosphoprotein binding;R-SMAD binding	GO:0000400;GO:0000403;GO:0000976;GO:0003682;GO:0003690;GO:0005515;GO:0030674;GO:0051219;GO:0070412														
chr20:39801238:T/C	PLCG1 p.Met1028Thr		4.0	0.0013093289689034			chr20	39801238	T	C	4		Yes	PLCG1	ENST00000244007.7	missense_variant	27.0	c.3083T>C	p.Met1028Thr	41172598							0.0113	0.259																	in utero embryonic development;negative regulation of inflammatory response to antigenic stimulus;epidermal growth factor receptor signaling pathway;phospholipid catabolic process;positive regulation of epithelial cell migration;cell migration;calcium-mediated signaling;Fc-epsilon receptor signaling pathway;positive regulation of blood vessel endothelial cell migration;positive regulation of angiogenesis;phosphatidylinositol metabolic process;phosphatidylinositol-mediated signaling;modulation of chemical synaptic transmission;T cell receptor signaling pathway;release of sequestered calcium ion into cytosol;positive regulation of release of sequestered calcium ion into cytosol;cellular response to epidermal growth factor stimulus;positive regulation of vascular endothelial cell proliferation;positive regulation of endothelial cell apoptotic process	GO:0001701;GO:0002862;GO:0007173;GO:0009395;GO:0010634;GO:0016477;GO:0019722;GO:0038095;GO:0043536;GO:0045766;GO:0046488;GO:0048015;GO:0050804;GO:0050852;GO:0051209;GO:0051281;GO:0071364;GO:1905564;GO:2000353	ruffle;cytoplasm;cytosol;plasma membrane;cell-cell junction;COP9 signalosome;lamellipodium;ruffle membrane;cell projection;Schaffer collateral - CA1 synapse;glutamatergic synapse	GO:0001726;GO:0005737;GO:0005829;GO:0005886;GO:0005911;GO:0008180;GO:0030027;GO:0032587;GO:0042995;GO:0098685;GO:0098978	phosphatidylinositol phospholipase C activity;phospholipase C activity;guanyl-nucleotide exchange factor activity;neurotrophin TRKA receptor binding;calcium ion binding;protein binding;protein kinase binding;receptor tyrosine kinase binding;glutamate receptor binding;calcium-dependent phospholipase C activity	GO:0004435;GO:0004629;GO:0005085;GO:0005168;GO:0005509;GO:0005515;GO:0019901;GO:0030971;GO:0035254;GO:0050429	25.0	29ff5368-5521-11e7-8f50-0ac135e8bacf,32ff1916-5521-11e7-8f50-0ac135e8bacf,3c88330c-5521-11e7-8f50-0ac135e8bacf,412efed6-5521-11e7-8f50-0ac135e8bacf,4362cec8-5521-11e7-8f50-0ac135e8bacf,4c90f780-5521-11e7-8f50-0ac135e8bacf,5189b3dc-5521-11e7-8f50-0ac135e8bacf,55522d94-5521-11e7-8f50-0ac135e8bacf,5a09c23a-5521-11e7-8f50-0ac135e8bacf,5be67180-5521-11e7-8f50-0ac135e8bacf,6d5dba0c-5521-11e7-8f50-0ac135e8bacf,7ac7dec6-5521-11e7-8f50-0ac135e8bacf,7cceab48-5521-11e7-8f50-0ac135e8bacf,854f7c00-5521-11e7-8f50-0ac135e8bacf,898a6694-5521-11e7-8f50-0ac135e8bacf,8ba07556-5521-11e7-8f50-0ac135e8bacf,8daf7f38-5521-11e7-8f50-0ac135e8bacf,8ed3dafe-5521-11e7-8f50-0ac135e8bacf,924f9444-5521-11e7-8f50-0ac135e8bacf,bf958bd4-5521-11e7-8f50-0ac135e8bacf,c02fa8f6-5521-11e7-8f50-0ac135e8bacf,cbc18b34-5521-11e7-8f50-0ac135e8bacf,d269a540-5521-11e7-8f50-0ac135e8bacf,d992af1e-5521-11e7-8f50-0ac135e8bacf,e4e93610-5521-11e7-8f50-0ac135e8bacf	EGF receptor (ErbB1) signaling pathway,VEGFR1 specific signals,Trk receptor signaling mediated by PI3K and PLC-gamma,TCR signaling in naive CD8 T cells,TCR signaling in naive CD4 T cells,Signaling events mediated by VEGFR1 and VEGFR2,Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met),Signaling events mediated by focal adhesion kinase,S1P4 pathway,S1P1 pathway,Regulation of CDC42 activity,PDGFR-beta signaling pathway,PDGFR-alpha signaling pathway,Nongenotropic Androgen signaling,Neurotrophic factor-mediated Trk receptor signaling,Netrin-mediated signaling events,NephrinNeph1 signaling in the kidney podocyte,N-cadherin signaling events,LPA receptor mediated events,FGF signaling pathway,Fc-epsilon receptor I signaling in mast cells,EPO signaling pathway,EPHA forward signaling,E-cadherin signaling in keratinocytes,Class I PI3K signaling events											
chr1:27094392:A/G	ARID1A p.Lys1034Glu		8.0	0.0119887165021156			chr1	27094392	A	G	4		Yes	ARID1A	ENST00000324856.13	missense_variant	11.0	c.3100A>G	p.Lys1034Glu	26767901							7.53e-06	0.0																	nucleosome disassembly;chromatin remodeling;regulation of transcription by RNA polymerase II;nervous system development;regulation of mitotic metaphase/anaphase transition;intracellular estrogen receptor signaling pathway;androgen receptor signaling pathway;intracellular glucocorticoid receptor signaling pathway;positive regulation of T cell differentiation;positive regulation of cell differentiation;positive regulation of myoblast differentiation;transcription initiation-coupled chromatin remodeling;positive regulation of DNA-templated transcription;regulation of G0 to G1 transition;positive regulation of stem cell population maintenance;regulation of G1/S transition of mitotic cell cycle;positive regulation of double-strand break repair;regulation of nucleotide-excision repair	GO:0006337;GO:0006338;GO:0006357;GO:0007399;GO:0030071;GO:0030520;GO:0030521;GO:0042921;GO:0045582;GO:0045597;GO:0045663;GO:0045815;GO:0045893;GO:0070316;GO:1902459;GO:2000045;GO:2000781;GO:2000819	chromatin;nucleus;nucleoplasm;SWI/SNF complex;brahma complex;npBAF complex;nBAF complex;bBAF complex	GO:0000785;GO:0005634;GO:0005654;GO:0016514;GO:0035060;GO:0071564;GO:0071565;GO:0140092	DNA binding;transcription coactivator activity;protein binding;nuclear receptor binding;nucleosome binding	GO:0003677;GO:0003713;GO:0005515;GO:0016922;GO:0031491														
chr2:148602671:A/G	ACVR2A 5_prime_UTR_variant		4.0	0.0019387359441644			chr2	148602671	A	G	4			ACVR2A	ENST00000241416.12	5_prime_UTR_variant	1.0	c.-51A>G		147845102																									gastrulation with mouth forming second;positive regulation of protein phosphorylation;protein phosphorylation;cell surface receptor protein serine/threonine kinase signaling pathway;spermatogenesis;determination of left/right symmetry;mesoderm development;anterior/posterior pattern specification;positive regulation of bone mineralization;BMP signaling pathway;activin receptor signaling pathway;positive regulation of activin receptor signaling pathway;odontogenesis of dentin-containing tooth;sperm ejaculation;penile erection;regulation of nitric oxide biosynthetic process;positive regulation of erythrocyte differentiation;positive regulation of osteoblast differentiation;positive regulation of transcription by RNA polymerase II;embryonic skeletal system development;Sertoli cell proliferation;positive regulation of SMAD protein signal transduction;cellular response to growth factor stimulus;cellular response to BMP stimulus	GO:0001702;GO:0001934;GO:0006468;GO:0007178;GO:0007283;GO:0007368;GO:0007498;GO:0009952;GO:0030501;GO:0030509;GO:0032924;GO:0032927;GO:0042475;GO:0042713;GO:0043084;GO:0045428;GO:0045648;GO:0045669;GO:0045944;GO:0048706;GO:0060011;GO:0060391;GO:0071363;GO:0071773	cytoplasm;plasma membrane;cell surface;inhibin-betaglycan-ActRII complex;receptor complex;activin receptor complex	GO:0005737;GO:0005886;GO:0009986;GO:0034673;GO:0043235;GO:0048179	protein serine/threonine kinase activity;transmembrane receptor protein serine/threonine kinase activity;protein binding;ATP binding;coreceptor activity;activin receptor activity;growth factor binding;PDZ domain binding;inhibin binding;metal ion binding;activin binding;BMP receptor activity	GO:0004674;GO:0004675;GO:0005515;GO:0005524;GO:0015026;GO:0017002;GO:0019838;GO:0030165;GO:0034711;GO:0046872;GO:0048185;GO:0098821	1.0	05263ad2-5522-11e7-8f50-0ac135e8bacf	ALK1 signaling events											
chr20:57415609:C/T	GNAS p.Pro150Ser						chr20	57415609	C	T	4		Yes	GNAS	ENST00000313949.11	missense_variant	1.0	c.448C>T	p.Pro150Ser	58840554							0.155	0.0404																	adenylate cyclase-activating G protein-coupled receptor signaling pathway;adenylate cyclase-activating dopamine receptor signaling pathway;sensory perception of chemical stimulus;developmental growth;bone development;platelet aggregation;positive regulation of cold-induced thermogenesis	GO:0007189;GO:0007191;GO:0007606;GO:0048589;GO:0060348;GO:0070527;GO:0120162	cytoplasm;cytosol;heterotrimeric G-protein complex;membrane;apical plasma membrane;extracellular exosome	GO:0005737;GO:0005829;GO:0005834;GO:0016020;GO:0016324;GO:0070062	GTPase activity;insulin-like growth factor receptor binding;protein binding;GTP binding;adenylate cyclase activator activity;G-protein beta/gamma-subunit complex binding;beta-2 adrenergic receptor binding;D1 dopamine receptor binding;mu-type opioid receptor binding;ionotropic glutamate receptor binding;metal ion binding;corticotropin-releasing hormone receptor 1 binding	GO:0003924;GO:0005159;GO:0005515;GO:0005525;GO:0010856;GO:0031683;GO:0031698;GO:0031748;GO:0031852;GO:0035255;GO:0046872;GO:0051430	4.0	72929504-5521-11e7-8f50-0ac135e8bacf,78974324-5521-11e7-8f50-0ac135e8bacf,916de6d2-5521-11e7-8f50-0ac135e8bacf,d306cfa2-5521-11e7-8f50-0ac135e8bacf	Rapid glucocorticoid signaling,Plasma membrane estrogen receptor signaling,LPA4-mediated signaling events,Endothelins											
chrX:44896893:T/C	KDM6A intron_variant		6.0	0.0016366612111292			chrX	44896893	T	C	4			KDM6A	ENST00000611820.4	intron_variant		c.548-7T>C		45037648																									chromatin remodeling;heart development;regulation of gene expression	GO:0006338;GO:0007507;GO:0010468	nucleus;nucleoplasm;histone methyltransferase complex;MLL3/4 complex	GO:0005634;GO:0005654;GO:0035097;GO:0044666	RNA polymerase II cis-regulatory region sequence-specific DNA binding;protein binding;chromatin DNA binding;histone demethylase activity;metal ion binding;histone H3K27me2/H3K27me3 demethylase activity	GO:0000978;GO:0005515;GO:0031490;GO:0032452;GO:0046872;GO:0071558														
chr19:36222924:C/T	KMT2B p.Ser1851=		2.0	0.0013093289689034			chr19	36222924	C	T	4		Yes	KMT2B	ENST00000420124.3	synonymous_variant	27.0	c.5553C>T	p.Ser1851=	35732023													COSV55861534	"[[""large intestine"", 1]]"	1.0	ENST00000420124.2	S1851%3D	Exact Match	Likely benign	MedGen:C3661900	not provided	criteria provided, multiple submitters, no conflicts	2056890.0		chromatin remodeling;methylation;positive regulation of DNA-templated transcription	GO:0006338;GO:0032259;GO:0045893	nucleus;nucleoplasm;histone methyltransferase complex;MLL1/2 complex	GO:0005634;GO:0005654;GO:0035097;GO:0044665	protein binding;zinc ion binding;histone H3K4 methyltransferase activity;unmethylated CpG binding;histone H3K4 monomethyltransferase activity;histone H3K4 trimethyltransferase activity	GO:0005515;GO:0008270;GO:0042800;GO:0045322;GO:0140945;GO:0140999				rs767726790		2.79209e-05	2.37982e-05	0.0	0.000319693	0.0	0.0	3.09847e-05	0.0	0.0
chr20:50140547:A/G	NFATC2 p.Leu78Pro		4.0	0.0015509887553315			chr20	50140547	A	G	4		Yes	NFATC2	ENST00000371564.8	missense_variant	2.0	c.233T>C	p.Leu78Pro	51524008							0.162	0.33																	negative regulation of transcription by RNA polymerase II;cytokine production;regulation of DNA-templated transcription;regulation of transcription by RNA polymerase II;transcription by RNA polymerase II;DNA damage response;response to xenobiotic stimulus;positive regulation of gene expression;myotube cell development;cell migration;positive regulation of B cell proliferation;calcineurin-NFAT signaling cascade;positive regulation of DNA-templated transcription;positive regulation of transcription by RNA polymerase II;B cell receptor signaling pathway;cartilage development;cellular response to calcium ion;positive regulation of myoblast fusion;negative regulation of vascular associated smooth muscle cell differentiation	GO:0000122;GO:0001816;GO:0006355;GO:0006357;GO:0006366;GO:0006974;GO:0009410;GO:0010628;GO:0014904;GO:0016477;GO:0030890;GO:0033173;GO:0045893;GO:0045944;GO:0050853;GO:0051216;GO:0071277;GO:1901741;GO:1905064	chromatin;nucleus;nucleoplasm;transcription regulator complex;cytoplasm;cytosol;transcription factor AP-1 complex;ribonucleoprotein complex	GO:0000785;GO:0005634;GO:0005654;GO:0005667;GO:0005737;GO:0005829;GO:0035976;GO:1990904	RNA polymerase II cis-regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA binding;chromatin binding;DNA-binding transcription factor activity;protein binding;transcription factor binding;phosphatase binding;molecular adaptor activity;14-3-3 protein binding;sequence-specific double-stranded DNA binding	GO:0000978;GO:0000981;GO:0001227;GO:0001228;GO:0003677;GO:0003682;GO:0003700;GO:0005515;GO:0008134;GO:0019902;GO:0060090;GO:0071889;GO:1990837	11.0	354c647e-5521-11e7-8f50-0ac135e8bacf,5d059d24-5521-11e7-8f50-0ac135e8bacf,87690d32-5521-11e7-8f50-0ac135e8bacf,a8411a5c-5521-11e7-8f50-0ac135e8bacf,ac694040-5521-11e7-8f50-0ac135e8bacf,bb3d7c4a-5521-11e7-8f50-0ac135e8bacf,c02fa8f6-5521-11e7-8f50-0ac135e8bacf,da3d4700-5521-11e7-8f50-0ac135e8bacf,edcdd2a4-5521-11e7-8f50-0ac135e8bacf,ee661b06-5521-11e7-8f50-0ac135e8bacf,fd2c9b80-5521-11e7-8f50-0ac135e8bacf	Validated transcriptional targets of AP1 family members Fra1 and Fra2,Role of Calcineurin-dependent NFAT signaling in lymphocytes,Noncanonical Wnt signaling pathway,IL2 signaling events mediated by PI3K,IL12 signaling mediated by STAT4,Glucocorticoid receptor regulatory network,Fc-epsilon receptor I signaling in mast cells,Downstream signaling in naive CD8 T cells,Calcium signaling in the CD4 TCR pathway,Calcineurin-regulated NFAT-dependent transcription in lymphocytes,AP-1 transcription factor network											
chr1:115256505:T/C	NRAS p.Asp69Gly	1.0	4.0	0.0015509887553315			chr1	115256505	T	C	4		Yes	NRAS	ENST00000369535.5	missense_variant	3.0	c.206A>G	p.Asp69Gly	114713884							1.89e-05	0.173																	MAPK cascade;positive regulation of endothelial cell proliferation;Ras protein signal transduction;myoblast differentiation	GO:0000165;GO:0001938;GO:0007265;GO:0045445	Golgi membrane;endoplasmic reticulum membrane;Golgi apparatus;cytosol;plasma membrane;membrane;extracellular exosome;tertiary granule membrane	GO:0000139;GO:0005789;GO:0005794;GO:0005829;GO:0005886;GO:0016020;GO:0070062;GO:0070821	GTPase activity;G protein activity;protein binding;GTP binding;GDP binding;protein-containing complex binding	GO:0003924;GO:0003925;GO:0005515;GO:0005525;GO:0019003;GO:0044877	22.0	29ff5368-5521-11e7-8f50-0ac135e8bacf,3be95afa-5521-11e7-8f50-0ac135e8bacf,3c88330c-5521-11e7-8f50-0ac135e8bacf,412efed6-5521-11e7-8f50-0ac135e8bacf,4362cec8-5521-11e7-8f50-0ac135e8bacf,576974d6-5521-11e7-8f50-0ac135e8bacf,65205a00-5521-11e7-8f50-0ac135e8bacf,720b3c92-5521-11e7-8f50-0ac135e8bacf,78974324-5521-11e7-8f50-0ac135e8bacf,7ac7dec6-5521-11e7-8f50-0ac135e8bacf,898a6694-5521-11e7-8f50-0ac135e8bacf,8f640d10-5521-11e7-8f50-0ac135e8bacf,95fd0bec-5521-11e7-8f50-0ac135e8bacf,a59cd558-5521-11e7-8f50-0ac135e8bacf,b7824902-5521-11e7-8f50-0ac135e8bacf,c70366de-5521-11e7-8f50-0ac135e8bacf,c92b28e0-5521-11e7-8f50-0ac135e8bacf,ce49e3cc-5521-11e7-8f50-0ac135e8bacf,da3d4700-5521-11e7-8f50-0ac135e8bacf,e1b66caa-5521-11e7-8f50-0ac135e8bacf,e4e93610-5521-11e7-8f50-0ac135e8bacf,ef96f9ea-5521-11e7-8f50-0ac135e8bacf	EGF receptor (ErbB1) signaling pathway,Trk receptor signaling mediated by the MAPK pathway,Trk receptor signaling mediated by PI3K and PLC-gamma,TCR signaling in naive CD8 T cells,TCR signaling in naive CD4 T cells,SHP2 signaling,Regulation of Ras family activation,Ras signaling in the CD4 TCR pathway,Plasma membrane estrogen receptor signaling,PDGFR-beta signaling pathway,Neurotrophic factor-mediated Trk receptor signaling,mTOR signaling pathway,Internalization of ErbB1,IL2-mediated signaling events,GMCSF-mediated signaling events,ErbB2ErbB3 signaling events,ErbB1 downstream signaling,EPHB forward signaling,Downstream signaling in naive CD8 T cells,CXCR3-mediated signaling events,Class I PI3K signaling events,C-MYB transcription factor network											
chr3:52436820:T/C	BAP1 p.Glu653Gly		2.0	0.002291325695581			chr3	52436820	T	C	4		Yes	BAP1	ENST00000460680.6	missense_variant	15.0	c.1958A>G	p.Glu653Gly	52402804							1.6e-06	0.0278																	mitotic cell cycle;regulation of cell growth;in utero embryonic development;tissue homeostasis;thrombocyte differentiation;chromatin remodeling;ubiquitin-dependent protein catabolic process;negative regulation of cell population proliferation;response to inorganic substance;gene expression;protein deubiquitination;neutrophil differentiation;myeloid cell apoptotic process;monoubiquitinated protein deubiquitination;common myeloid progenitor cell proliferation;protein modification process;platelet morphogenesis;erythrocyte maturation;nucleate erythrocyte differentiation;negative regulation of DNA-templated transcription;regulation of inflammatory response;regulation of cell cycle;hematopoietic stem cell homeostasis;macrophage homeostasis;neuron cellular homeostasis;leukocyte proliferation;protein K48-linked deubiquitination;regulation of cytokine production involved in inflammatory response;positive regulation of protein targeting to mitochondrion	GO:0000278;GO:0001558;GO:0001701;GO:0001894;GO:0002574;GO:0006338;GO:0006511;GO:0008285;GO:0010035;GO:0010467;GO:0016579;GO:0030223;GO:0033028;GO:0035520;GO:0035726;GO:0036211;GO:0036344;GO:0043249;GO:0043363;GO:0045892;GO:0050727;GO:0051726;GO:0061484;GO:0061519;GO:0070050;GO:0070661;GO:0071108;GO:1900015;GO:1903955	nucleus;nucleoplasm;cytoplasm;cytosol;PR-DUB complex	GO:0005634;GO:0005654;GO:0005737;GO:0005829;GO:0035517	chromatin binding;cysteine-type deubiquitinase activity;protein binding;peptidase activity;chromatin DNA binding;histone H2A deubiquitinase activity	GO:0003682;GO:0004843;GO:0005515;GO:0008233;GO:0031490;GO:0140950														
chr12:52387916:A/G	ACVR1B 3_prime_UTR_variant		8.0	0.0058329444703686			chr12	52387916	A	G	4			ACVR1B	ENST00000257963.9	3_prime_UTR_variant	9.0	c.*22A>G		51994132																									G1/S transition of mitotic cell cycle;in utero embryonic development;hair follicle development;regulation of DNA-templated transcription;protein phosphorylation;signal transduction;cell surface receptor protein serine/threonine kinase signaling pathway;nervous system development;positive regulation of gene expression;negative regulation of gene expression;peptidyl-threonine phosphorylation;negative regulation of cell growth;activin receptor signaling pathway;positive regulation of activin receptor signaling pathway;nodal signaling pathway;positive regulation of erythrocyte differentiation;protein autophosphorylation;cellular response to growth factor stimulus;extrinsic apoptotic signaling pathway;positive regulation of trophoblast cell migration	GO:0000082;GO:0001701;GO:0001942;GO:0006355;GO:0006468;GO:0007165;GO:0007178;GO:0007399;GO:0010628;GO:0010629;GO:0018107;GO:0030308;GO:0032924;GO:0032927;GO:0038092;GO:0045648;GO:0046777;GO:0071363;GO:0097191;GO:1901165	cytosol;plasma membrane;cell surface;receptor complex;activin receptor complex	GO:0005829;GO:0005886;GO:0009986;GO:0043235;GO:0048179	protein serine/threonine kinase activity;transmembrane receptor protein serine/threonine kinase activity;protein binding;ATP binding;activin receptor activity, type I;activin receptor activity;growth factor binding;ubiquitin protein ligase binding;inhibin binding;SMAD binding;metal ion binding;activin binding;I-SMAD binding	GO:0004674;GO:0004675;GO:0005515;GO:0005524;GO:0016361;GO:0017002;GO:0019838;GO:0031625;GO:0034711;GO:0046332;GO:0046872;GO:0048185;GO:0070411														
chr17:63534300:A/G	AXIN2 intron_variant		7.0	0.0018699098180582			chr17	63534300	A	G	4			AXIN2	ENST00000307078.10	intron_variant		c.1200+21T>C		65538182																									osteoblast differentiation;somitogenesis;positive regulation of protein phosphorylation;intramembranous ossification;secondary heart field specification;aortic valve morphogenesis;mitral valve morphogenesis;chondrocyte differentiation involved in endochondral bone morphogenesis;protein localization;dorsal/ventral axis specification;positive regulation of epithelial to mesenchymal transition;bone mineralization;regulation of mismatch repair;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;osteoblast proliferation;negative regulation of osteoblast proliferation;odontogenesis;proteasome-mediated ubiquitin-dependent protein catabolic process;maintenance of DNA repeat elements;positive regulation of fat cell differentiation;negative regulation of osteoblast differentiation;positive regulation of protein kinase activity;mRNA stabilization;cell development;canonical Wnt signaling pathway;regulation of chondrocyte development;regulation of centromeric sister chromatid cohesion;cellular response to dexamethasone stimulus;stem cell proliferation;negative regulation of canonical Wnt signaling pathway;regulation of extracellular matrix organization	GO:0001649;GO:0001756;GO:0001934;GO:0001957;GO:0003139;GO:0003180;GO:0003183;GO:0003413;GO:0008104;GO:0009950;GO:0010718;GO:0030282;GO:0032423;GO:0032436;GO:0033687;GO:0033689;GO:0042476;GO:0043161;GO:0043570;GO:0045600;GO:0045668;GO:0045860;GO:0048255;GO:0048468;GO:0060070;GO:0061181;GO:0070602;GO:0071549;GO:0072089;GO:0090090;GO:1903053	nucleus;cytoplasm;centrosome;cytosol;plasma membrane;beta-catenin destruction complex	GO:0005634;GO:0005737;GO:0005813;GO:0005829;GO:0005886;GO:0030877	protein binding;beta-catenin binding;enzyme binding;protein kinase binding;ubiquitin protein ligase binding;molecular adaptor activity;I-SMAD binding	GO:0005515;GO:0008013;GO:0019899;GO:0019901;GO:0031625;GO:0060090;GO:0070411	3.0	3ab9dba6-5521-11e7-8f50-0ac135e8bacf,6aae5178-5521-11e7-8f50-0ac135e8bacf,def3ca36-5521-11e7-8f50-0ac135e8bacf	Validated nuclear estrogen receptor alpha network,Regulation of nuclear beta catenin signaling and target gene transcription,Degradation of beta catenin											
chr10:88635676:T/C	BMPR1A 5_prime_UTR_variant		3.0	0.0016716518990913			chr10	88635676	T	C	4			BMPR1A	ENST00000372037.7	5_prime_UTR_variant	3.0	c.-100T>C		86875919																									angiogenesis;osteoblast differentiation;in utero embryonic development;mesoderm formation;somitogenesis;Mullerian duct regression;positive regulation of mesenchymal cell proliferation;chondrocyte differentiation;outflow tract septum morphogenesis;outflow tract morphogenesis;cardiac conduction system development;atrioventricular valve development;mitral valve morphogenesis;tricuspid valve morphogenesis;endocardial cushion morphogenesis;cardiac right ventricle morphogenesis;ventricular trabecula myocardium morphogenesis;ventricular compact myocardium morphogenesis;endocardial cushion formation;protein phosphorylation;immune response;transforming growth factor beta receptor signaling pathway;ectoderm development;dorsal/ventral axis specification;dorsal/ventral pattern formation;positive regulation of gene expression;negative regulation of gene expression;regulation of cardiac muscle cell apoptotic process;neural crest cell development;negative regulation of smooth muscle cell migration;central nervous system neuron differentiation;pituitary gland development;neural plate mediolateral regionalization;lung development;positive regulation of bone mineralization;BMP signaling pathway;positive regulation of transforming growth factor beta2 production;somatic stem cell population maintenance;hindlimb morphogenesis;dorsal aorta morphogenesis;odontogenesis of dentin-containing tooth;embryonic digit morphogenesis;positive regulation of osteoblast differentiation;positive regulation of transcription by RNA polymerase II;paraxial mesoderm structural organization;lateral mesoderm development;regulation of lateral mesodermal cell fate specification;mesendoderm development;embryonic organ development;developmental growth;epithelial cell proliferation;positive regulation of epithelial cell proliferation;negative regulation of neurogenesis;negative regulation of muscle cell differentiation;roof of mouth development;regulation of cardiac muscle cell proliferation;positive regulation of cardiac muscle cell proliferation;positive regulation of SMAD protein signal transduction;ventricular septum morphogenesis;heart formation;atrioventricular node cell development;pharyngeal arch artery morphogenesis;cellular response to growth factor stimulus;cellular response to BMP stimulus;positive regulation of miRNA transcription;positive regulation of cardiac ventricle development;positive regulation of vascular associated smooth muscle cell proliferation;fibrous ring of heart morphogenesis;regulation of neural crest cell differentiation;regulation of cellular senescence	GO:0001525;GO:0001649;GO:0001701;GO:0001707;GO:0001756;GO:0001880;GO:0002053;GO:0002062;GO:0003148;GO:0003151;GO:0003161;GO:0003171;GO:0003183;GO:0003186;GO:0003203;GO:0003215;GO:0003222;GO:0003223;GO:0003272;GO:0006468;GO:0006955;GO:0007179;GO:0007398;GO:0009950;GO:0009953;GO:0010628;GO:0010629;GO:0010665;GO:0014032;GO:0014912;GO:0021953;GO:0021983;GO:0021998;GO:0030324;GO:0030501;GO:0030509;GO:0032915;GO:0035019;GO:0035137;GO:0035912;GO:0042475;GO:0042733;GO:0045669;GO:0045944;GO:0048352;GO:0048368;GO:0048378;GO:0048382;GO:0048568;GO:0048589;GO:0050673;GO:0050679;GO:0050768;GO:0051148;GO:0060021;GO:0060043;GO:0060045;GO:0060391;GO:0060412;GO:0060914;GO:0060928;GO:0061626;GO:0071363;GO:0071773;GO:1902895;GO:1904414;GO:1904707;GO:1905285;GO:1905292;GO:2000772	plasma membrane;caveola;external side of plasma membrane;membrane;dendrite;neuronal cell body;receptor complex;HFE-transferrin receptor complex	GO:0005886;GO:0005901;GO:0009897;GO:0016020;GO:0030425;GO:0043025;GO:0043235;GO:1990712	protein serine/threonine kinase activity;transmembrane receptor protein serine/threonine kinase activity;transforming growth factor beta receptor activity, type I;protein binding;ATP binding;BMP binding;protein homodimerization activity;SMAD binding;metal ion binding;BMP receptor activity	GO:0004674;GO:0004675;GO:0005025;GO:0005515;GO:0005524;GO:0036122;GO:0042803;GO:0046332;GO:0046872;GO:0098821	1.0	f1ae1a1c-5521-11e7-8f50-0ac135e8bacf	BMP receptor signaling											
chr7:151962273:G/C	KMT2C p.Ala345Gly		8.0	0.0076994867008866			chr7	151962273	G	C	4		Yes	KMT2C	ENST00000262189.11	missense_variant	8.0	c.1034C>G	p.Ala345Gly	152265188							0.0755	0.0508					COSV105089105	"[[""haematopoietic and lymphoid tissue"", 1]]"	1.0	ENST00000355193.6	A345V	Genomic Location							chromatin remodeling;methylation;positive regulation of transcription by RNA polymerase II;response to electrical stimulus	GO:0006338;GO:0032259;GO:0045944;GO:0051602	nucleus;nucleoplasm;cytosol;histone methyltransferase complex;MLL3/4 complex	GO:0005634;GO:0005654;GO:0005829;GO:0035097;GO:0044666	DNA binding;transcription coactivator activity;RNA binding;protein binding;acyltransferase activity;histone methyltransferase activity;histone H3K4 methyltransferase activity;metal ion binding;histone H3K4 monomethyltransferase activity;histone H3K4 trimethyltransferase activity	GO:0003677;GO:0003713;GO:0003723;GO:0005515;GO:0016746;GO:0042054;GO:0042800;GO:0046872;GO:0140945;GO:0140999														
chr18:45368338:A/G	SMAD2 intron_variant		4.0	0.0012671594508975			chr18	45368338	A	G	4			SMAD2	ENST00000262160.11	intron_variant		c.1281-17T>C		47841967																									ureteric bud development;in utero embryonic development;endoderm formation;mesoderm formation;determination of left/right asymmetry in lateral mesoderm;aortic valve morphogenesis;pulmonary valve morphogenesis;endocardial cushion morphogenesis;DNA-templated transcription;regulation of DNA-templated transcription;transforming growth factor beta receptor signaling pathway;zygotic specification of dorsal/ventral axis;gastrulation;cell population proliferation;negative regulation of cell population proliferation;anatomical structure morphogenesis;post-embryonic development;anterior/posterior pattern specification;positive regulation of gene expression;positive regulation of epithelial to mesenchymal transition;regulation of transforming growth factor beta receptor signaling pathway;signal transduction involved in regulation of gene expression;insulin secretion;cell differentiation;lung development;adrenal gland development;positive regulation of BMP signaling pathway;pancreas development;primary miRNA processing;activin receptor signaling pathway;organ growth;intracellular signal transduction;nodal signaling pathway;cell fate commitment;negative regulation of DNA-templated transcription;positive regulation of DNA-templated transcription;positive regulation of transcription by RNA polymerase II;paraxial mesoderm morphogenesis;embryonic foregut morphogenesis;embryonic cranial skeleton morphogenesis;regulation of binding;pericardium development;SMAD protein signal transduction;secondary palate development;response to cholesterol;cellular response to glucose stimulus;odontoblast differentiation	GO:0001657;GO:0001701;GO:0001706;GO:0001707;GO:0003140;GO:0003180;GO:0003184;GO:0003203;GO:0006351;GO:0006355;GO:0007179;GO:0007352;GO:0007369;GO:0008283;GO:0008285;GO:0009653;GO:0009791;GO:0009952;GO:0010628;GO:0010718;GO:0017015;GO:0023019;GO:0030073;GO:0030154;GO:0030324;GO:0030325;GO:0030513;GO:0031016;GO:0031053;GO:0032924;GO:0035265;GO:0035556;GO:0038092;GO:0045165;GO:0045892;GO:0045893;GO:0045944;GO:0048340;GO:0048617;GO:0048701;GO:0051098;GO:0060039;GO:0060395;GO:0062009;GO:0070723;GO:0071333;GO:0071895	chromatin;nucleus;nucleoplasm;transcription regulator complex;cytoplasm;cytosol;activin responsive factor complex;protein-containing complex;SMAD protein complex;homomeric SMAD protein complex;heteromeric SMAD protein complex	GO:0000785;GO:0005634;GO:0005654;GO:0005667;GO:0005737;GO:0005829;GO:0032444;GO:0032991;GO:0071141;GO:0071142;GO:0071144	RNA polymerase II cis-regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;cis-regulatory region sequence-specific DNA binding;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA binding;chromatin binding;double-stranded DNA binding;DNA-binding transcription factor activity;transforming growth factor beta receptor binding;protein binding;phosphatase binding;ubiquitin protein ligase binding;type I transforming growth factor beta receptor binding;identical protein binding;SMAD binding;metal ion binding;tau protein binding;RNA polymerase II-specific DNA-binding transcription factor binding;co-SMAD binding;I-SMAD binding;R-SMAD binding;disordered domain specific binding;DNA-binding transcription factor binding	GO:0000978;GO:0000981;GO:0000987;GO:0001228;GO:0003677;GO:0003682;GO:0003690;GO:0003700;GO:0005160;GO:0005515;GO:0019902;GO:0031625;GO:0034713;GO:0042802;GO:0046332;GO:0046872;GO:0048156;GO:0061629;GO:0070410;GO:0070411;GO:0070412;GO:0097718;GO:0140297	5.0	35f28f90-5521-11e7-8f50-0ac135e8bacf,408a0c44-5521-11e7-8f50-0ac135e8bacf,68975856-5521-11e7-8f50-0ac135e8bacf,6cb6085a-5521-11e7-8f50-0ac135e8bacf,ba907368-5521-11e7-8f50-0ac135e8bacf	Validated targets of C-MYC transcriptional repression,TGF-beta receptor signaling,Regulation of nuclear SMAD23 signaling,Regulation of cytoplasmic and nuclear SMAD23 signaling,Glypican 1 network											
chr16:3778911:G/A	CREBBP p.Ala2046Val		5.0	0.0014994374517167			chr16	3778911	G	A	4		Yes	CREBBP	ENST00000262367.10	missense_variant	31.0	c.6137C>T	p.Ala2046Val	3728910							0.0115	0.106					COSV52118312	"[[""penis"", 1], [""vulva"", 1]]"	2.0	ENST00000382070.7	A2046V	Exact Match	Conflicting classifications of pathogenicity	.|MeSH:D030342,MedGen:C0950123|MONDO:MONDO:0019188,MedGen:C0035934,OMIM:PS180849,Orphanet:783	CREBBP-related condition|Inborn genetic diseases|Rubinstein-Taybi syndrome	criteria provided, conflicting classifications	1751812.0	Uncertain significance(2)|Benign(1)	negative regulation of transcription by RNA polymerase II;response to hypoxia;stimulatory C-type lectin receptor signaling pathway;chromatin remodeling;regulation of DNA-templated transcription;protein acetylation;signal transduction;canonical NF-kappaB signal transduction;regulation of smoothened signaling pathway;negative regulation of transcription by RNA polymerase I;N-terminal peptidyl-lysine acetylation;positive regulation of transforming growth factor beta receptor signaling pathway;protein destabilization;cellular response to nutrient levels;cellular response to UV;homeostatic process;embryonic digit morphogenesis;positive regulation of DNA-templated transcription;positive regulation of transcription by RNA polymerase II;rhythmic process;protein-containing complex assembly;regulation of cellular response to heat;positive regulation of protein localization to nucleus;positive regulation of double-strand break repair via homologous recombination	GO:0000122;GO:0001666;GO:0002223;GO:0006338;GO:0006355;GO:0006473;GO:0007165;GO:0007249;GO:0008589;GO:0016479;GO:0018076;GO:0030511;GO:0031648;GO:0031669;GO:0034644;GO:0042592;GO:0042733;GO:0045893;GO:0045944;GO:0048511;GO:0065003;GO:1900034;GO:1900182;GO:1905168	histone acetyltransferase complex;chromatin;nucleus;nucleoplasm;transcription regulator complex;cytoplasm;cytosol;nuclear body	GO:0000123;GO:0000785;GO:0005634;GO:0005654;GO:0005667;GO:0005737;GO:0005829;GO:0016604	transcription coactivator binding;p53 binding;chromatin binding;damaged DNA binding;transcription coactivator activity;transcription corepressor activity;histone acetyltransferase activity;protein binding;zinc ion binding;acetyltransferase activity;chromatin DNA binding;peptide N-acetyltransferase activity;MRF binding;histone H3K18 acetyltransferase activity;histone H3K27 acetyltransferase activity;RNA polymerase II-specific DNA-binding transcription factor binding;peptide-lysine-N-acetyltransferase activity;peptide lactyltransferase activity;DNA-binding transcription factor binding	GO:0001223;GO:0002039;GO:0003682;GO:0003684;GO:0003713;GO:0003714;GO:0004402;GO:0005515;GO:0008270;GO:0016407;GO:0031490;GO:0034212;GO:0043426;GO:0043993;GO:0044017;GO:0061629;GO:0061733;GO:0120300;GO:0140297	26.0	3814fa62-5521-11e7-8f50-0ac135e8bacf,4f25fa44-5521-11e7-8f50-0ac135e8bacf,4fc2fd96-5521-11e7-8f50-0ac135e8bacf,538cfdee-5521-11e7-8f50-0ac135e8bacf,54bc0812-5521-11e7-8f50-0ac135e8bacf,5d059d24-5521-11e7-8f50-0ac135e8bacf,5fa96cf8-5521-11e7-8f50-0ac135e8bacf,6309aefe-5521-11e7-8f50-0ac135e8bacf,68975856-5521-11e7-8f50-0ac135e8bacf,6f7a316e-5521-11e7-8f50-0ac135e8bacf,7455058a-5521-11e7-8f50-0ac135e8bacf,74f0d05c-5521-11e7-8f50-0ac135e8bacf,81be3ee4-5521-11e7-8f50-0ac135e8bacf,841dd9cc-5521-11e7-8f50-0ac135e8bacf,ac694040-5521-11e7-8f50-0ac135e8bacf,afa50a56-5521-11e7-8f50-0ac135e8bacf,b2bcaa9c-5521-11e7-8f50-0ac135e8bacf,b354a4de-5521-11e7-8f50-0ac135e8bacf,b568dee0-5521-11e7-8f50-0ac135e8bacf,bb3d7c4a-5521-11e7-8f50-0ac135e8bacf,bd570d7c-5521-11e7-8f50-0ac135e8bacf,bddf504e-5521-11e7-8f50-0ac135e8bacf,bf04bd82-5521-11e7-8f50-0ac135e8bacf,d6e9881a-5521-11e7-8f50-0ac135e8bacf,dce0a1a4-5521-11e7-8f50-0ac135e8bacf,ef96f9ea-5521-11e7-8f50-0ac135e8bacf	Validated targets of C-MYC transcriptional activation,Signaling events mediated by TCPTP,Signaling events mediated by Stem cell factor receptor (c-Kit),Signaling events mediated by HDAC Class III,Signaling events mediated by HDAC Class I,Role of Calcineurin-dependent NFAT signaling in lymphocytes,Retinoic acid receptors-mediated signaling,Regulation of retinoblastoma protein,Regulation of nuclear SMAD23 signaling,Regulation of Androgen receptor activity,Presenilin action in Notch and Wnt signaling,Posttranslational regulation of adherens junction stability and dissassembly,p53 pathway,Notch-mediated HESHEY network,IL12 signaling mediated by STAT4,IFN-gamma pathway,HIF-2-alpha transcription factor network,HIF-1-alpha transcription factor network,Hedgehog signaling events mediated by Gli proteins,Glucocorticoid receptor regulatory network,FoxO family signaling,FOXM1 transcription factor network,FOXA1 transcription factor network,E2F transcription factor network,Direct p53 effectors,C-MYB transcription factor network	rs753688167		6.98451e-06	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.000328515
chr14:36989432:C/T	NKX2-1 5_prime_UTR_variant		8.0	0.0120201628538193			chr14	36989432	C	T	4			NKX2-1	ENST00000354822.6	5_prime_UTR_variant	1.0	c.-98G>A		36520227																									negative regulation of transcription by RNA polymerase II;regulation of DNA-templated transcription;regulation of transcription by RNA polymerase II;phospholipid metabolic process;axon guidance;brain development;endoderm development;locomotory behavior;response to hormone;gene expression;positive regulation of gene expression;negative regulation of epithelial to mesenchymal transition;globus pallidus development;hippocampus development;cerebral cortex cell migration;forebrain dorsal/ventral pattern formation;hypothalamus development;forebrain neuron fate commitment;cerebral cortex GABAergic interneuron differentiation;pituitary gland development;cell differentiation;lung development;negative regulation of cell migration;negative regulation of transforming growth factor beta receptor signaling pathway;thyroid gland development;forebrain development;developmental induction;Leydig cell differentiation;positive regulation of circadian rhythm;negative regulation of DNA-templated transcription;positive regulation of DNA-templated transcription;positive regulation of transcription by RNA polymerase II;rhythmic process;anatomical structure formation involved in morphogenesis;oligodendrocyte differentiation;lung saccule development;epithelial tube branching involved in lung morphogenesis;club cell differentiation;type II pneumocyte differentiation;interneuron migration	GO:0000122;GO:0006355;GO:0006357;GO:0006644;GO:0007411;GO:0007420;GO:0007492;GO:0007626;GO:0009725;GO:0010467;GO:0010628;GO:0010719;GO:0021759;GO:0021766;GO:0021795;GO:0021798;GO:0021854;GO:0021877;GO:0021892;GO:0021983;GO:0030154;GO:0030324;GO:0030336;GO:0030512;GO:0030878;GO:0030900;GO:0031128;GO:0033327;GO:0042753;GO:0045892;GO:0045893;GO:0045944;GO:0048511;GO:0048646;GO:0048709;GO:0060430;GO:0060441;GO:0060486;GO:0060510;GO:1904936	chromatin;nucleus;nucleoplasm;transcription regulator complex	GO:0000785;GO:0005634;GO:0005654;GO:0005667	transcription cis-regulatory region binding;RNA polymerase II transcription regulatory region sequence-specific DNA binding;RNA polymerase II cis-regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;intronic transcription regulatory region sequence-specific DNA binding;DNA binding;DNA-binding transcription factor activity;protein binding;enzyme binding;RNA polymerase II-specific DNA-binding transcription factor binding	GO:0000976;GO:0000977;GO:0000978;GO:0000981;GO:0001161;GO:0003677;GO:0003700;GO:0005515;GO:0019899;GO:0061629	1.0	be728fa0-5521-11e7-8f50-0ac135e8bacf	FOXA2 and FOXA3 transcription factor networks											
chr11:118344655:C/T	KMT2A p.Ala927=						chr11	118344655	C	T	4		Yes	KMT2A	ENST00000534358.7	synonymous_variant	3.0	c.2781C>T	p.Ala927=	118473940																									apoptotic process;visual learning;post-embryonic development;anterior/posterior pattern specification;methylation;circadian regulation of gene expression;embryonic hemopoiesis;exploration behavior;response to potassium ion;protein modification process;T-helper 2 cell differentiation;transcription initiation-coupled chromatin remodeling;positive regulation of DNA-templated transcription;positive regulation of transcription by RNA polymerase II;fibroblast proliferation;negative regulation of fibroblast proliferation;regulation of short-term neuronal synaptic plasticity;spleen development;homeostasis of number of cells within a tissue;membrane depolarization;definitive hemopoiesis;protein-containing complex assembly;cellular response to transforming growth factor beta stimulus;negative regulation of DNA methylation-dependent heterochromatin formation	GO:0006915;GO:0008542;GO:0009791;GO:0009952;GO:0032259;GO:0032922;GO:0035162;GO:0035640;GO:0035864;GO:0036211;GO:0045064;GO:0045815;GO:0045893;GO:0045944;GO:0048144;GO:0048147;GO:0048172;GO:0048536;GO:0048873;GO:0051899;GO:0060216;GO:0065003;GO:0071560;GO:0090310	nucleus;nucleoplasm;cytosol;histone methyltransferase complex;MLL1 complex	GO:0005634;GO:0005654;GO:0005829;GO:0035097;GO:0071339	minor groove of adenine-thymine-rich DNA binding;chromatin binding;protein binding;zinc ion binding;histone H3K4 methyltransferase activity;identical protein binding;protein homodimerization activity;unmethylated CpG binding;lysine-acetylated histone binding;protein-cysteine methyltransferase activity;histone H3K4 monomethyltransferase activity;histone H3K4 trimethyltransferase activity	GO:0003680;GO:0003682;GO:0005515;GO:0008270;GO:0042800;GO:0042802;GO:0042803;GO:0045322;GO:0070577;GO:0106363;GO:0140945;GO:0140999														
chr17:7572927:T/C	TP53 p.Ter394TrpextTer9		1.0	0.5006335797254488			chr17	7572927	T	C	4		Yes	TP53	ENST00000269305.8	stop_lost	11.0	c.1182A>G	p.Ter394TrpextTer9	7669609													COSV107299806	"[[""haematopoietic and lymphoid tissue"", 1]]"	1.0	ENST00000610623.4	*394Wext*9	Exact Match	Uncertain significance	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	criteria provided, multiple submitters, no conflicts	1742467.0		negative regulation of transcription by RNA polymerase II;mitophagy;in utero embryonic development;somitogenesis;release of cytochrome c from mitochondria;hematopoietic progenitor cell differentiation;T cell proliferation involved in immune response;B cell lineage commitment;T cell lineage commitment;response to ischemia;nucleotide-excision repair;double-strand break repair;regulation of DNA-templated transcription;regulation of transcription by RNA polymerase II;protein import into nucleus;autophagy;DNA damage response;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;ER overload response;transforming growth factor beta receptor signaling pathway;Ras protein signal transduction;gastrulation;neuroblast proliferation;negative regulation of neuroblast proliferation;protein localization;negative regulation of DNA replication;negative regulation of cell population proliferation;determination of adult lifespan;mRNA transcription;rRNA transcription;response to salt stress;response to inorganic substance;response to X-ray;response to gamma radiation;positive regulation of gene expression;cardiac muscle cell apoptotic process;positive regulation of cardiac muscle cell apoptotic process;glial cell proliferation;viral process;glucose catabolic process to lactate via pyruvate;cerebellum development;negative regulation of cell growth;DNA damage response, signal transduction by p53 class mediator;negative regulation of transforming growth factor beta receptor signaling pathway;mitotic G1 DNA damage checkpoint signaling;negative regulation of telomere maintenance via telomerase;T cell differentiation in thymus;tumor necrosis factor-mediated signaling pathway;regulation of tissue remodeling;cellular response to UV;multicellular organism growth;positive regulation of mitochondrial membrane permeability;cellular response to glucose starvation;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;regulation of apoptotic process;positive regulation of apoptotic process;negative regulation of apoptotic process;entrainment of circadian clock by photoperiod;mitochondrial DNA repair;regulation of DNA damage response, signal transduction by p53 class mediator;positive regulation of neuron apoptotic process;transcription initiation-coupled chromatin remodeling;negative regulation of proteolysis;negative regulation of DNA-templated transcription;positive regulation of DNA-templated transcription;positive regulation of RNA polymerase II transcription preinitiation complex assembly;positive regulation of transcription by RNA polymerase II;response to antibiotic;fibroblast proliferation;negative regulation of fibroblast proliferation;circadian behavior;bone marrow development;embryonic organ development;positive regulation of peptidyl-tyrosine phosphorylation;protein stabilization;negative regulation of helicase activity;protein tetramerization;chromosome organization;neuron apoptotic process;regulation of cell cycle;hematopoietic stem cell differentiation;negative regulation of glial cell proliferation;type II interferon-mediated signaling pathway;cardiac septum morphogenesis;positive regulation of programmed necrotic cell death;protein-containing complex assembly;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;thymocyte apoptotic process;positive regulation of thymocyte apoptotic process;necroptotic process;cellular response to hypoxia;cellular response to xenobiotic stimulus;cellular response to ionizing radiation;cellular response to gamma radiation;cellular response to UV-C;stem cell proliferation;signal transduction by p53 class mediator;intrinsic apoptotic signaling pathway by p53 class mediator;reactive oxygen species metabolic process;cellular response to actinomycin D;positive regulation of release of cytochrome c from mitochondria;cellular senescence;replicative senescence;oxidative stress-induced premature senescence;intrinsic apoptotic signaling pathway;oligodendrocyte apoptotic process;positive regulation of execution phase of apoptosis;negative regulation of mitophagy;regulation of mitochondrial membrane permeability involved in apoptotic process;regulation of intrinsic apoptotic signaling pathway by p53 class mediator;regulation of cell cycle G2/M phase transition;positive regulation of miRNA transcription;negative regulation of G1 to G0 transition;negative regulation of miRNA processing;negative regulation of glucose catabolic process to lactate via pyruvate;negative regulation of pentose-phosphate shunt;intrinsic apoptotic signaling pathway in response to hypoxia;regulation of fibroblast apoptotic process;negative regulation of reactive oxygen species metabolic process;positive regulation of reactive oxygen species metabolic process;negative regulation of stem cell proliferation;positive regulation of cellular senescence;positive regulation of intrinsic apoptotic signaling pathway	GO:0000122;GO:0000423;GO:0001701;GO:0001756;GO:0001836;GO:0002244;GO:0002309;GO:0002326;GO:0002360;GO:0002931;GO:0006289;GO:0006302;GO:0006355;GO:0006357;GO:0006606;GO:0006914;GO:0006974;GO:0006977;GO:0006978;GO:0006983;GO:0007179;GO:0007265;GO:0007369;GO:0007405;GO:0007406;GO:0008104;GO:0008156;GO:0008285;GO:0008340;GO:0009299;GO:0009303;GO:0009651;GO:0010035;GO:0010165;GO:0010332;GO:0010628;GO:0010659;GO:0010666;GO:0014009;GO:0016032;GO:0019661;GO:0021549;GO:0030308;GO:0030330;GO:0030512;GO:0031571;GO:0032211;GO:0033077;GO:0033209;GO:0034103;GO:0034644;GO:0035264;GO:0035794;GO:0042149;GO:0042771;GO:0042981;GO:0043065;GO:0043066;GO:0043153;GO:0043504;GO:0043516;GO:0043525;GO:0045815;GO:0045861;GO:0045892;GO:0045893;GO:0045899;GO:0045944;GO:0046677;GO:0048144;GO:0048147;GO:0048512;GO:0048539;GO:0048568;GO:0050731;GO:0050821;GO:0051097;GO:0051262;GO:0051276;GO:0051402;GO:0051726;GO:0060218;GO:0060253;GO:0060333;GO:0060411;GO:0062100;GO:0065003;GO:0070059;GO:0070242;GO:0070245;GO:0070266;GO:0071456;GO:0071466;GO:0071479;GO:0071480;GO:0071494;GO:0072089;GO:0072331;GO:0072332;GO:0072593;GO:0072717;GO:0090200;GO:0090398;GO:0090399;GO:0090403;GO:0097193;GO:0097252;GO:1900119;GO:1901525;GO:1902108;GO:1902253;GO:1902749;GO:1902895;GO:1903451;GO:1903799;GO:1904024;GO:1905856;GO:1990144;GO:2000269;GO:2000378;GO:2000379;GO:2000647;GO:2000774;GO:2001244	chromatin;nucleus;nucleoplasm;replication fork;transcription regulator complex;nucleolus;cytoplasm;mitochondrion;mitochondrial matrix;endoplasmic reticulum;centrosome;cytosol;nuclear matrix;nuclear body;PML body;transcription repressor complex;protein-containing complex;site of double-strand break;germ cell nucleus	GO:0000785;GO:0005634;GO:0005654;GO:0005657;GO:0005667;GO:0005730;GO:0005737;GO:0005739;GO:0005759;GO:0005783;GO:0005813;GO:0005829;GO:0016363;GO:0016604;GO:0016605;GO:0017053;GO:0032991;GO:0035861;GO:0043073	transcription cis-regulatory region binding;RNA polymerase II cis-regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;cis-regulatory region sequence-specific DNA binding;core promoter sequence-specific DNA binding;TFIID-class transcription factor complex binding;DNA-binding transcription repressor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;protease binding;p53 binding;DNA binding;chromatin binding;DNA-binding transcription factor activity;mRNA 3'-UTR binding;copper ion binding;protein binding;zinc ion binding;enzyme binding;receptor tyrosine kinase binding;ubiquitin protein ligase binding;histone deacetylase regulator activity;ATP-dependent DNA/DNA annealing activity;identical protein binding;histone deacetylase binding;protein heterodimerization activity;protein-folding chaperone binding;protein phosphatase 2A binding;RNA polymerase II-specific DNA-binding transcription factor binding;14-3-3 protein binding;MDM2/MDM4 family protein binding;disordered domain specific binding;general transcription initiation factor binding;molecular function activator activity;promoter-specific chromatin binding	GO:0000976;GO:0000978;GO:0000981;GO:0000987;GO:0001046;GO:0001094;GO:0001227;GO:0001228;GO:0002020;GO:0002039;GO:0003677;GO:0003682;GO:0003700;GO:0003730;GO:0005507;GO:0005515;GO:0008270;GO:0019899;GO:0030971;GO:0031625;GO:0035033;GO:0036310;GO:0042802;GO:0042826;GO:0046982;GO:0051087;GO:0051721;GO:0061629;GO:0071889;GO:0097371;GO:0097718;GO:0140296;GO:0140677;GO:1990841	13.0	3814fa62-5521-11e7-8f50-0ac135e8bacf,4b62628c-5521-11e7-8f50-0ac135e8bacf,538cfdee-5521-11e7-8f50-0ac135e8bacf,76f15b4e-5521-11e7-8f50-0ac135e8bacf,7f189a50-5521-11e7-8f50-0ac135e8bacf,81be3ee4-5521-11e7-8f50-0ac135e8bacf,945aa686-5521-11e7-8f50-0ac135e8bacf,b1ac7318-5521-11e7-8f50-0ac135e8bacf,bb3d7c4a-5521-11e7-8f50-0ac135e8bacf,dce0a1a4-5521-11e7-8f50-0ac135e8bacf,f6898a78-5521-11e7-8f50-0ac135e8bacf,f823645e-5521-11e7-8f50-0ac135e8bacf,fd2c9b80-5521-11e7-8f50-0ac135e8bacf	Validated targets of C-MYC transcriptional activation,Signaling mediated by p38-alpha and p38-beta,Signaling events mediated by HDAC Class III,PLK3 signaling events,p75(NTR)-mediated signaling,p53 pathway,LKB1 signaling events,Hypoxic and oxygen homeostasis regulation of HIF-1-alpha,Glucocorticoid receptor regulatory network,Direct p53 effectors,BARD1 signaling events,Aurora A signaling,AP-1 transcription factor network											
chr13:32913061:T/A	BRCA2 p.Gly1523=						chr13	32913061	T	A	4		Yes	BRCA2	ENST00000380152.7	synonymous_variant	11.0	c.4569T>A	p.Gly1523=	32338924																									telomere maintenance via recombination;double-strand break repair via homologous recombination;oocyte maturation;inner cell mass cell proliferation;nucleotide-excision repair;double-strand break repair;chromatin remodeling;regulation of DNA-templated transcription;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;male meiosis I;spermatogenesis;brain development;female gonad development;response to X-ray;response to UV-C;response to gamma radiation;regulation of cytokinesis;negative regulation of mammary gland epithelial cell proliferation;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;positive regulation of DNA-templated transcription;positive regulation of mitotic cell cycle;centrosome duplication;establishment of protein localization to telomere;hematopoietic stem cell proliferation;cellular response to ionizing radiation;cellular senescence;mitotic recombination-dependent replication fork processing;regulation of DNA damage checkpoint	GO:0000722;GO:0000724;GO:0001556;GO:0001833;GO:0006289;GO:0006302;GO:0006338;GO:0006355;GO:0006978;GO:0007141;GO:0007283;GO:0007420;GO:0008585;GO:0010165;GO:0010225;GO:0010332;GO:0032465;GO:0033600;GO:0042771;GO:0045893;GO:0045931;GO:0051298;GO:0070200;GO:0071425;GO:0071479;GO:0090398;GO:1990426;GO:2000001	nuclear ubiquitin ligase complex;chromosome, telomeric region;lateral element;nucleus;nucleoplasm;centrosome;cytosol;secretory granule;protein-containing complex;BRCA2-MAGE-D1 complex;DNA repair complex	GO:0000152;GO:0000781;GO:0000800;GO:0005634;GO:0005654;GO:0005813;GO:0005829;GO:0030141;GO:0032991;GO:0033593;GO:1990391	protease binding;single-stranded DNA binding;histone acetyltransferase activity;protein binding;histone H3 acetyltransferase activity;histone H4 acetyltransferase activity;identical protein binding;gamma-tubulin binding	GO:0002020;GO:0003697;GO:0004402;GO:0005515;GO:0010484;GO:0010485;GO:0042802;GO:0043015	5.0	34a994cc-5521-11e7-8f50-0ac135e8bacf,812903c2-5521-11e7-8f50-0ac135e8bacf,bddf504e-5521-11e7-8f50-0ac135e8bacf,c45e106a-5521-11e7-8f50-0ac135e8bacf,f93a0482-5521-11e7-8f50-0ac135e8bacf	Validated transcriptional targets of deltaNp63 isoforms,p73 transcription factor network,FOXM1 transcription factor network,Fanconi anemia pathway,ATR signaling pathway											
chr12:52385775:G/A	ACVR1B p.Glu464Lys		8.0	0.0114942528735632			chr12	52385775	G	A	4		Yes	ACVR1B	ENST00000257963.9	missense_variant	8.0	c.1390G>A	p.Glu464Lys	51991991							0.0369	0.226																	G1/S transition of mitotic cell cycle;in utero embryonic development;hair follicle development;regulation of DNA-templated transcription;protein phosphorylation;signal transduction;cell surface receptor protein serine/threonine kinase signaling pathway;nervous system development;positive regulation of gene expression;negative regulation of gene expression;peptidyl-threonine phosphorylation;negative regulation of cell growth;activin receptor signaling pathway;positive regulation of activin receptor signaling pathway;nodal signaling pathway;positive regulation of erythrocyte differentiation;protein autophosphorylation;cellular response to growth factor stimulus;extrinsic apoptotic signaling pathway;positive regulation of trophoblast cell migration	GO:0000082;GO:0001701;GO:0001942;GO:0006355;GO:0006468;GO:0007165;GO:0007178;GO:0007399;GO:0010628;GO:0010629;GO:0018107;GO:0030308;GO:0032924;GO:0032927;GO:0038092;GO:0045648;GO:0046777;GO:0071363;GO:0097191;GO:1901165	cytosol;plasma membrane;cell surface;receptor complex;activin receptor complex	GO:0005829;GO:0005886;GO:0009986;GO:0043235;GO:0048179	protein serine/threonine kinase activity;transmembrane receptor protein serine/threonine kinase activity;protein binding;ATP binding;activin receptor activity, type I;activin receptor activity;growth factor binding;ubiquitin protein ligase binding;inhibin binding;SMAD binding;metal ion binding;activin binding;I-SMAD binding	GO:0004674;GO:0004675;GO:0005515;GO:0005524;GO:0016361;GO:0017002;GO:0019838;GO:0031625;GO:0034711;GO:0046332;GO:0046872;GO:0048185;GO:0070411														
chr11:57572122:G/A	CTNND1 intron_variant		2.0	0.0009332711152589			chr11	57572122	G	A	4			CTNND1	ENST00000399050.9	intron_variant		c.1605-13G>A		57804650																									Wnt signaling pathway;cell-cell adhesion mediated by cadherin;protein stabilization;negative regulation of canonical Wnt signaling pathway;cell-cell adhesion;regulation of postsynaptic membrane neurotransmitter receptor levels	GO:0016055;GO:0044331;GO:0050821;GO:0090090;GO:0098609;GO:0099072	nucleus;cytoplasm;cytosol;plasma membrane;cell-cell junction;adherens junction;zonula adherens;cell surface;catenin complex;lamellipodium;growth cone;midbody;dendritic spine;extracellular exosome;Schaffer collateral - CA1 synapse;hippocampal mossy fiber to CA3 synapse;presynaptic active zone cytoplasmic component;glutamatergic synapse;postsynaptic density, intracellular component	GO:0005634;GO:0005737;GO:0005829;GO:0005886;GO:0005911;GO:0005912;GO:0005915;GO:0009986;GO:0016342;GO:0030027;GO:0030426;GO:0030496;GO:0043197;GO:0070062;GO:0098685;GO:0098686;GO:0098831;GO:0098978;GO:0099092	signaling receptor binding;protein binding;beta-catenin binding;cadherin binding;protein sequestering activity;protein tyrosine kinase binding	GO:0005102;GO:0005515;GO:0008013;GO:0045296;GO:0140311;GO:1990782	7.0	49ac7526-5521-11e7-8f50-0ac135e8bacf,74f0d05c-5521-11e7-8f50-0ac135e8bacf,8ed3dafe-5521-11e7-8f50-0ac135e8bacf,bf958bd4-5521-11e7-8f50-0ac135e8bacf,d8fe5e5c-5521-11e7-8f50-0ac135e8bacf,d992af1e-5521-11e7-8f50-0ac135e8bacf,fae73f58-5521-11e7-8f50-0ac135e8bacf	Stabilization and expansion of the E-cadherin adherens junction,Posttranslational regulation of adherens junction stability and dissassembly,N-cadherin signaling events,FGF signaling pathway,E-cadherin signaling in the nascent adherens junction,E-cadherin signaling in keratinocytes,Arf6 trafficking events											
chrX:47045466:A/G	RBM10 p.Gln811=		5.0	0.0022950881351468			chrX	47045466	A	G	3		Yes	RBM10	ENST00000377604.8	synonymous_variant	22.0	c.2433A>G	p.Gln811=	47186067																									negative regulation of transcription by RNA polymerase II;mRNA splicing, via spliceosome;biological_process;negative regulation of mRNA splicing, via spliceosome;3'-UTR-mediated mRNA stabilization;negative regulation of vascular associated smooth muscle cell proliferation;vascular associated smooth muscle cell apoptotic process;positive regulation of vascular associated smooth muscle cell apoptotic process;vascular associated smooth muscle cell proliferation	GO:0000122;GO:0000398;GO:0008150;GO:0048025;GO:0070935;GO:1904706;GO:1905288;GO:1905461;GO:1990874	nucleus;nucleoplasm;nuclear speck;protein-containing complex	GO:0005634;GO:0005654;GO:0016607;GO:0032991	RNA binding;protein binding;miRNA binding;identical protein binding;metal ion binding	GO:0003723;GO:0005515;GO:0035198;GO:0042802;GO:0046872														
chrX:44928984:C/T	KDM6A p.Ala723Val		2.0	0.0013093289689034			chrX	44928984	C	T	3		Yes	KDM6A	ENST00000611820.4	missense_variant	18.0	c.2168C>T	p.Ala723Val	45069739							0.00056	0.0017																	chromatin remodeling;heart development;regulation of gene expression	GO:0006338;GO:0007507;GO:0010468	nucleus;nucleoplasm;histone methyltransferase complex;MLL3/4 complex	GO:0005634;GO:0005654;GO:0035097;GO:0044666	RNA polymerase II cis-regulatory region sequence-specific DNA binding;protein binding;chromatin DNA binding;histone demethylase activity;metal ion binding;histone H3K27me2/H3K27me3 demethylase activity	GO:0000978;GO:0005515;GO:0031490;GO:0032452;GO:0046872;GO:0071558														
chrX:44928954:T/C	KDM6A p.Leu713Pro		5.0	0.0023846897799646			chrX	44928954	T	C	3		Yes	KDM6A	ENST00000611820.4	missense_variant	18.0	c.2138T>C	p.Leu713Pro	45069709							0.000156	0.00269																	chromatin remodeling;heart development;regulation of gene expression	GO:0006338;GO:0007507;GO:0010468	nucleus;nucleoplasm;histone methyltransferase complex;MLL3/4 complex	GO:0005634;GO:0005654;GO:0035097;GO:0044666	RNA polymerase II cis-regulatory region sequence-specific DNA binding;protein binding;chromatin DNA binding;histone demethylase activity;metal ion binding;histone H3K27me2/H3K27me3 demethylase activity	GO:0000978;GO:0005515;GO:0031490;GO:0032452;GO:0046872;GO:0071558														
chr15:67457729:A/G	SMAD3 intron_variant		2.0	0.0010559662090813			chr15	67457729	A	G	3			SMAD3	ENST00000327367.9	intron_variant		c.532+7A>G		67165391																									negative regulation of transcription by RNA polymerase II;ureteric bud development;response to hypoxia;in utero embryonic development;mesoderm formation;somitogenesis;liver development;heart looping;osteoblast development;immune system development;regulation of DNA-templated transcription;regulation of transcription by RNA polymerase II;activation of cysteine-type endopeptidase activity involved in apoptotic process;immune response;transforming growth factor beta receptor signaling pathway;JNK cascade;endoderm development;cell population proliferation;negative regulation of cell population proliferation;anatomical structure morphogenesis;embryonic pattern specification;positive regulation of gene expression;negative regulation of gene expression;positive regulation of epithelial to mesenchymal transition;regulation of striated muscle tissue development;regulation of transforming growth factor beta receptor signaling pathway;signal transduction involved in regulation of gene expression;cell differentiation;negative regulation of cell growth;adrenal gland development;positive regulation of cell migration;positive regulation of bone mineralization;thyroid gland development;primary miRNA processing;positive regulation of chondrocyte differentiation;positive regulation of interleukin-1 beta production;regulation of transforming growth factor beta2 production;positive regulation of transforming growth factor beta3 production;activin receptor signaling pathway;negative regulation of osteoblast proliferation;nodal signaling pathway;wound healing;T cell activation;negative regulation of protein catabolic process;positive regulation of protein import into nucleus;negative regulation of apoptotic process;cell-cell junction organization;positive regulation of nitric oxide biosynthetic process;negative regulation of fat cell differentiation;negative regulation of osteoblast differentiation;positive regulation of DNA-templated transcription;positive regulation of transcription by RNA polymerase II;paraxial mesoderm morphogenesis;developmental growth;embryonic foregut morphogenesis;embryonic cranial skeleton morphogenesis;regulation of epithelial cell proliferation;negative regulation of inflammatory response;regulation of immune response;protein stabilization;positive regulation of positive chemotaxis;positive regulation of DNA-binding transcription factor activity;negative regulation of cytosolic calcium ion concentration;positive regulation of stress fiber assembly;positive regulation of focal adhesion assembly;pericardium development;transdifferentiation;SMAD protein signal transduction;negative regulation of wound healing;negative regulation of lung blood pressure;lens fiber cell differentiation;cellular response to glucose stimulus;cellular response to transforming growth factor beta stimulus;positive regulation of canonical Wnt signaling pathway;extrinsic apoptotic signaling pathway;cellular response to virus;positive regulation of extracellular matrix assembly;regulation of miRNA transcription;negative regulation of miRNA transcription;positive regulation of miRNA transcription;negative regulation of cardiac muscle hypertrophy in response to stress;response to angiotensin	GO:0000122;GO:0001657;GO:0001666;GO:0001701;GO:0001707;GO:0001756;GO:0001889;GO:0001947;GO:0002076;GO:0002520;GO:0006355;GO:0006357;GO:0006919;GO:0006955;GO:0007179;GO:0007254;GO:0007492;GO:0008283;GO:0008285;GO:0009653;GO:0009880;GO:0010628;GO:0010629;GO:0010718;GO:0016202;GO:0017015;GO:0023019;GO:0030154;GO:0030308;GO:0030325;GO:0030335;GO:0030501;GO:0030878;GO:0031053;GO:0032332;GO:0032731;GO:0032909;GO:0032916;GO:0032924;GO:0033689;GO:0038092;GO:0042060;GO:0042110;GO:0042177;GO:0042307;GO:0043066;GO:0045216;GO:0045429;GO:0045599;GO:0045668;GO:0045893;GO:0045944;GO:0048340;GO:0048589;GO:0048617;GO:0048701;GO:0050678;GO:0050728;GO:0050776;GO:0050821;GO:0050927;GO:0051091;GO:0051481;GO:0051496;GO:0051894;GO:0060039;GO:0060290;GO:0060395;GO:0061045;GO:0061767;GO:0070306;GO:0071333;GO:0071560;GO:0090263;GO:0097191;GO:0098586;GO:1901203;GO:1902893;GO:1902894;GO:1902895;GO:1903243;GO:1990776	chromatin;nucleus;nuclear inner membrane;nucleoplasm;transcription regulator complex;cytoplasm;cytosol;plasma membrane;receptor complex;SMAD protein complex;heteromeric SMAD protein complex	GO:0000785;GO:0005634;GO:0005637;GO:0005654;GO:0005667;GO:0005737;GO:0005829;GO:0005886;GO:0043235;GO:0071141;GO:0071144	transcription cis-regulatory region binding;RNA polymerase II cis-regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;cis-regulatory region sequence-specific DNA binding;DNA-binding transcription repressor activity;transcription corepressor binding;transcription coactivator binding;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA binding;DNA-binding transcription factor activity;transforming growth factor beta receptor binding;protein binding;collagen binding;beta-catenin binding;zinc ion binding;nuclear receptor binding;DEAD/H-box RNA helicase binding;protein kinase binding;phosphatase binding;chromatin DNA binding;ubiquitin protein ligase binding;nuclear mineralocorticoid receptor binding;sterol response element binding;nuclear glucocorticoid receptor binding;identical protein binding;protein homodimerization activity;ubiquitin binding;bHLH transcription factor binding;sequence-specific DNA binding;RNA polymerase II-specific DNA-binding transcription factor binding;co-SMAD binding;I-SMAD binding;R-SMAD binding;DNA-binding transcription factor binding;promoter-specific chromatin binding	GO:0000976;GO:0000978;GO:0000981;GO:0000987;GO:0001217;GO:0001222;GO:0001223;GO:0001228;GO:0003677;GO:0003700;GO:0005160;GO:0005515;GO:0005518;GO:0008013;GO:0008270;GO:0016922;GO:0017151;GO:0019901;GO:0019902;GO:0031490;GO:0031625;GO:0031962;GO:0032810;GO:0035259;GO:0042802;GO:0042803;GO:0043130;GO:0043425;GO:0043565;GO:0061629;GO:0070410;GO:0070411;GO:0070412;GO:0140297;GO:1990841	7.0	35f28f90-5521-11e7-8f50-0ac135e8bacf,3814fa62-5521-11e7-8f50-0ac135e8bacf,408a0c44-5521-11e7-8f50-0ac135e8bacf,603902ca-5521-11e7-8f50-0ac135e8bacf,68975856-5521-11e7-8f50-0ac135e8bacf,6cb6085a-5521-11e7-8f50-0ac135e8bacf,b354a4de-5521-11e7-8f50-0ac135e8bacf	Validated targets of C-MYC transcriptional repression,Validated targets of C-MYC transcriptional activation,TGF-beta receptor signaling,Regulation of Telomerase,Regulation of nuclear SMAD23 signaling,Regulation of cytoplasmic and nuclear SMAD23 signaling,HIF-1-alpha transcription factor network											
chr1:11317106:T/G	MTOR p.Ile130Leu		7.0	0.00263958398409			chr1	11317106	T	G	3		Yes	MTOR	ENST00000361445.9	missense_variant	4.0	c.388A>C	p.Ile130Leu	11257049							0.00515	0.0768																	regulation of cell growth;T-helper 1 cell lineage commitment;heart morphogenesis;heart valve morphogenesis;energy reserve metabolic process;'de novo' pyrimidine nucleobase biosynthetic process;protein phosphorylation;inflammatory response;DNA damage response;cytoskeleton organization;lysosome organization;germ cell development;response to nutrient;regulation of cell size;cellular response to starvation;response to heat;post-embryonic development;negative regulation of autophagy;positive regulation of lamellipodium assembly;positive regulation of gene expression;positive regulation of epithelial to mesenchymal transition;positive regulation of myotube differentiation;macroautophagy;regulation of macroautophagy;negative regulation of macroautophagy;phosphorylation;peptidyl-serine phosphorylation;neuronal action potential;protein catabolic process;positive regulation of cell growth;positive regulation of actin filament polymerization;T cell costimulation;ruffle organization;regulation of myelination;protein destabilization;response to nutrient levels;cellular response to nutrient levels;cellular response to nutrient;TOR signaling;positive regulation of phosphoprotein phosphatase activity;cellular response to insulin stimulus;regulation of actin cytoskeleton organization;calcineurin-NFAT signaling cascade;cellular response to amino acid starvation;multicellular organism growth;TORC1 signaling;regulation of circadian rhythm;negative regulation of apoptotic process;response to amino acid;anoikis;regulation of osteoclast differentiation;positive regulation of translation;negative regulation of cell size;positive regulation of glycolytic process;positive regulation of transcription by RNA polymerase III;positive regulation of translational initiation;protein autophosphorylation;positive regulation of lipid biosynthetic process;behavioral response to pain;rhythmic process;oligodendrocyte differentiation;positive regulation of oligodendrocyte differentiation;positive regulation of peptidyl-tyrosine phosphorylation;voluntary musculoskeletal movement;positive regulation of stress fiber assembly;positive regulation of keratinocyte migration;nucleus localization;positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction;cardiac muscle cell development;cardiac muscle contraction;cellular response to methionine;negative regulation of calcineurin-NFAT signaling cascade;cellular response to amino acid stimulus;cellular response to L-leucine;cellular response to hypoxia;cellular response to osmotic stress;regulation of membrane permeability;regulation of cellular response to heat;negative regulation of protein localization to nucleus;regulation of signal transduction by p53 class mediator;positive regulation of transcription of nucleolar large rRNA by RNA polymerase I;positive regulation of wound healing, spreading of epidermal cells;regulation of locomotor rhythm;positive regulation of cytoplasmic translational initiation;negative regulation of lysosome organization;positive regulation of pentose-phosphate shunt;cellular response to leucine starvation;regulation of autophagosome assembly	GO:0001558;GO:0002296;GO:0003007;GO:0003179;GO:0006112;GO:0006207;GO:0006468;GO:0006954;GO:0006974;GO:0007010;GO:0007040;GO:0007281;GO:0007584;GO:0008361;GO:0009267;GO:0009408;GO:0009791;GO:0010507;GO:0010592;GO:0010628;GO:0010718;GO:0010831;GO:0016236;GO:0016241;GO:0016242;GO:0016310;GO:0018105;GO:0019228;GO:0030163;GO:0030307;GO:0030838;GO:0031295;GO:0031529;GO:0031641;GO:0031648;GO:0031667;GO:0031669;GO:0031670;GO:0031929;GO:0032516;GO:0032869;GO:0032956;GO:0033173;GO:0034198;GO:0035264;GO:0038202;GO:0042752;GO:0043066;GO:0043200;GO:0043276;GO:0045670;GO:0045727;GO:0045792;GO:0045821;GO:0045945;GO:0045948;GO:0046777;GO:0046889;GO:0048266;GO:0048511;GO:0048709;GO:0048714;GO:0050731;GO:0050882;GO:0051496;GO:0051549;GO:0051647;GO:0051897;GO:0055013;GO:0060048;GO:0061431;GO:0070885;GO:0071230;GO:0071233;GO:0071456;GO:0071470;GO:0090559;GO:1900034;GO:1900181;GO:1901796;GO:1901838;GO:1903691;GO:1904059;GO:1904690;GO:1905672;GO:1905857;GO:1990253;GO:2000785	Golgi membrane;nucleus;nuclear envelope;nucleoplasm;cytoplasm;mitochondrial outer membrane;lysosome;lysosomal membrane;endoplasmic reticulum membrane;cytosol;endomembrane system;membrane;PML body;dendrite;TORC1 complex;TORC2 complex;phagocytic vesicle	GO:0000139;GO:0005634;GO:0005635;GO:0005654;GO:0005737;GO:0005741;GO:0005764;GO:0005765;GO:0005789;GO:0005829;GO:0012505;GO:0016020;GO:0016605;GO:0030425;GO:0031931;GO:0031932;GO:0045335	RNA polymerase III type 1 promoter sequence-specific DNA binding;RNA polymerase III type 2 promoter sequence-specific DNA binding;RNA polymerase III type 3 promoter sequence-specific DNA binding;TFIIIC-class transcription factor complex binding;protein kinase activity;protein serine/threonine kinase activity;protein binding;ATP binding;kinase activity;identical protein binding;ribosome binding;phosphoprotein binding;protein serine kinase activity	GO:0001002;GO:0001003;GO:0001006;GO:0001156;GO:0004672;GO:0004674;GO:0005515;GO:0005524;GO:0016301;GO:0042802;GO:0043022;GO:0051219;GO:0106310	15.0	5189b3dc-5521-11e7-8f50-0ac135e8bacf,603902ca-5521-11e7-8f50-0ac135e8bacf,8f640d10-5521-11e7-8f50-0ac135e8bacf,945aa686-5521-11e7-8f50-0ac135e8bacf,a04a1220-5521-11e7-8f50-0ac135e8bacf,a8411a5c-5521-11e7-8f50-0ac135e8bacf,aa5b6ede-5521-11e7-8f50-0ac135e8bacf,afa50a56-5521-11e7-8f50-0ac135e8bacf,c70366de-5521-11e7-8f50-0ac135e8bacf,c92b28e0-5521-11e7-8f50-0ac135e8bacf,d5aa2a46-5521-11e7-8f50-0ac135e8bacf,df93b3b8-5521-11e7-8f50-0ac135e8bacf,e1b66caa-5521-11e7-8f50-0ac135e8bacf,e6f69242-5521-11e7-8f50-0ac135e8bacf,e92d968a-5521-11e7-8f50-0ac135e8bacf	Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met),Regulation of Telomerase,mTOR signaling pathway,LKB1 signaling events,IL4-mediated signaling events,IL2 signaling events mediated by PI3K,IL12-mediated signaling events,IFN-gamma pathway,ErbB2ErbB3 signaling events,ErbB1 downstream signaling,EGFR-dependent Endothelin signaling events,CXCR4-mediated signaling events,CXCR3-mediated signaling events,Class I PI3K signaling events mediated by Akt,CDC42 signaling events											
chrX:47430214:A/G	ARAF intron_variant		5.0	0.0019420832717394			chrX	47430214	A	G	3			ARAF	ENST00000377045.9	intron_variant		c.1552-63A>G		47570815																									MAPK cascade;regulation of TOR signaling;regulation of proteasomal ubiquitin-dependent protein catabolic process;positive regulation of peptidyl-serine phosphorylation;protein modification process;negative regulation of apoptotic process	GO:0000165;GO:0032006;GO:0032434;GO:0033138;GO:0036211;GO:0043066	cellular_component;mitochondrion;cytosol	GO:0005575;GO:0005739;GO:0005829	protein kinase activity;protein serine/threonine kinase activity;MAP kinase kinase kinase activity;protein binding;ATP binding;metal ion binding;protein serine kinase activity	GO:0004672;GO:0004674;GO:0004709;GO:0005515;GO:0005524;GO:0046872;GO:0106310														
chr12:49415923:T/C	KMT2D p.His5475Arg						chr12	49415923	T	C	3		Yes	KMT2D	ENST00000301067.11	missense_variant	53.0	c.16424A>G	p.His5475Arg	49022140							3.65e-05	0.0404																	oocyte growth;regulation of DNA-templated transcription;positive regulation of cell population proliferation;heterochromatin formation;methylation;positive regulation of intracellular estrogen receptor signaling pathway;response to estrogen;positive regulation of transcription by RNA polymerase II;oogenesis;beta-catenin-TCF complex assembly	GO:0001555;GO:0006355;GO:0008284;GO:0031507;GO:0032259;GO:0033148;GO:0043627;GO:0045944;GO:0048477;GO:1904837	nucleus;nucleoplasm;MLL3/4 complex	GO:0005634;GO:0005654;GO:0044666	transcription cis-regulatory region binding;DNA binding;transcription coactivator activity;protein binding;histone H3K4 methyltransferase activity;metal ion binding;histone H3K4 monomethyltransferase activity;histone H3K4 trimethyltransferase activity	GO:0000976;GO:0003677;GO:0003713;GO:0005515;GO:0042800;GO:0046872;GO:0140945;GO:0140999														
chr1:27056256:C/T	ARID1A p.Pro418Ser		1.0	0.5006335797254488			chr1	27056256	C	T	3		Yes	ARID1A	ENST00000324856.13	missense_variant	2.0	c.1252C>T	p.Pro418Ser	26729765							7.83e-05	0.00095																	nucleosome disassembly;chromatin remodeling;regulation of transcription by RNA polymerase II;nervous system development;regulation of mitotic metaphase/anaphase transition;intracellular estrogen receptor signaling pathway;androgen receptor signaling pathway;intracellular glucocorticoid receptor signaling pathway;positive regulation of T cell differentiation;positive regulation of cell differentiation;positive regulation of myoblast differentiation;transcription initiation-coupled chromatin remodeling;positive regulation of DNA-templated transcription;regulation of G0 to G1 transition;positive regulation of stem cell population maintenance;regulation of G1/S transition of mitotic cell cycle;positive regulation of double-strand break repair;regulation of nucleotide-excision repair	GO:0006337;GO:0006338;GO:0006357;GO:0007399;GO:0030071;GO:0030520;GO:0030521;GO:0042921;GO:0045582;GO:0045597;GO:0045663;GO:0045815;GO:0045893;GO:0070316;GO:1902459;GO:2000045;GO:2000781;GO:2000819	chromatin;nucleus;nucleoplasm;SWI/SNF complex;brahma complex;npBAF complex;nBAF complex;bBAF complex	GO:0000785;GO:0005634;GO:0005654;GO:0016514;GO:0035060;GO:0071564;GO:0071565;GO:0140092	DNA binding;transcription coactivator activity;protein binding;nuclear receptor binding;nucleosome binding	GO:0003677;GO:0003713;GO:0005515;GO:0016922;GO:0031491				rs890504620										
chr12:52379118:G/A	ACVR1B p.Arg374=		1.0	0.5004223864836326			chr12	52379118	G	A	3		Yes	ACVR1B	ENST00000257963.9	synonymous_variant	6.0	c.1122G>A	p.Arg374=	51985334																									G1/S transition of mitotic cell cycle;in utero embryonic development;hair follicle development;regulation of DNA-templated transcription;protein phosphorylation;signal transduction;cell surface receptor protein serine/threonine kinase signaling pathway;nervous system development;positive regulation of gene expression;negative regulation of gene expression;peptidyl-threonine phosphorylation;negative regulation of cell growth;activin receptor signaling pathway;positive regulation of activin receptor signaling pathway;nodal signaling pathway;positive regulation of erythrocyte differentiation;protein autophosphorylation;cellular response to growth factor stimulus;extrinsic apoptotic signaling pathway;positive regulation of trophoblast cell migration	GO:0000082;GO:0001701;GO:0001942;GO:0006355;GO:0006468;GO:0007165;GO:0007178;GO:0007399;GO:0010628;GO:0010629;GO:0018107;GO:0030308;GO:0032924;GO:0032927;GO:0038092;GO:0045648;GO:0046777;GO:0071363;GO:0097191;GO:1901165	cytosol;plasma membrane;cell surface;receptor complex;activin receptor complex	GO:0005829;GO:0005886;GO:0009986;GO:0043235;GO:0048179	protein serine/threonine kinase activity;transmembrane receptor protein serine/threonine kinase activity;protein binding;ATP binding;activin receptor activity, type I;activin receptor activity;growth factor binding;ubiquitin protein ligase binding;inhibin binding;SMAD binding;metal ion binding;activin binding;I-SMAD binding	GO:0004674;GO:0004675;GO:0005515;GO:0005524;GO:0016361;GO:0017002;GO:0019838;GO:0031625;GO:0034711;GO:0046332;GO:0046872;GO:0048185;GO:0070411														
chr12:52385622:A/G	ACVR1B intron_variant		2.0	0.0013793103448275			chr12	52385622	A	G	3			ACVR1B	ENST00000257963.9	intron_variant		c.1262-25A>G		51991838																									G1/S transition of mitotic cell cycle;in utero embryonic development;hair follicle development;regulation of DNA-templated transcription;protein phosphorylation;signal transduction;cell surface receptor protein serine/threonine kinase signaling pathway;nervous system development;positive regulation of gene expression;negative regulation of gene expression;peptidyl-threonine phosphorylation;negative regulation of cell growth;activin receptor signaling pathway;positive regulation of activin receptor signaling pathway;nodal signaling pathway;positive regulation of erythrocyte differentiation;protein autophosphorylation;cellular response to growth factor stimulus;extrinsic apoptotic signaling pathway;positive regulation of trophoblast cell migration	GO:0000082;GO:0001701;GO:0001942;GO:0006355;GO:0006468;GO:0007165;GO:0007178;GO:0007399;GO:0010628;GO:0010629;GO:0018107;GO:0030308;GO:0032924;GO:0032927;GO:0038092;GO:0045648;GO:0046777;GO:0071363;GO:0097191;GO:1901165	cytosol;plasma membrane;cell surface;receptor complex;activin receptor complex	GO:0005829;GO:0005886;GO:0009986;GO:0043235;GO:0048179	protein serine/threonine kinase activity;transmembrane receptor protein serine/threonine kinase activity;protein binding;ATP binding;activin receptor activity, type I;activin receptor activity;growth factor binding;ubiquitin protein ligase binding;inhibin binding;SMAD binding;metal ion binding;activin binding;I-SMAD binding	GO:0004674;GO:0004675;GO:0005515;GO:0005524;GO:0016361;GO:0017002;GO:0019838;GO:0031625;GO:0034711;GO:0046332;GO:0046872;GO:0048185;GO:0070411														
chr11:92577089:G/A	FAT3 intron_variant						chr11	92577089	G	A	3			FAT3	ENST00000409404.6	intron_variant		c.10567-11G>A		92843923																									homophilic cell adhesion via plasma membrane adhesion molecules;retina layer formation;dendrite development;cell morphogenesis involved in neuron differentiation;cell-cell adhesion;interneuron migration;negative regulation of dendrite development	GO:0007156;GO:0010842;GO:0016358;GO:0048667;GO:0098609;GO:1904936;GO:2000171	plasma membrane;dendrite	GO:0005886;GO:0030425	calcium ion binding	GO:0005509														
chrX:70349860:A/G	MED12 intron_variant		1.0	0.5273322422258593			chrX	70349860	A	G	3			MED12	ENST00000374080.8	intron_variant		c.3868-25A>G		71130010																									neural tube closure;endoderm development;heart development;oligodendrocyte development;Schwann cell development;protein ubiquitination;spinal cord development;somatic stem cell population maintenance;post-anal tail morphogenesis;positive regulation of DNA-templated transcription;positive regulation of transcription by RNA polymerase II;embryonic neurocranium morphogenesis;Wnt signaling pathway, planar cell polarity pathway;positive regulation of transcription initiation by RNA polymerase II;axis elongation involved in somitogenesis;embryonic brain development	GO:0001843;GO:0007492;GO:0007507;GO:0014003;GO:0014044;GO:0016567;GO:0021510;GO:0035019;GO:0036342;GO:0045893;GO:0045944;GO:0048702;GO:0060071;GO:0060261;GO:0090245;GO:1990403	ubiquitin ligase complex;nucleus;nucleoplasm;membrane;mediator complex;CKM complex	GO:0000151;GO:0005634;GO:0005654;GO:0016020;GO:0016592;GO:1990508	RNA polymerase II cis-regulatory region sequence-specific DNA binding;chromatin binding;transcription coregulator activity;transcription coactivator activity;protein binding;beta-catenin binding;transcription factor binding;nuclear receptor coactivator activity;nuclear vitamin D receptor binding;nuclear thyroid hormone receptor binding;ubiquitin protein ligase activity	GO:0000978;GO:0003682;GO:0003712;GO:0003713;GO:0005515;GO:0008013;GO:0008134;GO:0030374;GO:0042809;GO:0046966;GO:0061630	1.0	6aae5178-5521-11e7-8f50-0ac135e8bacf	Regulation of nuclear beta catenin signaling and target gene transcription											
chr3:134967287:A/G	EPHB1 p.Asn876Asp		1.0	0.5003167898627244			chr3	134967287	A	G	3		Yes	EPHB1	ENST00000398015.8	missense_variant	14.0	c.2626A>G	p.Asn876Asp	135248445							0.432	0.486					COSV67662266	"[[""lung"", 1]]"	1.0	ENST00000493838.1	N876H	Genomic Location							angiogenesis;immunological synapse formation;protein phosphorylation;axon guidance;skeletal muscle satellite cell activation;optic nerve morphogenesis;hindbrain tangential cell migration;central nervous system projection neuron axonogenesis;neurogenesis;establishment of cell polarity;retinal ganglion cell axon guidance;cell-substrate adhesion;regulation of JNK cascade;protein autophosphorylation;ephrin receptor signaling pathway;camera-type eye morphogenesis;modulation of chemical synaptic transmission;detection of temperature stimulus involved in sensory perception of pain;positive regulation of synapse assembly;cell chemotaxis;dendritic spine development;dendritic spine morphogenesis;neural precursor cell proliferation;regulation of ERK1 and ERK2 cascade;negative regulation of skeletal muscle satellite cell proliferation;negative regulation of satellite cell differentiation	GO:0001525;GO:0001771;GO:0006468;GO:0007411;GO:0014719;GO:0021631;GO:0021934;GO:0021952;GO:0022008;GO:0030010;GO:0031290;GO:0031589;GO:0046328;GO:0046777;GO:0048013;GO:0048593;GO:0050804;GO:0050965;GO:0051965;GO:0060326;GO:0060996;GO:0060997;GO:0061351;GO:0070372;GO:1902723;GO:1902725	extracellular region;endoplasmic reticulum;cytosol;plasma membrane;axon;dendrite;early endosome membrane;filopodium tip;membrane raft;extracellular exosome;glutamatergic synapse	GO:0005576;GO:0005783;GO:0005829;GO:0005886;GO:0030424;GO:0030425;GO:0031901;GO:0032433;GO:0045121;GO:0070062;GO:0098978	transmembrane-ephrin receptor activity;protein binding;ATP binding;axon guidance receptor activity;protein-containing complex binding	GO:0005005;GO:0005515;GO:0005524;GO:0008046;GO:0044877	2.0	ccd4f708-5521-11e7-8f50-0ac135e8bacf,ce49e3cc-5521-11e7-8f50-0ac135e8bacf	Ephrin B reverse signaling,EPHB forward signaling											
chr10:88678964:T/A	BMPR1A p.Trp302Arg		7.0	0.0034723049114733			chr10	88678964	T	A	3		Yes	BMPR1A	ENST00000372037.7	missense_variant	10.0	c.904T>A	p.Trp302Arg	86919207							0.000812	0.152																	angiogenesis;osteoblast differentiation;in utero embryonic development;mesoderm formation;somitogenesis;Mullerian duct regression;positive regulation of mesenchymal cell proliferation;chondrocyte differentiation;outflow tract septum morphogenesis;outflow tract morphogenesis;cardiac conduction system development;atrioventricular valve development;mitral valve morphogenesis;tricuspid valve morphogenesis;endocardial cushion morphogenesis;cardiac right ventricle morphogenesis;ventricular trabecula myocardium morphogenesis;ventricular compact myocardium morphogenesis;endocardial cushion formation;protein phosphorylation;immune response;transforming growth factor beta receptor signaling pathway;ectoderm development;dorsal/ventral axis specification;dorsal/ventral pattern formation;positive regulation of gene expression;negative regulation of gene expression;regulation of cardiac muscle cell apoptotic process;neural crest cell development;negative regulation of smooth muscle cell migration;central nervous system neuron differentiation;pituitary gland development;neural plate mediolateral regionalization;lung development;positive regulation of bone mineralization;BMP signaling pathway;positive regulation of transforming growth factor beta2 production;somatic stem cell population maintenance;hindlimb morphogenesis;dorsal aorta morphogenesis;odontogenesis of dentin-containing tooth;embryonic digit morphogenesis;positive regulation of osteoblast differentiation;positive regulation of transcription by RNA polymerase II;paraxial mesoderm structural organization;lateral mesoderm development;regulation of lateral mesodermal cell fate specification;mesendoderm development;embryonic organ development;developmental growth;epithelial cell proliferation;positive regulation of epithelial cell proliferation;negative regulation of neurogenesis;negative regulation of muscle cell differentiation;roof of mouth development;regulation of cardiac muscle cell proliferation;positive regulation of cardiac muscle cell proliferation;positive regulation of SMAD protein signal transduction;ventricular septum morphogenesis;heart formation;atrioventricular node cell development;pharyngeal arch artery morphogenesis;cellular response to growth factor stimulus;cellular response to BMP stimulus;positive regulation of miRNA transcription;positive regulation of cardiac ventricle development;positive regulation of vascular associated smooth muscle cell proliferation;fibrous ring of heart morphogenesis;regulation of neural crest cell differentiation;regulation of cellular senescence	GO:0001525;GO:0001649;GO:0001701;GO:0001707;GO:0001756;GO:0001880;GO:0002053;GO:0002062;GO:0003148;GO:0003151;GO:0003161;GO:0003171;GO:0003183;GO:0003186;GO:0003203;GO:0003215;GO:0003222;GO:0003223;GO:0003272;GO:0006468;GO:0006955;GO:0007179;GO:0007398;GO:0009950;GO:0009953;GO:0010628;GO:0010629;GO:0010665;GO:0014032;GO:0014912;GO:0021953;GO:0021983;GO:0021998;GO:0030324;GO:0030501;GO:0030509;GO:0032915;GO:0035019;GO:0035137;GO:0035912;GO:0042475;GO:0042733;GO:0045669;GO:0045944;GO:0048352;GO:0048368;GO:0048378;GO:0048382;GO:0048568;GO:0048589;GO:0050673;GO:0050679;GO:0050768;GO:0051148;GO:0060021;GO:0060043;GO:0060045;GO:0060391;GO:0060412;GO:0060914;GO:0060928;GO:0061626;GO:0071363;GO:0071773;GO:1902895;GO:1904414;GO:1904707;GO:1905285;GO:1905292;GO:2000772	plasma membrane;caveola;external side of plasma membrane;membrane;dendrite;neuronal cell body;receptor complex;HFE-transferrin receptor complex	GO:0005886;GO:0005901;GO:0009897;GO:0016020;GO:0030425;GO:0043025;GO:0043235;GO:1990712	protein serine/threonine kinase activity;transmembrane receptor protein serine/threonine kinase activity;transforming growth factor beta receptor activity, type I;protein binding;ATP binding;BMP binding;protein homodimerization activity;SMAD binding;metal ion binding;BMP receptor activity	GO:0004674;GO:0004675;GO:0005025;GO:0005515;GO:0005524;GO:0036122;GO:0042803;GO:0046332;GO:0046872;GO:0098821	1.0	f1ae1a1c-5521-11e7-8f50-0ac135e8bacf	BMP receptor signaling											
chr1:115256479:A/G	NRAS p.Phe78Leu		2.0	0.0030234315948601			chr1	115256479	A	G	3		Yes	NRAS	ENST00000369535.5	missense_variant	3.0	c.232T>C	p.Phe78Leu	114713858							0.0115	0.355																	MAPK cascade;positive regulation of endothelial cell proliferation;Ras protein signal transduction;myoblast differentiation	GO:0000165;GO:0001938;GO:0007265;GO:0045445	Golgi membrane;endoplasmic reticulum membrane;Golgi apparatus;cytosol;plasma membrane;membrane;extracellular exosome;tertiary granule membrane	GO:0000139;GO:0005789;GO:0005794;GO:0005829;GO:0005886;GO:0016020;GO:0070062;GO:0070821	GTPase activity;G protein activity;protein binding;GTP binding;GDP binding;protein-containing complex binding	GO:0003924;GO:0003925;GO:0005515;GO:0005525;GO:0019003;GO:0044877	22.0	29ff5368-5521-11e7-8f50-0ac135e8bacf,3be95afa-5521-11e7-8f50-0ac135e8bacf,3c88330c-5521-11e7-8f50-0ac135e8bacf,412efed6-5521-11e7-8f50-0ac135e8bacf,4362cec8-5521-11e7-8f50-0ac135e8bacf,576974d6-5521-11e7-8f50-0ac135e8bacf,65205a00-5521-11e7-8f50-0ac135e8bacf,720b3c92-5521-11e7-8f50-0ac135e8bacf,78974324-5521-11e7-8f50-0ac135e8bacf,7ac7dec6-5521-11e7-8f50-0ac135e8bacf,898a6694-5521-11e7-8f50-0ac135e8bacf,8f640d10-5521-11e7-8f50-0ac135e8bacf,95fd0bec-5521-11e7-8f50-0ac135e8bacf,a59cd558-5521-11e7-8f50-0ac135e8bacf,b7824902-5521-11e7-8f50-0ac135e8bacf,c70366de-5521-11e7-8f50-0ac135e8bacf,c92b28e0-5521-11e7-8f50-0ac135e8bacf,ce49e3cc-5521-11e7-8f50-0ac135e8bacf,da3d4700-5521-11e7-8f50-0ac135e8bacf,e1b66caa-5521-11e7-8f50-0ac135e8bacf,e4e93610-5521-11e7-8f50-0ac135e8bacf,ef96f9ea-5521-11e7-8f50-0ac135e8bacf	EGF receptor (ErbB1) signaling pathway,Trk receptor signaling mediated by the MAPK pathway,Trk receptor signaling mediated by PI3K and PLC-gamma,TCR signaling in naive CD8 T cells,TCR signaling in naive CD4 T cells,SHP2 signaling,Regulation of Ras family activation,Ras signaling in the CD4 TCR pathway,Plasma membrane estrogen receptor signaling,PDGFR-beta signaling pathway,Neurotrophic factor-mediated Trk receptor signaling,mTOR signaling pathway,Internalization of ErbB1,IL2-mediated signaling events,GMCSF-mediated signaling events,ErbB2ErbB3 signaling events,ErbB1 downstream signaling,EPHB forward signaling,Downstream signaling in naive CD8 T cells,CXCR3-mediated signaling events,Class I PI3K signaling events,C-MYB transcription factor network											
chr3:134967185:C/G	EPHB1 p.Arg842Gly						chr3	134967185	C	G	3		Yes	EPHB1	ENST00000398015.8	missense_variant	14.0	c.2524C>G	p.Arg842Gly	135248343							0.343	0.414					COSV67674342	"[[""liver"", 1]]"	1.0	ENST00000493838.1	R842W	Genomic Location							angiogenesis;immunological synapse formation;protein phosphorylation;axon guidance;skeletal muscle satellite cell activation;optic nerve morphogenesis;hindbrain tangential cell migration;central nervous system projection neuron axonogenesis;neurogenesis;establishment of cell polarity;retinal ganglion cell axon guidance;cell-substrate adhesion;regulation of JNK cascade;protein autophosphorylation;ephrin receptor signaling pathway;camera-type eye morphogenesis;modulation of chemical synaptic transmission;detection of temperature stimulus involved in sensory perception of pain;positive regulation of synapse assembly;cell chemotaxis;dendritic spine development;dendritic spine morphogenesis;neural precursor cell proliferation;regulation of ERK1 and ERK2 cascade;negative regulation of skeletal muscle satellite cell proliferation;negative regulation of satellite cell differentiation	GO:0001525;GO:0001771;GO:0006468;GO:0007411;GO:0014719;GO:0021631;GO:0021934;GO:0021952;GO:0022008;GO:0030010;GO:0031290;GO:0031589;GO:0046328;GO:0046777;GO:0048013;GO:0048593;GO:0050804;GO:0050965;GO:0051965;GO:0060326;GO:0060996;GO:0060997;GO:0061351;GO:0070372;GO:1902723;GO:1902725	extracellular region;endoplasmic reticulum;cytosol;plasma membrane;axon;dendrite;early endosome membrane;filopodium tip;membrane raft;extracellular exosome;glutamatergic synapse	GO:0005576;GO:0005783;GO:0005829;GO:0005886;GO:0030424;GO:0030425;GO:0031901;GO:0032433;GO:0045121;GO:0070062;GO:0098978	transmembrane-ephrin receptor activity;protein binding;ATP binding;axon guidance receptor activity;protein-containing complex binding	GO:0005005;GO:0005515;GO:0005524;GO:0008046;GO:0044877	2.0	ccd4f708-5521-11e7-8f50-0ac135e8bacf,ce49e3cc-5521-11e7-8f50-0ac135e8bacf	Ephrin B reverse signaling,EPHB forward signaling											
chr4:55151444:A/G	PDGFRA intron_variant		4.0	0.0022675736961451			chr4	55151444	A	G	3			PDGFRA	ENST00000257290.10	intron_variant		c.2324-94A>G		54285277																									luteinization;in utero embryonic development;cell activation;hematopoietic progenitor cell differentiation;cell surface receptor protein tyrosine kinase signaling pathway;multicellular organism development;estrogen metabolic process;positive regulation of cell population proliferation;negative regulation of platelet activation;positive regulation of phospholipase C activity;peptidyl-tyrosine phosphorylation;signal transduction involved in regulation of gene expression;extracellular matrix organization;lung development;adrenal gland development;positive regulation of cell migration;male genitalia development;regulation of actin cytoskeleton organization;Leydig cell differentiation;positive regulation of kinase activity;cellular response to reactive oxygen species;platelet-derived growth factor receptor-alpha signaling pathway;positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway;wound healing;odontogenesis of dentin-containing tooth;protein autophosphorylation;platelet-derived growth factor receptor signaling pathway;positive regulation of fibroblast proliferation;embryonic digestive tract morphogenesis;embryonic cranial skeleton morphogenesis;embryonic skeletal system morphogenesis;positive regulation of calcium-mediated signaling;white fat cell differentiation;positive regulation of chemotaxis;positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction;cardiac myofibril assembly;roof of mouth development;face morphogenesis;cell chemotaxis;retina vasculature development in camera-type eye;positive regulation of ERK1 and ERK2 cascade;platelet aggregation;cellular response to amino acid stimulus;metanephric glomerular capillary formation;regulation of mesenchymal stem cell differentiation	GO:0001553;GO:0001701;GO:0001775;GO:0002244;GO:0007169;GO:0007275;GO:0008210;GO:0008284;GO:0010544;GO:0010863;GO:0018108;GO:0023019;GO:0030198;GO:0030324;GO:0030325;GO:0030335;GO:0030539;GO:0032956;GO:0033327;GO:0033674;GO:0034614;GO:0035790;GO:0038091;GO:0042060;GO:0042475;GO:0046777;GO:0048008;GO:0048146;GO:0048557;GO:0048701;GO:0048704;GO:0050850;GO:0050872;GO:0050921;GO:0051897;GO:0055003;GO:0060021;GO:0060325;GO:0060326;GO:0061298;GO:0070374;GO:0070527;GO:0071230;GO:0072277;GO:2000739	nucleus;nucleoplasm;cytoplasm;endoplasmic reticulum membrane;Golgi apparatus;plasma membrane;microvillus;cilium;external side of plasma membrane;membrane;cell junction;protein-containing complex;receptor complex	GO:0005634;GO:0005654;GO:0005737;GO:0005789;GO:0005794;GO:0005886;GO:0005902;GO:0005929;GO:0009897;GO:0016020;GO:0030054;GO:0032991;GO:0043235	protein kinase activity;transmembrane receptor protein tyrosine kinase activity;platelet-derived growth factor alpha-receptor activity;vascular endothelial growth factor receptor activity;platelet-derived growth factor receptor binding;protein binding;ATP binding;vascular endothelial growth factor binding;protein homodimerization activity;protein-containing complex binding;platelet-derived growth factor binding	GO:0004672;GO:0004714;GO:0005018;GO:0005021;GO:0005161;GO:0005515;GO:0005524;GO:0038085;GO:0042803;GO:0044877;GO:0048407	3.0	7cceab48-5521-11e7-8f50-0ac135e8bacf,7d53b9ca-5521-11e7-8f50-0ac135e8bacf,fa553886-5521-11e7-8f50-0ac135e8bacf	PDGFR-alpha signaling pathway,PDGF receptor signaling network,ATF-2 transcription factor network											
chr19:1220410:A/G	STK11 p.His168Arg		3.0	0.0022034907744477			chr19	1220410	A	G	3		Yes	STK11	ENST00000326873.12	missense_variant	4.0	c.503A>G	p.His168Arg	1220411							0.0	0.106					COSV58820092	"[[""lung"", 1]]"	1.0	ENST00000586243.5	H168R	Exact Match							regulation of cell growth;tissue homeostasis;vasculature development;protein phosphorylation;protein dephosphorylation;autophagy;DNA damage response;signal transduction;spermatogenesis;axonogenesis;negative regulation of cell population proliferation;response to ionizing radiation;positive regulation of autophagy;response to activity;peptidyl-threonine phosphorylation;establishment of cell polarity;regulation of Wnt signaling pathway;negative regulation of cell growth;positive regulation of transforming growth factor beta receptor signaling pathway;activation of protein kinase activity;response to glucagon;response to lipid;protein localization to nucleus;glucose homeostasis;anoikis;positive thymic T cell selection;positive regulation of gluconeogenesis;protein autophosphorylation;regulation of dendrite morphogenesis;positive regulation of axonogenesis;T cell receptor signaling pathway;Golgi localization;regulation of cell cycle;regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction;epithelial cell proliferation involved in prostate gland development;negative regulation of epithelial cell proliferation involved in prostate gland development;G1 to G0 transition;cellular response to UV-B;intrinsic apoptotic signaling pathway by p53 class mediator;negative regulation of canonical Wnt signaling pathway;response to thyroid hormone;dendrite extension;negative regulation of cold-induced thermogenesis;positive regulation of protein localization to nucleus;positive regulation of vesicle transport along microtubule;regulation of signal transduction by p53 class mediator;negative regulation of TORC1 signaling	GO:0001558;GO:0001894;GO:0001944;GO:0006468;GO:0006470;GO:0006914;GO:0006974;GO:0007165;GO:0007283;GO:0007409;GO:0008285;GO:0010212;GO:0010508;GO:0014823;GO:0018107;GO:0030010;GO:0030111;GO:0030308;GO:0030511;GO:0032147;GO:0033762;GO:0033993;GO:0034504;GO:0042593;GO:0043276;GO:0045059;GO:0045722;GO:0046777;GO:0048814;GO:0050772;GO:0050852;GO:0051645;GO:0051726;GO:0051896;GO:0060767;GO:0060770;GO:0070314;GO:0071493;GO:0072332;GO:0090090;GO:0097066;GO:0097484;GO:0120163;GO:1900182;GO:1901610;GO:1901796;GO:1904262	nucleus;nucleoplasm;cytoplasm;mitochondrion;cytosol;membrane;Z disc;extracellular exosome;intracellular protein-containing complex;serine/threonine protein kinase complex	GO:0005634;GO:0005654;GO:0005737;GO:0005739;GO:0005829;GO:0016020;GO:0030018;GO:0070062;GO:0140535;GO:1902554	magnesium ion binding;p53 binding;protein serine/threonine kinase activity;protein binding;ATP binding;LRR domain binding;protein kinase activator activity;protein-containing complex binding;protein serine kinase activity	GO:0000287;GO:0002039;GO:0004674;GO:0005515;GO:0005524;GO:0030275;GO:0030295;GO:0044877;GO:0106310	1.0	945aa686-5521-11e7-8f50-0ac135e8bacf	LKB1 signaling events											
chr5:98191964:A/G	CHD1 3_prime_UTR_variant						chr5	98191964	A	G	3			CHD1	ENST00000614616.4	3_prime_UTR_variant	36.0	c.*120T>C		98856260																									chromatin remodeling;nucleosome organization;positive regulation by host of viral transcription	GO:0006338;GO:0034728;GO:0043923	nuclear chromosome;chromatin;nucleus;nucleoplasm;cytoplasm	GO:0000228;GO:0000785;GO:0005634;GO:0005654;GO:0005737	DNA binding;chromatin binding;helicase activity;protein binding;ATP binding;ATP hydrolysis activity;methylated histone binding;histone binding;ATP-dependent chromatin remodeler activity	GO:0003677;GO:0003682;GO:0004386;GO:0005515;GO:0005524;GO:0016887;GO:0035064;GO:0042393;GO:0140658														
chr2:203384878:T/C	BMPR2 p.Ser307=		2.0	0.0016332244517032			chr2	203384878	T	C	3		Yes	BMPR2	ENST00000374580.10	synonymous_variant	7.0	c.921T>C	p.Ser307=	202520155																									blood vessel development;osteoblast differentiation;mesoderm formation;maternal placenta development;endothelial cell proliferation;lymphangiogenesis;blood vessel remodeling;chondrocyte development;negative regulation of systemic arterial blood pressure;outflow tract septum morphogenesis;outflow tract morphogenesis;aortic valve development;pulmonary valve development;atrioventricular valve morphogenesis;mitral valve morphogenesis;tricuspid valve morphogenesis;endocardial cushion development;negative regulation of cell proliferation involved in heart valve morphogenesis;protein phosphorylation;cell surface receptor protein serine/threonine kinase signaling pathway;cellular response to starvation;anterior/posterior pattern specification;positive regulation of gene expression;positive regulation of epithelial cell migration;regulation of lung blood pressure;proteoglycan biosynthetic process;negative regulation of cell growth;positive regulation of bone mineralization;BMP signaling pathway;activin receptor signaling pathway;regulation of cell population proliferation;positive regulation of osteoblast differentiation;positive regulation of ossification;negative regulation of vasoconstriction;positive regulation of transcription by RNA polymerase II;lung alveolus development;negative regulation of smooth muscle cell proliferation;cardiac muscle tissue development;positive regulation of axon extension involved in axon guidance;negative regulation of muscle cell differentiation;limb development;endochondral bone morphogenesis;positive regulation of SMAD protein signal transduction;ventricular septum morphogenesis;atrial septum morphogenesis;lung vasculature development;lymphatic endothelial cell differentiation;artery development;venous blood vessel development;positive regulation of cartilage development;retina vasculature development in camera-type eye;pharyngeal arch artery morphogenesis;cellular response to growth factor stimulus;cellular response to BMP stimulus;endothelial cell apoptotic process;negative regulation of chondrocyte proliferation;semi-lunar valve development	GO:0001568;GO:0001649;GO:0001707;GO:0001893;GO:0001935;GO:0001946;GO:0001974;GO:0002063;GO:0003085;GO:0003148;GO:0003151;GO:0003176;GO:0003177;GO:0003181;GO:0003183;GO:0003186;GO:0003197;GO:0003252;GO:0006468;GO:0007178;GO:0009267;GO:0009952;GO:0010628;GO:0010634;GO:0014916;GO:0030166;GO:0030308;GO:0030501;GO:0030509;GO:0032924;GO:0042127;GO:0045669;GO:0045778;GO:0045906;GO:0045944;GO:0048286;GO:0048662;GO:0048738;GO:0048842;GO:0051148;GO:0060173;GO:0060350;GO:0060391;GO:0060412;GO:0060413;GO:0060426;GO:0060836;GO:0060840;GO:0060841;GO:0061036;GO:0061298;GO:0061626;GO:0071363;GO:0071773;GO:0072577;GO:1902731;GO:1905314	extracellular space;nucleoplasm;plasma membrane;caveola;clathrin-coated pit;adherens junction;basal plasma membrane;cell surface;postsynaptic density;apical plasma membrane;axon;dendrite;neuronal cell body;receptor complex	GO:0005615;GO:0005654;GO:0005886;GO:0005901;GO:0005905;GO:0005912;GO:0009925;GO:0009986;GO:0014069;GO:0016324;GO:0030424;GO:0030425;GO:0043025;GO:0043235	transforming growth factor beta receptor activity;protein binding;ATP binding;activin receptor activity, type II;growth factor binding;BMP binding;cadherin binding;metal ion binding;BMP receptor activity;protein tyrosine kinase binding	GO:0005024;GO:0005515;GO:0005524;GO:0016362;GO:0019838;GO:0036122;GO:0045296;GO:0046872;GO:0098821;GO:1990782	3.0	049349a0-5522-11e7-8f50-0ac135e8bacf,05263ad2-5522-11e7-8f50-0ac135e8bacf,f1ae1a1c-5521-11e7-8f50-0ac135e8bacf	ALK2 signaling events,ALK1 signaling events,BMP receptor signaling											
chr19:5220019:A/G	PTPRS p.Asp1232=		8.0	0.0039279869067103			chr19	5220019	A	G	3		Yes	PTPRS	ENST00000587303.5	synonymous_variant	21.0	c.3696T>C	p.Asp1232=	5220008																									protein dephosphorylation;negative regulation of neuron projection development;spinal cord development;cerebellum development;hippocampus development;cerebral cortex development;corpus callosum development;negative regulation of axon extension;negative regulation of interferon-alpha production;negative regulation of interferon-beta production;negative regulation of toll-like receptor 9 signaling pathway;peptidyl-tyrosine dephosphorylation;negative regulation of collateral sprouting;negative regulation of axon regeneration;modulation of chemical synaptic transmission;negative regulation of dendritic spine development;establishment of endothelial intestinal barrier;regulation of postsynaptic density assembly;trans-synaptic signaling;synaptic membrane adhesion	GO:0006470;GO:0010977;GO:0021510;GO:0021549;GO:0021766;GO:0021987;GO:0022038;GO:0030517;GO:0032687;GO:0032688;GO:0034164;GO:0035335;GO:0048671;GO:0048681;GO:0050804;GO:0061000;GO:0090557;GO:0099151;GO:0099537;GO:0099560	cytosol;plasma membrane;axon;growth cone;synaptic vesicle membrane;presynaptic membrane;perikaryon;extracellular exosome;Schaffer collateral - CA1 synapse;postsynaptic density membrane;glutamatergic synapse	GO:0005829;GO:0005886;GO:0030424;GO:0030426;GO:0030672;GO:0042734;GO:0043204;GO:0070062;GO:0098685;GO:0098839;GO:0098978	phosphoprotein phosphatase activity;protein tyrosine phosphatase activity;protein binding;heparin binding;chondroitin sulfate binding;heparan sulfate proteoglycan binding	GO:0004721;GO:0004725;GO:0005515;GO:0008201;GO:0035374;GO:0043395														
chr6:7230607:G/A	RREB1 p.Gly759Ser		1.0	0.5006335797254488			chr6	7230607	G	A	3		Yes	RREB1	ENST00000379938.7	missense_variant	10.0	c.2275G>A	p.Gly759Ser	7230374							0.333	0.0299					COSV58553632	"[[""large intestine"", 1]]"	1.0	ENST00000379938.6	G759S	Exact Match							negative regulation of transcription by RNA polymerase II;regulation of DNA-templated transcription;regulation of transcription by RNA polymerase II;transcription by RNA polymerase II;positive regulation of epithelial cell migration;positive regulation of mammary gland epithelial cell proliferation;positive regulation of DNA-templated transcription;positive regulation of transcription by RNA polymerase II;positive regulation of brown fat cell differentiation;positive regulation of substrate adhesion-dependent cell spreading;positive regulation of wound healing, spreading of epidermal cells;positive regulation of lamellipodium morphogenesis	GO:0000122;GO:0006355;GO:0006357;GO:0006366;GO:0010634;GO:0033601;GO:0045893;GO:0045944;GO:0090336;GO:1900026;GO:1903691;GO:2000394	fibrillar center;nucleus;cytoplasm;nuclear body;nuclear speck;extracellular exosome	GO:0001650;GO:0005634;GO:0005737;GO:0016604;GO:0016607;GO:0070062	RNA polymerase II transcription regulatory region sequence-specific DNA binding;RNA polymerase II cis-regulatory region sequence-specific DNA binding;DNA-binding transcription activator activity, RNA polymerase II-specific;metal ion binding	GO:0000977;GO:0000978;GO:0001228;GO:0046872				rs1462133464										
chr19:11121184:A/G	SMARCA4 p.Asn751Asp		3.0	0.0012379589314885			chr19	11121184	A	G	3		Yes	SMARCA4	ENST00000344626.9	missense_variant	15.0	c.2251A>G	p.Asn751Asp	11010508							0.00131	0.0276											Uncertain significance	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Hereditary cancer-predisposing syndrome	criteria provided, single submitter	1788435.0		negative regulation of transcription by RNA polymerase II;RNA polymerase I preinitiation complex assembly;neural retina development;nucleosome disassembly;chromatin remodeling;regulation of transcription by RNA polymerase II;nervous system development;positive regulation of cell population proliferation;regulation of mitotic metaphase/anaphase transition;positive regulation of Wnt signaling pathway;negative regulation of cell growth;positive regulation by host of viral transcription;positive regulation of T cell differentiation;negative regulation of cell differentiation;positive regulation of cell differentiation;positive regulation of myoblast differentiation;transcription initiation-coupled chromatin remodeling;negative regulation of DNA-templated transcription;positive regulation of DNA-templated transcription;positive regulation of transcription by RNA polymerase II;positive regulation of DNA-binding transcription factor activity;negative regulation of androgen receptor signaling pathway;regulation of G0 to G1 transition;positive regulation of cold-induced thermogenesis;positive regulation of transcription of nucleolar large rRNA by RNA polymerase I;positive regulation of stem cell population maintenance;positive regulation of glucose mediated signaling pathway;positive regulation of miRNA transcription;regulation of G1/S transition of mitotic cell cycle;positive regulation of double-strand break repair;regulation of nucleotide-excision repair	GO:0000122;GO:0001188;GO:0003407;GO:0006337;GO:0006338;GO:0006357;GO:0007399;GO:0008284;GO:0030071;GO:0030177;GO:0030308;GO:0043923;GO:0045582;GO:0045596;GO:0045597;GO:0045663;GO:0045815;GO:0045892;GO:0045893;GO:0045944;GO:0051091;GO:0060766;GO:0070316;GO:0120162;GO:1901838;GO:1902459;GO:1902661;GO:1902895;GO:2000045;GO:2000781;GO:2000819	kinetochore;chromatin;fibrillar center;extracellular space;nucleus;nucleoplasm;nucleolus;membrane;nuclear matrix;SWI/SNF complex;RSC-type complex;protein-containing complex;npBAF complex;nBAF complex;bBAF complex;GBAF complex	GO:0000776;GO:0000785;GO:0001650;GO:0005615;GO:0005634;GO:0005654;GO:0005730;GO:0016020;GO:0016363;GO:0016514;GO:0016586;GO:0032991;GO:0071564;GO:0071565;GO:0140092;GO:0140288	RNA polymerase I core promoter sequence-specific DNA binding;transcription coregulator binding;p53 binding;DNA binding;transcription coactivator activity;transcription corepressor activity;RNA binding;helicase activity;protein binding;ATP binding;ATP-dependent activity, acting on DNA;transcription factor binding;hydrolase activity;Tat protein binding;nucleosomal DNA binding;nuclear androgen receptor binding;DNA polymerase binding;lysine-acetylated histone binding;ATP-dependent chromatin remodeler activity	GO:0001164;GO:0001221;GO:0002039;GO:0003677;GO:0003713;GO:0003714;GO:0003723;GO:0004386;GO:0005515;GO:0005524;GO:0008094;GO:0008134;GO:0016787;GO:0030957;GO:0031492;GO:0050681;GO:0070182;GO:0070577;GO:0140658	5.0	3a1b0394-5521-11e7-8f50-0ac135e8bacf,6309aefe-5521-11e7-8f50-0ac135e8bacf,6aae5178-5521-11e7-8f50-0ac135e8bacf,bb3d7c4a-5521-11e7-8f50-0ac135e8bacf,dce0a1a4-5521-11e7-8f50-0ac135e8bacf	Validated nuclear estrogen receptor beta network,Regulation of retinoblastoma protein,Regulation of nuclear beta catenin signaling and target gene transcription,Glucocorticoid receptor regulatory network,Direct p53 effectors											
chr6:35425760:A/G	FANCE p.Gln323Arg		5.0	0.0025836073931309			chr6	35425760	A	G	3		Yes	FANCE	ENST00000229769.3	missense_variant	4.0	c.968A>G	p.Gln323Arg	35457983							0.145	0.33											Uncertain significance	MONDO:MONDO:0010953,MedGen:C3160739,OMIM:600901,Orphanet:84	Fanconi anemia complementation group E	criteria provided, single submitter	639143.0		interstrand cross-link repair	GO:0036297	chromatin;nucleus;nucleoplasm;chromosome;centrosome;cytosol;Fanconi anaemia nuclear complex	GO:0000785;GO:0005634;GO:0005654;GO:0005694;GO:0005813;GO:0005829;GO:0043240	molecular_function	GO:0003674	2.0	c45e106a-5521-11e7-8f50-0ac135e8bacf,f6898a78-5521-11e7-8f50-0ac135e8bacf	Fanconi anemia pathway,BARD1 signaling events	rs1034716031										
chr7:151962100:T/C	KMT2C intron_variant		2.0	0.0022675736961451			chr7	151962100	T	C	3			KMT2C	ENST00000262189.11	intron_variant		c.1184+23A>G		152265015																									chromatin remodeling;methylation;positive regulation of transcription by RNA polymerase II;response to electrical stimulus	GO:0006338;GO:0032259;GO:0045944;GO:0051602	nucleus;nucleoplasm;cytosol;histone methyltransferase complex;MLL3/4 complex	GO:0005634;GO:0005654;GO:0005829;GO:0035097;GO:0044666	DNA binding;transcription coactivator activity;RNA binding;protein binding;acyltransferase activity;histone methyltransferase activity;histone H3K4 methyltransferase activity;metal ion binding;histone H3K4 monomethyltransferase activity;histone H3K4 trimethyltransferase activity	GO:0003677;GO:0003713;GO:0003723;GO:0005515;GO:0016746;GO:0042054;GO:0042800;GO:0046872;GO:0140945;GO:0140999														
chr19:36229183:G/A	KMT2B p.Gly2625Ser						chr19	36229183	G	A	3		Yes	KMT2B	ENST00000420124.3	missense_variant	37.0	c.7873G>A	p.Gly2625Ser	35738282							0.00376	0.0768																	chromatin remodeling;methylation;positive regulation of DNA-templated transcription	GO:0006338;GO:0032259;GO:0045893	nucleus;nucleoplasm;histone methyltransferase complex;MLL1/2 complex	GO:0005634;GO:0005654;GO:0035097;GO:0044665	protein binding;zinc ion binding;histone H3K4 methyltransferase activity;unmethylated CpG binding;histone H3K4 monomethyltransferase activity;histone H3K4 trimethyltransferase activity	GO:0005515;GO:0008270;GO:0042800;GO:0045322;GO:0140945;GO:0140999				rs778555952										
chr17:7572847:A/G	TP53 3_prime_UTR_variant		3.0	0.0024909020089876			chr17	7572847	A	G	3			TP53	ENST00000269305.8	3_prime_UTR_variant	11.0	c.*80T>C		7669529																									negative regulation of transcription by RNA polymerase II;mitophagy;in utero embryonic development;somitogenesis;release of cytochrome c from mitochondria;hematopoietic progenitor cell differentiation;T cell proliferation involved in immune response;B cell lineage commitment;T cell lineage commitment;response to ischemia;nucleotide-excision repair;double-strand break repair;regulation of DNA-templated transcription;regulation of transcription by RNA polymerase II;protein import into nucleus;autophagy;DNA damage response;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;ER overload response;transforming growth factor beta receptor signaling pathway;Ras protein signal transduction;gastrulation;neuroblast proliferation;negative regulation of neuroblast proliferation;protein localization;negative regulation of DNA replication;negative regulation of cell population proliferation;determination of adult lifespan;mRNA transcription;rRNA transcription;response to salt stress;response to inorganic substance;response to X-ray;response to gamma radiation;positive regulation of gene expression;cardiac muscle cell apoptotic process;positive regulation of cardiac muscle cell apoptotic process;glial cell proliferation;viral process;glucose catabolic process to lactate via pyruvate;cerebellum development;negative regulation of cell growth;DNA damage response, signal transduction by p53 class mediator;negative regulation of transforming growth factor beta receptor signaling pathway;mitotic G1 DNA damage checkpoint signaling;negative regulation of telomere maintenance via telomerase;T cell differentiation in thymus;tumor necrosis factor-mediated signaling pathway;regulation of tissue remodeling;cellular response to UV;multicellular organism growth;positive regulation of mitochondrial membrane permeability;cellular response to glucose starvation;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;regulation of apoptotic process;positive regulation of apoptotic process;negative regulation of apoptotic process;entrainment of circadian clock by photoperiod;mitochondrial DNA repair;regulation of DNA damage response, signal transduction by p53 class mediator;positive regulation of neuron apoptotic process;transcription initiation-coupled chromatin remodeling;negative regulation of proteolysis;negative regulation of DNA-templated transcription;positive regulation of DNA-templated transcription;positive regulation of RNA polymerase II transcription preinitiation complex assembly;positive regulation of transcription by RNA polymerase II;response to antibiotic;fibroblast proliferation;negative regulation of fibroblast proliferation;circadian behavior;bone marrow development;embryonic organ development;positive regulation of peptidyl-tyrosine phosphorylation;protein stabilization;negative regulation of helicase activity;protein tetramerization;chromosome organization;neuron apoptotic process;regulation of cell cycle;hematopoietic stem cell differentiation;negative regulation of glial cell proliferation;type II interferon-mediated signaling pathway;cardiac septum morphogenesis;positive regulation of programmed necrotic cell death;protein-containing complex assembly;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;thymocyte apoptotic process;positive regulation of thymocyte apoptotic process;necroptotic process;cellular response to hypoxia;cellular response to xenobiotic stimulus;cellular response to ionizing radiation;cellular response to gamma radiation;cellular response to UV-C;stem cell proliferation;signal transduction by p53 class mediator;intrinsic apoptotic signaling pathway by p53 class mediator;reactive oxygen species metabolic process;cellular response to actinomycin D;positive regulation of release of cytochrome c from mitochondria;cellular senescence;replicative senescence;oxidative stress-induced premature senescence;intrinsic apoptotic signaling pathway;oligodendrocyte apoptotic process;positive regulation of execution phase of apoptosis;negative regulation of mitophagy;regulation of mitochondrial membrane permeability involved in apoptotic process;regulation of intrinsic apoptotic signaling pathway by p53 class mediator;regulation of cell cycle G2/M phase transition;positive regulation of miRNA transcription;negative regulation of G1 to G0 transition;negative regulation of miRNA processing;negative regulation of glucose catabolic process to lactate via pyruvate;negative regulation of pentose-phosphate shunt;intrinsic apoptotic signaling pathway in response to hypoxia;regulation of fibroblast apoptotic process;negative regulation of reactive oxygen species metabolic process;positive regulation of reactive oxygen species metabolic process;negative regulation of stem cell proliferation;positive regulation of cellular senescence;positive regulation of intrinsic apoptotic signaling pathway	GO:0000122;GO:0000423;GO:0001701;GO:0001756;GO:0001836;GO:0002244;GO:0002309;GO:0002326;GO:0002360;GO:0002931;GO:0006289;GO:0006302;GO:0006355;GO:0006357;GO:0006606;GO:0006914;GO:0006974;GO:0006977;GO:0006978;GO:0006983;GO:0007179;GO:0007265;GO:0007369;GO:0007405;GO:0007406;GO:0008104;GO:0008156;GO:0008285;GO:0008340;GO:0009299;GO:0009303;GO:0009651;GO:0010035;GO:0010165;GO:0010332;GO:0010628;GO:0010659;GO:0010666;GO:0014009;GO:0016032;GO:0019661;GO:0021549;GO:0030308;GO:0030330;GO:0030512;GO:0031571;GO:0032211;GO:0033077;GO:0033209;GO:0034103;GO:0034644;GO:0035264;GO:0035794;GO:0042149;GO:0042771;GO:0042981;GO:0043065;GO:0043066;GO:0043153;GO:0043504;GO:0043516;GO:0043525;GO:0045815;GO:0045861;GO:0045892;GO:0045893;GO:0045899;GO:0045944;GO:0046677;GO:0048144;GO:0048147;GO:0048512;GO:0048539;GO:0048568;GO:0050731;GO:0050821;GO:0051097;GO:0051262;GO:0051276;GO:0051402;GO:0051726;GO:0060218;GO:0060253;GO:0060333;GO:0060411;GO:0062100;GO:0065003;GO:0070059;GO:0070242;GO:0070245;GO:0070266;GO:0071456;GO:0071466;GO:0071479;GO:0071480;GO:0071494;GO:0072089;GO:0072331;GO:0072332;GO:0072593;GO:0072717;GO:0090200;GO:0090398;GO:0090399;GO:0090403;GO:0097193;GO:0097252;GO:1900119;GO:1901525;GO:1902108;GO:1902253;GO:1902749;GO:1902895;GO:1903451;GO:1903799;GO:1904024;GO:1905856;GO:1990144;GO:2000269;GO:2000378;GO:2000379;GO:2000647;GO:2000774;GO:2001244	chromatin;nucleus;nucleoplasm;replication fork;transcription regulator complex;nucleolus;cytoplasm;mitochondrion;mitochondrial matrix;endoplasmic reticulum;centrosome;cytosol;nuclear matrix;nuclear body;PML body;transcription repressor complex;protein-containing complex;site of double-strand break;germ cell nucleus	GO:0000785;GO:0005634;GO:0005654;GO:0005657;GO:0005667;GO:0005730;GO:0005737;GO:0005739;GO:0005759;GO:0005783;GO:0005813;GO:0005829;GO:0016363;GO:0016604;GO:0016605;GO:0017053;GO:0032991;GO:0035861;GO:0043073	transcription cis-regulatory region binding;RNA polymerase II cis-regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;cis-regulatory region sequence-specific DNA binding;core promoter sequence-specific DNA binding;TFIID-class transcription factor complex binding;DNA-binding transcription repressor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;protease binding;p53 binding;DNA binding;chromatin binding;DNA-binding transcription factor activity;mRNA 3'-UTR binding;copper ion binding;protein binding;zinc ion binding;enzyme binding;receptor tyrosine kinase binding;ubiquitin protein ligase binding;histone deacetylase regulator activity;ATP-dependent DNA/DNA annealing activity;identical protein binding;histone deacetylase binding;protein heterodimerization activity;protein-folding chaperone binding;protein phosphatase 2A binding;RNA polymerase II-specific DNA-binding transcription factor binding;14-3-3 protein binding;MDM2/MDM4 family protein binding;disordered domain specific binding;general transcription initiation factor binding;molecular function activator activity;promoter-specific chromatin binding	GO:0000976;GO:0000978;GO:0000981;GO:0000987;GO:0001046;GO:0001094;GO:0001227;GO:0001228;GO:0002020;GO:0002039;GO:0003677;GO:0003682;GO:0003700;GO:0003730;GO:0005507;GO:0005515;GO:0008270;GO:0019899;GO:0030971;GO:0031625;GO:0035033;GO:0036310;GO:0042802;GO:0042826;GO:0046982;GO:0051087;GO:0051721;GO:0061629;GO:0071889;GO:0097371;GO:0097718;GO:0140296;GO:0140677;GO:1990841	13.0	3814fa62-5521-11e7-8f50-0ac135e8bacf,4b62628c-5521-11e7-8f50-0ac135e8bacf,538cfdee-5521-11e7-8f50-0ac135e8bacf,76f15b4e-5521-11e7-8f50-0ac135e8bacf,7f189a50-5521-11e7-8f50-0ac135e8bacf,81be3ee4-5521-11e7-8f50-0ac135e8bacf,945aa686-5521-11e7-8f50-0ac135e8bacf,b1ac7318-5521-11e7-8f50-0ac135e8bacf,bb3d7c4a-5521-11e7-8f50-0ac135e8bacf,dce0a1a4-5521-11e7-8f50-0ac135e8bacf,f6898a78-5521-11e7-8f50-0ac135e8bacf,f823645e-5521-11e7-8f50-0ac135e8bacf,fd2c9b80-5521-11e7-8f50-0ac135e8bacf	Validated targets of C-MYC transcriptional activation,Signaling mediated by p38-alpha and p38-beta,Signaling events mediated by HDAC Class III,PLK3 signaling events,p75(NTR)-mediated signaling,p53 pathway,LKB1 signaling events,Hypoxic and oxygen homeostasis regulation of HIF-1-alpha,Glucocorticoid receptor regulatory network,Direct p53 effectors,BARD1 signaling events,Aurora A signaling,AP-1 transcription factor network											
chr20:39801259:T/C	PLCG1 p.Leu1035Pro		1.0	0.5006335797254488			chr20	39801259	T	C	3		Yes	PLCG1	ENST00000244007.7	missense_variant	27.0	c.3104T>C	p.Leu1035Pro	41172619							0.00444	0.197																	in utero embryonic development;negative regulation of inflammatory response to antigenic stimulus;epidermal growth factor receptor signaling pathway;phospholipid catabolic process;positive regulation of epithelial cell migration;cell migration;calcium-mediated signaling;Fc-epsilon receptor signaling pathway;positive regulation of blood vessel endothelial cell migration;positive regulation of angiogenesis;phosphatidylinositol metabolic process;phosphatidylinositol-mediated signaling;modulation of chemical synaptic transmission;T cell receptor signaling pathway;release of sequestered calcium ion into cytosol;positive regulation of release of sequestered calcium ion into cytosol;cellular response to epidermal growth factor stimulus;positive regulation of vascular endothelial cell proliferation;positive regulation of endothelial cell apoptotic process	GO:0001701;GO:0002862;GO:0007173;GO:0009395;GO:0010634;GO:0016477;GO:0019722;GO:0038095;GO:0043536;GO:0045766;GO:0046488;GO:0048015;GO:0050804;GO:0050852;GO:0051209;GO:0051281;GO:0071364;GO:1905564;GO:2000353	ruffle;cytoplasm;cytosol;plasma membrane;cell-cell junction;COP9 signalosome;lamellipodium;ruffle membrane;cell projection;Schaffer collateral - CA1 synapse;glutamatergic synapse	GO:0001726;GO:0005737;GO:0005829;GO:0005886;GO:0005911;GO:0008180;GO:0030027;GO:0032587;GO:0042995;GO:0098685;GO:0098978	phosphatidylinositol phospholipase C activity;phospholipase C activity;guanyl-nucleotide exchange factor activity;neurotrophin TRKA receptor binding;calcium ion binding;protein binding;protein kinase binding;receptor tyrosine kinase binding;glutamate receptor binding;calcium-dependent phospholipase C activity	GO:0004435;GO:0004629;GO:0005085;GO:0005168;GO:0005509;GO:0005515;GO:0019901;GO:0030971;GO:0035254;GO:0050429	25.0	29ff5368-5521-11e7-8f50-0ac135e8bacf,32ff1916-5521-11e7-8f50-0ac135e8bacf,3c88330c-5521-11e7-8f50-0ac135e8bacf,412efed6-5521-11e7-8f50-0ac135e8bacf,4362cec8-5521-11e7-8f50-0ac135e8bacf,4c90f780-5521-11e7-8f50-0ac135e8bacf,5189b3dc-5521-11e7-8f50-0ac135e8bacf,55522d94-5521-11e7-8f50-0ac135e8bacf,5a09c23a-5521-11e7-8f50-0ac135e8bacf,5be67180-5521-11e7-8f50-0ac135e8bacf,6d5dba0c-5521-11e7-8f50-0ac135e8bacf,7ac7dec6-5521-11e7-8f50-0ac135e8bacf,7cceab48-5521-11e7-8f50-0ac135e8bacf,854f7c00-5521-11e7-8f50-0ac135e8bacf,898a6694-5521-11e7-8f50-0ac135e8bacf,8ba07556-5521-11e7-8f50-0ac135e8bacf,8daf7f38-5521-11e7-8f50-0ac135e8bacf,8ed3dafe-5521-11e7-8f50-0ac135e8bacf,924f9444-5521-11e7-8f50-0ac135e8bacf,bf958bd4-5521-11e7-8f50-0ac135e8bacf,c02fa8f6-5521-11e7-8f50-0ac135e8bacf,cbc18b34-5521-11e7-8f50-0ac135e8bacf,d269a540-5521-11e7-8f50-0ac135e8bacf,d992af1e-5521-11e7-8f50-0ac135e8bacf,e4e93610-5521-11e7-8f50-0ac135e8bacf	EGF receptor (ErbB1) signaling pathway,VEGFR1 specific signals,Trk receptor signaling mediated by PI3K and PLC-gamma,TCR signaling in naive CD8 T cells,TCR signaling in naive CD4 T cells,Signaling events mediated by VEGFR1 and VEGFR2,Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met),Signaling events mediated by focal adhesion kinase,S1P4 pathway,S1P1 pathway,Regulation of CDC42 activity,PDGFR-beta signaling pathway,PDGFR-alpha signaling pathway,Nongenotropic Androgen signaling,Neurotrophic factor-mediated Trk receptor signaling,Netrin-mediated signaling events,NephrinNeph1 signaling in the kidney podocyte,N-cadherin signaling events,LPA receptor mediated events,FGF signaling pathway,Fc-epsilon receptor I signaling in mast cells,EPO signaling pathway,EPHA forward signaling,E-cadherin signaling in keratinocytes,Class I PI3K signaling events											
chr20:40733307:T/C	PTPRT p.Asn1170Asp		6.0	0.0022988505747126			chr20	40733307	T	C	3		Yes	PTPRT	ENST00000373193.7	missense_variant	26.0	c.3508A>G	p.Asn1170Asp	42104667							0.613	0.666																	protein dephosphorylation;cell adhesion;homophilic cell adhesion via plasma membrane adhesion molecules;signal transduction;cell surface receptor protein tyrosine kinase signaling pathway;negative regulation of cell migration;peptidyl-tyrosine dephosphorylation;regulation of synapse organization;cellular response to interleukin-6;negative regulation of receptor signaling pathway via STAT;peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity	GO:0006470;GO:0007155;GO:0007156;GO:0007165;GO:0007169;GO:0030336;GO:0035335;GO:0050807;GO:0071354;GO:1904893;GO:1990264	plasma membrane;cell surface;membrane;postsynaptic density membrane;glutamatergic synapse	GO:0005886;GO:0009986;GO:0016020;GO:0098839;GO:0098978	protein tyrosine phosphatase activity;transmembrane receptor protein tyrosine phosphatase activity;protein binding;beta-catenin binding;thiolester hydrolase activity;protein phosphatase binding;protein homodimerization activity;alpha-catenin binding;gamma-catenin binding;cadherin binding;alpha-actinin binding;delta-catenin binding;STAT family protein binding	GO:0004725;GO:0005001;GO:0005515;GO:0008013;GO:0016790;GO:0019903;GO:0042803;GO:0045294;GO:0045295;GO:0045296;GO:0051393;GO:0070097;GO:0097677				rs1299441440		6.97749e-06	0.0	0.0	0.0	0.0	0.0	1.54832e-05	0.0	0.0
chr10:68280462:A/G	CTNNA3 p.Tyr482His		3.0	0.0021646443156699			chr10	68280462	A	G	3		Yes	CTNNA3	ENST00000433211.7	missense_variant	11.0	c.1444T>C	p.Tyr482His	66520704							0.625	0.666											Uncertain significance	MONDO:MONDO:0000908,MedGen:C3810138,OMIM:615616	Arrhythmogenic right ventricular dysplasia 13	criteria provided, single submitter	2758389.0		cell migration;bundle of His cell-Purkinje myocyte adhesion involved in cell communication;regulation of heart rate by cardiac conduction;cell-cell adhesion;regulation of ventricular cardiac muscle cell action potential	GO:0016477;GO:0086073;GO:0086091;GO:0098609;GO:0098911	cytoplasm;cytoskeleton;adherens junction;fascia adherens;lamellipodium;desmosome	GO:0005737;GO:0005856;GO:0005912;GO:0005916;GO:0030027;GO:0030057	protein binding;beta-catenin binding;cadherin binding;actin filament binding	GO:0005515;GO:0008013;GO:0045296;GO:0051015														
chrX:70349887:A/G	MED12 p.Glu1290=						chrX	70349887	A	G	3		Yes	MED12	ENST00000374080.8	synonymous_variant	28.0	c.3870A>G	p.Glu1290=	71130037																									neural tube closure;endoderm development;heart development;oligodendrocyte development;Schwann cell development;protein ubiquitination;spinal cord development;somatic stem cell population maintenance;post-anal tail morphogenesis;positive regulation of DNA-templated transcription;positive regulation of transcription by RNA polymerase II;embryonic neurocranium morphogenesis;Wnt signaling pathway, planar cell polarity pathway;positive regulation of transcription initiation by RNA polymerase II;axis elongation involved in somitogenesis;embryonic brain development	GO:0001843;GO:0007492;GO:0007507;GO:0014003;GO:0014044;GO:0016567;GO:0021510;GO:0035019;GO:0036342;GO:0045893;GO:0045944;GO:0048702;GO:0060071;GO:0060261;GO:0090245;GO:1990403	ubiquitin ligase complex;nucleus;nucleoplasm;membrane;mediator complex;CKM complex	GO:0000151;GO:0005634;GO:0005654;GO:0016020;GO:0016592;GO:1990508	RNA polymerase II cis-regulatory region sequence-specific DNA binding;chromatin binding;transcription coregulator activity;transcription coactivator activity;protein binding;beta-catenin binding;transcription factor binding;nuclear receptor coactivator activity;nuclear vitamin D receptor binding;nuclear thyroid hormone receptor binding;ubiquitin protein ligase activity	GO:0000978;GO:0003682;GO:0003712;GO:0003713;GO:0005515;GO:0008013;GO:0008134;GO:0030374;GO:0042809;GO:0046966;GO:0061630	1.0	6aae5178-5521-11e7-8f50-0ac135e8bacf	Regulation of nuclear beta catenin signaling and target gene transcription											
